data_2m80_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m80 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.463 0.201 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.01 -36.2 17.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.69 0.281 . . . . 0.0 111.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -101.14 -33.35 10.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.205 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.9 -47.43 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.042 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.4 m -60.58 -45.46 93.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.85 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -62.59 -35.77 80.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.08 99.22 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.061 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.68 -41.5 95.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.08 -29.12 68.8 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.033 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.1 tpt -69.61 -46.58 65.95 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.139 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.4 pt -73.02 -15.0 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -61.4 -65.53 0.68 Allowed 'General case' 0 N--CA 1.458 -0.049 0 CA-C-O 120.71 0.291 . . . . 0.0 111.093 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.66 -22.81 25.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.227 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.63 68.12 14.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.764 0.316 . . . . 0.0 110.86 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.89 -30.96 20.83 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.628 2.218 . . . . 0.0 112.527 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.433 ' CE2' HG12 ' A' ' 86' ' ' VAL . 69.6 m-85 -90.84 68.0 6.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.59 139.79 42.88 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.379 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -124.38 115.42 20.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.48 96.24 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -111.81 174.77 5.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.129 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.79 -176.39 3.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -94.33 -38.72 10.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -151.72 72.37 1.02 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.51 148.15 60.5 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.62 -24.38 36.64 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.869 2.38 . . . . 0.0 112.888 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 94' ' ' GLU . 78.5 m-20 -88.73 -40.87 12.92 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.612 0.244 . . . . 0.0 110.669 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.51 -43.89 89.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.783 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.1 m -55.38 -32.36 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.5 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -70.16 -56.6 6.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.938 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.49 77.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.568 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -75.43 -31.81 60.48 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.893 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 t -64.76 -49.17 71.83 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.6 mm -65.13 -41.15 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -38.23 83.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.029 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -72.9 -30.19 63.74 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.346 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -32.55 34.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.944 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.3 mt -81.53 -8.09 59.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 t30 53.16 46.01 27.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.169 0.509 . . . . 0.0 110.696 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.98 43.45 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.68 18.42 10.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.647 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.32 -47.43 3.1 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.85 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -68.25 -23.65 64.81 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.336 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 25' ' ' TYR . 14.0 p -116.34 158.72 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -120.37 111.23 17.49 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.264 0.554 . . . . 0.0 110.372 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.37 132.4 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.96 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -126.71 131.69 51.31 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.69 142.74 27.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.671 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.8 pt -131.95 78.94 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.137 0.494 . . . . 0.0 111.394 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.78 -33.87 0.96 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.402 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.8 m -62.43 -37.17 84.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.073 0.436 . . . . 0.0 111.418 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 119.16 31.56 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.93 -174.73 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.133 2.555 . . . . 0.0 112.745 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -31.96 71.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.16 -48.51 78.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.553 0.216 . . . . 0.0 110.996 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.21 -33.95 65.65 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.217 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -57.07 -46.05 82.8 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.958 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -48.63 77.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.945 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.73 -48.6 79.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -62.46 -39.28 92.9 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.888 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -52.04 67.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.012 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.9 -40.53 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.07 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.1 -53.17 61.4 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.09 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.56 -36.17 77.83 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 1.9 mt-30 -61.19 -33.06 72.84 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.886 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -78.96 -28.85 43.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.196 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -76.61 -46.38 31.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.046 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.15 -44.65 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 113.13 49.12 0.58 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.441 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -130.37 103.45 6.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.794 0.331 . . . . 0.0 110.573 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -94.63 38.62 1.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -153.08 148.43 27.0 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mt -117.11 152.65 49.15 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.7 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 35' ' ' ASP . 84.3 Cg_endo -80.01 179.1 30.51 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.652 -1.395 . . . . 0.0 113.297 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.4 m -150.13 145.22 26.19 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.964 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.24 111.29 34.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -110.41 116.65 52.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.433 HG12 ' CE2' ' A' ' 25' ' ' TYR . 6.5 t -113.15 142.75 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 42.69 41.21 2.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.68 43.01 92.96 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.941 -0.572 . . . . 0.0 114.176 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 138.63 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 111.087 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -52.51 111.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.0 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.83 -22.08 11.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.775 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.16 148.31 19.11 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.157 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -119.37 175.79 5.65 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 110.749 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 3.0 tm-20 -61.86 -25.88 67.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.558 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.8 m -82.56 -36.37 26.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.497 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.403 ' HG2' ' CD2' ' A' ' 100' ' ' PHE . 4.9 tt0 -58.01 -32.36 67.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.501 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 -48.73 73.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.689 0.28 . . . . 0.0 110.724 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -74.27 -32.61 62.99 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.182 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.33 -38.66 85.25 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.345 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.403 ' CD2' ' HG2' ' A' ' 96' ' ' GLN . 5.6 m-85 -78.31 -44.05 26.3 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -58.5 -40.69 83.53 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.87 93.26 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.062 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -75.38 -28.96 59.69 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.37 23.15 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.4 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.6 p -122.96 19.63 10.06 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.93 -43.37 71.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.561 0.219 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.79 -51.19 69.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -40.03 86.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.78 -40.38 96.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.772 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 mt -66.34 -29.77 70.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.418 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 m -78.52 -30.26 47.0 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -59.56 -44.14 93.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.277 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 pt -67.01 -24.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.83 26.07 8.72 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.673 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tp -85.26 -46.15 11.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.843 0.321 . . . . 0.0 110.74 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.48 145.54 31.77 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.749 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 C--O 1.251 1.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.567 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.33 -35.87 29.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.211 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.7 -35.71 16.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.114 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -66.61 -49.03 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -65.64 -43.12 90.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.208 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -60.43 -37.35 80.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.566 0.222 . . . . 0.0 110.935 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.45 99.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.19 -40.31 77.14 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.82 -36.13 83.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.047 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.6 mmm -68.26 -45.64 72.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.308 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.7 pt -71.79 -14.58 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.677 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -60.92 -59.89 4.65 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -84.67 -10.91 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -124.03 72.95 55.72 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.8 -26.79 18.73 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.62 2.213 . . . . 0.0 112.792 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -93.57 70.73 4.24 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 132.98 53.09 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.152 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.94 108.16 10.72 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.603 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.96 136.09 33.25 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.214 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -132.47 172.8 12.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.596 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.92 177.9 5.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.525 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.8 m -77.15 83.87 3.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.34 45.97 16.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.402 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -70.08 155.19 93.87 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.126 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.75 -32.49 29.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.843 2.362 . . . . 0.0 112.582 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.49 -33.3 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.105 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 33' ' ' CYS . 31.2 m -69.43 -41.72 75.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.72 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -55.52 -32.69 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.592 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -59.16 -50.39 74.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 110.86 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.62 -35.87 75.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.529 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 -32.01 61.59 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.669 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -44.69 93.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 42' ' ' ILE . 30.7 mm -67.39 -48.93 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.327 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -65.34 -30.64 71.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.401 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -81.38 -32.25 32.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.974 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.0 mt -80.73 -7.73 59.45 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 52.18 43.95 30.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.875 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.47 31.6 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -102.92 28.15 6.45 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -112.71 -41.77 3.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -67.09 -24.45 65.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.281 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.9 t -100.59 159.23 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.656 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -110.89 111.14 22.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.386 0.612 . . . . 0.0 110.09 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.65 138.88 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.111 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 138.94 54.32 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.157 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.67 129.94 47.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.3 mt -88.99 69.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.128 0.49 . . . . 0.0 110.287 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.34 -40.95 0.34 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.993 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.7 p -57.29 -33.73 67.96 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.418 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.36 124.11 82.62 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.309 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.02 -176.24 2.54 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -36.58 75.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.8 -49.46 72.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.711 0.291 . . . . 0.0 111.009 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.57 -37.69 83.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.83 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -56.81 -31.46 64.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -52.33 65.91 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 111.081 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -67.16 -30.05 69.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.617 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.36 -54.37 47.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -57.92 -36.85 73.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.151 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.9 mt -69.52 -46.61 75.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.68 -49.66 74.22 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.142 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -45.66 80.8 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.028 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -26.45 68.55 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.22 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -31.3 35.56 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.143 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.67 -45.05 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.413 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.49 -41.28 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.56 4.29 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.441 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -120.19 107.77 13.41 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.669 0.271 . . . . 0.0 110.771 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -94.04 43.36 1.11 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.553 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -147.3 158.27 43.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -138.65 153.73 72.57 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.45 167.58 79.67 Favored 'Cis proline' 0 C--N 1.353 0.8 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.921 0.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 p -136.56 132.74 35.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.093 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.2 mt -110.92 114.57 47.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.17 117.1 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 91' ' ' TRP . 14.4 p -114.89 128.01 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 m120 59.36 40.58 20.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.72 80.52 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.914 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -171.84 134.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 110.776 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.91 106.59 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.409 ' HB2' ' CG1' ' A' ' 86' ' ' VAL . 1.6 m95 -124.12 0.46 8.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.34 6.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.827 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.2 t -122.82 179.12 4.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.902 0.382 . . . . 0.0 111.297 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -41.91 96.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.575 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -67.51 -28.7 68.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.412 ' HG2' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -56.98 -34.84 68.49 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 111.246 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.99 -38.68 72.7 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.183 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -79.33 -48.48 14.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.592 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -58.33 -50.25 74.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.412 ' CD1' ' HG2' ' A' ' 96' ' ' GLN . 10.8 m-85 -62.22 -39.19 91.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.392 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.66 -45.97 90.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.796 0.332 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.37 94.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.044 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -75.48 -29.49 59.59 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.02 13.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.503 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -117.21 16.99 14.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -49.92 47.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.72 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.0 -41.6 71.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.85 -43.64 87.84 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.718 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -54.78 -46.95 74.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.71 0.29 . . . . 0.0 110.737 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.56 -40.17 95.09 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.8 m -70.77 -35.27 72.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.634 0.254 . . . . 0.0 110.95 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -52.11 66.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.333 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 pt -62.21 -25.11 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.97 20.19 7.31 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.929 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.91 -49.06 14.92 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.843 0.322 . . . . 0.0 110.461 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.4 mt -110.15 126.61 28.6 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.839 2.359 . . . . 0.0 112.311 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.563 0.22 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.51 47.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -83.86 -39.75 19.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.836 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.49 -47.72 87.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.938 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.3 m -61.19 -42.2 98.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -59.82 -39.43 85.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.751 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.74 97.32 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.973 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.07 -41.92 97.16 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -61.79 -36.56 81.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.779 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.41 -49.98 67.2 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.0 pt -71.4 -15.27 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.48 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -63.98 1.09 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.693 0.283 . . . . 0.0 111.099 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.8 t -85.55 -23.77 27.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -118.46 66.42 6.68 Favored Pre-proline 0 CA--C 1.53 0.212 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.63 -28.95 25.25 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.692 2.261 . . . . 0.0 112.501 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.437 ' HB3' HG12 ' A' ' 52' ' ' VAL . 3.2 m-85 -94.49 67.4 3.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -108.02 127.41 53.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.425 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.24 106.08 12.9 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.27 125.08 34.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.632 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t -138.22 179.12 6.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.76 156.33 43.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.635 0.255 . . . . 0.0 111.413 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 m -84.66 55.17 3.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.079 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -127.09 -46.69 1.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.759 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 153.67 42.15 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.88 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.06 -17.61 32.2 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.877 2.385 . . . . 0.0 113.073 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -52.87 -43.81 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.445 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.88 -58.24 9.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.579 0.228 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.6 m -60.45 -31.7 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -74.48 -31.79 62.34 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.03 64.9 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-O 120.745 0.307 . . . . 0.0 111.007 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -75.6 -28.17 58.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.1 p -63.5 -47.82 80.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.887 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.4 mm -67.47 -44.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.145 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -63.44 -39.14 93.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.989 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -69.16 -31.94 70.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.89 -31.09 35.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.905 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.1 mt -80.53 -7.96 59.4 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 56.12 47.88 18.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 110.76 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.5 m -135.3 32.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -24.91 54.96 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.492 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.95 -41.67 22.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.627 0.251 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.35 -20.24 66.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.605 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.437 HG12 ' HB3' ' A' ' 25' ' ' TYR . 19.6 t -117.89 163.67 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 122.16 0.184 . . . . 0.0 110.529 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -123.31 111.36 16.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.162 0.506 . . . . 0.0 110.294 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.46 134.34 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.054 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -132.47 130.09 40.04 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -100.72 151.15 22.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.49 -144.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.59 14.39 25.6 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.752 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -149.1 33.81 0.74 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.806 0.303 . . . . 0.0 111.331 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -97.15 116.31 65.96 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.947 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.4 Cg_exo -62.19 -170.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.116 2.544 . . . . 0.0 112.493 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.68 2.31 14.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -106.91 -39.53 5.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.628 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.24 -39.6 62.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.324 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -60.92 -38.42 85.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.715 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.29 -35.43 79.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.551 0.215 . . . . 0.0 111.236 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -64.55 -53.14 52.52 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.314 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -69.61 -36.59 76.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.343 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -46.27 73.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.381 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.19 -51.67 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.586 0.232 . . . . 0.0 111.45 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.55 -54.98 37.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.865 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -42.75 99.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.297 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.17 -27.81 68.97 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.539 0.209 . . . . 0.0 111.407 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -30.18 34.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.397 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.2 t -87.94 -48.3 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 p -113.57 -31.77 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.1 35.53 38.2 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.57 93.09 2.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 40.21 1.06 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -113.7 89.96 3.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.634 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.48 151.91 93.4 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.063 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.23 170.51 71.25 Favored 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 123.531 -1.445 . . . . 0.0 112.99 0.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.55 133.44 18.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.55 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mt -112.51 111.53 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.7 t -101.77 116.72 45.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 t -125.1 131.8 72.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t30 63.28 33.07 14.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.89 45.18 93.26 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.832 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -175.44 137.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.545 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -59.15 102.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -25.27 8.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.829 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -111.1 139.01 15.34 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.233 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.96 -177.75 3.57 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -43.71 68.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.958 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 m -70.22 -32.82 70.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.891 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -52.26 -36.15 51.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.432 0.16 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.19 -54.37 41.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.18 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -33.84 66.17 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.428 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -62.02 -42.35 99.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.62 0.248 . . . . 0.0 111.304 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.431 ' CE2' ' HG3' ' A' ' 109' ' ' GLU . 4.7 m-85 -77.83 -44.19 28.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.471 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -61.57 -42.42 98.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.48 67.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.596 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -83.54 -38.56 21.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.1 35.65 2.3 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.942 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 18.28 16.42 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.693 0.246 . . . . 0.0 111.47 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -51.42 66.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.606 0.241 . . . . 0.0 110.778 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -66.28 -38.46 87.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.034 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.26 -39.84 95.74 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.431 ' HG3' ' CE2' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -58.47 -49.38 77.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.911 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.36 -30.68 68.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.067 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 78.9 m -78.24 -34.12 49.35 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.741 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -47.08 86.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.53 -26.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.717 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.85 7.17 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.585 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -45.83 49.93 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.721 0.296 . . . . 0.0 110.511 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -79.93 -60.32 0.51 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.038 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.481 2.121 . . . . 0.0 112.413 179.833 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 120.735 0.302 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.46 68.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.419 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.83 -38.28 23.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.851 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.89 -51.35 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -60.27 -35.36 75.36 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.795 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -57.19 -42.43 81.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.68 0.276 . . . . 0.0 110.814 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.76 88.51 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.429 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -63.27 -35.41 80.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.33 -39.07 91.93 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.5 mtp -64.46 -44.73 90.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.983 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 17' ' ' GLU . 37.1 pt -73.25 -14.69 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.419 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.26 -61.29 2.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.636 0.255 . . . . 0.0 110.855 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 m -83.37 -18.84 37.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.741 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -122.5 64.39 21.28 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.438 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.91 -23.66 61.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.503 ' HB3' HG13 ' A' ' 52' ' ' VAL . 13.2 m-85 -94.44 71.79 3.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -114.01 139.6 49.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.423 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.83 134.15 49.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.425 HD11 ' CD1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -107.92 127.67 53.95 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -117.09 153.7 32.3 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.365 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.75 -41.91 71.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.024 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 56' ' ' ASP . 14.5 m 66.25 33.65 7.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.324 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -159.36 -41.0 0.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.068 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.57 147.21 32.67 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.18 -20.55 24.85 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.018 2.479 . . . . 0.0 112.632 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.59 -39.86 58.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.113 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.59 -36.91 60.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.176 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.28 -35.11 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.442 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -58.47 -52.78 64.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.553 0.216 . . . . 0.0 110.875 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.97 75.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.64 -29.26 61.2 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 t -65.19 -48.95 71.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 42' ' ' ILE . 30.8 mm -65.21 -41.38 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -65.94 -36.9 84.63 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.159 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -62.59 -37.2 85.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -83.83 -30.76 26.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.372 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.71 -8.45 59.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 48.09 45.25 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.89 38.27 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -99.69 31.34 3.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -120.66 -49.84 2.22 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -25.51 68.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.265 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 25' ' ' TYR . 58.2 t -118.14 154.01 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.407 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.4 111.29 19.82 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.269 0.557 . . . . 0.0 110.21 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -107.93 141.63 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.287 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -126.13 125.72 42.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 3.0 m-20 -90.88 126.64 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.401 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.4 mt -79.27 60.3 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.698 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.53 18.07 4.95 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.811 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.3 p -129.97 10.02 5.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.813 0.307 . . . . 0.0 111.802 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.68 131.31 21.85 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-O 120.505 0.193 . . . . 0.0 111.11 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 64' ' ' GLU . 51.6 Cg_endo -68.3 -172.94 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.896 2.397 . . . . 0.0 112.095 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 6.35 4.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.91 -44.16 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.664 0.268 . . . . 0.0 110.817 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 3.5 tp10 -81.1 -42.95 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.31 -32.75 70.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.59 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -57.59 6.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.908 -0.133 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -31.73 67.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.172 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -73.11 -53.3 11.39 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.469 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -54.23 -42.16 69.55 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.439 ' N ' ' HG3' ' A' ' 69' ' ' ARG . 15.7 mt -62.04 -57.41 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.546 0.213 . . . . 0.0 111.249 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.16 86.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.668 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.425 ' CD1' HD11 ' A' ' 28' ' ' LEU . 1.1 m-85 -64.47 -51.5 62.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -58.8 -26.27 63.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.487 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -31.43 31.81 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.439 0.162 . . . . 0.0 111.385 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.1 t -84.96 -48.8 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.9 m -147.92 -37.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -45.95 -35.44 6.26 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.649 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t 61.34 -166.19 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.819 0.31 . . . . 0.0 111.184 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.33 40.54 1.11 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -160.69 130.53 5.07 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.4 mt -131.98 152.99 81.22 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.749 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.72 178.7 33.2 Favored 'Cis proline' 0 C--N 1.351 0.673 0 C-N-CA 123.688 -1.38 . . . . 0.0 113.027 0.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 t -144.31 155.98 44.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.04 114.68 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.0 t -101.17 118.38 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.73 131.79 72.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.948 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.51 31.5 16.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.203 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.73 44.91 94.18 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.59 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -173.12 137.76 0.71 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.362 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -57.56 108.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -130.33 5.12 4.79 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.73 139.84 8.27 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.941 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.7 177.54 7.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.932 0.396 . . . . 0.0 111.067 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -65.59 -45.38 83.44 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -37.4 85.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.31 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.01 -34.98 66.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.235 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.0 mt -66.33 -53.56 34.83 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.726 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -64.75 -35.92 82.63 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.131 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -69.31 -41.41 76.77 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -76.78 -45.81 27.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.515 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -62.31 -43.23 99.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.677 0.275 . . . . 0.0 111.061 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.93 97.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -73.24 -28.15 61.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.394 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.76 28.12 14.99 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.56 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.1 p -114.93 13.41 17.04 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.33 -51.7 28.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.535 0.207 . . . . 0.0 111.011 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.05 -44.25 97.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.85 -50.6 70.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.099 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.77 -37.66 87.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.192 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.5 mt -55.81 -46.23 78.11 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.083 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -64.91 -31.46 72.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.903 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.1 72.17 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.982 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.47 -27.83 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.541 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.05 21.41 7.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.055 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.17 -46.17 7.54 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.839 0.32 . . . . 0.0 110.799 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.3 mt -93.11 160.26 33.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.82 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.559 2.173 . . . . 0.0 112.448 179.851 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.74 -37.86 9.12 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.664 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -90.38 -39.16 12.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.143 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.83 -45.1 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.865 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -62.33 -43.7 98.21 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.77 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.67 -47.01 82.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.754 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.15 82.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.764 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -64.3 -34.27 77.75 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.172 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.56 -38.36 83.99 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.971 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -45.32 87.35 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.115 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 pt -72.16 -14.37 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.536 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -61.88 -64.59 0.89 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.603 0.24 . . . . 0.0 110.782 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -84.6 -25.99 28.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.788 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -119.72 66.17 9.93 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.809 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.39 -20.38 36.66 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.689 2.259 . . . . 0.0 112.867 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.412 ' HB3' HG23 ' A' ' 52' ' ' VAL . 18.4 m-85 -90.41 72.94 7.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.843 0.354 . . . . 0.0 110.628 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.93 137.98 42.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 102.91 6.13 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.752 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.62 122.0 25.98 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -120.56 149.99 41.57 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.185 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.53 -38.07 4.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.443 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t 67.66 13.47 9.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.691 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.44 -33.49 7.34 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.71 0.291 . . . . 0.0 110.927 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.13 155.69 36.13 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.874 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.95 -12.37 35.06 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.748 2.299 . . . . 0.0 113.091 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.4 -29.79 59.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 48.8 t -78.65 -49.63 12.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 m -51.15 -36.7 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.278 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -71.66 -43.14 66.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.96 72.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.461 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -74.12 -32.34 63.14 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.546 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -61.25 -42.74 99.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.796 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -66.32 -44.73 90.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.004 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -35.57 81.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.095 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -67.12 -33.62 75.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.132 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -82.07 -32.52 30.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.055 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.1 mt -82.13 -7.79 59.63 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 50.94 49.95 20.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.953 0.406 . . . . 0.0 111.031 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.17 33.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.091 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -83.07 -28.96 29.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.389 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.64 -42.65 34.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -65.26 -22.74 66.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.426 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 25' ' ' TYR . 11.1 p -108.91 163.2 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.393 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -120.2 111.17 17.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.23 0.538 . . . . 0.0 109.902 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.22 145.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -131.11 97.09 4.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.753 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.99 144.02 35.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.684 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.5 pt -99.96 64.28 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.105 0.479 . . . . 0.0 111.562 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -32.35 2.8 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.208 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 m -96.06 37.36 1.24 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.956 0.378 . . . . 0.0 111.576 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.455 ' HB2' ' CB ' ' A' ' 64' ' ' GLU . 2.7 pp -145.58 116.76 5.03 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.231 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.65 -176.85 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.989 2.459 . . . . 0.0 112.421 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -32.31 66.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.326 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -55.12 -41.83 72.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.273 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 7.0 mm-40 -77.53 -32.72 54.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.676 0.275 . . . . 0.0 110.824 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -54.15 -50.17 67.58 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.083 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.33 -42.1 98.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -38.98 75.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.14 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -73.53 -44.02 58.59 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.347 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -56.32 -39.16 72.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.49 -52.82 28.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.04 -54.5 46.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.337 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.46 -35.23 67.66 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.323 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -36.26 81.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.597 0.237 . . . . 0.0 111.073 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -28.86 32.56 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.553 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -81.08 -47.22 20.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.174 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.37 -39.77 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.07 42.29 3.07 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.707 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -121.95 108.43 13.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.758 0.313 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.88 38.08 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.6 160.95 43.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.119 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -123.06 155.76 63.79 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 96.6 Cg_endo -77.86 177.59 38.45 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.757 -1.351 . . . . 0.0 113.131 0.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 p -145.55 117.8 8.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 116.27 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.995 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 m -115.93 127.08 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.402 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.84 129.52 75.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 59.61 35.1 22.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.894 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.37 32.06 78.52 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.766 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -150.75 133.2 15.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.107 0.479 . . . . 0.0 110.045 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -59.74 102.37 0.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.256 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -106.81 -22.8 12.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.748 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.64 139.99 11.42 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.874 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.71 178.1 5.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -37.1 78.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.322 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t -98.19 -22.24 16.29 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.416 ' HA ' ' HG2' ' A' ' 99' ' ' ARG . 5.4 tt0 -57.15 -31.99 65.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.55 -43.65 96.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.95 -53.5 45.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.494 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 96' ' ' GLN . 1.7 ptt180 -59.78 -41.66 91.61 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.674 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -64.83 -42.75 94.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.81 -40.73 98.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.522 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.09 90.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -73.83 -27.53 61.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.24 24.22 32.25 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.61 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.4 p -116.54 11.26 14.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -52.08 44.56 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.671 0.272 . . . . 0.0 110.484 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -67.77 -47.73 68.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.76 -53.09 52.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.984 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.43 -41.55 76.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.885 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -63.29 -38.27 90.51 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.213 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -35.84 64.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.571 0.225 . . . . 0.0 110.57 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -66.7 -45.39 78.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.255 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.3 pt -65.42 -27.29 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.595 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.69 22.46 8.06 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.861 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 -45.46 7.04 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.78 0.29 . . . . 0.0 110.726 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.35 137.84 28.92 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 C--O 1.251 1.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.611 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.408 0.147 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.69 38.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.371 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.44 -37.94 19.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.875 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.46 -48.75 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.124 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 m -60.01 -41.76 92.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -60.02 -35.61 75.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.949 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.24 98.67 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.875 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 20' ' ' ILE . 7.1 mm-40 -61.23 -34.15 74.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.55 -34.87 67.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.74 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.7 mtt -68.14 -46.4 70.95 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.003 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -71.89 -17.19 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.317 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -64.99 0.76 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.695 0.284 . . . . 0.0 110.856 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 t -86.06 -27.83 24.49 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -119.78 66.27 10.16 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.553 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.36 -16.61 43.78 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.513 ' HB3' HG13 ' A' ' 52' ' ' VAL . 57.1 m-85 -90.43 68.57 6.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.435 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -112.52 136.17 52.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.265 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.64 112.28 14.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.293 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 117.13 27.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.039 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -138.6 169.17 18.26 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.25 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.25 159.65 28.27 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.187 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -103.0 21.9 14.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.423 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -153.34 32.16 0.47 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.49 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.4 144.49 32.45 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.915 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.77 -28.67 24.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.714 2.276 . . . . 0.0 112.763 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -111.08 23.31 14.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.15 -42.05 3.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.569 0.223 . . . . 0.0 111.059 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.58 -31.98 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.363 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -65.73 -51.77 56.56 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.091 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.68 79.17 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.572 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -75.42 -30.4 60.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 t -61.43 -47.88 83.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mm -62.53 -43.81 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -64.46 -36.45 84.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.049 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -29.6 63.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.18 -33.52 32.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.606 0.241 . . . . 0.0 111.014 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.82 -7.81 59.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 53.89 46.2 26.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.037 0.446 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.98 28.92 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.977 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.38 -6.7 36.94 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.34 -45.82 17.14 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 110.457 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -68.4 -28.04 66.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 25' ' ' TYR . 42.5 t -103.1 160.12 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.682 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 6.2 m-85 -114.46 111.18 21.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.095 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.16 135.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.045 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 118.1 33.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.835 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -95.45 144.31 26.07 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.278 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.4 pt -107.62 96.51 4.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.27 -79.61 0.1 Allowed Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.892 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 p -140.73 57.49 1.57 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.93 0.395 . . . . 0.0 110.784 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.96 136.09 66.66 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.205 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.19 -169.8 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.737 2.291 . . . . 0.0 112.133 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 2.1 mtp180 -75.7 1.19 15.29 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.51 -43.31 6.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.614 0.245 . . . . 0.0 110.984 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -75.29 -49.21 19.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.92 -35.51 75.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.361 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -67.53 -51.84 46.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.328 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -58.13 -42.39 85.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.87 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -61.9 -39.51 92.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.185 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -57.24 -54.35 47.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -68.57 -44.75 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.16 -42.06 72.63 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.999 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.423 ' CE1' HG23 ' A' ' 83' ' ' THR . 3.3 m-85 -70.51 -45.33 65.8 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.135 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.96 -27.96 69.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -32.36 31.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.42 -41.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.32 -38.46 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 36.76 6.42 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.633 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.0 m -137.04 113.24 9.87 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 38.86 1.19 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.895 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -134.36 129.4 35.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 1.3 mp -98.6 164.95 16.02 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 7.9 Cg_exo -72.29 144.65 81.08 Favored 'Cis proline' 0 C--N 1.352 0.761 0 C-N-CA 123.593 -1.42 . . . . 0.0 111.999 -0.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.423 HG23 ' CE1' ' A' ' 72' ' ' PHE . 89.5 m -107.2 105.72 15.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -101.9 111.1 30.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.332 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.5 118.17 52.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -121.72 112.58 35.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 66.06 42.96 3.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.059 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.48 50.74 64.3 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.122 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -173.4 138.4 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.97 94.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -97.6 -29.48 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.496 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.47 135.71 10.71 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.146 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.86 -177.48 3.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.013 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.15 -52.24 43.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -31.66 69.43 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -33.85 33.06 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 48.3 mt -51.36 -59.72 3.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.247 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -78.36 -33.04 49.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.148 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -57.46 -49.06 77.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.5 -39.87 67.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.027 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.77 -47.82 84.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.843 0.354 . . . . 0.0 110.721 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.81 76.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.353 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -74.81 -27.78 60.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.69 23.24 43.3 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.469 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.2 p -113.57 0.07 14.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.9 -47.4 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.603 0.239 . . . . 0.0 110.92 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.06 -46.05 72.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.231 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.88 -45.74 89.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.588 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -59.42 -40.01 85.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 tp -62.63 -40.7 97.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.22 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -77.34 -33.12 55.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 110.711 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -66.61 -43.66 84.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.358 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.6 pt -61.12 -25.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.26 21.87 6.41 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.703 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 tt -88.16 -55.02 3.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.745 0.307 . . . . 0.0 110.761 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 mp -89.09 140.99 29.04 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.699 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.867 2.378 . . . . 0.0 112.52 -179.864 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.01 -34.19 63.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.327 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -97.36 -37.4 10.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.28 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.0 -47.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.652 0.263 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -61.08 -43.75 98.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.658 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -63.46 -35.57 80.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.064 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.82 95.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.07 -36.66 80.22 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.806 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -69.15 -32.49 71.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -48.11 62.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.088 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 pt -70.69 -15.05 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.486 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -61.3 -61.76 2.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -83.66 -19.82 34.67 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.39 68.53 10.46 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 110.563 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.42 -18.97 38.32 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.665 2.243 . . . . 0.0 112.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.465 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.4 m-85 -90.59 69.51 6.74 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.51 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.78 139.71 41.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -129.15 125.87 38.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.012 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.83 113.63 26.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.81 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 175.88 13.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.01 170.89 15.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.319 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -102.47 -15.15 16.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -85.88 -39.44 16.99 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.6 m -72.67 141.35 82.34 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.87 -39.09 1.94 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.871 2.381 . . . . 0.0 113.122 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -61.31 -29.94 70.19 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.74 0.305 . . . . 0.0 111.047 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.4 m -72.04 -34.77 69.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.886 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -58.15 -34.84 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.72 -54.38 36.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.514 0.197 . . . . 0.0 111.198 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.34 72.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.572 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -75.15 -32.02 61.21 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.763 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -63.46 -44.51 94.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.969 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.1 mm -63.49 -43.92 98.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.038 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -34.24 77.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.307 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -28.08 63.81 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.186 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -80.6 -32.51 36.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.897 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -81.91 -7.69 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 52.73 49.73 19.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.2 m -122.69 26.17 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.299 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -26.66 65.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.734 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -81.2 -31.79 33.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.704 0.287 . . . . 0.0 110.913 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -75.9 -28.73 58.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 25' ' ' TYR . 13.5 p -112.46 161.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.815 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -120.46 111.13 17.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.368 0.604 . . . . 0.0 109.99 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.4 t -107.85 135.54 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.991 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.09 113.55 26.5 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.92 145.09 29.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.938 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.77 78.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -43.94 0.33 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.803 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -95.55 37.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 111.169 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.94 105.02 43.37 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.682 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.9 164.09 2.66 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.038 2.492 . . . . 0.0 112.678 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.13 -36.16 5.65 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.551 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -75.11 -49.5 19.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.007 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.3 -36.49 83.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.221 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -59.86 -48.05 83.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.003 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.16 -29.18 67.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -55.46 -53.45 56.2 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.228 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -74.01 -32.35 63.34 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.73 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -49.83 74.76 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -73.93 -39.03 51.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.074 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.72 -50.75 72.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.072 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -63.61 -33.87 76.57 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -32.84 70.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.884 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -78.94 -29.59 44.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.98 -44.14 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.191 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.26 -42.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.27 45.97 1.11 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.45 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 p -102.76 85.35 2.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 110.415 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 22.91 1.63 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 152.68 15.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.21 159.37 57.35 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.052 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.2 156.42 98.16 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.793 0.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.3 t -144.92 131.25 19.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.9 mt -112.02 122.79 66.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.343 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.12 121.65 64.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.352 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.89 121.87 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.98 43.37 3.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.63 75.28 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.854 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -174.16 134.99 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.559 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -62.86 101.21 0.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -113.32 -26.31 8.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.628 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.68 141.08 16.67 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.697 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.58 154.2 39.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.603 0.24 . . . . 0.0 111.171 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -36.72 68.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.0 m -86.0 -27.18 25.0 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -37.4 69.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.616 0.246 . . . . 0.0 111.083 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.14 -37.29 78.22 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.121 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -67.92 -54.48 18.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.186 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -60.36 -29.59 69.01 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -79.48 -45.56 19.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.343 0.116 . . . . 0.0 111.108 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -62.77 -43.98 97.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.91 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.1 -46.74 68.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.508 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -76.8 -34.8 57.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.42 32.97 3.26 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.89 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.4 p -115.39 20.57 14.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.717 0.258 . . . . 0.0 111.562 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.01 -47.35 13.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.644 0.259 . . . . 0.0 110.563 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.59 -45.85 90.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.263 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.68 -41.53 98.15 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.79 -42.17 98.66 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.867 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -38.27 81.88 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 m -77.55 -34.67 53.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.619 0.247 . . . . 0.0 110.573 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.88 -45.32 82.47 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -61.87 -24.6 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.3 23.02 7.16 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.676 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.33 -45.22 8.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.822 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.8 mp -98.71 146.28 31.35 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--O 1.248 0.989 0 C-N-CA 122.688 2.258 . . . . 0.0 112.699 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.356 0.122 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 15' ' ' LYS . . . -66.76 -10.48 47.76 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -119.8 -41.56 2.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.498 0.19 . . . . 0.0 111.205 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 t -56.76 -51.11 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 m -59.79 -33.58 71.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.06 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 13.8 mttm -65.72 -32.75 74.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.914 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.29 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.557 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.563 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -37.89 89.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.425 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -46.25 85.82 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.115 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.8 pt -74.16 -17.5 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.646 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -61.93 2.11 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.664 0.268 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m -84.28 -19.06 34.46 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.3 69.09 59.98 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 121.046 0.45 . . . . 0.0 110.155 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 -21.37 70.3 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.943 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -90.28 66.08 6.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.864 0.364 . . . . 0.0 110.257 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -109.46 142.88 39.84 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.075 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.52 132.04 36.77 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.54 114.39 27.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.187 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -131.97 172.71 12.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.68 -82.17 0.33 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.653 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.1 p -176.66 -62.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -139.41 42.04 2.04 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.931 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.97 161.19 69.48 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.577 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.64 -34.84 50.02 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.444 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.04 -35.04 14.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.467 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 71.8 m -67.58 -43.66 80.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.248 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -57.5 -32.5 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.384 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -63.47 -51.63 64.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.593 0.235 . . . . 0.0 110.805 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.01 79.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.702 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.66 -33.28 62.48 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.709 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -58.96 -43.72 91.36 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.3 mm -66.48 -46.52 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.367 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -34.43 78.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.92 -39.22 87.3 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.916 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -81.79 -24.63 35.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.497 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.5 mt -80.88 -8.28 59.68 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.4 t30 49.79 47.49 22.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.29 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.4 m -141.23 41.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.42 -18.01 20.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.706 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -77.22 -45.32 26.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.681 0.277 . . . . 0.0 110.665 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -61.01 -24.56 66.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.43 ' CG2' HD21 ' A' ' 115' ' ' LEU . 15.7 t -102.76 160.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.363 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -113.92 111.12 21.17 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.374 0.607 . . . . 0.0 110.137 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -108.22 143.01 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.369 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -131.52 129.72 41.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.91 131.43 34.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 tt -91.91 29.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.52 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.29 9.97 54.13 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.146 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 29.28 7.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.009 0.405 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HB2' ' CB ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -141.92 134.6 13.93 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.747 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.72 -177.62 2.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.202 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -56.79 -28.26 61.07 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.209 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.34 -56.82 13.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.962 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.404 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 10.7 mt-10 -69.91 -30.75 68.25 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -54.6 -45.52 73.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.861 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.17 -41.21 97.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.674 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -59.6 -46.78 87.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.163 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.36 90.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.211 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -60.99 -53.17 60.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 mt -63.77 -36.93 78.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.048 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.14 -55.13 17.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.228 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -41.22 77.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.27 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.24 69.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.517 0.198 . . . . 0.0 111.22 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -81.98 -30.37 31.66 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.581 0.229 . . . . 0.0 111.174 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.0 t -83.3 -46.27 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.328 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.21 -38.03 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.87 36.49 7.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.514 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.72 104.25 9.19 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.22 39.43 1.02 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -129.78 132.58 46.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -110.68 142.39 26.03 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.704 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 87.6 Cg_endo -79.17 -177.03 19.77 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.511 -1.454 . . . . 0.0 112.923 0.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.17 125.61 11.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.36 118.95 52.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.337 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 m -112.95 117.67 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.799 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.1 138.53 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.39 33.15 22.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.94 45.71 91.56 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.426 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -175.24 136.64 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -58.98 109.2 0.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.299 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.81 -21.82 10.48 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.283 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -138.28 138.06 9.24 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.041 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 96' ' ' GLN . 8.9 t -119.99 -170.44 1.96 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.502 0.178 . . . . 0.0 110.543 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.88 -33.18 34.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -29.32 34.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.427 ' HB2' HG22 ' A' ' 93' ' ' THR . 17.9 tt0 -65.08 -30.22 71.16 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.7 mt -56.97 -59.72 4.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.482 0.182 . . . . 0.0 111.315 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -62.25 -38.01 87.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -67.56 -40.09 84.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.41 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -77.16 -35.31 56.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.531 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.8 -42.49 97.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.52 -49.56 68.51 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.343 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -70.95 -26.19 63.06 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.49 23.12 27.21 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.542 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.34 -20.63 21.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 tp -57.3 -53.45 57.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.529 0.204 . . . . 0.0 110.825 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.78 -36.98 80.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.03 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.2 -41.57 98.49 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.149 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.64 -35.91 81.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.9 m -72.75 -37.22 67.76 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -47.32 83.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.249 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 33.9 pt -69.48 -24.53 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.4 26.9 9.62 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.43 HD21 ' CG2' ' A' ' 52' ' ' VAL . 4.2 tp -92.03 -40.16 11.24 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.736 0.268 . . . . 0.0 110.845 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 6.3 tp -65.42 -47.64 68.83 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.451 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 116' ' ' LEU . 70.7 Cg_exo . . . . . 0 C--O 1.252 1.204 0 C-N-CA 122.575 2.183 . . . . 0.0 112.606 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.6 -37.25 49.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -34.96 17.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.2 -48.02 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.149 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -67.31 -46.89 72.16 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -58.14 -38.27 76.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.688 0.28 . . . . 0.0 111.179 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.36 84.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -67.56 -38.28 83.88 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -61.76 -38.3 87.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.073 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.13 -47.74 73.12 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.8 pt -74.06 -14.63 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.634 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -61.7 2.36 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.59 0.234 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -83.76 -19.57 34.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -122.13 68.03 26.32 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.49 -24.02 42.94 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.429 ' HB3' HG22 ' A' ' 52' ' ' VAL . 4.4 m-85 -92.4 69.21 5.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.487 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.09 139.62 43.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.283 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -128.37 100.05 5.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.747 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.69 94.4 5.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 p -103.25 154.49 19.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.954 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.33 29.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.215 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -94.88 36.73 1.17 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -48.55 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.087 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.6 m -69.17 137.17 89.24 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.205 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.19 -30.72 10.24 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.755 2.303 . . . . 0.0 112.858 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -58.74 -36.06 73.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.124 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m -65.23 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.58 -37.17 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.296 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.45 -46.08 84.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.566 0.222 . . . . 0.0 110.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.11 -33.46 72.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -74.96 -33.4 61.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.57 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -59.11 -41.76 88.95 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.802 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 42' ' ' ILE . 22.8 mm -71.06 -36.91 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -34.05 76.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.765 0.317 . . . . 0.0 111.005 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -80.86 -31.55 35.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -83.52 -33.69 25.45 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.6 mt -80.75 -7.64 59.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 53.09 51.42 15.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.223 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.5 26.68 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.378 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.27 -28.92 70.05 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -89.99 -25.58 20.8 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -79.16 -42.38 26.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' A' ' 25' ' ' TYR . 11.4 p -120.93 154.86 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -118.26 111.13 18.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.0 110.383 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.48 134.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.886 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -130.06 132.9 46.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.58 148.83 22.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.414 HG22 HD23 ' A' ' 60' ' ' LEU . 9.6 pt -107.79 85.19 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.52 -47.45 0.2 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.308 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -58.7 -41.45 86.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.765 0.282 . . . . 0.0 111.253 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.414 HD23 HG22 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -59.75 112.48 5.38 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.369 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.79 -173.54 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.101 2.534 . . . . 0.0 112.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -34.48 67.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.32 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -52.69 64.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.76 -34.25 69.32 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.204 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -55.38 -42.58 74.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.586 0.231 . . . . 0.0 110.845 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.52 -47.98 51.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -57.12 -48.05 79.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.192 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -38.31 81.14 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -52.42 64.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.916 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 mm -59.86 -47.11 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.11 -52.39 65.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -58.25 -45.91 86.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.028 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -62.72 -27.51 69.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 -28.66 36.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.971 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 t -81.89 -48.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.102 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.29 -38.17 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.52 40.88 5.89 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.285 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.32 105.75 15.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.358 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.49 34.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -123.63 157.59 33.43 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -142.97 138.99 16.35 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.017 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.49 177.53 38.83 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.5 -1.458 . . . . 0.0 112.745 0.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.4 p -132.08 137.6 47.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.7 mt -118.64 112.31 37.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.46 122.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.262 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.96 124.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.37 35.29 12.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.078 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.52 46.27 70.88 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.745 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -176.15 135.94 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -59.49 107.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.032 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.26 4.32 7.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.117 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -149.11 141.18 8.71 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.028 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -121.19 -179.0 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.35 . . . . 0.0 111.237 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -72.81 -42.4 63.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.232 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.61 66.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.325 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -52.6 -38.19 59.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.571 0.224 . . . . 0.0 111.295 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.6 mt -56.88 -60.34 3.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -34.96 78.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.041 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -60.8 -44.94 96.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -79.7 -40.67 28.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -40.88 90.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.831 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -43.53 87.9 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.195 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -72.73 -29.34 63.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.531 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 24.85 19.26 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.714 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.5 p -110.88 9.83 22.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -49.01 69.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.416 0.151 . . . . 0.0 110.878 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.76 -46.39 89.8 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.67 -43.77 80.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -39.34 69.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.8 tp -56.21 -42.9 77.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.303 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.1 m -77.47 -33.03 54.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.871 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -68.63 -43.16 76.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.528 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.4 pt -64.12 -23.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.15 25.16 8.03 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.555 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.78 -46.5 14.12 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -65.51 -59.69 9.0 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.899 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--O 1.248 1.002 0 C-N-CA 122.455 2.103 . . . . 0.0 112.43 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.52 -29.03 34.54 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.657 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -106.21 -38.51 6.23 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.344 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.94 -48.15 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.8 m -60.59 -42.85 97.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -58.69 -35.55 72.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 110.715 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.88 -48.22 72.24 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -63.77 -34.18 77.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.51 -33.85 73.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.59 79.53 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.3 pt -73.25 -16.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.468 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -61.48 -62.21 1.98 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.767 0.318 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -84.65 -20.39 31.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -123.14 67.92 35.35 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.393 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.95 -22.57 55.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.665 2.243 . . . . 0.0 112.643 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -91.19 68.61 6.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.492 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -108.53 139.35 43.42 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.187 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -140.79 114.55 8.93 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.87 140.4 35.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.242 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -146.5 145.69 30.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.153 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.65 -175.32 5.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.39 50.51 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.028 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -48.94 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.7 t -68.74 133.78 90.42 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.267 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.99 -34.1 48.8 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.811 2.341 . . . . 0.0 112.715 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.17 -31.94 69.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.641 0.258 . . . . 0.0 111.084 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 68.9 m -68.98 -56.33 8.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.09 -35.85 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.882 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -62.03 -45.1 95.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.5 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.01 82.15 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.348 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -75.04 -29.39 60.77 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -62.95 -45.19 93.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.8 -42.43 89.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -35.5 78.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -69.36 -31.86 70.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.156 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -78.59 -30.37 46.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.888 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.5 mt -80.46 -7.09 59.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.3 t30 56.15 47.82 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.14 30.81 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -19.46 59.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.367 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 -35.18 21.67 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -74.54 -25.12 59.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.526 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.88 160.75 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.64 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.28 111.51 17.45 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.289 0.566 . . . . 0.0 110.336 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 p -112.15 141.65 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.516 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -125.23 124.51 41.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.22 144.99 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.072 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.8 mt -113.02 82.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.968 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.06 22.46 4.01 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.952 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -150.35 24.82 0.8 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.865 0.332 . . . . 0.0 111.391 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -171.79 58.28 0.25 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 111.263 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 60' ' ' LEU . 61.7 Cg_endo -89.75 160.6 5.16 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.766 2.311 . . . . 0.0 113.108 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.6 -75.48 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.1 -50.26 73.34 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -82.6 -28.1 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.678 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -65.17 -41.67 94.41 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.082 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.31 -40.66 86.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.624 0.25 . . . . 0.0 110.764 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -72.52 -44.61 61.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -34.72 77.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -63.81 -50.06 70.44 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.926 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 mt -60.16 -37.71 74.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.03 -54.66 16.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.177 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.54 -36.42 78.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.164 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.1 -31.06 72.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -29.19 41.35 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.3 t -81.16 -44.19 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.4 -40.82 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.27 36.58 6.55 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.423 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.0 t -111.26 105.16 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.73 0.3 . . . . 0.0 110.653 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.63 37.11 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -130.12 116.79 18.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.032 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.82 147.87 34.27 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.653 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.77 175.29 48.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.813 0.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.7 p -134.93 133.62 39.77 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.8 111.07 34.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.751 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 m -107.51 124.06 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.944 0.402 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.35 127.23 73.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.723 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 62.83 37.11 12.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.006 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.84 49.44 72.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.729 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.51 136.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.65 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -59.22 102.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -115.86 -11.22 11.58 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.89 142.77 14.23 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.64 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 m -130.31 159.67 36.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.641 0.258 . . . . 0.0 111.104 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -39.68 75.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.13 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -76.88 -29.02 55.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.556 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.28 -31.81 34.45 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 mt -70.27 -49.04 53.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.057 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -59.63 -53.29 59.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.495 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -36.35 70.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.539 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.72 -42.38 34.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.1 74.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.5 97.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.357 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -73.73 -27.86 61.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.531 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.09 28.73 12.76 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.334 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 p -107.83 6.52 27.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -45.83 88.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.654 0.264 . . . . 0.0 110.73 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.76 -38.14 86.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.99 -41.64 95.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -59.12 -44.97 92.03 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.546 0.212 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -41.51 85.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.212 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -80.72 -32.06 35.9 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -42.85 99.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.38 -21.83 29.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.634 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.16 26.65 13.67 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.781 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 tp -88.46 -43.58 11.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 110.8 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -56.81 20.35 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.084 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 C--O 1.25 1.102 0 C-N-CA 122.459 2.106 . . . . 0.0 112.702 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.275 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.07 73.4 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.763 0.316 . . . . 0.0 110.834 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.9 -28.05 11.34 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.444 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.83 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.635 0.255 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.2 m -61.45 -46.1 91.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -61.65 -37.65 84.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.049 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.17 87.48 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.99 -41.53 87.84 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.786 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -64.52 -35.75 81.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.63 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.3 mtp -66.34 -46.79 75.62 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.985 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.6 pt -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.636 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.88 -63.88 1.01 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.603 0.239 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -25.59 25.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.746 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -121.7 63.05 14.37 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.735 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.46 -18.21 54.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 112.845 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.418 ' HB3' HG11 ' A' ' 52' ' ' VAL . 19.5 m-85 -88.08 73.68 8.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.91 139.96 39.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.05 98.93 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.777 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.71 129.33 36.92 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -144.22 -176.6 5.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.84 109.88 9.94 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.2 p -50.29 -34.34 23.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.444 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -40.71 62.87 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.432 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 90.6 m -72.53 137.37 80.67 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.233 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -24.5 50.14 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.068 2.512 . . . . 0.0 112.836 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -55.99 -39.26 71.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.959 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -63.73 -39.45 94.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.406 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -62.84 -41.11 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.32 -47.41 73.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.861 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.16 89.74 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.538 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -75.25 -30.88 60.62 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.946 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.67 -49.01 76.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.35 -38.73 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -34.06 76.6 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.29 -33.54 75.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.273 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 -33.2 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.944 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.14 -7.73 59.29 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 53.26 48.77 21.33 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.896 0.379 . . . . 0.0 110.929 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.69 29.4 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.385 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -69.99 -35.0 74.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.051 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.01 -33.18 26.58 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.894 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -66.82 -21.31 66.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.579 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 25' ' ' TYR . 19.9 t -125.59 161.03 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.17 111.58 16.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -97.42 141.72 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -127.45 96.17 4.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.992 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.35 144.2 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.3 pt -139.47 99.11 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.466 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.52 29.31 8.33 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.007 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.0 m -145.9 -83.5 0.13 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.92 0.36 . . . . 0.0 110.94 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.401 HD23 ' HG3' ' A' ' 64' ' ' GLU . 11.8 mt 60.52 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.273 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.36 62.5 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.129 2.552 . . . . 0.0 113.418 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 62.21 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -54.38 -43.13 71.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.54 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.401 ' HG3' HD23 ' A' ' 60' ' ' LEU . 20.3 tp10 -60.01 -42.72 94.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.091 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -56.23 -42.85 77.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.983 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 35.5 mt-10 -79.9 -27.03 39.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.5 -46.79 75.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.464 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -71.99 -40.78 68.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -58.38 -39.98 81.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.6 mt -79.38 -41.54 22.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.653 0.263 . . . . 0.0 111.08 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.03 -54.33 47.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.25 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -58.3 -41.61 84.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.464 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -61.63 -32.22 72.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.737 0.303 . . . . 0.0 111.039 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -31.01 46.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -77.83 -43.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.08 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 m -134.39 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 111.94 47.66 0.71 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.601 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.54 96.17 5.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.798 0.333 . . . . 0.0 110.492 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.93 24.75 2.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.226 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.82 170.35 15.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.149 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.23 151.19 43.7 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.24 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.46 172.77 60.98 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.786 -1.339 . . . . 0.0 112.783 0.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 t -159.32 135.53 8.98 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.791 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.45 129.08 57.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.336 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.81 131.33 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.86 125.18 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.068 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 63.27 39.2 9.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.8 50.1 71.27 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.592 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -172.39 135.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.626 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -56.38 112.78 1.34 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.217 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -102.9 -29.75 11.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.538 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.32 161.74 31.84 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.095 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 t -129.1 -174.93 3.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.769 0.318 . . . . 0.0 111.386 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -55.68 -45.43 77.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.843 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.5 m -64.06 -38.18 90.15 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.822 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -60.79 -30.31 69.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.6 mt -59.13 -57.8 11.46 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.516 0.198 . . . . 0.0 110.962 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -39.03 88.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.865 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -65.97 -41.3 91.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.247 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -73.72 -38.23 64.88 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.861 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.69 -52.99 31.37 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.835 0.35 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -35.86 78.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -74.25 -28.13 61.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.289 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.64 24.5 32.96 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.572 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.1 p -115.14 2.1 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -57.23 13.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.527 0.203 . . . . 0.0 110.996 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -66.83 -37.85 85.3 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.017 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.31 -52.36 65.61 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.848 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.35 -34.03 76.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.157 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 mt -61.21 -43.19 99.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.965 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.2 m -69.43 -29.22 66.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.891 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.37 -52.08 67.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.915 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.07 -25.75 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.747 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.19 7.45 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.899 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 tt -85.76 -50.65 7.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.675 0.274 . . . . 0.0 110.692 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.77 138.44 20.07 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 122.924 2.416 . . . . 0.0 112.478 -179.764 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 111.42 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.99 -29.69 20.55 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-O 120.72 0.295 . . . . 0.0 110.467 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.57 -31.58 9.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 t -64.3 -57.22 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.064 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -60.26 -44.67 95.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.107 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -61.62 -34.45 75.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.791 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.12 72.19 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -77.03 -28.51 54.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.941 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.66 -35.48 67.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.048 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 14.2 ptp -70.75 -41.58 71.59 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.812 -0.177 . . . . 0.0 111.441 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -73.86 -19.86 17.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.547 0.213 . . . . 0.0 111.412 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -62.22 1.88 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 m -87.57 -20.93 25.75 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.266 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -127.53 70.59 76.6 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 120.855 0.359 . . . . 0.0 110.72 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.19 -22.52 53.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.718 2.278 . . . . 0.0 112.794 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -89.09 70.99 8.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.903 0.382 . . . . 0.0 110.275 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.83 140.68 38.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -142.77 106.91 4.72 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.783 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.7 tt -88.82 125.25 34.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.7 172.79 12.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.009 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.73 145.57 14.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.169 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -76.39 75.74 3.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 110.739 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -142.09 -53.65 0.43 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.747 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 142.05 30.2 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.29 -34.73 81.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.962 2.441 . . . . 0.0 112.593 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -33.69 76.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.6 m -58.44 -51.34 70.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.619 0.247 . . . . 0.0 110.75 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 t -59.33 -40.32 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -59.73 -48.95 79.62 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.33 76.6 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.516 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.0 -32.45 67.21 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.561 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -62.06 -44.6 96.33 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.1 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.13 -50.4 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.509 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.02 -32.87 74.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.916 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -66.36 -37.07 84.48 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.0 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -83.8 -27.69 28.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.471 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 mt -80.92 -7.72 59.57 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.57 49.08 20.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 m -127.28 38.9 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -93.21 16.59 12.74 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.523 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.9 -42.63 3.54 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.928 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -25.13 61.76 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.393 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.34 158.3 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.645 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -116.05 111.01 19.69 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.261 0.553 . . . . 0.0 110.207 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.2 t -104.25 134.85 44.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -120.97 98.21 5.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.0 132.07 34.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 pt -120.58 91.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.402 . . . . 0.0 111.293 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 13.09 8.08 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.127 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 t -135.72 56.75 1.82 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.018 0.437 . . . . 0.0 110.702 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -112.39 140.08 23.32 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.291 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 64' ' ' GLU . 86.3 Cg_endo -81.54 45.1 1.88 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.879 2.386 . . . . 0.0 114.314 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 67.47 -57.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.607 0.363 . . . . 0.0 111.764 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.33 -33.66 54.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.623 0.249 . . . . 0.0 111.007 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 18.9 mm-40 -70.01 -39.71 75.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.919 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -51.22 70.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.989 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -41.48 80.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.6 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -65.66 -38.67 90.0 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.884 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -62.17 -44.52 96.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.304 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.72 -41.72 87.07 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.4 mt -73.38 -43.87 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -52.27 65.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.23 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.47 -34.71 74.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -63.44 -30.31 71.45 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.047 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.84 -29.8 35.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.148 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -82.53 -44.54 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.194 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.89 -41.93 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 40.68 2.85 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.62 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.2 t -116.42 115.36 25.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -96.4 39.27 1.16 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -154.73 159.64 40.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.174 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.7 mt -127.42 152.22 76.07 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.882 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.4 ' HD2' ' HG3' ' A' ' 94' ' ' GLU . 72.8 Cg_endo -76.5 174.88 50.7 Favored 'Cis proline' 0 C--N 1.354 0.834 0 C-N-CA 123.482 -1.466 . . . . 0.0 113.007 0.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -129.0 121.61 28.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.876 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -106.1 111.23 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.871 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 m -112.18 119.46 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.2 t -117.08 122.1 69.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.963 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.27 38.57 7.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.38 49.02 78.06 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.679 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -174.31 136.68 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 110.693 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.05 106.15 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.283 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -24.03 9.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.752 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.4 148.11 18.5 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.595 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -124.81 175.58 7.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.71 0.29 . . . . 0.0 111.17 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HG3' ' HD2' ' A' ' 82' ' ' PRO . 15.7 tt0 -71.01 -27.64 63.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.31 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -94.45 -29.28 15.04 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.419 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 6.9 tt0 -57.91 -35.06 70.53 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 pp -57.6 -42.02 82.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.569 0.223 . . . . 0.0 111.206 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.74 -35.1 52.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.941 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -70.59 -51.76 26.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-O 120.709 0.29 . . . . 0.0 111.433 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.78 -37.68 79.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.422 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.35 -50.77 68.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.907 0.384 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.92 -35.93 81.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.282 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -72.29 -25.72 61.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.49 44.19 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.557 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 p -103.75 -14.86 15.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.12 69.86 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.623 0.249 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.56 -45.37 72.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.3 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.16 -43.74 95.56 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -39.94 84.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.84 -40.86 85.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.099 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.9 m -75.59 -34.08 60.61 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.855 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -60.21 -48.22 82.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.068 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.5 pt -65.28 -24.75 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.862 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.7 22.29 7.08 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.72 -46.0 13.73 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.838 0.319 . . . . 0.0 110.906 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.29 60.9 13.72 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.742 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 122.743 2.296 . . . . 0.0 112.795 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.31 -36.54 21.32 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.43 -39.32 6.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.129 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.67 -55.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.345 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -60.99 -39.11 88.42 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.684 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -35.37 78.74 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.933 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.51 92.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.834 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.8 mm-40 -60.46 -36.78 79.05 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.92 -31.66 68.35 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.968 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.1 mtt -69.22 -47.76 63.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.172 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -72.45 -16.55 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.582 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -61.48 -61.23 2.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.7 m -79.39 -18.59 52.01 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.634 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -120.89 68.21 15.97 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.411 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.4 -27.05 40.49 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.596 2.197 . . . . 0.0 112.573 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB3' HG22 ' A' ' 52' ' ' VAL . 28.5 m-85 -90.09 65.74 6.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.975 0.416 . . . . 0.0 110.356 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.74 141.73 38.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -141.12 101.35 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.392 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.32 139.04 35.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.664 0.269 . . . . 0.0 110.904 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.421 ' OG ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -153.1 -176.08 5.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.373 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.36 -170.62 2.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.013 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 m -109.07 -39.78 5.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.261 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.9 37.3 3.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.664 0.269 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 t -97.08 138.33 21.26 Favored Pre-proline 0 C--O 1.234 0.272 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.958 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.14 -28.4 41.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.827 2.351 . . . . 0.0 112.239 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.91 -37.65 58.56 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.337 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.0 t -70.2 -45.99 65.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.497 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.84 -37.43 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.546 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -68.51 -46.9 68.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.674 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.27 93.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.385 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -75.39 -28.76 59.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.089 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 t -60.82 -48.31 82.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.108 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.52 -45.37 92.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -66.98 -31.97 72.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.35 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -68.33 -33.93 75.18 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.99 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -81.11 -36.29 30.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.707 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -80.61 -7.85 59.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.121 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.9 46.02 26.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.2 m -119.02 35.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.73 3.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -124.05 -50.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.608 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -62.19 -25.73 67.94 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 25' ' ' TYR . 10.0 p -113.21 156.75 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.418 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.37 111.14 18.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.326 0.584 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 t -104.31 132.83 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.787 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -119.14 113.04 20.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.675 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -99.72 111.54 23.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.635 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 pt -98.69 76.9 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.614 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 26.9 8.57 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.983 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.4 30.6 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 15.1 mt -113.3 132.68 22.34 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.14 -167.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.818 2.345 . . . . 0.0 112.506 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 9.58 5.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.077 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -116.07 -41.3 3.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.371 0.129 . . . . 0.0 110.93 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.1 tt0 -82.56 -40.84 20.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.898 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -60.85 -40.55 93.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -41.09 96.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.968 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -56.62 -47.7 79.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.042 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -34.46 78.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.103 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -48.36 71.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.72 -42.37 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.238 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.67 -42.74 79.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.269 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -49.47 71.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -24.78 65.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.05 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.87 48.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.164 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.2 t -87.83 -47.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.3 -41.57 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.8 38.98 2.81 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.685 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -102.98 109.01 20.4 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.443 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.22 31.06 1.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -169.52 167.81 9.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.766 0.317 . . . . 0.0 111.269 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -136.31 159.7 69.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.421 ' HB3' ' OG ' ' A' ' 29' ' ' SER . 73.3 Cg_endo -77.77 156.15 95.24 Favored 'Cis proline' 0 C--N 1.352 0.727 0 C-N-CA 123.442 -1.482 . . . . 0.0 112.906 0.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 t -127.31 125.59 41.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.188 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.98 111.25 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 111.086 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.83 120.46 60.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.555 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.37 120.46 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.024 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.84 40.11 5.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 48.99 75.2 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.971 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -171.99 134.87 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -56.91 115.18 2.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.4 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.0 3.09 5.29 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.07 136.7 5.27 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.91 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.24 167.03 13.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.927 0.394 . . . . 0.0 111.635 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.76 -38.84 89.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.746 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -29.84 29.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -55.49 -31.89 62.39 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.266 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.51 -55.65 32.25 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.624 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -34.98 74.44 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -70.19 -42.97 71.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -73.87 -41.06 62.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.93 -41.93 77.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.259 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.08 74.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.314 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.85 -26.65 63.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.264 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.41 25.58 25.57 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.519 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.9 p -114.56 13.14 17.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -45.3 68.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.619 0.247 . . . . 0.0 110.899 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.7 -43.14 97.48 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.918 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.63 -40.06 82.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.46 -40.81 92.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.752 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 mp -58.76 -37.07 75.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.134 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.3 m -72.57 -35.62 68.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.6 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -65.88 -46.58 77.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 pt -64.69 -25.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.43 27.04 7.0 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.407 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -85.73 -46.54 10.6 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.603 0.202 . . . . 0.0 110.761 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.1 mp -72.55 -59.5 2.44 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.969 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.392 2.061 . . . . 0.0 112.444 179.886 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.468 0.175 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.6 -37.72 58.71 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.864 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.42 -37.5 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.101 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.6 t -67.29 -47.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.087 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -62.78 -43.67 98.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.877 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -39.33 90.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.658 0.266 . . . . 0.0 110.732 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.93 93.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.88 -36.6 80.53 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.71 -34.01 77.31 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.05 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -43.97 74.95 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.242 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.0 pt -74.21 -15.12 16.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.655 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -61.49 -65.25 0.72 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.622 0.248 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.43 -23.99 27.65 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -123.56 67.58 38.84 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 110.832 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 -18.18 51.87 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.578 2.185 . . . . 0.0 112.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' A' ' 52' ' ' VAL . 10.6 m-85 -92.78 73.33 4.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.367 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.33 140.03 48.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.86 102.24 5.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.554 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.83 112.32 23.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 99.6 p -162.47 -177.76 5.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.942 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 69.32 118.81 0.03 OUTLIER 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -177.5 -48.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.863 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.65 34.75 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.043 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.27 134.42 21.36 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.664 0.268 . . . . 0.0 111.499 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.88 -33.17 10.37 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.76 -34.67 71.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.5 m -64.87 -39.51 93.67 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.36 -36.02 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.116 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -57.58 -45.09 85.68 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.771 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.48 87.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.12 -31.87 61.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.813 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -49.0 77.54 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.773 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.03 -40.87 88.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -67.95 -34.51 76.71 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.404 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.13 -33.06 65.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.494 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.35 -35.91 24.8 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.099 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.1 mt -80.95 -7.94 59.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.801 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.23 47.95 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.206 0.527 . . . . 0.0 110.528 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.8 m -119.97 24.43 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.195 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.7 21.07 12.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -105.48 -43.9 4.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.933 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -76.34 -21.12 56.53 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.934 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.43 HG13 ' HB3' ' A' ' 25' ' ' TYR . 28.9 t -107.51 156.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.778 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -114.08 110.97 20.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.263 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.07 133.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.658 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -125.36 136.25 53.26 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' SER . 10.0 p-10 -97.04 127.5 43.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -93.91 71.76 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.72 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.38 29.67 5.85 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.35 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.46 -45.69 2.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.998 0.399 . . . . 0.0 111.299 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -53.12 122.68 30.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.763 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 12.6 Cg_exo -70.45 -170.81 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.121 2.548 . . . . 0.0 111.857 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -68.01 -30.89 70.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -72.93 -46.81 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.294 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 13.0 tp10 -62.47 -34.19 76.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -56.39 -32.28 64.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.487 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -57.85 -53.74 54.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -61.31 -40.75 95.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.542 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.05 -36.02 80.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.418 ' CD ' ' HD2' ' A' ' 79' ' ' ARG . 9.9 mtm180 -60.6 -54.66 42.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.29 -39.79 79.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.031 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.52 -46.27 84.01 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.867 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -46.44 85.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -26.28 68.41 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.35 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -81.96 -30.81 31.51 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.205 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.4 t -83.8 -47.23 18.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.359 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.17 -38.9 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.29 7.27 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.74 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.95 109.74 4.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.66 0.267 . . . . 0.0 110.641 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.418 ' HD2' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -99.1 42.27 1.11 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.63 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.73 129.17 54.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.598 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -96.38 147.86 33.6 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.42 166.85 81.64 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.652 -1.395 . . . . 0.0 112.522 0.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.3 p -125.11 115.26 20.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.8 mt -109.58 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -111.47 116.44 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.03 129.52 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 m120 60.9 37.03 18.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.54 81.78 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -172.84 136.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 0.0 110.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -63.31 104.59 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.103 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -110.08 -26.02 9.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.726 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -117.83 139.75 15.04 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.048 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -117.66 -170.31 1.84 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.286 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 95' ' ' SER . 24.3 pm0 -77.31 -35.13 55.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.457 ' N ' ' HG2' ' A' ' 94' ' ' GLU . 8.1 t -84.01 -34.44 24.31 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.91 -39.17 25.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.613 0.244 . . . . 0.0 111.596 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.12 -55.6 32.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.394 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -41.54 64.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.517 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.0 mmt-85 -57.56 -36.83 72.17 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.537 0.208 . . . . 0.0 111.206 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.19 -44.99 24.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -42.98 99.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.746 0.308 . . . . 0.0 111.001 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.78 81.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -71.11 -27.26 63.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 27.42 13.17 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.493 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.7 p -112.44 14.82 20.34 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -52.27 58.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.489 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.39 -41.79 75.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.65 -46.94 80.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.799 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -62.69 -40.24 96.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -33.65 68.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 m -74.25 -34.38 63.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -67.36 -43.86 80.42 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.304 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.27 -24.35 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.81 25.51 9.73 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.786 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.45 -44.78 10.48 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.8 0.3 . . . . 0.0 110.798 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.86 56.46 23.58 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.96 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.716 2.277 . . . . 0.0 112.623 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 120.483 0.183 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -34.6 66.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.367 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -83.99 -35.47 23.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.009 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.9 t -56.06 -51.39 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -59.24 -42.39 90.97 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.248 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.34 -39.19 93.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.238 . . . . 0.0 110.736 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.84 90.13 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.693 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.22 -37.09 77.86 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.63 -33.81 76.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.909 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.5 69.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.318 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -72.51 -14.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.727 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -60.99 -57.85 10.9 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.201 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -86.25 -2.03 58.01 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -129.72 73.67 81.32 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.45 -36.35 35.02 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.709 2.273 . . . . 0.0 112.61 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.425 ' HB3' HG21 ' A' ' 52' ' ' VAL . 9.7 m-85 -99.97 68.39 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.941 0.4 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -106.89 139.38 41.38 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.513 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -136.05 112.54 9.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.62 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.33 114.98 26.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.624 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.82 175.75 5.52 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.272 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.49 173.59 6.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.481 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 p -70.12 72.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.274 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.3 t90 55.19 64.31 1.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.353 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -85.34 163.84 43.3 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.578 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.47 -34.18 86.53 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.593 2.195 . . . . 0.0 112.484 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.59 -32.48 13.41 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.393 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.92 -42.99 89.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.851 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.44 -36.39 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.226 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.14 -56.6 18.89 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.96 71.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.421 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.571 ' HA ' ' CE2' ' A' ' 43' ' ' TRP . 3.1 m-80 -69.0 -38.25 79.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -65.54 -37.63 87.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.196 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 mm -57.88 -59.7 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.79 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.571 ' CE2' ' HA ' ' A' ' 40' ' ' ASN . 1.6 p90 -72.96 -16.11 61.54 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 20.9 t-20 -73.55 -43.17 60.51 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.587 0.232 . . . . 0.0 111.06 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -81.31 -31.23 33.64 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.447 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -80.48 -6.92 58.88 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 54.29 48.54 20.54 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.168 0.508 . . . . 0.0 110.794 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.0 m -116.63 28.1 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HG3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mt-30 -83.03 -16.23 47.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.701 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -83.63 -38.99 20.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.647 0.261 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 25' ' ' TYR . 14.0 p -110.26 162.34 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -118.98 111.41 18.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.185 0.517 . . . . 0.0 109.958 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.17 141.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.229 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -135.64 126.7 27.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.887 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.78 141.67 28.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 pt -89.93 52.64 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 24.31 29.17 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.014 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -126.67 28.76 5.83 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 110.881 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.82 129.25 7.25 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.85 -177.05 2.02 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.721 2.281 . . . . 0.0 111.955 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -58.4 -36.69 73.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.638 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -62.85 -52.4 63.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.166 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -58.68 -36.18 73.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -56.36 -38.18 71.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.061 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.43 -55.49 15.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.041 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -41.29 86.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.849 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.9 t-105 -65.78 -38.7 89.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -58.73 -43.33 90.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.132 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.5 -46.29 86.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.913 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.1 76.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.17 -40.99 97.88 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -61.62 -30.75 70.9 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 111.143 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 -29.68 36.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.02 -43.0 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.145 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.11 -44.83 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.62 0.86 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.575 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.5 100.54 8.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.773 0.32 . . . . 0.0 110.472 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -91.34 29.43 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.54 176.24 11.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.317 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.86 153.05 81.31 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.28 -178.07 21.99 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.705 -0.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.3 p -131.64 131.43 43.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.405 ' HB ' ' CA ' ' A' ' 92' ' ' GLY . 21.3 mt -114.02 111.43 35.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.787 0.327 . . . . 0.0 111.253 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.72 129.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.631 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.6 t -123.41 119.08 56.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.66 41.73 3.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.61 50.44 64.26 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.746 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -175.12 135.06 0.34 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -60.46 102.82 0.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.54 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -106.7 -30.21 9.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.351 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.405 ' CA ' ' HB ' ' A' ' 84' ' ' ILE . . . -122.46 146.15 16.66 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.981 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.95 173.05 7.48 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.812 0.339 . . . . 0.0 111.352 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -36.66 80.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.7 m -84.82 -29.63 25.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.548 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.23 -35.12 48.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.559 0.218 . . . . 0.0 111.513 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 mt -67.52 -57.61 6.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.352 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -32.85 73.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.424 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -69.8 -40.96 75.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -78.65 -35.76 44.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.179 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.04 -43.88 87.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.56 70.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -72.31 -28.8 63.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.357 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.55 26.48 10.79 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.548 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.7 p -111.53 18.29 19.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -50.72 61.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.568 0.223 . . . . 0.0 110.483 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.32 -38.08 81.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -43.98 98.01 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.607 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.2 -41.98 93.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tp -65.88 -27.38 68.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.346 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.8 m -79.02 -34.9 43.54 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.605 0.24 . . . . 0.0 110.443 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -41.05 87.01 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 pt -64.9 -25.19 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.53 8.01 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.717 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -101.77 -54.15 2.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.84 0.32 . . . . 0.0 110.77 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.55 109.69 31.17 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.685 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.615 2.21 . . . . 0.0 112.478 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.68 -23.61 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.716 0.293 . . . . 0.0 110.816 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -120.7 -36.73 3.12 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 t -61.36 -55.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.876 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -70.23 -39.77 74.86 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.811 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -38.49 77.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.24 -49.32 72.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.12 -37.66 88.16 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.91 -37.47 86.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -46.14 83.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.471 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.3 pt -72.24 -16.6 18.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.597 0.237 . . . . 0.0 111.53 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -63.74 1.18 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.176 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.1 m -88.61 -16.97 31.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.484 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -124.55 70.5 56.12 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.583 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.24 -22.38 46.64 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.733 2.289 . . . . 0.0 112.614 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -94.2 66.51 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.426 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -110.77 127.84 55.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.075 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -112.41 113.74 26.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.687 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.34 126.81 35.99 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -119.17 157.91 27.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.304 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.86 175.85 9.1 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.429 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -97.8 112.86 24.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.957 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 57.5 39.87 27.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -109.91 148.45 38.28 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.888 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.19 -30.86 52.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.877 2.385 . . . . 0.0 112.296 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB3' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -69.76 -45.91 67.0 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 t -57.54 -52.62 64.65 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -62.41 -36.2 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.221 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -66.38 -55.46 15.77 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.83 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.22 68.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.746 0.307 . . . . 0.0 111.302 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.488 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 1.2 m-80 -72.34 -38.19 68.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 p -64.48 -37.61 88.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.54 -61.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.459 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.488 ' CD1' ' HA ' ' A' ' 40' ' ' ASN . 12.3 p-90 -65.92 -39.17 90.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.35 -38.36 77.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.697 0.284 . . . . 0.0 111.243 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -83.86 -32.02 25.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 mt -81.07 -8.03 59.68 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 51.64 47.3 25.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 110.944 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.52 33.25 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.418 ' HG3' ' CZ3' ' A' ' 43' ' ' TRP . 3.4 tt0 -74.17 -15.87 61.01 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.594 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.12 -30.59 23.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.666 0.27 . . . . 0.0 110.706 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -82.27 -31.15 30.24 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.345 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.0 t -133.68 149.75 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.764 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.46 111.62 19.53 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.383 0.611 . . . . 0.0 110.715 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.64 141.46 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.167 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.45 135.83 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.914 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.77 177.19 6.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.1 tt -63.93 -24.6 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.742 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.28 5.64 55.85 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.535 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 m 59.65 31.82 21.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.149 0.475 . . . . 0.0 110.6 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.94 132.02 67.3 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.704 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.91 175.89 1.64 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.7 2.267 . . . . 0.0 111.877 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -51.91 -28.09 15.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.571 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.73 -55.4 5.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.465 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -69.25 -33.05 72.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.439 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -53.49 -43.81 68.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.925 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -38.36 86.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.783 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -66.03 -37.24 85.38 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -66.9 -48.05 69.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.54 0.21 . . . . 0.0 111.096 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -56.87 -51.35 69.38 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.517 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -65.92 -45.44 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.573 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 12' ' ' PHE . . . -60.55 -54.59 43.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.492 0.187 . . . . 0.0 111.413 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.81 -38.76 82.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.725 0.298 . . . . 0.0 110.949 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.401 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 25.6 tt0 -69.13 -27.62 65.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -31.76 40.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.251 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.16 -48.59 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.333 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.36 -41.19 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 103.92 40.4 2.32 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -123.78 97.37 5.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.744 0.307 . . . . 0.0 110.552 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -86.52 49.99 1.91 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -170.72 170.66 6.52 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.144 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.61 161.71 53.09 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.401 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 70.7 Cg_endo -73.85 169.87 72.25 Favored 'Cis proline' 0 C--N 1.355 0.881 0 C-N-CA 123.497 -1.46 . . . . 0.0 113.017 0.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.65 127.99 13.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.7 mm -102.01 111.6 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.89 117.14 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.981 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.68 124.17 72.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 62.12 38.99 13.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.018 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.0 91.72 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.882 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.21 136.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.963 0.411 . . . . 0.0 110.637 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -60.54 107.99 0.76 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -115.53 -24.82 8.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.706 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.11 140.0 12.74 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.247 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 173.36 6.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -31.14 70.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.479 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -28.16 18.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.13 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -55.1 -37.95 67.49 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.213 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.59 -44.18 87.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.355 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.95 -34.59 59.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.4 mmt85 -72.82 -37.69 67.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.346 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.75 -45.94 56.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.11 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.23 -39.28 92.29 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.65 0.262 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.09 -50.56 65.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -69.15 -27.4 65.51 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.614 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 24.5 12.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.599 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.2 p -108.46 20.04 19.07 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.594 0.197 . . . . 0.0 111.454 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -50.72 11.3 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.658 0.266 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.44 -42.39 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.37 -51.45 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.749 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -39.58 94.72 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.94 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.49 -38.07 76.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.97 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.0 m -78.26 -34.48 49.03 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.628 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -64.12 -44.19 92.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.355 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.6 pt -64.58 -26.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.78 22.3 8.12 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.907 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.71 -44.47 17.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.877 0.37 . . . . 0.0 110.52 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -52.8 1.41 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.441 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--O 1.248 1.013 0 C-N-CA 122.387 2.058 . . . . 0.0 112.367 -179.902 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.609 0.242 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.33 -27.5 55.98 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.913 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 -39.53 5.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.482 0.182 . . . . 0.0 111.427 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.78 -52.54 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.11 -40.55 96.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 110.965 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.34 -35.03 77.82 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.542 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.92 -46.56 88.82 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.17 -36.41 79.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.803 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.86 -33.62 74.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.902 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -49.12 61.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pt -71.68 -14.43 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.406 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -63.62 1.21 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.65 0.262 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -84.41 -19.01 34.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -120.29 62.21 8.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.742 0.306 . . . . 0.0 110.829 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.97 -15.38 43.42 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.702 2.268 . . . . 0.0 113.019 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.514 ' HB3' HG11 ' A' ' 52' ' ' VAL . 5.6 m-85 -93.88 74.27 4.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.271 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.49 121.2 40.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.003 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -112.77 121.96 46.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.997 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.6 mt -98.92 117.96 34.62 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.669 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 94.1 p -119.52 154.44 33.84 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.555 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.74 164.25 12.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.478 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.91 39.41 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.84 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -161.31 -44.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.428 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.83 147.47 88.88 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-O 120.569 0.223 . . . . 0.0 111.064 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.93 -17.7 36.63 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.19 -38.11 67.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.329 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.1 p -62.61 -39.18 92.97 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.83 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.3 -37.31 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -64.0 -49.38 72.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.749 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.34 88.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.533 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -75.35 -31.39 60.53 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.621 0.248 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -59.82 -45.97 90.7 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.2 mm -65.74 -41.81 91.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.92 -34.69 78.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.098 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -67.17 -34.16 76.94 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -34.68 26.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.1 mt -80.63 -7.71 59.37 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 53.53 45.82 27.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.671 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.35 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -93.62 17.63 11.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.394 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.66 -44.9 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.679 0.276 . . . . 0.0 110.861 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -64.7 -26.38 68.35 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.395 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' A' ' 25' ' ' TYR . 20.6 t -110.05 157.76 10.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.683 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.4 111.24 20.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.288 0.566 . . . . 0.0 110.477 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 t -96.06 131.55 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.99 115.61 15.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.047 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -81.48 151.06 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.5 mm -98.35 72.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.88 26.01 2.08 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.143 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -130.49 32.69 4.39 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -142.66 126.92 9.78 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.53 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.76 -171.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.061 2.507 . . . . 0.0 112.507 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.11 9.44 3.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.44 -41.65 3.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.568 0.223 . . . . 0.0 110.951 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 32.1 tp10 -68.48 -37.95 80.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.059 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -63.79 -35.19 79.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.92 -57.38 12.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.127 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.74 87.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.087 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -46.27 89.16 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -44.94 64.72 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.226 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.7 mt -66.69 -47.32 83.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.2 90.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.437 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 10.9 m-85 -59.16 -53.5 57.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.19 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.65 -25.87 63.18 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.96 -30.85 56.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.972 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.34 -44.29 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.253 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.6 m -120.52 -44.03 2.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.54 23.25 21.94 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.954 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.44 75.8 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.485 ' HB2' ' HB3' ' A' ' 72' ' ' PHE . 5.7 mtt180 -119.43 29.82 7.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.835 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.36 111.51 8.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.283 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.5 mt -45.9 131.92 6.94 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.38 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.14 150.48 85.66 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 124.034 -1.236 . . . . 0.0 112.747 0.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.6 m -142.98 128.63 19.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.402 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 84' ' ' ILE . 28.6 mm -112.07 113.02 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.85 116.45 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.99 129.59 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.74 34.09 12.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.762 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.44 46.6 92.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.681 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -175.9 137.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.6 102.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.968 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -116.46 -25.72 7.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.712 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.12 138.61 14.57 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.933 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -123.35 -173.63 2.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.689 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.13 -37.83 63.97 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -95.24 -27.29 15.58 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.703 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.19 -39.04 66.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 93' ' ' THR . 17.1 mt -66.77 -47.23 72.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -62.28 -38.51 89.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.066 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -71.37 -38.92 71.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.276 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -74.28 -35.36 63.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.008 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -50.35 20.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.738 0.304 . . . . 0.0 111.05 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -36.84 71.66 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.47 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -72.41 -27.4 62.33 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.17 25.74 20.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.52 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 p -109.07 -5.33 16.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.08 -42.15 72.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.539 0.209 . . . . 0.0 111.273 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.61 -51.0 70.31 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -61.56 -44.01 97.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 -36.17 76.03 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.89 -40.51 93.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.805 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.7 m -74.6 -30.62 61.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.42 -24.62 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.736 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.06 7.19 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.769 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.89 -51.44 5.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.795 0.331 . . . . 0.0 110.743 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.15 109.4 37.4 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--O 1.251 1.141 0 C-N-CA 122.546 2.164 . . . . 0.0 112.873 -179.854 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.415 0.15 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.59 -32.35 40.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -96.51 -35.45 11.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.19 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.1 t -57.8 -51.76 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.526 0.203 . . . . 0.0 111.121 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.17 -36.76 78.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -65.51 -33.45 75.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.041 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.62 58.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.74 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 -34.06 76.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -70.03 -33.38 71.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -46.48 71.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.21 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 pt -71.99 -15.13 17.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.536 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -64.99 0.76 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.676 0.274 . . . . 0.0 111.026 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -24.21 26.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -119.72 68.37 11.61 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.808 0.337 . . . . 0.0 110.861 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.91 -19.63 30.43 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 112.945 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.405 ' HB3' HG11 ' A' ' 52' ' ' VAL . 37.7 m-85 -92.94 70.51 4.64 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.73 53.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.292 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -128.01 107.68 10.03 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.48 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.13 124.07 28.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.958 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 m -129.5 172.32 11.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.954 0.406 . . . . 0.0 111.428 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.35 -175.32 2.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.274 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.83 98.31 11.52 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.43 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.6 44.77 26.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.659 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -78.92 159.33 73.76 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.011 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.66 -36.3 14.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.642 2.228 . . . . 0.0 112.597 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.33 -36.51 13.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.24 -34.18 76.92 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.44 -33.38 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.582 0.229 . . . . 0.0 111.233 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -63.23 -48.89 76.33 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.998 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.27 76.8 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.134 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -75.35 -31.47 60.56 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -61.44 -49.19 77.85 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mm -69.05 -37.38 76.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.046 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.08 75.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.081 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.47 -30.05 57.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.271 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -81.57 -33.37 31.67 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.965 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.7 -7.71 59.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 50.64 50.11 19.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.012 0.434 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -112.48 33.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.435 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.1 -25.29 43.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.477 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -37.07 21.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 110.993 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -84.77 -15.0 46.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.491 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 25' ' ' TYR . 23.0 t -126.03 159.36 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.466 0.174 . . . . 0.0 110.947 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.65 111.74 17.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.307 0.575 . . . . 0.0 110.476 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.64 133.74 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -124.21 127.49 47.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.912 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 142.19 29.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.981 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.413 ' HB ' ' CD1' ' A' ' 60' ' ' LEU . 4.9 pt -136.35 72.28 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.32 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.9 28.02 7.2 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.154 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -141.2 42.55 1.79 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' CD1' ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -135.86 118.83 12.39 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 -176.97 2.11 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.676 2.251 . . . . 0.0 112.439 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -59.34 -34.4 72.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.281 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -59.19 -51.84 68.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.653 0.263 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.35 -44.33 65.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.833 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.2 -34.8 70.77 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.374 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.78 -49.43 76.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.616 0.246 . . . . 0.0 111.093 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -42.11 93.75 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.02 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -68.67 -32.01 71.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.07 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -47.27 81.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.951 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mt -76.85 -44.79 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.165 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.18 64.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.617 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -48.6 80.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.166 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.99 -23.87 65.69 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.492 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -30.98 39.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.123 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.7 t -86.91 -48.07 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.477 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.38 -37.62 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.42 33.57 8.56 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.416 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.52 93.53 0.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.61 34.08 1.92 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.82 112.56 24.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.412 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -91.11 147.37 35.51 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 94' ' ' GLU . 10.7 Cg_exo -71.57 128.13 13.73 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.309 -0.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.93 131.25 48.42 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.05 111.14 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -110.86 121.81 64.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.58 127.72 74.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 m120 60.95 39.17 16.94 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.146 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.99 49.97 72.73 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.819 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -172.65 134.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -67.55 106.82 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.901 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -117.55 -24.32 7.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.486 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.95 139.66 15.83 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.084 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.01 -179.55 4.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.696 0.284 . . . . 0.0 110.714 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 9.4 pt-20 -71.36 -35.97 71.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.0 m -95.07 -25.38 16.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.18 -33.34 52.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.498 0.189 . . . . 0.0 111.236 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.68 -50.28 69.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.44 -34.64 78.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 -73.42 -42.63 61.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -67.17 -44.92 78.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.049 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.5 -48.07 82.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.07 85.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.272 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -73.25 -24.75 60.5 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.73 56.72 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.529 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.0 p -105.13 -18.11 14.25 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.44 -47.7 72.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.635 0.255 . . . . 0.0 111.002 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -45.18 82.91 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.06 -37.96 89.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -48.6 79.32 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.89 -40.57 80.59 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.174 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -33.61 73.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.734 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -49.54 65.18 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.203 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 pt -65.77 -24.91 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.799 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.14 24.21 8.62 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.738 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -82.5 -42.92 17.82 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.697 0.249 . . . . 0.0 110.581 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mp -117.5 143.14 31.59 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.244 0.821 0 C-N-CA 122.603 2.202 . . . . 0.0 112.309 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 120.43 0.157 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.3 -27.5 47.3 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.673 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.9 -38.53 5.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.157 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 t -61.78 -57.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 111.259 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -46.8 79.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.249 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -60.36 -34.12 73.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.31 96.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.642 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.62 -34.23 70.91 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -70.33 -36.56 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.8 tpp -69.26 -46.16 67.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.103 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.421 HD13 ' HA3' ' A' ' 88' ' ' GLY . 1.7 pt -72.57 -14.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -63.71 1.13 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.658 0.265 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.05 -23.57 26.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.971 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -120.7 61.01 8.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.797 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.66 -16.64 42.48 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.766 2.31 . . . . 0.0 112.937 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB3' HG12 ' A' ' 52' ' ' VAL . 8.9 m-85 -89.42 67.1 7.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.954 0.407 . . . . 0.0 110.448 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.66 137.73 45.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.199 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -143.42 104.98 4.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.3 mp -78.79 125.65 29.66 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.4 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -148.03 -176.8 5.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.268 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.05 175.22 13.22 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.97 33.78 4.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.837 0.351 . . . . 0.0 111.251 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.09 -47.04 0.78 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.263 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 143.71 80.23 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.178 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.1 -39.39 13.66 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.644 2.23 . . . . 0.0 112.376 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -71.08 -34.18 70.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.207 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.5 m -60.15 -40.54 90.23 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.818 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.52 -36.93 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.746 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -71.59 -36.41 70.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.043 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.74 91.14 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.64 0.257 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -75.76 -29.5 58.85 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.577 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.8 p -61.16 -42.8 99.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.6 0.238 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.49 -52.62 39.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.245 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -60.09 -35.57 75.49 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.218 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.55 -33.67 74.5 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.882 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -79.04 -31.26 44.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.862 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -80.79 -7.56 59.44 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 55.85 48.24 18.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.235 0.54 . . . . 0.0 110.508 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.74 39.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -98.97 28.28 4.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.287 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -124.38 -49.43 1.8 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.7 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -68.29 -18.4 64.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.42 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.436 HG12 ' HB3' ' A' ' 25' ' ' TYR . 15.4 t -106.08 159.48 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -116.69 111.11 19.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 110.083 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.71 136.34 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.474 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.68 111.7 24.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.987 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -92.73 126.18 37.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.415 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.9 mt -85.99 63.99 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.057 0.456 . . . . 0.0 110.434 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.17 23.4 6.5 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.973 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -155.57 36.1 0.37 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.703 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.13 98.4 1.63 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.819 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.44 174.82 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.107 2.538 . . . . 0.0 112.661 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.14 -32.06 4.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -48.86 73.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.624 0.25 . . . . 0.0 111.009 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -78.67 -38.64 38.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.91 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -58.7 -40.39 83.51 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.886 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -42.89 99.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.683 0.278 . . . . 0.0 110.921 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -64.17 -42.07 96.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.685 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -34.21 73.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.193 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.15 -45.16 83.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 111.015 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.8 mt -74.72 -40.55 47.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.995 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.9 -54.49 44.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.233 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -39.83 79.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.992 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -28.43 68.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -30.88 31.93 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.335 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.01 -48.5 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.554 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.1 -40.99 2.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.63 42.55 1.69 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.949 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.5 101.81 5.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -94.82 37.66 1.14 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.768 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -161.07 -175.84 5.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.303 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.8 165.14 36.05 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.898 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.16 146.09 82.1 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.687 0.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 106.66 13.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.712 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.464 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 4.0 mp -102.3 111.05 30.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.761 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.7 t -117.99 116.47 51.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 91' ' ' TRP . 13.5 p -115.66 134.96 57.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.7 t30 58.02 32.9 22.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.421 ' HA3' HD13 ' A' ' 20' ' ' ILE . . . 66.91 32.42 80.95 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.758 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -148.16 132.26 17.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.176 0.512 . . . . 0.0 110.372 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -66.99 100.68 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.381 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.42 ' HB2' HG11 ' A' ' 86' ' ' VAL . 2.0 t-105 -102.44 -31.86 10.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.244 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.55 142.04 17.33 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.113 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 p -127.44 -172.01 2.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.563 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.91 49.23 1.78 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.271 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.84 -43.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.929 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -52.64 -33.12 45.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.02 -56.67 19.03 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.457 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -60.48 -42.56 96.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -58.3 -40.0 80.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.414 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.08 -46.21 16.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.923 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.77 -42.04 96.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.72 93.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -70.36 -27.08 64.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.279 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.26 24.22 24.94 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.497 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.1 p -113.41 19.09 17.24 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -44.45 81.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -54.91 -44.49 74.24 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.702 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.08 -38.68 83.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.723 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.66 -41.63 77.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.704 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.54 -22.0 47.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.49 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 m -77.94 -26.67 49.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.261 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -23.81 60.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -102.89 -23.66 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.13 23.93 9.36 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.166 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -38.5 11.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.949 0.375 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.42 142.45 44.03 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.836 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.379 2.052 . . . . 0.0 112.636 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.58 -30.41 36.91 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 110.684 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -100.04 -31.16 11.58 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 t -61.86 -52.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.029 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 t -62.13 -37.19 84.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.853 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -36.02 77.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.15 89.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.686 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -40.69 97.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.2 -30.9 70.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.719 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -68.18 -44.26 76.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.855 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -71.88 -14.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.517 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -63.58 1.23 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.653 0.263 . . . . 0.0 110.866 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -83.97 -24.98 30.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.403 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . 14.3 m-70 -118.58 64.29 5.91 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.782 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.82 -21.1 29.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.582 2.188 . . . . 0.0 112.793 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HB3' HG11 ' A' ' 52' ' ' VAL . 25.9 m-85 -92.1 69.74 5.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -110.89 130.76 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -118.91 101.63 8.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.414 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.403 HD12 ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -76.83 126.61 31.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.217 -179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.75 168.19 28.18 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.28 179.08 7.06 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.3 p -97.12 29.13 3.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.284 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -39.72 6.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.343 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.64 148.51 34.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 111.329 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.33 -39.45 7.31 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.711 2.274 . . . . 0.0 112.627 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.42 -33.25 71.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.103 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.3 m -55.17 -43.1 73.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.623 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.83 -43.27 89.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.028 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -61.47 -51.68 67.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.069 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.53 -41.06 80.15 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.709 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -73.9 -29.87 62.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.231 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -60.06 -40.69 90.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.118 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.1 mm -70.02 -51.1 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.412 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -62.45 -33.35 74.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.967 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -68.26 -34.7 76.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.098 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -78.6 -32.92 47.81 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.2 mt -80.68 -7.74 59.42 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 53.49 48.91 20.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.573 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.7 m -119.1 40.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -97.02 30.2 2.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.986 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.46 -49.43 2.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -68.01 -22.86 64.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.258 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 25' ' ' TYR . 44.2 t -114.98 156.09 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.49 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -116.15 111.28 20.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.252 0.548 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.35 142.19 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.386 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -126.52 104.88 8.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.94 151.58 31.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.5 mm -114.31 69.75 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.115 0.483 . . . . 0.0 111.066 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 -2.25 8.6 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.162 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -106.95 -34.44 7.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.016 0.408 . . . . 0.0 111.566 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 21.2 mt -64.72 122.58 79.75 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.171 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.2 Cg_exo -62.63 -172.0 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.017 2.478 . . . . 0.0 112.534 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -78.89 8.57 5.33 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.219 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -113.43 -42.61 3.45 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.604 0.24 . . . . 0.0 110.805 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.1 -36.24 72.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.275 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -57.24 -38.27 73.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.397 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -49.99 75.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.137 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -57.78 -36.28 71.95 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -37.51 79.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.828 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -66.31 -46.45 76.85 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.5 mm -67.88 -45.62 83.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.61 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.91 -53.54 57.27 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.36 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 2.9 m-85 -65.96 -28.98 69.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.651 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.511 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 5.3 mt-30 -56.92 -40.78 76.95 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 110.741 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -28.37 44.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.427 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.45 -48.16 48.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 110.686 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.8 m -144.45 -41.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 123.81 63.21 0.19 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.967 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' A' ' 72' ' ' PHE . 26.1 m -96.99 44.81 1.05 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.671 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -73.49 -16.58 61.29 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.866 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -140.1 121.04 14.56 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.0 mt -82.04 155.51 69.99 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.669 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.85 174.74 51.3 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 124.074 -1.219 . . . . 0.0 112.784 0.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.19 113.83 5.33 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mt -102.34 121.96 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.479 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.88 121.53 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.89 121.29 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 64.24 40.16 6.91 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.129 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.13 49.65 75.86 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.952 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.41 136.12 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.39 . . . . 0.0 110.541 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.4 104.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.307 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.86 -27.68 12.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.535 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.84 141.5 14.48 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.003 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.37 172.29 10.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.734 0.302 . . . . 0.0 111.282 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.94 -26.02 62.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.486 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -29.13 14.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -56.94 -34.05 67.61 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -56.44 19.45 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 110.805 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.95 -34.08 72.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -41.03 63.62 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.324 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.73 -43.45 59.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -50.57 73.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.8 0.333 . . . . 0.0 111.029 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.69 84.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -27.18 60.05 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.769 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.41 27.03 26.26 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.175 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.0 p -107.95 -6.78 16.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 -50.05 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.612 0.244 . . . . 0.0 110.755 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.09 -41.59 88.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.0 -45.79 90.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.667 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -56.15 -40.58 74.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.058 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.24 -46.33 86.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 m -78.59 -31.19 47.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.998 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -59.28 -38.89 81.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.7 pt -79.45 -24.5 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.19 25.13 8.03 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.948 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 -48.66 5.73 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.764 0.282 . . . . 0.0 110.722 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.09 113.07 66.11 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.544 2.163 . . . . 0.0 112.829 -179.702 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.572 0.225 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 t 72.9 -61.54 0.5 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.419 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.01 -36.2 17.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.69 0.281 . . . . 0.0 111.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -101.14 -33.35 10.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.205 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.9 -47.43 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.042 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.4 m -60.58 -45.46 93.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.85 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -62.59 -35.77 80.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.08 99.22 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.061 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.68 -41.5 95.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.08 -29.12 68.8 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.033 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.1 tpt -69.61 -46.58 65.95 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.139 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.4 pt -73.02 -15.0 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -61.4 -65.53 0.68 Allowed 'General case' 0 N--CA 1.458 -0.049 0 CA-C-O 120.71 0.291 . . . . 0.0 111.093 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.66 -22.81 25.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.227 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.63 68.12 14.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.764 0.316 . . . . 0.0 110.86 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.89 -30.96 20.83 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.628 2.218 . . . . 0.0 112.527 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.433 ' CE2' HG12 ' A' ' 86' ' ' VAL . 69.6 m-85 -90.84 68.0 6.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.59 139.79 42.88 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.379 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -124.38 115.42 20.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.48 96.24 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -111.81 174.77 5.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.129 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.79 -176.39 3.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -94.33 -38.72 10.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -151.72 72.37 1.02 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.51 148.15 60.5 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.62 -24.38 36.64 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.869 2.38 . . . . 0.0 112.888 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 94' ' ' GLU . 78.5 m-20 -88.73 -40.87 12.92 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.612 0.244 . . . . 0.0 110.669 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.51 -43.89 89.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.783 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.1 m -55.38 -32.36 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.5 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -70.16 -56.6 6.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.938 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.49 77.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.568 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -75.43 -31.81 60.48 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.893 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 t -64.76 -49.17 71.83 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.6 mm -65.13 -41.15 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -38.23 83.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.029 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -72.9 -30.19 63.74 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.346 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -32.55 34.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.944 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.3 mt -81.53 -8.09 59.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 t30 53.16 46.01 27.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.169 0.509 . . . . 0.0 110.696 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.98 43.45 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.68 18.42 10.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.647 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.32 -47.43 3.1 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.85 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -68.25 -23.65 64.81 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.336 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 25' ' ' TYR . 14.0 p -116.34 158.72 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -120.37 111.23 17.49 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.264 0.554 . . . . 0.0 110.372 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.37 132.4 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.96 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -126.71 131.69 51.31 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.69 142.74 27.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.671 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.8 pt -131.95 78.94 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.137 0.494 . . . . 0.0 111.394 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.78 -33.87 0.96 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.402 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.8 m -62.43 -37.17 84.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.073 0.436 . . . . 0.0 111.418 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 119.16 31.56 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.93 -174.73 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.133 2.555 . . . . 0.0 112.745 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -31.96 71.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.16 -48.51 78.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.553 0.216 . . . . 0.0 110.996 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.21 -33.95 65.65 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.217 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -57.07 -46.05 82.8 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.958 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -48.63 77.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.945 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.73 -48.6 79.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -62.46 -39.28 92.9 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.888 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -52.04 67.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.012 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.9 -40.53 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.07 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.1 -53.17 61.4 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.09 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.56 -36.17 77.83 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 1.9 mt-30 -61.19 -33.06 72.84 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.886 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -78.96 -28.85 43.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.196 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -76.61 -46.38 31.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.046 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.15 -44.65 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 113.13 49.12 0.58 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.441 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -130.37 103.45 6.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.794 0.331 . . . . 0.0 110.573 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -94.63 38.62 1.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -153.08 148.43 27.0 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mt -117.11 152.65 49.15 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.7 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 35' ' ' ASP . 84.3 Cg_endo -80.01 179.1 30.51 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.652 -1.395 . . . . 0.0 113.297 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.4 m -150.13 145.22 26.19 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.964 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.24 111.29 34.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -110.41 116.65 52.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.433 HG12 ' CE2' ' A' ' 25' ' ' TYR . 6.5 t -113.15 142.75 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 42.69 41.21 2.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.68 43.01 92.96 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.941 -0.572 . . . . 0.0 114.176 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 138.63 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 111.087 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -52.51 111.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.0 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.83 -22.08 11.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.775 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.16 148.31 19.11 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.157 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -119.37 175.79 5.65 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 110.749 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 3.0 tm-20 -61.86 -25.88 67.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.558 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.8 m -82.56 -36.37 26.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.497 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.403 ' HG2' ' CD2' ' A' ' 100' ' ' PHE . 4.9 tt0 -58.01 -32.36 67.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.501 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 -48.73 73.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.689 0.28 . . . . 0.0 110.724 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -74.27 -32.61 62.99 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.182 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.33 -38.66 85.25 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.345 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.403 ' CD2' ' HG2' ' A' ' 96' ' ' GLN . 5.6 m-85 -78.31 -44.05 26.3 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -58.5 -40.69 83.53 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.87 93.26 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.062 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -75.38 -28.96 59.69 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.37 23.15 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.4 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.6 p -122.96 19.63 10.06 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.93 -43.37 71.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.561 0.219 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.79 -51.19 69.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -40.03 86.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.78 -40.38 96.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.772 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 mt -66.34 -29.77 70.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.418 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 m -78.52 -30.26 47.0 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -59.56 -44.14 93.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.277 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 pt -67.01 -24.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.83 26.07 8.72 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.673 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tp -85.26 -46.15 11.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.843 0.321 . . . . 0.0 110.74 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.48 145.54 31.77 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.749 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 C--O 1.251 1.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.567 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 tpt . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m -56.31 -30.29 62.35 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.639 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.33 -35.87 29.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.211 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.7 -35.71 16.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.114 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -66.61 -49.03 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -65.64 -43.12 90.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.208 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -60.43 -37.35 80.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.566 0.222 . . . . 0.0 110.935 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.45 99.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.19 -40.31 77.14 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.82 -36.13 83.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.047 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.6 mmm -68.26 -45.64 72.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.308 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.7 pt -71.79 -14.58 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.677 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -60.92 -59.89 4.65 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -84.67 -10.91 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -124.03 72.95 55.72 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.8 -26.79 18.73 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.62 2.213 . . . . 0.0 112.792 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -93.57 70.73 4.24 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 132.98 53.09 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.152 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.94 108.16 10.72 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.603 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.96 136.09 33.25 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.214 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -132.47 172.8 12.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.596 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.92 177.9 5.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.525 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.8 m -77.15 83.87 3.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.34 45.97 16.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.402 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -70.08 155.19 93.87 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.126 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.75 -32.49 29.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.843 2.362 . . . . 0.0 112.582 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.49 -33.3 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.105 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 33' ' ' CYS . 31.2 m -69.43 -41.72 75.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.72 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -55.52 -32.69 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.592 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -59.16 -50.39 74.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 110.86 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.62 -35.87 75.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.529 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 -32.01 61.59 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.669 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -44.69 93.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 42' ' ' ILE . 30.7 mm -67.39 -48.93 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.327 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -65.34 -30.64 71.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.401 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -81.38 -32.25 32.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.974 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.0 mt -80.73 -7.73 59.45 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 52.18 43.95 30.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.875 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.47 31.6 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -102.92 28.15 6.45 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -112.71 -41.77 3.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -67.09 -24.45 65.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.281 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.9 t -100.59 159.23 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.656 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -110.89 111.14 22.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.386 0.612 . . . . 0.0 110.09 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.65 138.88 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.111 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 138.94 54.32 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.157 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.67 129.94 47.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.3 mt -88.99 69.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.128 0.49 . . . . 0.0 110.287 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.34 -40.95 0.34 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.993 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.7 p -57.29 -33.73 67.96 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.418 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.36 124.11 82.62 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.309 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.02 -176.24 2.54 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -36.58 75.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.8 -49.46 72.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.711 0.291 . . . . 0.0 111.009 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.57 -37.69 83.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.83 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -56.81 -31.46 64.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -52.33 65.91 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 111.081 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -67.16 -30.05 69.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.617 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.36 -54.37 47.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -57.92 -36.85 73.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.151 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.9 mt -69.52 -46.61 75.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.68 -49.66 74.22 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.142 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -45.66 80.8 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.028 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -26.45 68.55 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.22 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -31.3 35.56 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.143 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.67 -45.05 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.413 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.49 -41.28 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.56 4.29 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.441 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -120.19 107.77 13.41 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.669 0.271 . . . . 0.0 110.771 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -94.04 43.36 1.11 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.553 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -147.3 158.27 43.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -138.65 153.73 72.57 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.45 167.58 79.67 Favored 'Cis proline' 0 C--N 1.353 0.8 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.921 0.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 p -136.56 132.74 35.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.093 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.2 mt -110.92 114.57 47.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.17 117.1 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 91' ' ' TRP . 14.4 p -114.89 128.01 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 m120 59.36 40.58 20.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.72 80.52 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.914 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -171.84 134.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 110.776 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.91 106.59 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.409 ' HB2' ' CG1' ' A' ' 86' ' ' VAL . 1.6 m95 -124.12 0.46 8.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.34 6.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.827 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.2 t -122.82 179.12 4.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.902 0.382 . . . . 0.0 111.297 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -41.91 96.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.575 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -67.51 -28.7 68.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.412 ' HG2' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -56.98 -34.84 68.49 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 111.246 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.99 -38.68 72.7 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.183 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -79.33 -48.48 14.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.592 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -58.33 -50.25 74.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.412 ' CD1' ' HG2' ' A' ' 96' ' ' GLN . 10.8 m-85 -62.22 -39.19 91.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.392 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.66 -45.97 90.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.796 0.332 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.37 94.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.044 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -75.48 -29.49 59.59 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.02 13.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.503 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -117.21 16.99 14.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -49.92 47.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.72 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.0 -41.6 71.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.85 -43.64 87.84 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.718 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -54.78 -46.95 74.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.71 0.29 . . . . 0.0 110.737 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.56 -40.17 95.09 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.8 m -70.77 -35.27 72.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.634 0.254 . . . . 0.0 110.95 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -52.11 66.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.333 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 pt -62.21 -25.11 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.97 20.19 7.31 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.929 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.91 -49.06 14.92 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.843 0.322 . . . . 0.0 110.461 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.4 mt -110.15 126.61 28.6 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.839 2.359 . . . . 0.0 112.311 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.1 p -52.95 -35.13 58.41 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.352 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.51 47.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -83.86 -39.75 19.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.836 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.49 -47.72 87.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.938 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.3 m -61.19 -42.2 98.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -59.82 -39.43 85.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.751 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.74 97.32 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.973 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.07 -41.92 97.16 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -61.79 -36.56 81.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.779 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.41 -49.98 67.2 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.0 pt -71.4 -15.27 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.48 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -63.98 1.09 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.693 0.283 . . . . 0.0 111.099 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.8 t -85.55 -23.77 27.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -118.46 66.42 6.68 Favored Pre-proline 0 CA--C 1.53 0.212 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.63 -28.95 25.25 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.692 2.261 . . . . 0.0 112.501 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.437 ' HB3' HG12 ' A' ' 52' ' ' VAL . 3.2 m-85 -94.49 67.4 3.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -108.02 127.41 53.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.425 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.24 106.08 12.9 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.27 125.08 34.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.632 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t -138.22 179.12 6.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.76 156.33 43.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.635 0.255 . . . . 0.0 111.413 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 m -84.66 55.17 3.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.079 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -127.09 -46.69 1.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.759 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 153.67 42.15 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.88 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.06 -17.61 32.2 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.877 2.385 . . . . 0.0 113.073 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -52.87 -43.81 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.445 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.88 -58.24 9.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.579 0.228 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.6 m -60.45 -31.7 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -74.48 -31.79 62.34 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.03 64.9 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-O 120.745 0.307 . . . . 0.0 111.007 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -75.6 -28.17 58.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.1 p -63.5 -47.82 80.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.887 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.4 mm -67.47 -44.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.145 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -63.44 -39.14 93.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.989 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -69.16 -31.94 70.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.89 -31.09 35.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.905 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.1 mt -80.53 -7.96 59.4 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 56.12 47.88 18.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 110.76 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.5 m -135.3 32.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -24.91 54.96 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.492 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.95 -41.67 22.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.627 0.251 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.35 -20.24 66.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.605 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.437 HG12 ' HB3' ' A' ' 25' ' ' TYR . 19.6 t -117.89 163.67 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 122.16 0.184 . . . . 0.0 110.529 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -123.31 111.36 16.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.162 0.506 . . . . 0.0 110.294 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.46 134.34 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.054 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -132.47 130.09 40.04 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -100.72 151.15 22.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.49 -144.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.59 14.39 25.6 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.752 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -149.1 33.81 0.74 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.806 0.303 . . . . 0.0 111.331 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -97.15 116.31 65.96 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.947 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.4 Cg_exo -62.19 -170.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.116 2.544 . . . . 0.0 112.493 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.68 2.31 14.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -106.91 -39.53 5.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.628 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.24 -39.6 62.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.324 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -60.92 -38.42 85.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.715 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.29 -35.43 79.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.551 0.215 . . . . 0.0 111.236 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -64.55 -53.14 52.52 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.314 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -69.61 -36.59 76.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.343 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -46.27 73.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.381 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.19 -51.67 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.586 0.232 . . . . 0.0 111.45 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.55 -54.98 37.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.865 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -42.75 99.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.297 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.17 -27.81 68.97 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.539 0.209 . . . . 0.0 111.407 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -30.18 34.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.397 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.2 t -87.94 -48.3 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 p -113.57 -31.77 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.1 35.53 38.2 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.57 93.09 2.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 40.21 1.06 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -113.7 89.96 3.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.634 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.48 151.91 93.4 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.063 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.23 170.51 71.25 Favored 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 123.531 -1.445 . . . . 0.0 112.99 0.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.55 133.44 18.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.55 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mt -112.51 111.53 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.7 t -101.77 116.72 45.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 t -125.1 131.8 72.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t30 63.28 33.07 14.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.89 45.18 93.26 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.832 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -175.44 137.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.545 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -59.15 102.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -25.27 8.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.829 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -111.1 139.01 15.34 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.233 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.96 -177.75 3.57 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -43.71 68.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.958 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 m -70.22 -32.82 70.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.891 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -52.26 -36.15 51.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.432 0.16 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.19 -54.37 41.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.18 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -33.84 66.17 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.428 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -62.02 -42.35 99.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.62 0.248 . . . . 0.0 111.304 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.431 ' CE2' ' HG3' ' A' ' 109' ' ' GLU . 4.7 m-85 -77.83 -44.19 28.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.471 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -61.57 -42.42 98.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.48 67.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.596 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -83.54 -38.56 21.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.1 35.65 2.3 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.942 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 18.28 16.42 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.693 0.246 . . . . 0.0 111.47 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -51.42 66.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.606 0.241 . . . . 0.0 110.778 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -66.28 -38.46 87.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.034 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.26 -39.84 95.74 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.431 ' HG3' ' CE2' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -58.47 -49.38 77.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.911 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.36 -30.68 68.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.067 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 78.9 m -78.24 -34.12 49.35 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.741 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -47.08 86.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.53 -26.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.717 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.85 7.17 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.585 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -45.83 49.93 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.721 0.296 . . . . 0.0 110.511 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -79.93 -60.32 0.51 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.038 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.481 2.121 . . . . 0.0 112.413 179.833 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 p -173.97 -50.63 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.28 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.46 68.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.419 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.83 -38.28 23.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.851 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.89 -51.35 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -60.27 -35.36 75.36 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.795 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -57.19 -42.43 81.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.68 0.276 . . . . 0.0 110.814 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.76 88.51 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -63.27 -35.41 80.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.33 -39.07 91.93 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.5 mtp -64.46 -44.73 90.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.983 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 17' ' ' GLU . 37.1 pt -73.25 -14.69 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.419 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.26 -61.29 2.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.636 0.255 . . . . 0.0 110.855 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 m -83.37 -18.84 37.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.741 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -122.5 64.39 21.28 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.438 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.91 -23.66 61.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.503 ' HB3' HG13 ' A' ' 52' ' ' VAL . 13.2 m-85 -94.44 71.79 3.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -114.01 139.6 49.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.423 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.83 134.15 49.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.425 HD11 ' CD1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -107.92 127.67 53.95 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -117.09 153.7 32.3 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.365 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.75 -41.91 71.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.024 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 56' ' ' ASP . 14.5 m 66.25 33.65 7.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.324 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -159.36 -41.0 0.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.068 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.57 147.21 32.67 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.18 -20.55 24.85 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.018 2.479 . . . . 0.0 112.632 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.59 -39.86 58.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.113 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.59 -36.91 60.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.176 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.28 -35.11 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.442 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -58.47 -52.78 64.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.553 0.216 . . . . 0.0 110.875 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.97 75.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.64 -29.26 61.2 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 t -65.19 -48.95 71.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 42' ' ' ILE . 30.8 mm -65.21 -41.38 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -65.94 -36.9 84.63 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.159 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -62.59 -37.2 85.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -83.83 -30.76 26.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.372 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.71 -8.45 59.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 48.09 45.25 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.89 38.27 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -99.69 31.34 3.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -120.66 -49.84 2.22 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -25.51 68.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.265 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 25' ' ' TYR . 58.2 t -118.14 154.01 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.407 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.4 111.29 19.82 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.269 0.557 . . . . 0.0 110.21 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -107.93 141.63 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.287 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -126.13 125.72 42.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 3.0 m-20 -90.88 126.64 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.401 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.4 mt -79.27 60.3 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.698 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.53 18.07 4.95 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.811 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.3 p -129.97 10.02 5.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.813 0.307 . . . . 0.0 111.802 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.68 131.31 21.85 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-O 120.505 0.193 . . . . 0.0 111.11 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 64' ' ' GLU . 51.6 Cg_endo -68.3 -172.94 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.896 2.397 . . . . 0.0 112.095 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 6.35 4.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.91 -44.16 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.664 0.268 . . . . 0.0 110.817 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 3.5 tp10 -81.1 -42.95 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.31 -32.75 70.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.59 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -57.59 6.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.908 -0.133 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -31.73 67.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.172 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -73.11 -53.3 11.39 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.469 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -54.23 -42.16 69.55 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.439 ' N ' ' HG3' ' A' ' 69' ' ' ARG . 15.7 mt -62.04 -57.41 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.546 0.213 . . . . 0.0 111.249 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.16 86.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.668 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' CD1' HD11 ' A' ' 28' ' ' LEU . 1.1 m-85 -64.47 -51.5 62.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -58.8 -26.27 63.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.487 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -31.43 31.81 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.439 0.162 . . . . 0.0 111.385 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.1 t -84.96 -48.8 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.9 m -147.92 -37.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -45.95 -35.44 6.26 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.649 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t 61.34 -166.19 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.819 0.31 . . . . 0.0 111.184 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.33 40.54 1.11 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -160.69 130.53 5.07 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.4 mt -131.98 152.99 81.22 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.749 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.72 178.7 33.2 Favored 'Cis proline' 0 C--N 1.351 0.673 0 C-N-CA 123.688 -1.38 . . . . 0.0 113.027 0.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 t -144.31 155.98 44.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.04 114.68 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.0 t -101.17 118.38 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.73 131.79 72.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.948 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.51 31.5 16.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.203 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.73 44.91 94.18 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.59 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -173.12 137.76 0.71 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.362 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -57.56 108.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -130.33 5.12 4.79 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.73 139.84 8.27 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.941 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.7 177.54 7.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.932 0.396 . . . . 0.0 111.067 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -65.59 -45.38 83.44 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -37.4 85.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.31 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.01 -34.98 66.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.235 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.0 mt -66.33 -53.56 34.83 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.726 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -64.75 -35.92 82.63 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.131 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -69.31 -41.41 76.77 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -76.78 -45.81 27.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.515 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -62.31 -43.23 99.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.677 0.275 . . . . 0.0 111.061 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.93 97.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -73.24 -28.15 61.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.394 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.76 28.12 14.99 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.56 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.1 p -114.93 13.41 17.04 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.33 -51.7 28.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.535 0.207 . . . . 0.0 111.011 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.05 -44.25 97.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.85 -50.6 70.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.099 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.77 -37.66 87.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.192 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.5 mt -55.81 -46.23 78.11 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.083 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -64.91 -31.46 72.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.903 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.1 72.17 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.982 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.47 -27.83 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.541 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.05 21.41 7.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.055 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.17 -46.17 7.54 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.839 0.32 . . . . 0.0 110.799 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.3 mt -93.11 160.26 33.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.82 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.559 2.173 . . . . 0.0 112.448 179.851 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.884 0.373 . . . . 0.0 111.595 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -60.36 -29.09 68.69 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.45 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.74 -37.86 9.12 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.664 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -90.38 -39.16 12.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.143 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.83 -45.1 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.865 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -62.33 -43.7 98.21 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.77 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.67 -47.01 82.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.754 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.15 82.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.764 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -64.3 -34.27 77.75 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.172 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.56 -38.36 83.99 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.971 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -45.32 87.35 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.115 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 pt -72.16 -14.37 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.536 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -61.88 -64.59 0.89 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.603 0.24 . . . . 0.0 110.782 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -84.6 -25.99 28.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.788 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -119.72 66.17 9.93 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.809 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.39 -20.38 36.66 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.689 2.259 . . . . 0.0 112.867 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.412 ' HB3' HG23 ' A' ' 52' ' ' VAL . 18.4 m-85 -90.41 72.94 7.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.843 0.354 . . . . 0.0 110.628 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.93 137.98 42.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 102.91 6.13 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.752 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.62 122.0 25.98 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -120.56 149.99 41.57 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.185 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.53 -38.07 4.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.443 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t 67.66 13.47 9.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.691 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.44 -33.49 7.34 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.71 0.291 . . . . 0.0 110.927 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.13 155.69 36.13 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.874 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.95 -12.37 35.06 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.748 2.299 . . . . 0.0 113.091 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.4 -29.79 59.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 48.8 t -78.65 -49.63 12.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 m -51.15 -36.7 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.278 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -71.66 -43.14 66.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.96 72.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.461 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -74.12 -32.34 63.14 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.546 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -61.25 -42.74 99.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.796 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -66.32 -44.73 90.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.004 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -35.57 81.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.095 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -67.12 -33.62 75.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.132 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -82.07 -32.52 30.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.055 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.1 mt -82.13 -7.79 59.63 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 50.94 49.95 20.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.953 0.406 . . . . 0.0 111.031 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.17 33.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.091 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -83.07 -28.96 29.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.389 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.64 -42.65 34.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -65.26 -22.74 66.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.426 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 25' ' ' TYR . 11.1 p -108.91 163.2 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.393 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -120.2 111.17 17.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.23 0.538 . . . . 0.0 109.902 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.22 145.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -131.11 97.09 4.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.753 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.99 144.02 35.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.684 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.5 pt -99.96 64.28 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.105 0.479 . . . . 0.0 111.562 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -32.35 2.8 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.208 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 m -96.06 37.36 1.24 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.956 0.378 . . . . 0.0 111.576 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.455 ' HB2' ' CB ' ' A' ' 64' ' ' GLU . 2.7 pp -145.58 116.76 5.03 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.231 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.65 -176.85 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.989 2.459 . . . . 0.0 112.421 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -32.31 66.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.326 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -55.12 -41.83 72.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.273 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 7.0 mm-40 -77.53 -32.72 54.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.676 0.275 . . . . 0.0 110.824 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -54.15 -50.17 67.58 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.083 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.33 -42.1 98.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -38.98 75.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.14 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -73.53 -44.02 58.59 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.347 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -56.32 -39.16 72.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.49 -52.82 28.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.04 -54.5 46.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.337 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.46 -35.23 67.66 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.323 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -36.26 81.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.597 0.237 . . . . 0.0 111.073 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -28.86 32.56 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.553 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -81.08 -47.22 20.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.174 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.37 -39.77 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.07 42.29 3.07 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.707 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -121.95 108.43 13.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.758 0.313 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.88 38.08 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.6 160.95 43.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.119 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -123.06 155.76 63.79 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 96.6 Cg_endo -77.86 177.59 38.45 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.757 -1.351 . . . . 0.0 113.131 0.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 p -145.55 117.8 8.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 116.27 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.995 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 m -115.93 127.08 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.402 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.84 129.52 75.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 59.61 35.1 22.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.894 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.37 32.06 78.52 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.766 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -150.75 133.2 15.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.107 0.479 . . . . 0.0 110.045 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -59.74 102.37 0.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.256 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -106.81 -22.8 12.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.748 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.64 139.99 11.42 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.874 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.71 178.1 5.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -37.1 78.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.322 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t -98.19 -22.24 16.29 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.416 ' HA ' ' HG2' ' A' ' 99' ' ' ARG . 5.4 tt0 -57.15 -31.99 65.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.55 -43.65 96.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.95 -53.5 45.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.494 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 96' ' ' GLN . 1.7 ptt180 -59.78 -41.66 91.61 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.674 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -64.83 -42.75 94.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.81 -40.73 98.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.522 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.09 90.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -73.83 -27.53 61.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.24 24.22 32.25 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.61 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.4 p -116.54 11.26 14.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -52.08 44.56 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.671 0.272 . . . . 0.0 110.484 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -67.77 -47.73 68.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.76 -53.09 52.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.984 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.43 -41.55 76.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.885 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -63.29 -38.27 90.51 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.213 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -35.84 64.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.571 0.225 . . . . 0.0 110.57 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -66.7 -45.39 78.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.255 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.3 pt -65.42 -27.29 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.595 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.69 22.46 8.06 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.861 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 -45.46 7.04 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.78 0.29 . . . . 0.0 110.726 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.35 137.84 28.92 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 C--O 1.251 1.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.611 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.603 0.239 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p -57.02 -34.87 68.62 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.066 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.69 38.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.371 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.44 -37.94 19.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.875 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.46 -48.75 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.124 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 m -60.01 -41.76 92.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -60.02 -35.61 75.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.949 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.24 98.67 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.875 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 20' ' ' ILE . 7.1 mm-40 -61.23 -34.15 74.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.55 -34.87 67.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.74 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.7 mtt -68.14 -46.4 70.95 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.003 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -71.89 -17.19 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.317 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -64.99 0.76 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.695 0.284 . . . . 0.0 110.856 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 t -86.06 -27.83 24.49 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -119.78 66.27 10.16 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.553 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.36 -16.61 43.78 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.513 ' HB3' HG13 ' A' ' 52' ' ' VAL . 57.1 m-85 -90.43 68.57 6.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.435 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -112.52 136.17 52.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.265 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.64 112.28 14.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.293 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 117.13 27.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.039 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -138.6 169.17 18.26 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.25 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.25 159.65 28.27 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.187 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -103.0 21.9 14.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.423 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -153.34 32.16 0.47 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.49 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.4 144.49 32.45 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.915 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.77 -28.67 24.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.714 2.276 . . . . 0.0 112.763 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -111.08 23.31 14.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.15 -42.05 3.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.569 0.223 . . . . 0.0 111.059 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.58 -31.98 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.363 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -65.73 -51.77 56.56 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.091 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.68 79.17 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.572 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -75.42 -30.4 60.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 t -61.43 -47.88 83.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mm -62.53 -43.81 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -64.46 -36.45 84.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.049 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -29.6 63.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.18 -33.52 32.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.606 0.241 . . . . 0.0 111.014 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.82 -7.81 59.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 53.89 46.2 26.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.037 0.446 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.98 28.92 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.977 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.38 -6.7 36.94 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.34 -45.82 17.14 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 110.457 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -68.4 -28.04 66.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 25' ' ' TYR . 42.5 t -103.1 160.12 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.682 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 6.2 m-85 -114.46 111.18 21.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.095 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.16 135.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.045 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 118.1 33.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.835 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -95.45 144.31 26.07 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.278 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.4 pt -107.62 96.51 4.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.27 -79.61 0.1 Allowed Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.892 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 p -140.73 57.49 1.57 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.93 0.395 . . . . 0.0 110.784 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.96 136.09 66.66 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.205 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.19 -169.8 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.737 2.291 . . . . 0.0 112.133 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 2.1 mtp180 -75.7 1.19 15.29 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.51 -43.31 6.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.614 0.245 . . . . 0.0 110.984 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -75.29 -49.21 19.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.92 -35.51 75.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.361 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -67.53 -51.84 46.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.328 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -58.13 -42.39 85.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.87 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -61.9 -39.51 92.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.185 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -57.24 -54.35 47.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -68.57 -44.75 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.16 -42.06 72.63 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.999 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.423 ' CE1' HG23 ' A' ' 83' ' ' THR . 3.3 m-85 -70.51 -45.33 65.8 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.135 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.96 -27.96 69.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -32.36 31.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.42 -41.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.32 -38.46 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 36.76 6.42 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.633 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.0 m -137.04 113.24 9.87 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 38.86 1.19 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.895 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -134.36 129.4 35.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 1.3 mp -98.6 164.95 16.02 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 7.9 Cg_exo -72.29 144.65 81.08 Favored 'Cis proline' 0 C--N 1.352 0.761 0 C-N-CA 123.593 -1.42 . . . . 0.0 111.999 -0.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.423 HG23 ' CE1' ' A' ' 72' ' ' PHE . 89.5 m -107.2 105.72 15.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -101.9 111.1 30.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.332 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.5 118.17 52.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -121.72 112.58 35.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 66.06 42.96 3.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.059 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.48 50.74 64.3 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.122 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -173.4 138.4 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.97 94.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -97.6 -29.48 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.496 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.47 135.71 10.71 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.146 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.86 -177.48 3.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.013 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.15 -52.24 43.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -31.66 69.43 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -33.85 33.06 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 48.3 mt -51.36 -59.72 3.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.247 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -78.36 -33.04 49.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.148 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -57.46 -49.06 77.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.5 -39.87 67.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.027 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.77 -47.82 84.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.843 0.354 . . . . 0.0 110.721 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.81 76.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.353 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -74.81 -27.78 60.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.69 23.24 43.3 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.469 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.2 p -113.57 0.07 14.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.9 -47.4 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.603 0.239 . . . . 0.0 110.92 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.06 -46.05 72.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.231 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.88 -45.74 89.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.588 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -59.42 -40.01 85.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 tp -62.63 -40.7 97.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.22 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -77.34 -33.12 55.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 110.711 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -66.61 -43.66 84.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.358 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.6 pt -61.12 -25.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.26 21.87 6.41 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.703 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 tt -88.16 -55.02 3.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.745 0.307 . . . . 0.0 110.761 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 mp -89.09 140.99 29.04 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.699 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.867 2.378 . . . . 0.0 112.52 -179.864 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.65 0.262 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.17 -35.62 49.41 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.01 -34.19 63.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.327 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -97.36 -37.4 10.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.28 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.0 -47.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.652 0.263 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -61.08 -43.75 98.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.658 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -63.46 -35.57 80.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.064 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.82 95.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.07 -36.66 80.22 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.806 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -69.15 -32.49 71.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -48.11 62.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.088 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 pt -70.69 -15.05 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.486 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -61.3 -61.76 2.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -83.66 -19.82 34.67 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.39 68.53 10.46 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 110.563 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.42 -18.97 38.32 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.665 2.243 . . . . 0.0 112.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.465 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.4 m-85 -90.59 69.51 6.74 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.51 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.78 139.71 41.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -129.15 125.87 38.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.012 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.83 113.63 26.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.81 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 175.88 13.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.01 170.89 15.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.319 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -102.47 -15.15 16.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -85.88 -39.44 16.99 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.6 m -72.67 141.35 82.34 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.87 -39.09 1.94 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.871 2.381 . . . . 0.0 113.122 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -61.31 -29.94 70.19 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.74 0.305 . . . . 0.0 111.047 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.4 m -72.04 -34.77 69.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.886 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -58.15 -34.84 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.72 -54.38 36.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.514 0.197 . . . . 0.0 111.198 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.34 72.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.572 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -75.15 -32.02 61.21 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.763 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -63.46 -44.51 94.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.969 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.1 mm -63.49 -43.92 98.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.038 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -34.24 77.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.307 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -28.08 63.81 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.186 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -80.6 -32.51 36.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.897 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -81.91 -7.69 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 52.73 49.73 19.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.2 m -122.69 26.17 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.299 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -26.66 65.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.734 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -81.2 -31.79 33.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.704 0.287 . . . . 0.0 110.913 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -75.9 -28.73 58.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 25' ' ' TYR . 13.5 p -112.46 161.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.815 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -120.46 111.13 17.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.368 0.604 . . . . 0.0 109.99 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.4 t -107.85 135.54 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.991 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.09 113.55 26.5 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.92 145.09 29.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.938 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.77 78.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -43.94 0.33 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.803 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -95.55 37.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 111.169 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.94 105.02 43.37 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.682 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.9 164.09 2.66 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.038 2.492 . . . . 0.0 112.678 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.13 -36.16 5.65 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.551 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -75.11 -49.5 19.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.007 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.3 -36.49 83.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.221 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -59.86 -48.05 83.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.003 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.16 -29.18 67.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -55.46 -53.45 56.2 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.228 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -74.01 -32.35 63.34 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.73 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -49.83 74.76 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -73.93 -39.03 51.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.074 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.72 -50.75 72.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.072 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -63.61 -33.87 76.57 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -32.84 70.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.884 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -78.94 -29.59 44.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.98 -44.14 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.191 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.26 -42.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.27 45.97 1.11 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.45 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 p -102.76 85.35 2.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 110.415 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 22.91 1.63 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 152.68 15.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.21 159.37 57.35 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.052 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.2 156.42 98.16 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.793 0.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.3 t -144.92 131.25 19.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.9 mt -112.02 122.79 66.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.343 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.12 121.65 64.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.352 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.89 121.87 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.98 43.37 3.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.63 75.28 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.854 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -174.16 134.99 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.559 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -62.86 101.21 0.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -113.32 -26.31 8.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.628 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.68 141.08 16.67 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.697 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.58 154.2 39.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.603 0.24 . . . . 0.0 111.171 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -36.72 68.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.0 m -86.0 -27.18 25.0 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -37.4 69.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.616 0.246 . . . . 0.0 111.083 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.14 -37.29 78.22 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.121 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -67.92 -54.48 18.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.186 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -60.36 -29.59 69.01 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -79.48 -45.56 19.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.343 0.116 . . . . 0.0 111.108 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -62.77 -43.98 97.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.91 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.1 -46.74 68.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.508 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -76.8 -34.8 57.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.42 32.97 3.26 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.89 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.4 p -115.39 20.57 14.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.717 0.258 . . . . 0.0 111.562 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.01 -47.35 13.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.644 0.259 . . . . 0.0 110.563 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.59 -45.85 90.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.263 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.68 -41.53 98.15 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.79 -42.17 98.66 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.867 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -38.27 81.88 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 m -77.55 -34.67 53.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.619 0.247 . . . . 0.0 110.573 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.88 -45.32 82.47 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -61.87 -24.6 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.3 23.02 7.16 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.676 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.33 -45.22 8.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.822 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.8 mp -98.71 146.28 31.35 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--O 1.248 0.989 0 C-N-CA 122.688 2.258 . . . . 0.0 112.699 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 120.757 0.313 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -58.63 -28.22 65.45 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.296 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 15' ' ' LYS . . . -66.76 -10.48 47.76 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -119.8 -41.56 2.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.498 0.19 . . . . 0.0 111.205 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 t -56.76 -51.11 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 m -59.79 -33.58 71.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.06 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 13.8 mttm -65.72 -32.75 74.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.914 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.29 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.557 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.563 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -37.89 89.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.425 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -46.25 85.82 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.115 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.8 pt -74.16 -17.5 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.646 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -61.93 2.11 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.664 0.268 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m -84.28 -19.06 34.46 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.3 69.09 59.98 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 121.046 0.45 . . . . 0.0 110.155 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 -21.37 70.3 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.943 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -90.28 66.08 6.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.864 0.364 . . . . 0.0 110.257 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -109.46 142.88 39.84 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.075 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.52 132.04 36.77 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.4 tp -110.54 114.39 27.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.187 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -131.97 172.71 12.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.68 -82.17 0.33 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.653 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.1 p -176.66 -62.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -139.41 42.04 2.04 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.931 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.97 161.19 69.48 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.577 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.64 -34.84 50.02 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.444 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.04 -35.04 14.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.467 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 71.8 m -67.58 -43.66 80.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.248 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -57.5 -32.5 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.384 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -63.47 -51.63 64.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.593 0.235 . . . . 0.0 110.805 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.01 79.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.702 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.66 -33.28 62.48 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.709 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -58.96 -43.72 91.36 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.3 mm -66.48 -46.52 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.367 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -34.43 78.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.92 -39.22 87.3 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.916 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -81.79 -24.63 35.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.497 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.5 mt -80.88 -8.28 59.68 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.4 t30 49.79 47.49 22.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.29 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.4 m -141.23 41.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.42 -18.01 20.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.706 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -77.22 -45.32 26.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.681 0.277 . . . . 0.0 110.665 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -61.01 -24.56 66.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.43 ' CG2' HD21 ' A' ' 115' ' ' LEU . 15.7 t -102.76 160.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.363 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -113.92 111.12 21.17 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.374 0.607 . . . . 0.0 110.137 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -108.22 143.01 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.369 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -131.52 129.72 41.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.91 131.43 34.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 tt -91.91 29.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.52 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.29 9.97 54.13 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.146 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 29.28 7.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.009 0.405 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HB2' ' CB ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -141.92 134.6 13.93 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.747 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.72 -177.62 2.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.202 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -56.79 -28.26 61.07 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.209 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.34 -56.82 13.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.962 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.404 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 10.7 mt-10 -69.91 -30.75 68.25 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -54.6 -45.52 73.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.861 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.17 -41.21 97.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.674 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -59.6 -46.78 87.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.163 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.36 90.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.211 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -60.99 -53.17 60.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 mt -63.77 -36.93 78.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.048 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.14 -55.13 17.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.228 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -41.22 77.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.27 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.24 69.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.517 0.198 . . . . 0.0 111.22 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -81.98 -30.37 31.66 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.581 0.229 . . . . 0.0 111.174 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.0 t -83.3 -46.27 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.328 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.21 -38.03 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.87 36.49 7.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.514 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.72 104.25 9.19 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.22 39.43 1.02 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -129.78 132.58 46.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -110.68 142.39 26.03 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.704 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 87.6 Cg_endo -79.17 -177.03 19.77 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.511 -1.454 . . . . 0.0 112.923 0.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.17 125.61 11.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.36 118.95 52.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.337 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 m -112.95 117.67 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.799 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.1 138.53 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.39 33.15 22.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.94 45.71 91.56 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.426 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -175.24 136.64 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -58.98 109.2 0.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.299 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.81 -21.82 10.48 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.283 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -138.28 138.06 9.24 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.041 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 96' ' ' GLN . 8.9 t -119.99 -170.44 1.96 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.502 0.178 . . . . 0.0 110.543 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.88 -33.18 34.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -29.32 34.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.427 ' HB2' HG22 ' A' ' 93' ' ' THR . 17.9 tt0 -65.08 -30.22 71.16 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.7 mt -56.97 -59.72 4.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.482 0.182 . . . . 0.0 111.315 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -62.25 -38.01 87.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -67.56 -40.09 84.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.41 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -77.16 -35.31 56.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.531 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.8 -42.49 97.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.52 -49.56 68.51 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.343 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -70.95 -26.19 63.06 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.49 23.12 27.21 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.542 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.34 -20.63 21.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 tp -57.3 -53.45 57.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.529 0.204 . . . . 0.0 110.825 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.78 -36.98 80.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.03 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.2 -41.57 98.49 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.149 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.64 -35.91 81.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.9 m -72.75 -37.22 67.76 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -47.32 83.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.249 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 33.9 pt -69.48 -24.53 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.4 26.9 9.62 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.43 HD21 ' CG2' ' A' ' 52' ' ' VAL . 4.2 tp -92.03 -40.16 11.24 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.736 0.268 . . . . 0.0 110.845 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 6.3 tp -65.42 -47.64 68.83 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.451 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 116' ' ' LEU . 70.7 Cg_exo . . . . . 0 C--O 1.252 1.204 0 C-N-CA 122.575 2.183 . . . . 0.0 112.606 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.9 mtt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.504 0.192 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.43 -57.58 0.61 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.658 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.6 -37.25 49.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -34.96 17.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.2 -48.02 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.149 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -67.31 -46.89 72.16 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -58.14 -38.27 76.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.688 0.28 . . . . 0.0 111.179 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.36 84.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -67.56 -38.28 83.88 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -61.76 -38.3 87.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.073 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.13 -47.74 73.12 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.8 pt -74.06 -14.63 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.634 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -61.7 2.36 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.59 0.234 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -83.76 -19.57 34.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -122.13 68.03 26.32 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.49 -24.02 42.94 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.429 ' HB3' HG22 ' A' ' 52' ' ' VAL . 4.4 m-85 -92.4 69.21 5.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.487 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.09 139.62 43.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.283 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -128.37 100.05 5.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.747 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.69 94.4 5.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 p -103.25 154.49 19.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.954 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.33 29.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.215 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -94.88 36.73 1.17 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -48.55 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.087 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.6 m -69.17 137.17 89.24 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.205 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.19 -30.72 10.24 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.755 2.303 . . . . 0.0 112.858 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -58.74 -36.06 73.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.124 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m -65.23 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.58 -37.17 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.296 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.45 -46.08 84.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.566 0.222 . . . . 0.0 110.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.11 -33.46 72.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -74.96 -33.4 61.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.57 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -59.11 -41.76 88.95 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.802 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 42' ' ' ILE . 22.8 mm -71.06 -36.91 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -34.05 76.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.765 0.317 . . . . 0.0 111.005 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -80.86 -31.55 35.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -83.52 -33.69 25.45 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.6 mt -80.75 -7.64 59.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 53.09 51.42 15.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.223 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.5 26.68 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.378 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.27 -28.92 70.05 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -89.99 -25.58 20.8 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -79.16 -42.38 26.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' A' ' 25' ' ' TYR . 11.4 p -120.93 154.86 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -118.26 111.13 18.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.0 110.383 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.48 134.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.886 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -130.06 132.9 46.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.58 148.83 22.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.414 HG22 HD23 ' A' ' 60' ' ' LEU . 9.6 pt -107.79 85.19 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.52 -47.45 0.2 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.308 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -58.7 -41.45 86.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.765 0.282 . . . . 0.0 111.253 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.414 HD23 HG22 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -59.75 112.48 5.38 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.369 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.79 -173.54 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.101 2.534 . . . . 0.0 112.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -34.48 67.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.32 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -52.69 64.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.76 -34.25 69.32 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.204 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -55.38 -42.58 74.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.586 0.231 . . . . 0.0 110.845 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.52 -47.98 51.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -57.12 -48.05 79.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.192 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -38.31 81.14 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -52.42 64.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.916 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 mm -59.86 -47.11 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.11 -52.39 65.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -58.25 -45.91 86.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.028 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -62.72 -27.51 69.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 -28.66 36.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.971 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 t -81.89 -48.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.102 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.29 -38.17 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.52 40.88 5.89 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.285 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.32 105.75 15.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.358 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.49 34.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -123.63 157.59 33.43 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -142.97 138.99 16.35 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.017 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.49 177.53 38.83 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.5 -1.458 . . . . 0.0 112.745 0.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.4 p -132.08 137.6 47.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.7 mt -118.64 112.31 37.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.46 122.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.262 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.96 124.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.37 35.29 12.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.078 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.52 46.27 70.88 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.745 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -176.15 135.94 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -59.49 107.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.032 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.26 4.32 7.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.117 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -149.11 141.18 8.71 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.028 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -121.19 -179.0 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.35 . . . . 0.0 111.237 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -72.81 -42.4 63.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.232 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.61 66.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.325 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -52.6 -38.19 59.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.571 0.224 . . . . 0.0 111.295 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.6 mt -56.88 -60.34 3.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -34.96 78.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.041 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -60.8 -44.94 96.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -79.7 -40.67 28.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -40.88 90.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.831 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -43.53 87.9 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.195 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -72.73 -29.34 63.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.531 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 24.85 19.26 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.714 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.5 p -110.88 9.83 22.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -49.01 69.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.416 0.151 . . . . 0.0 110.878 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.76 -46.39 89.8 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.67 -43.77 80.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -39.34 69.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.8 tp -56.21 -42.9 77.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.303 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.1 m -77.47 -33.03 54.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.871 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -68.63 -43.16 76.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.528 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.4 pt -64.12 -23.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.15 25.16 8.03 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.555 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.78 -46.5 14.12 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -65.51 -59.69 9.0 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.899 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--O 1.248 1.002 0 C-N-CA 122.455 2.103 . . . . 0.0 112.43 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.4 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p -53.26 -34.75 58.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.491 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.52 -29.03 34.54 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.657 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -106.21 -38.51 6.23 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.344 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.94 -48.15 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.8 m -60.59 -42.85 97.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -58.69 -35.55 72.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 110.715 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.88 -48.22 72.24 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -63.77 -34.18 77.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.51 -33.85 73.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.59 79.53 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.3 pt -73.25 -16.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.468 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -61.48 -62.21 1.98 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.767 0.318 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -84.65 -20.39 31.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -123.14 67.92 35.35 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.393 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.95 -22.57 55.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.665 2.243 . . . . 0.0 112.643 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -91.19 68.61 6.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.492 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -108.53 139.35 43.42 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.187 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -140.79 114.55 8.93 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.87 140.4 35.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.242 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -146.5 145.69 30.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.153 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.65 -175.32 5.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.39 50.51 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.028 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -48.94 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.7 t -68.74 133.78 90.42 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.267 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.99 -34.1 48.8 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.811 2.341 . . . . 0.0 112.715 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.17 -31.94 69.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.641 0.258 . . . . 0.0 111.084 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 68.9 m -68.98 -56.33 8.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.09 -35.85 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.882 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -62.03 -45.1 95.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.5 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.01 82.15 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.348 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -75.04 -29.39 60.77 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -62.95 -45.19 93.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.8 -42.43 89.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -35.5 78.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -69.36 -31.86 70.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.156 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -78.59 -30.37 46.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.888 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.5 mt -80.46 -7.09 59.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.3 t30 56.15 47.82 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.14 30.81 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -19.46 59.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.367 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 -35.18 21.67 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -74.54 -25.12 59.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.526 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.88 160.75 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.64 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.28 111.51 17.45 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.289 0.566 . . . . 0.0 110.336 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 p -112.15 141.65 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.516 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -125.23 124.51 41.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.22 144.99 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.072 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.8 mt -113.02 82.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.968 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.06 22.46 4.01 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.952 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -150.35 24.82 0.8 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.865 0.332 . . . . 0.0 111.391 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -171.79 58.28 0.25 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 111.263 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 60' ' ' LEU . 61.7 Cg_endo -89.75 160.6 5.16 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.766 2.311 . . . . 0.0 113.108 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.6 -75.48 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.1 -50.26 73.34 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -82.6 -28.1 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.678 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -65.17 -41.67 94.41 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.082 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.31 -40.66 86.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.624 0.25 . . . . 0.0 110.764 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -72.52 -44.61 61.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -34.72 77.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -63.81 -50.06 70.44 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.926 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 mt -60.16 -37.71 74.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.03 -54.66 16.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.177 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.54 -36.42 78.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.164 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.1 -31.06 72.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -29.19 41.35 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.3 t -81.16 -44.19 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.4 -40.82 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.27 36.58 6.55 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.423 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.0 t -111.26 105.16 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.73 0.3 . . . . 0.0 110.653 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.63 37.11 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -130.12 116.79 18.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.032 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.82 147.87 34.27 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.653 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.77 175.29 48.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.813 0.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.7 p -134.93 133.62 39.77 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.8 111.07 34.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.751 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 m -107.51 124.06 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.944 0.402 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.35 127.23 73.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.723 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 62.83 37.11 12.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.006 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.84 49.44 72.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.729 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.51 136.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.65 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -59.22 102.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -115.86 -11.22 11.58 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.89 142.77 14.23 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.64 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 m -130.31 159.67 36.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.641 0.258 . . . . 0.0 111.104 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -39.68 75.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.13 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -76.88 -29.02 55.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.556 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.28 -31.81 34.45 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 mt -70.27 -49.04 53.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.057 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -59.63 -53.29 59.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.495 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -36.35 70.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.539 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.72 -42.38 34.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.1 74.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.5 97.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.357 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -73.73 -27.86 61.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.531 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.09 28.73 12.76 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.334 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 p -107.83 6.52 27.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -45.83 88.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.654 0.264 . . . . 0.0 110.73 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.76 -38.14 86.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.99 -41.64 95.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -59.12 -44.97 92.03 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.546 0.212 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -41.51 85.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.212 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -80.72 -32.06 35.9 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -42.85 99.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.38 -21.83 29.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.634 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.16 26.65 13.67 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.781 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 tp -88.46 -43.58 11.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 110.8 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -56.81 20.35 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.084 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 C--O 1.25 1.102 0 C-N-CA 122.459 2.106 . . . . 0.0 112.702 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.46 23.53 10.13 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.07 73.4 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.763 0.316 . . . . 0.0 110.834 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.9 -28.05 11.34 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.444 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.83 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.635 0.255 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.2 m -61.45 -46.1 91.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -61.65 -37.65 84.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.049 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.17 87.48 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.99 -41.53 87.84 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.786 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -64.52 -35.75 81.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.63 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.3 mtp -66.34 -46.79 75.62 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.985 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.6 pt -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.636 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.88 -63.88 1.01 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.603 0.239 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -25.59 25.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.746 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -121.7 63.05 14.37 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.735 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.46 -18.21 54.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 112.845 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.418 ' HB3' HG11 ' A' ' 52' ' ' VAL . 19.5 m-85 -88.08 73.68 8.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.91 139.96 39.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.05 98.93 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.777 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.71 129.33 36.92 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -144.22 -176.6 5.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.84 109.88 9.94 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.2 p -50.29 -34.34 23.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.444 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -40.71 62.87 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.432 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 90.6 m -72.53 137.37 80.67 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.233 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -24.5 50.14 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.068 2.512 . . . . 0.0 112.836 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -55.99 -39.26 71.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.959 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -63.73 -39.45 94.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.406 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -62.84 -41.11 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.32 -47.41 73.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.861 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.16 89.74 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.538 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -75.25 -30.88 60.62 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.946 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.67 -49.01 76.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.35 -38.73 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -34.06 76.6 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.29 -33.54 75.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.273 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 -33.2 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.944 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.14 -7.73 59.29 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 53.26 48.77 21.33 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.896 0.379 . . . . 0.0 110.929 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.69 29.4 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.385 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -69.99 -35.0 74.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.051 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.01 -33.18 26.58 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.894 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -66.82 -21.31 66.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.579 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 25' ' ' TYR . 19.9 t -125.59 161.03 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.17 111.58 16.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -97.42 141.72 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -127.45 96.17 4.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.992 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.35 144.2 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.3 pt -139.47 99.11 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.466 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.52 29.31 8.33 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.007 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.0 m -145.9 -83.5 0.13 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.92 0.36 . . . . 0.0 110.94 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.401 HD23 ' HG3' ' A' ' 64' ' ' GLU . 11.8 mt 60.52 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.273 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.36 62.5 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.129 2.552 . . . . 0.0 113.418 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 62.21 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -54.38 -43.13 71.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.54 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.401 ' HG3' HD23 ' A' ' 60' ' ' LEU . 20.3 tp10 -60.01 -42.72 94.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.091 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -56.23 -42.85 77.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.983 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 35.5 mt-10 -79.9 -27.03 39.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.5 -46.79 75.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.464 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -71.99 -40.78 68.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -58.38 -39.98 81.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.6 mt -79.38 -41.54 22.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.653 0.263 . . . . 0.0 111.08 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.03 -54.33 47.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.25 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -58.3 -41.61 84.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.464 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -61.63 -32.22 72.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.737 0.303 . . . . 0.0 111.039 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -31.01 46.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -77.83 -43.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.08 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 m -134.39 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 111.94 47.66 0.71 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.601 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.54 96.17 5.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.798 0.333 . . . . 0.0 110.492 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.93 24.75 2.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.226 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.82 170.35 15.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.149 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.23 151.19 43.7 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.24 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.46 172.77 60.98 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.786 -1.339 . . . . 0.0 112.783 0.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 t -159.32 135.53 8.98 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.791 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.45 129.08 57.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.336 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.81 131.33 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.86 125.18 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.068 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 63.27 39.2 9.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.8 50.1 71.27 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.592 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -172.39 135.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.626 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -56.38 112.78 1.34 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.217 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -102.9 -29.75 11.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.538 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.32 161.74 31.84 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.095 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 t -129.1 -174.93 3.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.769 0.318 . . . . 0.0 111.386 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -55.68 -45.43 77.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.843 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.5 m -64.06 -38.18 90.15 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.822 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -60.79 -30.31 69.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.6 mt -59.13 -57.8 11.46 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.516 0.198 . . . . 0.0 110.962 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -39.03 88.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.865 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -65.97 -41.3 91.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.247 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -73.72 -38.23 64.88 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.861 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.69 -52.99 31.37 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.835 0.35 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -35.86 78.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -74.25 -28.13 61.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.289 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.64 24.5 32.96 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.572 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.1 p -115.14 2.1 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -57.23 13.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.527 0.203 . . . . 0.0 110.996 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -66.83 -37.85 85.3 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.017 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.31 -52.36 65.61 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.848 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.35 -34.03 76.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.157 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 mt -61.21 -43.19 99.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.965 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.2 m -69.43 -29.22 66.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.891 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.37 -52.08 67.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.915 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.07 -25.75 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.747 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.19 7.45 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.899 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 tt -85.76 -50.65 7.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.675 0.274 . . . . 0.0 110.692 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.77 138.44 20.07 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 122.924 2.416 . . . . 0.0 112.478 -179.764 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.491 0.186 . . . . 0.0 111.478 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m 64.12 20.88 12.37 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.42 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.99 -29.69 20.55 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-O 120.72 0.295 . . . . 0.0 110.467 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.57 -31.58 9.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 t -64.3 -57.22 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.064 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -60.26 -44.67 95.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.107 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -61.62 -34.45 75.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.791 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.12 72.19 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -77.03 -28.51 54.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.941 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.66 -35.48 67.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.048 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 14.2 ptp -70.75 -41.58 71.59 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.812 -0.177 . . . . 0.0 111.441 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -73.86 -19.86 17.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.547 0.213 . . . . 0.0 111.412 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -62.22 1.88 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 m -87.57 -20.93 25.75 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.266 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -127.53 70.59 76.6 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 120.855 0.359 . . . . 0.0 110.72 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.19 -22.52 53.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.718 2.278 . . . . 0.0 112.794 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -89.09 70.99 8.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.903 0.382 . . . . 0.0 110.275 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.83 140.68 38.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -142.77 106.91 4.72 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.783 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.7 tt -88.82 125.25 34.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.7 172.79 12.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.009 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.73 145.57 14.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.169 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -76.39 75.74 3.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 110.739 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -142.09 -53.65 0.43 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.747 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 142.05 30.2 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.29 -34.73 81.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.962 2.441 . . . . 0.0 112.593 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -33.69 76.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.6 m -58.44 -51.34 70.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.619 0.247 . . . . 0.0 110.75 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 t -59.33 -40.32 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -59.73 -48.95 79.62 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.33 76.6 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.516 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.0 -32.45 67.21 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.561 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -62.06 -44.6 96.33 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.1 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.13 -50.4 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.509 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.02 -32.87 74.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.916 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -66.36 -37.07 84.48 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.0 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -83.8 -27.69 28.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.471 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 mt -80.92 -7.72 59.57 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.57 49.08 20.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 m -127.28 38.9 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -93.21 16.59 12.74 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.523 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.9 -42.63 3.54 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.928 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -25.13 61.76 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.393 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.34 158.3 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.645 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -116.05 111.01 19.69 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.261 0.553 . . . . 0.0 110.207 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.2 t -104.25 134.85 44.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -120.97 98.21 5.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.0 132.07 34.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 pt -120.58 91.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.402 . . . . 0.0 111.293 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 13.09 8.08 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.127 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 t -135.72 56.75 1.82 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.018 0.437 . . . . 0.0 110.702 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -112.39 140.08 23.32 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.291 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 64' ' ' GLU . 86.3 Cg_endo -81.54 45.1 1.88 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.879 2.386 . . . . 0.0 114.314 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 67.47 -57.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.607 0.363 . . . . 0.0 111.764 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.33 -33.66 54.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.623 0.249 . . . . 0.0 111.007 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 18.9 mm-40 -70.01 -39.71 75.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.919 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -51.22 70.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.989 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -41.48 80.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.6 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -65.66 -38.67 90.0 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.884 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -62.17 -44.52 96.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.304 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.72 -41.72 87.07 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.4 mt -73.38 -43.87 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -52.27 65.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.23 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.47 -34.71 74.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -63.44 -30.31 71.45 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.047 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.84 -29.8 35.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.148 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -82.53 -44.54 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.194 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.89 -41.93 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 40.68 2.85 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.62 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.2 t -116.42 115.36 25.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -96.4 39.27 1.16 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -154.73 159.64 40.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.174 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.7 mt -127.42 152.22 76.07 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.882 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.4 ' HD2' ' HG3' ' A' ' 94' ' ' GLU . 72.8 Cg_endo -76.5 174.88 50.7 Favored 'Cis proline' 0 C--N 1.354 0.834 0 C-N-CA 123.482 -1.466 . . . . 0.0 113.007 0.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -129.0 121.61 28.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.876 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -106.1 111.23 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.871 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 m -112.18 119.46 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.2 t -117.08 122.1 69.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.963 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.27 38.57 7.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.38 49.02 78.06 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.679 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -174.31 136.68 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 110.693 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.05 106.15 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.283 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -24.03 9.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.752 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.4 148.11 18.5 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.595 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -124.81 175.58 7.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.71 0.29 . . . . 0.0 111.17 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HG3' ' HD2' ' A' ' 82' ' ' PRO . 15.7 tt0 -71.01 -27.64 63.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.31 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -94.45 -29.28 15.04 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.419 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 6.9 tt0 -57.91 -35.06 70.53 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 pp -57.6 -42.02 82.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.569 0.223 . . . . 0.0 111.206 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.74 -35.1 52.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.941 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -70.59 -51.76 26.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-O 120.709 0.29 . . . . 0.0 111.433 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.78 -37.68 79.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.422 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.35 -50.77 68.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.907 0.384 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.92 -35.93 81.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.282 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -72.29 -25.72 61.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.49 44.19 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.557 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 p -103.75 -14.86 15.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.12 69.86 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.623 0.249 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.56 -45.37 72.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.3 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.16 -43.74 95.56 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -39.94 84.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.84 -40.86 85.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.099 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.9 m -75.59 -34.08 60.61 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.855 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -60.21 -48.22 82.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.068 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.5 pt -65.28 -24.75 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.862 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.7 22.29 7.08 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.72 -46.0 13.73 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.838 0.319 . . . . 0.0 110.906 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.29 60.9 13.72 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.742 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 122.743 2.296 . . . . 0.0 112.795 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -64.2 -17.39 63.49 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.31 -36.54 21.32 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.43 -39.32 6.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.129 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.67 -55.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.345 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -60.99 -39.11 88.42 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.684 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -35.37 78.74 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.933 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.51 92.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.834 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.8 mm-40 -60.46 -36.78 79.05 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.92 -31.66 68.35 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.968 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.1 mtt -69.22 -47.76 63.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.172 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -72.45 -16.55 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.582 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -61.48 -61.23 2.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.7 m -79.39 -18.59 52.01 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.634 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -120.89 68.21 15.97 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.411 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.4 -27.05 40.49 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.596 2.197 . . . . 0.0 112.573 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB3' HG22 ' A' ' 52' ' ' VAL . 28.5 m-85 -90.09 65.74 6.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.975 0.416 . . . . 0.0 110.356 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.74 141.73 38.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -141.12 101.35 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.392 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.32 139.04 35.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.664 0.269 . . . . 0.0 110.904 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.421 ' OG ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -153.1 -176.08 5.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.373 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.36 -170.62 2.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.013 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 m -109.07 -39.78 5.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.261 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.9 37.3 3.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.664 0.269 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 t -97.08 138.33 21.26 Favored Pre-proline 0 C--O 1.234 0.272 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.958 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.14 -28.4 41.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.827 2.351 . . . . 0.0 112.239 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.91 -37.65 58.56 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.337 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.0 t -70.2 -45.99 65.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.497 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.84 -37.43 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.546 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -68.51 -46.9 68.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.674 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.27 93.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.385 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -75.39 -28.76 59.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.089 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 t -60.82 -48.31 82.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.108 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.52 -45.37 92.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -66.98 -31.97 72.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.35 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -68.33 -33.93 75.18 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.99 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -81.11 -36.29 30.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.707 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -80.61 -7.85 59.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.121 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.9 46.02 26.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.2 m -119.02 35.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.73 3.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -124.05 -50.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.608 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -62.19 -25.73 67.94 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 25' ' ' TYR . 10.0 p -113.21 156.75 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.418 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.37 111.14 18.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.326 0.584 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 t -104.31 132.83 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.787 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -119.14 113.04 20.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.675 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -99.72 111.54 23.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.635 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.4 pt -98.69 76.9 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.614 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 26.9 8.57 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.983 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.4 30.6 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 15.1 mt -113.3 132.68 22.34 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.14 -167.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.818 2.345 . . . . 0.0 112.506 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 9.58 5.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.077 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -116.07 -41.3 3.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.371 0.129 . . . . 0.0 110.93 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.1 tt0 -82.56 -40.84 20.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.898 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -60.85 -40.55 93.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -41.09 96.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.968 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -56.62 -47.7 79.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.042 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -34.46 78.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.103 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -48.36 71.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.72 -42.37 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.238 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.67 -42.74 79.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.269 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -49.47 71.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -24.78 65.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.05 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.87 48.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.164 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.2 t -87.83 -47.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.3 -41.57 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.8 38.98 2.81 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.685 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -102.98 109.01 20.4 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.443 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.22 31.06 1.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -169.52 167.81 9.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.766 0.317 . . . . 0.0 111.269 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -136.31 159.7 69.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.421 ' HB3' ' OG ' ' A' ' 29' ' ' SER . 73.3 Cg_endo -77.77 156.15 95.24 Favored 'Cis proline' 0 C--N 1.352 0.727 0 C-N-CA 123.442 -1.482 . . . . 0.0 112.906 0.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 t -127.31 125.59 41.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.188 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.98 111.25 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 111.086 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.83 120.46 60.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.555 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.37 120.46 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.024 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.84 40.11 5.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 48.99 75.2 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.971 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -171.99 134.87 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -56.91 115.18 2.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.4 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.0 3.09 5.29 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.07 136.7 5.27 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.91 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.24 167.03 13.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.927 0.394 . . . . 0.0 111.635 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.76 -38.84 89.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.746 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -29.84 29.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -55.49 -31.89 62.39 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.266 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.51 -55.65 32.25 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.624 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -34.98 74.44 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -70.19 -42.97 71.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -73.87 -41.06 62.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.93 -41.93 77.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.259 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.08 74.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.314 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.85 -26.65 63.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.264 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.41 25.58 25.57 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.519 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.9 p -114.56 13.14 17.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -45.3 68.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.619 0.247 . . . . 0.0 110.899 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.7 -43.14 97.48 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.918 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.63 -40.06 82.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.46 -40.81 92.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.752 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 mp -58.76 -37.07 75.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.134 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.3 m -72.57 -35.62 68.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.6 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -65.88 -46.58 77.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 pt -64.69 -25.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.43 27.04 7.0 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.407 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -85.73 -46.54 10.6 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.603 0.202 . . . . 0.0 110.761 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.1 mp -72.55 -59.5 2.44 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.969 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.392 2.061 . . . . 0.0 112.444 179.886 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p -125.48 -50.31 1.64 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.468 0.175 . . . . 0.0 110.778 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.6 -37.72 58.71 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.864 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.42 -37.5 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.101 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.6 t -67.29 -47.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.087 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -62.78 -43.67 98.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.877 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -39.33 90.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.658 0.266 . . . . 0.0 110.732 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.93 93.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.88 -36.6 80.53 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.71 -34.01 77.31 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.05 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -43.97 74.95 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.242 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.0 pt -74.21 -15.12 16.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.655 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -61.49 -65.25 0.72 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.622 0.248 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.43 -23.99 27.65 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -123.56 67.58 38.84 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 110.832 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 -18.18 51.87 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.578 2.185 . . . . 0.0 112.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' A' ' 52' ' ' VAL . 10.6 m-85 -92.78 73.33 4.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.367 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.33 140.03 48.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.86 102.24 5.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.554 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.83 112.32 23.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 99.6 p -162.47 -177.76 5.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.942 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 69.32 118.81 0.03 OUTLIER 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -177.5 -48.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.863 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.65 34.75 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.043 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.27 134.42 21.36 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.664 0.268 . . . . 0.0 111.499 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.88 -33.17 10.37 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.76 -34.67 71.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.5 m -64.87 -39.51 93.67 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.36 -36.02 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.116 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -57.58 -45.09 85.68 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.771 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.48 87.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.12 -31.87 61.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.813 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -49.0 77.54 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.773 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.03 -40.87 88.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -67.95 -34.51 76.71 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.404 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.13 -33.06 65.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.494 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.35 -35.91 24.8 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.099 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.1 mt -80.95 -7.94 59.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.801 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.23 47.95 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.206 0.527 . . . . 0.0 110.528 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.8 m -119.97 24.43 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.195 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.7 21.07 12.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -105.48 -43.9 4.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.933 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -76.34 -21.12 56.53 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.934 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.43 HG13 ' HB3' ' A' ' 25' ' ' TYR . 28.9 t -107.51 156.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.778 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -114.08 110.97 20.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.263 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.07 133.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.658 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -125.36 136.25 53.26 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' SER . 10.0 p-10 -97.04 127.5 43.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -93.91 71.76 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.72 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.38 29.67 5.85 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.35 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.46 -45.69 2.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.998 0.399 . . . . 0.0 111.299 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -53.12 122.68 30.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.763 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 12.6 Cg_exo -70.45 -170.81 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.121 2.548 . . . . 0.0 111.857 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -68.01 -30.89 70.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -72.93 -46.81 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.294 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 13.0 tp10 -62.47 -34.19 76.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -56.39 -32.28 64.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.487 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -57.85 -53.74 54.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -61.31 -40.75 95.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.542 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.05 -36.02 80.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.418 ' CD ' ' HD2' ' A' ' 79' ' ' ARG . 9.9 mtm180 -60.6 -54.66 42.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.29 -39.79 79.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.031 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.52 -46.27 84.01 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.867 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.55 -46.44 85.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -26.28 68.41 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.35 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -81.96 -30.81 31.51 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.205 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.4 t -83.8 -47.23 18.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.359 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.17 -38.9 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.29 7.27 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.74 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.95 109.74 4.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.66 0.267 . . . . 0.0 110.641 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.418 ' HD2' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -99.1 42.27 1.11 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.63 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.73 129.17 54.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.598 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -96.38 147.86 33.6 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.42 166.85 81.64 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.652 -1.395 . . . . 0.0 112.522 0.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.3 p -125.11 115.26 20.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.8 mt -109.58 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -111.47 116.44 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.03 129.52 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 m120 60.9 37.03 18.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.54 81.78 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -172.84 136.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 0.0 110.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -63.31 104.59 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.103 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -110.08 -26.02 9.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.726 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -117.83 139.75 15.04 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.048 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -117.66 -170.31 1.84 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.286 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 95' ' ' SER . 24.3 pm0 -77.31 -35.13 55.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.457 ' N ' ' HG2' ' A' ' 94' ' ' GLU . 8.1 t -84.01 -34.44 24.31 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.91 -39.17 25.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.613 0.244 . . . . 0.0 111.596 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.12 -55.6 32.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.394 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -41.54 64.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.517 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.0 mmt-85 -57.56 -36.83 72.17 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.537 0.208 . . . . 0.0 111.206 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.19 -44.99 24.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -42.98 99.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.746 0.308 . . . . 0.0 111.001 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.78 81.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -71.11 -27.26 63.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 27.42 13.17 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.493 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.7 p -112.44 14.82 20.34 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -52.27 58.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.489 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.39 -41.79 75.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.65 -46.94 80.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.799 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -62.69 -40.24 96.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -33.65 68.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 m -74.25 -34.38 63.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -67.36 -43.86 80.42 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.304 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.27 -24.35 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.81 25.51 9.73 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.786 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.45 -44.78 10.48 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.8 0.3 . . . . 0.0 110.798 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.86 56.46 23.58 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.96 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.716 2.277 . . . . 0.0 112.623 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.6 mtm . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.679 0.276 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.95 -35.23 64.02 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -34.6 66.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.367 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -83.99 -35.47 23.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.009 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.9 t -56.06 -51.39 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -59.24 -42.39 90.97 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.248 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.34 -39.19 93.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.238 . . . . 0.0 110.736 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.84 90.13 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.693 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.22 -37.09 77.86 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.63 -33.81 76.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.909 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.5 69.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.318 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -72.51 -14.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.727 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -60.99 -57.85 10.9 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.201 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -86.25 -2.03 58.01 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -129.72 73.67 81.32 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.45 -36.35 35.02 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.709 2.273 . . . . 0.0 112.61 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.425 ' HB3' HG21 ' A' ' 52' ' ' VAL . 9.7 m-85 -99.97 68.39 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.941 0.4 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -106.89 139.38 41.38 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.513 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -136.05 112.54 9.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.62 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.33 114.98 26.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.624 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.82 175.75 5.52 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.272 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.49 173.59 6.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.481 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 p -70.12 72.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.274 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.3 t90 55.19 64.31 1.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.353 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -85.34 163.84 43.3 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.578 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.47 -34.18 86.53 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.593 2.195 . . . . 0.0 112.484 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.59 -32.48 13.41 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.393 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.92 -42.99 89.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.851 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.44 -36.39 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.226 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.14 -56.6 18.89 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.96 71.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.421 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.571 ' HA ' ' CE2' ' A' ' 43' ' ' TRP . 3.1 m-80 -69.0 -38.25 79.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -65.54 -37.63 87.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.196 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 mm -57.88 -59.7 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.79 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.571 ' CE2' ' HA ' ' A' ' 40' ' ' ASN . 1.6 p90 -72.96 -16.11 61.54 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 20.9 t-20 -73.55 -43.17 60.51 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.587 0.232 . . . . 0.0 111.06 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -81.31 -31.23 33.64 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.447 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -80.48 -6.92 58.88 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 54.29 48.54 20.54 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.168 0.508 . . . . 0.0 110.794 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.0 m -116.63 28.1 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HG3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mt-30 -83.03 -16.23 47.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.701 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -83.63 -38.99 20.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.647 0.261 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 25' ' ' TYR . 14.0 p -110.26 162.34 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -118.98 111.41 18.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.185 0.517 . . . . 0.0 109.958 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.17 141.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.229 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -135.64 126.7 27.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.887 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.78 141.67 28.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 pt -89.93 52.64 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 24.31 29.17 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.014 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -126.67 28.76 5.83 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 110.881 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.82 129.25 7.25 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.85 -177.05 2.02 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.721 2.281 . . . . 0.0 111.955 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -58.4 -36.69 73.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.638 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -62.85 -52.4 63.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.166 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -58.68 -36.18 73.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -56.36 -38.18 71.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.061 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.43 -55.49 15.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.041 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -41.29 86.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.849 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.9 t-105 -65.78 -38.7 89.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -58.73 -43.33 90.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.132 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.5 -46.29 86.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.913 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.1 76.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.17 -40.99 97.88 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -61.62 -30.75 70.9 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 111.143 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 -29.68 36.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.02 -43.0 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.145 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.11 -44.83 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.62 0.86 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.575 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.5 100.54 8.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.773 0.32 . . . . 0.0 110.472 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -91.34 29.43 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.54 176.24 11.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.317 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.86 153.05 81.31 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.28 -178.07 21.99 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.705 -0.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.3 p -131.64 131.43 43.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.405 ' HB ' ' CA ' ' A' ' 92' ' ' GLY . 21.3 mt -114.02 111.43 35.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.787 0.327 . . . . 0.0 111.253 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.72 129.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.631 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.6 t -123.41 119.08 56.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.66 41.73 3.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.61 50.44 64.26 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.746 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -175.12 135.06 0.34 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -60.46 102.82 0.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.54 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -106.7 -30.21 9.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.351 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.405 ' CA ' ' HB ' ' A' ' 84' ' ' ILE . . . -122.46 146.15 16.66 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.981 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.95 173.05 7.48 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.812 0.339 . . . . 0.0 111.352 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -36.66 80.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.7 m -84.82 -29.63 25.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.548 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.23 -35.12 48.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.559 0.218 . . . . 0.0 111.513 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 mt -67.52 -57.61 6.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.352 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -32.85 73.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.424 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -69.8 -40.96 75.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -78.65 -35.76 44.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.179 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.04 -43.88 87.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.56 70.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -72.31 -28.8 63.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.357 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.55 26.48 10.79 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.548 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.7 p -111.53 18.29 19.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -50.72 61.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.568 0.223 . . . . 0.0 110.483 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.32 -38.08 81.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -43.98 98.01 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.607 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.2 -41.98 93.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tp -65.88 -27.38 68.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.346 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.8 m -79.02 -34.9 43.54 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.605 0.24 . . . . 0.0 110.443 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -41.05 87.01 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 pt -64.9 -25.19 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.53 8.01 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.717 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -101.77 -54.15 2.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.84 0.32 . . . . 0.0 110.77 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.55 109.69 31.17 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.685 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.615 2.21 . . . . 0.0 112.478 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.9 mtt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 120.757 0.313 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 p 53.87 22.95 3.55 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.364 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.68 -23.61 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.716 0.293 . . . . 0.0 110.816 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -120.7 -36.73 3.12 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 t -61.36 -55.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.876 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -70.23 -39.77 74.86 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.811 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -38.49 77.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.24 -49.32 72.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.12 -37.66 88.16 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.91 -37.47 86.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -46.14 83.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.471 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.3 pt -72.24 -16.6 18.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.597 0.237 . . . . 0.0 111.53 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -63.74 1.18 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.176 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.1 m -88.61 -16.97 31.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.484 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -124.55 70.5 56.12 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.583 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.24 -22.38 46.64 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.733 2.289 . . . . 0.0 112.614 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -94.2 66.51 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.426 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -110.77 127.84 55.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.075 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -112.41 113.74 26.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.687 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.34 126.81 35.99 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -119.17 157.91 27.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.304 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.86 175.85 9.1 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.429 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -97.8 112.86 24.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.957 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 57.5 39.87 27.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -109.91 148.45 38.28 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.888 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.19 -30.86 52.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.877 2.385 . . . . 0.0 112.296 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB3' ' HG3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -69.76 -45.91 67.0 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 t -57.54 -52.62 64.65 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -62.41 -36.2 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.221 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -66.38 -55.46 15.77 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.83 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.22 68.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.746 0.307 . . . . 0.0 111.302 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.488 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 1.2 m-80 -72.34 -38.19 68.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 p -64.48 -37.61 88.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.54 -61.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.459 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.488 ' CD1' ' HA ' ' A' ' 40' ' ' ASN . 12.3 p-90 -65.92 -39.17 90.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.35 -38.36 77.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.697 0.284 . . . . 0.0 111.243 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -83.86 -32.02 25.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.0 mt -81.07 -8.03 59.68 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 51.64 47.3 25.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 110.944 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.52 33.25 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.418 ' HG3' ' CZ3' ' A' ' 43' ' ' TRP . 3.4 tt0 -74.17 -15.87 61.01 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.594 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.12 -30.59 23.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.666 0.27 . . . . 0.0 110.706 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -82.27 -31.15 30.24 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.345 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.0 t -133.68 149.75 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.764 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.46 111.62 19.53 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.383 0.611 . . . . 0.0 110.715 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.64 141.46 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.167 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.45 135.83 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.914 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.77 177.19 6.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.1 tt -63.93 -24.6 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.742 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.28 5.64 55.85 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.535 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 m 59.65 31.82 21.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.149 0.475 . . . . 0.0 110.6 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.94 132.02 67.3 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.704 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.91 175.89 1.64 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.7 2.267 . . . . 0.0 111.877 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -51.91 -28.09 15.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.571 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.73 -55.4 5.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.465 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -69.25 -33.05 72.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.439 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -53.49 -43.81 68.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.925 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -38.36 86.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.783 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -66.03 -37.24 85.38 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -66.9 -48.05 69.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.54 0.21 . . . . 0.0 111.096 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -56.87 -51.35 69.38 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.517 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -65.92 -45.44 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.573 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 12' ' ' PHE . . . -60.55 -54.59 43.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.492 0.187 . . . . 0.0 111.413 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.81 -38.76 82.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.725 0.298 . . . . 0.0 110.949 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.401 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 25.6 tt0 -69.13 -27.62 65.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -31.76 40.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.251 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.16 -48.59 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.333 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.36 -41.19 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 103.92 40.4 2.32 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -123.78 97.37 5.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.744 0.307 . . . . 0.0 110.552 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -86.52 49.99 1.91 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -170.72 170.66 6.52 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.144 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.61 161.71 53.09 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.401 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 70.7 Cg_endo -73.85 169.87 72.25 Favored 'Cis proline' 0 C--N 1.355 0.881 0 C-N-CA 123.497 -1.46 . . . . 0.0 113.017 0.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.65 127.99 13.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.7 mm -102.01 111.6 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.89 117.14 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.981 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.68 124.17 72.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 62.12 38.99 13.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.018 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.0 91.72 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.882 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.21 136.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.963 0.411 . . . . 0.0 110.637 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -60.54 107.99 0.76 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -115.53 -24.82 8.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.706 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.11 140.0 12.74 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.247 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 173.36 6.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -31.14 70.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.479 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -28.16 18.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.13 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -55.1 -37.95 67.49 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.213 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.59 -44.18 87.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.355 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.95 -34.59 59.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.4 mmt85 -72.82 -37.69 67.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.346 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.75 -45.94 56.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.11 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.23 -39.28 92.29 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.65 0.262 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.09 -50.56 65.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -69.15 -27.4 65.51 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.614 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 24.5 12.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.599 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.2 p -108.46 20.04 19.07 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.594 0.197 . . . . 0.0 111.454 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -50.72 11.3 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.658 0.266 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.44 -42.39 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.37 -51.45 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.749 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -39.58 94.72 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.94 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.49 -38.07 76.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.97 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.0 m -78.26 -34.48 49.03 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.628 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -64.12 -44.19 92.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.355 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.6 pt -64.58 -26.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.78 22.3 8.12 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.907 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.71 -44.47 17.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.877 0.37 . . . . 0.0 110.52 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -52.8 1.41 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.441 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--O 1.248 1.013 0 C-N-CA 122.387 2.058 . . . . 0.0 112.367 -179.902 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.3 mtt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.652 0.263 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.3 p -54.93 -38.36 67.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.33 -27.5 55.98 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.913 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 -39.53 5.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.482 0.182 . . . . 0.0 111.427 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.78 -52.54 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.11 -40.55 96.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 110.965 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.34 -35.03 77.82 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.542 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.92 -46.56 88.82 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.17 -36.41 79.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.803 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.86 -33.62 74.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.902 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -49.12 61.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pt -71.68 -14.43 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.406 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -63.62 1.21 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.65 0.262 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -84.41 -19.01 34.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -120.29 62.21 8.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.742 0.306 . . . . 0.0 110.829 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.97 -15.38 43.42 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.702 2.268 . . . . 0.0 113.019 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.514 ' HB3' HG11 ' A' ' 52' ' ' VAL . 5.6 m-85 -93.88 74.27 4.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.271 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.49 121.2 40.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.003 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -112.77 121.96 46.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.997 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.6 mt -98.92 117.96 34.62 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.669 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 94.1 p -119.52 154.44 33.84 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.555 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.74 164.25 12.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.478 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.91 39.41 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.84 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -161.31 -44.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.428 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.83 147.47 88.88 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-O 120.569 0.223 . . . . 0.0 111.064 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.93 -17.7 36.63 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.19 -38.11 67.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.329 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.1 p -62.61 -39.18 92.97 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.83 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.3 -37.31 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -64.0 -49.38 72.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.749 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.34 88.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.533 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -75.35 -31.39 60.53 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.621 0.248 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -59.82 -45.97 90.7 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.2 mm -65.74 -41.81 91.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.92 -34.69 78.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.098 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -67.17 -34.16 76.94 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -34.68 26.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.1 mt -80.63 -7.71 59.37 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 53.53 45.82 27.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.671 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.35 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -93.62 17.63 11.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.394 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.66 -44.9 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.679 0.276 . . . . 0.0 110.861 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -64.7 -26.38 68.35 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.395 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' A' ' 25' ' ' TYR . 20.6 t -110.05 157.76 10.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.683 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.4 111.24 20.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.288 0.566 . . . . 0.0 110.477 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 t -96.06 131.55 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.99 115.61 15.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.047 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -81.48 151.06 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.5 mm -98.35 72.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.88 26.01 2.08 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.143 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -130.49 32.69 4.39 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -142.66 126.92 9.78 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.53 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.76 -171.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.061 2.507 . . . . 0.0 112.507 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.11 9.44 3.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.44 -41.65 3.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.568 0.223 . . . . 0.0 110.951 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 32.1 tp10 -68.48 -37.95 80.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.059 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -63.79 -35.19 79.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.92 -57.38 12.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.127 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.74 87.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.087 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -46.27 89.16 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -44.94 64.72 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.226 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.7 mt -66.69 -47.32 83.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.2 90.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.437 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 10.9 m-85 -59.16 -53.5 57.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.19 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.65 -25.87 63.18 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.96 -30.85 56.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.972 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.34 -44.29 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.253 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.6 m -120.52 -44.03 2.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.54 23.25 21.94 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.954 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.44 75.8 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.485 ' HB2' ' HB3' ' A' ' 72' ' ' PHE . 5.7 mtt180 -119.43 29.82 7.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.835 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.36 111.51 8.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.283 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.5 mt -45.9 131.92 6.94 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.38 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.14 150.48 85.66 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 124.034 -1.236 . . . . 0.0 112.747 0.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.6 m -142.98 128.63 19.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.402 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 84' ' ' ILE . 28.6 mm -112.07 113.02 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.85 116.45 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.99 129.59 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.74 34.09 12.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.762 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.44 46.6 92.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.681 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -175.9 137.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.6 102.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.968 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -116.46 -25.72 7.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.712 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.12 138.61 14.57 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.933 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -123.35 -173.63 2.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.689 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.13 -37.83 63.97 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -95.24 -27.29 15.58 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.703 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.19 -39.04 66.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 93' ' ' THR . 17.1 mt -66.77 -47.23 72.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -62.28 -38.51 89.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.066 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -71.37 -38.92 71.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.276 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -74.28 -35.36 63.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.008 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -50.35 20.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.738 0.304 . . . . 0.0 111.05 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -36.84 71.66 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.47 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -72.41 -27.4 62.33 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.17 25.74 20.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.52 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 p -109.07 -5.33 16.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.08 -42.15 72.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.539 0.209 . . . . 0.0 111.273 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.61 -51.0 70.31 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -61.56 -44.01 97.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 -36.17 76.03 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.89 -40.51 93.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.805 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.7 m -74.6 -30.62 61.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.42 -24.62 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.736 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.06 7.19 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.769 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.89 -51.44 5.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.795 0.331 . . . . 0.0 110.743 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.15 109.4 37.4 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--O 1.251 1.141 0 C-N-CA 122.546 2.164 . . . . 0.0 112.873 -179.854 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.618 0.247 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p -60.31 -27.8 67.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.203 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.59 -32.35 40.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -96.51 -35.45 11.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.19 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.1 t -57.8 -51.76 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.526 0.203 . . . . 0.0 111.121 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.17 -36.76 78.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -65.51 -33.45 75.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.041 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.62 58.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.74 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 -34.06 76.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -70.03 -33.38 71.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -46.48 71.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.21 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 pt -71.99 -15.13 17.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.536 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -64.99 0.76 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.676 0.274 . . . . 0.0 111.026 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -24.21 26.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -119.72 68.37 11.61 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.808 0.337 . . . . 0.0 110.861 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.91 -19.63 30.43 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 112.945 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.405 ' HB3' HG11 ' A' ' 52' ' ' VAL . 37.7 m-85 -92.94 70.51 4.64 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.73 53.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.292 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -128.01 107.68 10.03 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.48 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.13 124.07 28.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.958 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 m -129.5 172.32 11.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.954 0.406 . . . . 0.0 111.428 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.35 -175.32 2.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.274 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.83 98.31 11.52 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.43 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.6 44.77 26.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.659 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -78.92 159.33 73.76 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.011 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.66 -36.3 14.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.642 2.228 . . . . 0.0 112.597 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.33 -36.51 13.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.24 -34.18 76.92 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.44 -33.38 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.582 0.229 . . . . 0.0 111.233 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -63.23 -48.89 76.33 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.998 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.27 76.8 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.134 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -75.35 -31.47 60.56 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -61.44 -49.19 77.85 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mm -69.05 -37.38 76.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.046 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.08 75.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.081 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.47 -30.05 57.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.271 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -81.57 -33.37 31.67 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.965 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.7 -7.71 59.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 50.64 50.11 19.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.012 0.434 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -112.48 33.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.435 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.1 -25.29 43.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.477 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -37.07 21.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 110.993 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -84.77 -15.0 46.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.491 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 25' ' ' TYR . 23.0 t -126.03 159.36 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.466 0.174 . . . . 0.0 110.947 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.65 111.74 17.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.307 0.575 . . . . 0.0 110.476 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.64 133.74 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -124.21 127.49 47.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.912 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 142.19 29.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.981 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.413 ' HB ' ' CD1' ' A' ' 60' ' ' LEU . 4.9 pt -136.35 72.28 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.32 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.9 28.02 7.2 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.154 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -141.2 42.55 1.79 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' CD1' ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -135.86 118.83 12.39 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 -176.97 2.11 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.676 2.251 . . . . 0.0 112.439 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -59.34 -34.4 72.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.281 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -59.19 -51.84 68.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.653 0.263 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.35 -44.33 65.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.833 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.2 -34.8 70.77 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.374 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.78 -49.43 76.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.616 0.246 . . . . 0.0 111.093 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -42.11 93.75 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.02 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -68.67 -32.01 71.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.07 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -47.27 81.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.951 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mt -76.85 -44.79 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.165 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.18 64.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.617 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -48.6 80.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.166 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.99 -23.87 65.69 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.492 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -30.98 39.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.123 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.7 t -86.91 -48.07 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.477 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.38 -37.62 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.42 33.57 8.56 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.416 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.52 93.53 0.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.61 34.08 1.92 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.82 112.56 24.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.412 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -91.11 147.37 35.51 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 94' ' ' GLU . 10.7 Cg_exo -71.57 128.13 13.73 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.309 -0.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.93 131.25 48.42 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.05 111.14 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -110.86 121.81 64.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.58 127.72 74.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 m120 60.95 39.17 16.94 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.146 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.99 49.97 72.73 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.819 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -172.65 134.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -67.55 106.82 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.901 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -117.55 -24.32 7.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.486 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.95 139.66 15.83 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.084 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.01 -179.55 4.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.696 0.284 . . . . 0.0 110.714 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 9.4 pt-20 -71.36 -35.97 71.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.0 m -95.07 -25.38 16.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.18 -33.34 52.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.498 0.189 . . . . 0.0 111.236 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.68 -50.28 69.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.44 -34.64 78.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 -73.42 -42.63 61.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -67.17 -44.92 78.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.049 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.5 -48.07 82.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.07 85.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.272 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -73.25 -24.75 60.5 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.73 56.72 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.529 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.0 p -105.13 -18.11 14.25 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.44 -47.7 72.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.635 0.255 . . . . 0.0 111.002 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -45.18 82.91 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.06 -37.96 89.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -48.6 79.32 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.89 -40.57 80.59 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.174 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -33.61 73.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.734 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -49.54 65.18 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.203 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 pt -65.77 -24.91 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.799 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.14 24.21 8.62 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.738 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -82.5 -42.92 17.82 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.697 0.249 . . . . 0.0 110.581 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mp -117.5 143.14 31.59 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.244 0.821 0 C-N-CA 122.603 2.202 . . . . 0.0 112.309 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 120.544 0.212 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.1 p -54.68 -31.75 58.3 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.034 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.3 -27.5 47.3 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.673 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.9 -38.53 5.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.157 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 t -61.78 -57.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 111.259 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -46.8 79.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.249 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -60.36 -34.12 73.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.31 96.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.642 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.62 -34.23 70.91 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -70.33 -36.56 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.8 tpp -69.26 -46.16 67.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.103 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.421 HD13 ' HA3' ' A' ' 88' ' ' GLY . 1.7 pt -72.57 -14.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -63.71 1.13 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.658 0.265 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.05 -23.57 26.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.971 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -120.7 61.01 8.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.797 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.66 -16.64 42.48 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.766 2.31 . . . . 0.0 112.937 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB3' HG12 ' A' ' 52' ' ' VAL . 8.9 m-85 -89.42 67.1 7.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.954 0.407 . . . . 0.0 110.448 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.66 137.73 45.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.199 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -143.42 104.98 4.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.3 mp -78.79 125.65 29.66 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.4 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -148.03 -176.8 5.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.268 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.05 175.22 13.22 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.97 33.78 4.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.837 0.351 . . . . 0.0 111.251 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.09 -47.04 0.78 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.263 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 143.71 80.23 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.178 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.1 -39.39 13.66 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.644 2.23 . . . . 0.0 112.376 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -71.08 -34.18 70.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.207 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.5 m -60.15 -40.54 90.23 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.818 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.52 -36.93 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.746 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -71.59 -36.41 70.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.043 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.74 91.14 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.64 0.257 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -75.76 -29.5 58.85 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.577 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.8 p -61.16 -42.8 99.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.6 0.238 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.49 -52.62 39.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.245 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -60.09 -35.57 75.49 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.218 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.55 -33.67 74.5 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.882 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -79.04 -31.26 44.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.862 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -80.79 -7.56 59.44 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 55.85 48.24 18.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.235 0.54 . . . . 0.0 110.508 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.74 39.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -98.97 28.28 4.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.287 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -124.38 -49.43 1.8 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.7 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -68.29 -18.4 64.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.42 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.436 HG12 ' HB3' ' A' ' 25' ' ' TYR . 15.4 t -106.08 159.48 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -116.69 111.11 19.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 110.083 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.71 136.34 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.474 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.68 111.7 24.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.987 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -92.73 126.18 37.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.415 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.9 mt -85.99 63.99 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.057 0.456 . . . . 0.0 110.434 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.17 23.4 6.5 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.973 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -155.57 36.1 0.37 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.703 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.13 98.4 1.63 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.819 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.44 174.82 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.107 2.538 . . . . 0.0 112.661 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.14 -32.06 4.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -48.86 73.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.624 0.25 . . . . 0.0 111.009 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -78.67 -38.64 38.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.91 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -58.7 -40.39 83.51 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.886 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -42.89 99.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.683 0.278 . . . . 0.0 110.921 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -64.17 -42.07 96.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.685 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -34.21 73.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.193 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.15 -45.16 83.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 111.015 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.8 mt -74.72 -40.55 47.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.995 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.9 -54.49 44.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.233 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -39.83 79.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.992 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -28.43 68.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -30.88 31.93 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.335 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.01 -48.5 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.554 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.1 -40.99 2.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.63 42.55 1.69 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.949 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.5 101.81 5.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -94.82 37.66 1.14 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.768 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -161.07 -175.84 5.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.303 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.8 165.14 36.05 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.898 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.16 146.09 82.1 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.687 0.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 106.66 13.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.712 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.464 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 4.0 mp -102.3 111.05 30.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.761 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.7 t -117.99 116.47 51.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 91' ' ' TRP . 13.5 p -115.66 134.96 57.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.7 t30 58.02 32.9 22.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.421 ' HA3' HD13 ' A' ' 20' ' ' ILE . . . 66.91 32.42 80.95 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.758 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -148.16 132.26 17.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.176 0.512 . . . . 0.0 110.372 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -66.99 100.68 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.381 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.42 ' HB2' HG11 ' A' ' 86' ' ' VAL . 2.0 t-105 -102.44 -31.86 10.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.244 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.55 142.04 17.33 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.113 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 p -127.44 -172.01 2.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.563 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.91 49.23 1.78 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.271 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.84 -43.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.929 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -52.64 -33.12 45.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.02 -56.67 19.03 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.457 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -60.48 -42.56 96.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -58.3 -40.0 80.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.414 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.08 -46.21 16.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.923 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.77 -42.04 96.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.72 93.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -70.36 -27.08 64.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.279 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.26 24.22 24.94 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.497 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.1 p -113.41 19.09 17.24 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -44.45 81.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -54.91 -44.49 74.24 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.702 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.08 -38.68 83.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.723 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.66 -41.63 77.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.704 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.54 -22.0 47.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.49 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 m -77.94 -26.67 49.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.261 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -23.81 60.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -102.89 -23.66 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.13 23.93 9.36 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.166 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -38.5 11.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.949 0.375 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.42 142.45 44.03 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.836 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.379 2.052 . . . . 0.0 112.636 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.805 0.336 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.82 17.67 10.66 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.82 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.58 -30.41 36.91 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 110.684 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -100.04 -31.16 11.58 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 t -61.86 -52.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.029 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 t -62.13 -37.19 84.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.853 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -36.02 77.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.15 89.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.686 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -40.69 97.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.2 -30.9 70.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.719 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -68.18 -44.26 76.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.855 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -71.88 -14.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.517 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -63.58 1.23 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.653 0.263 . . . . 0.0 110.866 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -83.97 -24.98 30.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.403 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . 14.3 m-70 -118.58 64.29 5.91 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.782 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.82 -21.1 29.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.582 2.188 . . . . 0.0 112.793 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HB3' HG11 ' A' ' 52' ' ' VAL . 25.9 m-85 -92.1 69.74 5.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -110.89 130.76 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -118.91 101.63 8.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.414 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.403 HD12 ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -76.83 126.61 31.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.217 -179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.75 168.19 28.18 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.28 179.08 7.06 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.3 p -97.12 29.13 3.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.284 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -39.72 6.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.343 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.64 148.51 34.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 111.329 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.33 -39.45 7.31 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.711 2.274 . . . . 0.0 112.627 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.42 -33.25 71.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.103 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.3 m -55.17 -43.1 73.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.623 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.83 -43.27 89.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.028 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -61.47 -51.68 67.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.069 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.53 -41.06 80.15 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.709 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -73.9 -29.87 62.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.231 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -60.06 -40.69 90.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.118 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.1 mm -70.02 -51.1 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.412 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -62.45 -33.35 74.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.967 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -68.26 -34.7 76.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.098 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -78.6 -32.92 47.81 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.2 mt -80.68 -7.74 59.42 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 53.49 48.91 20.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.573 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.7 m -119.1 40.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -97.02 30.2 2.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.986 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.46 -49.43 2.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -68.01 -22.86 64.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.258 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 25' ' ' TYR . 44.2 t -114.98 156.09 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.49 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -116.15 111.28 20.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.252 0.548 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.35 142.19 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.386 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -126.52 104.88 8.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.94 151.58 31.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.5 mm -114.31 69.75 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.115 0.483 . . . . 0.0 111.066 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 -2.25 8.6 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.162 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -106.95 -34.44 7.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.016 0.408 . . . . 0.0 111.566 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 21.2 mt -64.72 122.58 79.75 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.171 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.2 Cg_exo -62.63 -172.0 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.017 2.478 . . . . 0.0 112.534 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -78.89 8.57 5.33 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.219 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -113.43 -42.61 3.45 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.604 0.24 . . . . 0.0 110.805 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.1 -36.24 72.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.275 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -57.24 -38.27 73.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.397 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -49.99 75.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.137 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -57.78 -36.28 71.95 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -37.51 79.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.828 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -66.31 -46.45 76.85 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.5 mm -67.88 -45.62 83.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.61 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.91 -53.54 57.27 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.36 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 2.9 m-85 -65.96 -28.98 69.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.651 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.511 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 5.3 mt-30 -56.92 -40.78 76.95 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 110.741 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -28.37 44.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.427 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.45 -48.16 48.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 110.686 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.8 m -144.45 -41.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 123.81 63.21 0.19 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.967 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' A' ' 72' ' ' PHE . 26.1 m -96.99 44.81 1.05 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.671 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -73.49 -16.58 61.29 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.866 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -140.1 121.04 14.56 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.0 mt -82.04 155.51 69.99 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.669 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.85 174.74 51.3 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 124.074 -1.219 . . . . 0.0 112.784 0.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.19 113.83 5.33 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mt -102.34 121.96 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.479 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.88 121.53 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.89 121.29 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 64.24 40.16 6.91 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.129 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.13 49.65 75.86 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.952 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.41 136.12 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.39 . . . . 0.0 110.541 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.4 104.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.307 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.86 -27.68 12.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.535 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.84 141.5 14.48 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.003 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.37 172.29 10.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.734 0.302 . . . . 0.0 111.282 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.94 -26.02 62.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.486 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -29.13 14.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -56.94 -34.05 67.61 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -56.44 19.45 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 110.805 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.95 -34.08 72.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -41.03 63.62 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.324 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.73 -43.45 59.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -50.57 73.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.8 0.333 . . . . 0.0 111.029 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.69 84.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -27.18 60.05 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.769 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.41 27.03 26.26 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.175 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.0 p -107.95 -6.78 16.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 -50.05 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.612 0.244 . . . . 0.0 110.755 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.09 -41.59 88.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.0 -45.79 90.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.667 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -56.15 -40.58 74.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.058 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.24 -46.33 86.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 m -78.59 -31.19 47.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.998 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -59.28 -38.89 81.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.7 pt -79.45 -24.5 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.19 25.13 8.03 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.948 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 -48.66 5.73 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.764 0.282 . . . . 0.0 110.722 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.09 113.07 66.11 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.544 2.163 . . . . 0.0 112.829 -179.702 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.463 0.201 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.01 -36.2 17.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.69 0.281 . . . . 0.0 111.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -101.14 -33.35 10.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.205 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.9 -47.43 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.042 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.4 m -60.58 -45.46 93.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.85 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -62.59 -35.77 80.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.08 99.22 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.061 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.68 -41.5 95.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.08 -29.12 68.8 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.033 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.1 tpt -69.61 -46.58 65.95 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.139 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.4 pt -73.02 -15.0 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -61.4 -65.53 0.68 Allowed 'General case' 0 N--CA 1.458 -0.049 0 CA-C-O 120.71 0.291 . . . . 0.0 111.093 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.66 -22.81 25.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.227 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -120.63 68.12 14.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.764 0.316 . . . . 0.0 110.86 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.89 -30.96 20.83 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.628 2.218 . . . . 0.0 112.527 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.483 ' HB3' HG23 ' A' ' 52' ' ' VAL . 69.6 m-85 -90.84 68.0 6.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.59 139.79 42.88 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.379 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.496 HE21 HG23 ' A' ' 84' ' ' ILE . 20.0 mp0 -124.38 115.42 20.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.652 HD12 HD13 ' A' ' 57' ' ' ILE . 3.2 mm? -86.48 96.24 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -111.81 174.77 5.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.129 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -95.79 -176.39 3.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -94.33 -38.72 10.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -151.72 72.37 1.02 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -125.51 148.15 60.5 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.62 -24.38 36.64 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.869 2.38 . . . . 0.0 112.888 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 78.5 m-20 -88.73 -40.87 12.92 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.612 0.244 . . . . 0.0 110.669 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.51 -43.89 89.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.783 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.1 m -55.38 -32.36 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.5 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -70.16 -56.6 6.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.938 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.49 77.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.568 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -75.43 -31.81 60.48 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.893 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 t -64.76 -49.17 71.83 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.6 mm -65.13 -41.15 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.528 ' NE1' HG11 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -67.53 -38.23 83.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.029 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -72.9 -30.19 63.74 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.346 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -32.55 34.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.944 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.3 mt -81.53 -8.09 59.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 t30 53.16 46.01 27.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.169 0.509 . . . . 0.0 110.696 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 52' ' ' VAL . 11.2 m -123.98 43.45 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.68 18.42 10.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.647 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.32 -47.43 3.1 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.85 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -68.25 -23.65 64.81 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.336 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 48' ' ' VAL . 14.0 p -116.34 158.72 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' N ' HG22 ' A' ' 52' ' ' VAL . 38.9 m-85 -120.37 111.23 17.49 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.264 0.554 . . . . 0.0 110.372 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.37 132.4 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.96 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -126.71 131.69 51.31 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.69 142.74 27.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.671 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.684 ' CB ' HD21 ' A' ' 60' ' ' LEU . 10.8 pt -131.95 78.94 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.137 0.494 . . . . 0.0 111.394 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.78 -33.87 0.96 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.402 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.8 m -62.43 -37.17 84.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.073 0.436 . . . . 0.0 111.418 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.684 HD21 ' CB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -57.86 119.16 31.56 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.93 -174.73 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.133 2.555 . . . . 0.0 112.745 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -31.96 71.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.16 -48.51 78.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.553 0.216 . . . . 0.0 110.996 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.21 -33.95 65.65 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.217 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -57.07 -46.05 82.8 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.958 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -48.63 77.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.945 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.73 -48.6 79.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.472 ' HE1' HD11 ' A' ' 28' ' ' LEU . 1.2 t-105 -62.46 -39.28 92.9 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.888 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -58.74 -52.04 67.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.012 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.9 -40.53 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.07 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -59.1 -53.17 61.4 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.09 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.447 ' HE2' HG21 ' A' ' 83' ' ' THR . 0.1 OUTLIER -60.56 -36.17 77.83 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.47 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 1.9 mt-30 -61.19 -33.06 72.84 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.886 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -78.96 -28.85 43.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.196 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.9 t -76.61 -46.38 31.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.046 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.15 -44.65 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 113.13 49.12 0.58 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.441 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -130.37 103.45 6.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.794 0.331 . . . . 0.0 110.573 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 69' ' ' ARG . 8.7 ttp180 -94.63 38.62 1.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -153.08 148.43 27.0 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mt -117.11 152.65 49.15 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.7 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 35' ' ' ASP . 84.3 Cg_endo -80.01 179.1 30.51 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.652 -1.395 . . . . 0.0 113.297 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.787 HG23 ' CE2' ' A' ' 90' ' ' PHE . 97.4 m -150.13 145.22 26.19 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.496 HG23 HE21 ' A' ' 27' ' ' GLN . 4.9 mp -117.24 111.29 34.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -110.41 116.65 52.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.458 HG12 ' OD1' ' A' ' 87' ' ' ASN . 6.5 t -113.15 142.75 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.458 ' OD1' HG12 ' A' ' 86' ' ' VAL . 2.0 p-10 42.69 41.21 2.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.68 43.01 92.96 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.941 -0.572 . . . . 0.0 114.176 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 138.63 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 111.087 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.787 ' CE2' HG23 ' A' ' 83' ' ' THR . 6.9 t80 -52.51 111.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.0 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.83 -22.08 11.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.775 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.16 148.31 19.11 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.157 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -119.37 175.79 5.65 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 110.749 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.446 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 3.0 tm-20 -61.86 -25.88 67.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.558 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.8 m -82.56 -36.37 26.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.497 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.418 ' HG2' ' CD2' ' A' ' 100' ' ' PHE . 4.9 tt0 -58.01 -32.36 67.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.501 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 -48.73 73.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.689 0.28 . . . . 0.0 110.724 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -74.27 -32.61 62.99 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.182 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.33 -38.66 85.25 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.345 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CD2' ' HG2' ' A' ' 96' ' ' GLN . 5.6 m-85 -78.31 -44.05 26.3 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -58.5 -40.69 83.53 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.87 93.26 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.062 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -75.38 -28.96 59.69 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.37 23.15 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.4 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.6 p -122.96 19.63 10.06 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.93 -43.37 71.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.561 0.219 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.79 -51.19 69.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -40.03 86.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.78 -40.38 96.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.772 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HB3' HD13 ' A' ' 116' ' ' LEU . 9.3 mt -66.34 -29.77 70.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.418 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 m -78.52 -30.26 47.0 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -59.56 -44.14 93.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.277 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 pt -67.01 -24.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.83 26.07 8.72 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.673 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 116' ' ' LEU . 5.8 tp -85.26 -46.15 11.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.843 0.321 . . . . 0.0 110.74 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.616 HD12 ' HB3' ' A' ' 115' ' ' LEU . 6.5 mp -108.48 145.54 31.77 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.749 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 C--O 1.251 1.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.567 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.33 -35.87 29.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.211 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.7 -35.71 16.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.114 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -66.61 -49.03 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -65.64 -43.12 90.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.208 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -60.43 -37.35 80.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.566 0.222 . . . . 0.0 110.935 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.45 99.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.19 -40.31 77.14 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.82 -36.13 83.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.047 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.6 mmm -68.26 -45.64 72.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.308 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.7 pt -71.79 -14.58 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.677 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -60.92 -59.89 4.65 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -84.67 -10.91 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -124.03 72.95 55.72 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.8 -26.79 18.73 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.62 2.213 . . . . 0.0 112.792 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -93.57 70.73 4.24 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 132.98 53.09 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.152 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.462 ' HB3' HG13 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -126.94 108.16 10.72 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.603 179.624 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.96 136.09 33.25 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.214 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -132.47 172.8 12.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.596 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -95.92 177.9 5.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.525 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.8 m -77.15 83.87 3.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.34 45.97 16.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.402 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -70.08 155.19 93.87 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.126 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.75 -32.49 29.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.843 2.362 . . . . 0.0 112.582 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.49 -33.3 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.105 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 33' ' ' CYS . 31.2 m -69.43 -41.72 75.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.72 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -55.52 -32.69 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.592 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -59.16 -50.39 74.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 110.86 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' A' ' 97' ' ' LEU . . . -59.62 -35.87 75.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.529 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 -32.01 61.59 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.669 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -44.69 93.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.39 -48.93 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.327 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -65.34 -30.64 71.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.401 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -81.38 -32.25 32.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.974 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.0 mt -80.73 -7.73 59.45 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 52.18 43.95 30.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.875 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.47 31.6 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -102.92 28.15 6.45 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -112.71 -41.77 3.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -67.09 -24.45 65.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.281 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 53' ' ' PHE . 17.9 t -100.59 159.23 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.656 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.412 ' N ' HG12 ' A' ' 52' ' ' VAL . 2.3 t80 -110.89 111.14 22.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.386 0.612 . . . . 0.0 110.09 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 27' ' ' GLN . 14.8 t -110.65 138.88 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.111 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 138.94 54.32 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.157 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.67 129.94 47.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.764 HG23 HD21 ' A' ' 60' ' ' LEU . 52.3 mt -88.99 69.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.128 0.49 . . . . 0.0 110.287 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.34 -40.95 0.34 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.993 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.7 p -57.29 -33.73 67.96 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.418 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.764 HD21 HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -80.36 124.11 82.62 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.309 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.02 -176.24 2.54 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -36.58 75.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.8 -49.46 72.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.711 0.291 . . . . 0.0 111.009 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.57 -37.69 83.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.83 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -56.81 -31.46 64.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -52.33 65.91 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 111.081 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.493 ' HA ' HD12 ' A' ' 70' ' ' ILE . 4.3 mptt -67.16 -30.05 69.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.617 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.36 -54.37 47.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -57.92 -36.85 73.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.151 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 67' ' ' LYS . 24.9 mt -69.52 -46.61 75.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.892 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.586 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -62.68 -49.66 74.22 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.142 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -45.66 80.8 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.028 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -26.45 68.55 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.22 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -31.3 35.56 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.143 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 71' ' ' ALA . 21.8 t -83.67 -45.05 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.413 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.49 -41.28 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.56 4.29 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.441 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -120.19 107.77 13.41 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.669 0.271 . . . . 0.0 110.771 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -94.04 43.36 1.11 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.553 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 83' ' ' THR . 6.7 t-20 -147.3 158.27 43.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.162 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -138.65 153.73 72.57 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.45 167.58 79.67 Favored 'Cis proline' 0 C--N 1.353 0.8 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.921 0.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 80' ' ' ASN . 2.1 p -136.56 132.74 35.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.093 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.407 HG23 ' HG3' ' A' ' 27' ' ' GLN . 18.2 mt -110.92 114.57 47.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.17 117.1 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.695 HG12 ' HB2' ' A' ' 91' ' ' TRP . 14.4 p -114.89 128.01 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 m120 59.36 40.58 20.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.72 80.52 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.914 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -171.84 134.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 110.776 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.41 ' CE1' HG22 ' A' ' 83' ' ' THR . 73.9 t80 -68.91 106.59 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.941 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.695 ' HB2' HG12 ' A' ' 86' ' ' VAL . 1.6 m95 -124.12 0.46 8.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.34 6.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.827 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 96' ' ' GLN . 12.2 t -122.82 179.12 4.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.902 0.382 . . . . 0.0 111.297 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -41.91 96.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.575 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -67.51 -28.7 68.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' A' ' 100' ' ' PHE . 2.2 tm0? -56.98 -34.84 68.49 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 111.246 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 39' ' ' ALA . 9.3 mt -70.99 -38.68 72.7 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.183 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -79.33 -48.48 14.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.592 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -58.33 -50.25 74.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 96' ' ' GLN . 10.8 m-85 -62.22 -39.19 91.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.392 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.66 -45.97 90.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.796 0.332 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.37 94.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.044 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -75.48 -29.49 59.59 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.02 13.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.503 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -117.21 16.99 14.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -49.92 47.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.72 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.0 -41.6 71.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.85 -43.64 87.84 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.718 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -54.78 -46.95 74.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.71 0.29 . . . . 0.0 110.737 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.56 -40.17 95.09 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 116' ' ' LEU . 50.8 m -70.77 -35.27 72.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.634 0.254 . . . . 0.0 110.95 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -52.11 66.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.333 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.48 HD11 HD12 ' A' ' 115' ' ' LEU . 5.3 pt -62.21 -25.11 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.97 20.19 7.31 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.929 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.48 HD12 HD11 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -77.91 -49.06 14.92 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.843 0.322 . . . . 0.0 110.461 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 111' ' ' THR . 3.4 mt -110.15 126.61 28.6 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.839 2.359 . . . . 0.0 112.311 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.563 0.22 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.51 47.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -83.86 -39.75 19.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.836 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.49 -47.72 87.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.938 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.522 HG22 ' OE2' ' A' ' 18' ' ' GLU . 19.3 m -61.19 -42.2 98.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -59.82 -39.43 85.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.751 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.74 97.32 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.973 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.07 -41.92 97.16 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.522 ' OE2' HG22 ' A' ' 14' ' ' THR . 28.7 mt-10 -61.79 -36.56 81.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.779 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.41 -49.98 67.2 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' HB ' ' HA2' ' A' ' 88' ' ' GLY . 35.0 pt -71.4 -15.27 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.48 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -63.98 1.09 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.693 0.283 . . . . 0.0 111.099 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.8 t -85.55 -23.77 27.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -118.46 66.42 6.68 Favored Pre-proline 0 CA--C 1.53 0.212 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.63 -28.95 25.25 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.692 2.261 . . . . 0.0 112.501 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.489 ' HB3' HG13 ' A' ' 52' ' ' VAL . 3.2 m-85 -94.49 67.4 3.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -108.02 127.41 53.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.425 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.527 ' HG2' HG23 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -117.24 106.08 12.9 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.27 125.08 34.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.632 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t -138.22 179.12 6.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.76 156.33 43.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.635 0.255 . . . . 0.0 111.413 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 m -84.66 55.17 3.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.079 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -127.09 -46.69 1.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.759 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 153.67 42.15 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.88 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.06 -17.61 32.2 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.877 2.385 . . . . 0.0 113.073 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -52.87 -43.81 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.445 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.88 -58.24 9.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.579 0.228 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.6 m -60.45 -31.7 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -74.48 -31.79 62.34 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.03 64.9 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-O 120.745 0.307 . . . . 0.0 111.007 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -75.6 -28.17 58.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.1 p -63.5 -47.82 80.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.887 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 46' ' ' LEU . 32.4 mm -67.47 -44.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.145 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.446 ' HE1' HG21 ' A' ' 52' ' ' VAL . 1.2 m-90 -63.44 -39.14 93.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.989 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -69.16 -31.94 70.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.89 -31.09 35.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.905 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.64 HD12 HG22 ' A' ' 42' ' ' ILE . 14.1 mt -80.53 -7.96 59.4 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 56.12 47.88 18.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 110.76 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.5 m -135.3 32.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -24.91 54.96 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.492 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.95 -41.67 22.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.627 0.251 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.35 -20.24 66.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.605 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 25' ' ' TYR . 19.6 t -117.89 163.67 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 122.16 0.184 . . . . 0.0 110.529 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.486 ' N ' HG12 ' A' ' 52' ' ' VAL . 3.1 m-85 -123.31 111.36 16.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.162 0.506 . . . . 0.0 110.294 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 27' ' ' GLN . 21.8 t -120.46 134.34 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.054 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -132.47 130.09 40.04 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -100.72 151.15 22.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HB ' HD11 ' A' ' 60' ' ' LEU . 2.6 pt -122.49 -144.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.59 14.39 25.6 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.752 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -149.1 33.81 0.74 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.806 0.303 . . . . 0.0 111.331 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -97.15 116.31 65.96 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.947 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.4 Cg_exo -62.19 -170.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.116 2.544 . . . . 0.0 112.493 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.68 2.31 14.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -106.91 -39.53 5.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.628 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.24 -39.6 62.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.324 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -60.92 -38.42 85.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.715 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.29 -35.43 79.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.551 0.215 . . . . 0.0 111.236 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -64.55 -53.14 52.52 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.314 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -69.61 -36.59 76.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.343 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -46.27 73.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.381 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.19 -51.67 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.586 0.232 . . . . 0.0 111.45 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.55 -54.98 37.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.865 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.431 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -61.48 -42.75 99.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.297 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.17 -27.81 68.97 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.539 0.209 . . . . 0.0 111.407 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -30.18 34.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.397 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 71' ' ' ALA . 38.2 t -87.94 -48.3 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 90' ' ' PHE . 9.2 p -113.57 -31.77 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.1 35.53 38.2 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.411 ' H ' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -144.57 93.09 2.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 40.21 1.06 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -113.7 89.96 3.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.634 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.48 151.91 93.4 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.063 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.23 170.51 71.25 Favored 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 123.531 -1.445 . . . . 0.0 112.99 0.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.568 HG22 ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -148.55 133.44 18.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.55 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.527 HG23 ' HG2' ' A' ' 27' ' ' GLN . 5.1 mt -112.51 111.53 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.7 t -101.77 116.72 45.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 t -125.1 131.8 72.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t30 63.28 33.07 14.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' ' 20' ' ' ILE . . . 64.89 45.18 93.26 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.832 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -175.44 137.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.545 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.568 ' CE1' HG22 ' A' ' 83' ' ' THR . 45.0 t80 -59.15 102.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -25.27 8.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.829 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 84' ' ' ILE . . . -111.1 139.01 15.34 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.233 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.96 -177.75 3.57 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -43.71 68.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.958 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 m -70.22 -32.82 70.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.891 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -52.26 -36.15 51.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.432 0.16 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.19 -54.37 41.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.18 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -33.84 66.17 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.428 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -62.02 -42.35 99.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.62 0.248 . . . . 0.0 111.304 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 109' ' ' GLU . 4.7 m-85 -77.83 -44.19 28.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.471 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -61.57 -42.42 98.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.48 67.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.596 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -83.54 -38.56 21.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.1 35.65 2.3 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.942 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 18.28 16.42 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.693 0.246 . . . . 0.0 111.47 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -51.42 66.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.606 0.241 . . . . 0.0 110.778 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -66.28 -38.46 87.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.034 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.26 -39.84 95.74 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.439 ' HG3' ' CE2' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -58.47 -49.38 77.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.911 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.785 HD12 HD13 ' A' ' 115' ' ' LEU . 3.7 mm? -59.36 -30.68 68.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.067 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.517 HG23 ' HD3' ' A' ' 117' ' ' PRO . 78.9 m -78.24 -34.12 49.35 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.741 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -47.08 86.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.53 -26.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.717 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.85 7.17 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.585 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.785 HD13 HD12 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -73.7 -45.83 49.93 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.721 0.296 . . . . 0.0 110.511 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -79.93 -60.32 0.51 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.038 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.517 ' HD3' HG23 ' A' ' 111' ' ' THR . 73.7 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.481 2.121 . . . . 0.0 112.413 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 120.735 0.302 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.46 68.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.419 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.83 -38.28 23.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.851 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.89 -51.35 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -60.27 -35.36 75.36 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.795 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -57.19 -42.43 81.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.68 0.276 . . . . 0.0 110.814 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.76 88.51 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -63.27 -35.41 80.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.33 -39.07 91.93 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.5 mtp -64.46 -44.73 90.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.983 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.433 HG12 ' HA ' ' A' ' 17' ' ' GLU . 37.1 pt -73.25 -14.69 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.419 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.26 -61.29 2.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.636 0.255 . . . . 0.0 110.855 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 m -83.37 -18.84 37.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.741 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -122.5 64.39 21.28 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.438 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 34.4 Cg_endo -64.91 -23.66 61.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.514 ' HB3' HG13 ' A' ' 52' ' ' VAL . 13.2 m-85 -94.44 71.79 3.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 2.1 t80 -114.01 139.6 49.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.423 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.679 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -127.83 134.15 49.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.872 HD23 HD11 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -107.92 127.67 53.95 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -117.09 153.7 32.3 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.365 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.612 ' HB1' ' CD1' ' A' ' 32' ' ' TRP . . . -70.75 -41.91 71.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.024 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 56' ' ' ASP . 14.5 m 66.25 33.65 7.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.324 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.612 ' CD1' ' HB1' ' A' ' 30' ' ' ALA . 48.6 p-90 -159.36 -41.0 0.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.068 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.57 147.21 32.67 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.18 -20.55 24.85 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.018 2.479 . . . . 0.0 112.632 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.59 -39.86 58.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.113 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.59 -36.91 60.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.176 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.28 -35.11 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.442 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -58.47 -52.78 64.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.553 0.216 . . . . 0.0 110.875 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.97 75.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.64 -29.26 61.2 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 t -65.19 -48.95 71.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.642 HG22 HD12 ' A' ' 46' ' ' LEU . 30.8 mm -65.21 -41.38 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.407 ' HH2' HG11 ' A' ' 52' ' ' VAL . 8.6 m95 -65.94 -36.9 84.63 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.159 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -62.59 -37.2 85.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -83.83 -30.76 26.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.372 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.642 HD12 HG22 ' A' ' 42' ' ' ILE . 21.9 mt -80.71 -8.45 59.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 48.09 45.25 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 46' ' ' LEU . 30.0 m -119.89 38.27 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -99.69 31.34 3.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -120.66 -49.84 2.22 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -25.51 68.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.265 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 25' ' ' TYR . 58.2 t -118.14 154.01 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.407 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -116.4 111.29 19.82 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.269 0.557 . . . . 0.0 110.21 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG23 ' HB3' ' A' ' 27' ' ' GLN . 10.5 p -107.93 141.63 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.287 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -126.13 125.72 42.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 3.0 m-20 -90.88 126.64 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.401 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.872 HD11 HD23 ' A' ' 28' ' ' LEU . 18.4 mt -79.27 60.3 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.698 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.53 18.07 4.95 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.811 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.46 ' H ' HD22 ' A' ' 60' ' ' LEU . 83.3 p -129.97 10.02 5.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.813 0.307 . . . . 0.0 111.802 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -108.68 131.31 21.85 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-O 120.505 0.193 . . . . 0.0 111.11 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 64' ' ' GLU . 51.6 Cg_endo -68.3 -172.94 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.896 2.397 . . . . 0.0 112.095 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 6.35 4.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.91 -44.16 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.664 0.268 . . . . 0.0 110.817 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 3.5 tp10 -81.1 -42.95 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.31 -32.75 70.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.59 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -57.59 6.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.908 -0.133 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -31.73 67.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.172 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -73.11 -53.3 11.39 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.469 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -54.23 -42.16 69.55 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.452 ' N ' ' HG3' ' A' ' 69' ' ' ARG . 15.7 mt -62.04 -57.41 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.546 0.213 . . . . 0.0 111.249 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.22 -46.16 86.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.668 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.543 ' CD2' HD21 ' A' ' 28' ' ' LEU . 1.1 m-85 -64.47 -51.5 62.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -58.8 -26.27 63.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.487 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -31.43 31.81 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.439 0.162 . . . . 0.0 111.385 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 71' ' ' ALA . 50.1 t -84.96 -48.8 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.603 HG21 HG21 ' A' ' 85' ' ' VAL . 4.9 m -147.92 -37.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.912 ' HA2' HG21 ' A' ' 83' ' ' THR . . . -45.95 -35.44 6.26 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.649 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t 61.34 -166.19 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.819 0.31 . . . . 0.0 111.184 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.33 40.54 1.11 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -160.69 130.53 5.07 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 83' ' ' THR . 27.4 mt -131.98 152.99 81.22 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.749 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.72 178.7 33.2 Favored 'Cis proline' 0 C--N 1.351 0.673 0 C-N-CA 123.688 -1.38 . . . . 0.0 113.027 0.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.912 HG21 ' HA2' ' A' ' 77' ' ' GLY . 4.4 t -144.31 155.98 44.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.04 114.68 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.603 HG21 HG21 ' A' ' 76' ' ' VAL . 19.0 t -101.17 118.38 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.73 131.79 72.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.948 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER 62.51 31.5 16.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.203 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.73 44.91 94.18 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.59 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -173.12 137.76 0.71 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.362 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -57.56 108.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -130.33 5.12 4.79 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.73 139.84 8.27 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.941 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.7 177.54 7.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.932 0.396 . . . . 0.0 111.067 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -65.59 -45.38 83.44 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -37.4 85.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.31 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.01 -34.98 66.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.235 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.0 mt -66.33 -53.56 34.83 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.726 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -64.75 -35.92 82.63 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.131 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -69.31 -41.41 76.77 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.514 ' CB ' HD12 ' A' ' 106' ' ' LEU . 8.5 m-85 -76.78 -45.81 27.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.515 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -62.31 -43.23 99.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.677 0.275 . . . . 0.0 111.061 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.93 97.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -73.24 -28.15 61.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.394 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.76 28.12 14.99 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.56 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.1 p -114.93 13.41 17.04 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.514 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.3 OUTLIER -70.33 -51.7 28.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.535 0.207 . . . . 0.0 111.011 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.05 -44.25 97.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.85 -50.6 70.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.099 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.77 -37.66 87.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.192 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.438 ' HB2' HD12 ' A' ' 116' ' ' LEU . 11.5 mt -55.81 -46.23 78.11 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.083 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -64.91 -31.46 72.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.903 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.1 72.17 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.982 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.47 -27.83 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.541 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.05 21.41 7.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.055 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -93.17 -46.17 7.54 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.839 0.32 . . . . 0.0 110.799 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 110' ' ' LEU . 17.3 mt -93.11 160.26 33.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.82 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.559 2.173 . . . . 0.0 112.448 179.851 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.74 -37.86 9.12 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.664 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -90.38 -39.16 12.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.143 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.418 HG21 ' NZ ' ' A' ' 74' ' ' LYS . 30.1 t -57.83 -45.1 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.865 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -62.33 -43.7 98.21 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.77 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.67 -47.01 82.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.754 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.15 82.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.764 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -64.3 -34.27 77.75 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.172 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.56 -38.36 83.99 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.971 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -45.32 87.35 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.115 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 pt -72.16 -14.37 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.536 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -61.88 -64.59 0.89 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.603 0.24 . . . . 0.0 110.782 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -84.6 -25.99 28.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.788 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -119.72 66.17 9.93 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.809 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.39 -20.38 36.66 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.689 2.259 . . . . 0.0 112.867 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -90.41 72.94 7.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.843 0.354 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.93 137.98 42.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 102.91 6.13 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.752 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.62 122.0 25.98 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -120.56 149.99 41.57 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.185 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.53 -38.07 4.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.443 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t 67.66 13.47 9.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.691 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.44 -33.49 7.34 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.71 0.291 . . . . 0.0 110.927 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.13 155.69 36.13 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.874 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' A' ' 37' ' ' VAL . 39.8 Cg_endo -67.95 -12.37 35.06 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.748 2.299 . . . . 0.0 113.091 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.4 -29.79 59.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 48.8 t -78.65 -49.63 12.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 34' ' ' PRO . 28.9 m -51.15 -36.7 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.278 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -71.66 -43.14 66.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.96 72.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.461 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -74.12 -32.34 63.14 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.546 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -61.25 -42.74 99.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.796 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -66.32 -44.73 90.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.004 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -35.57 81.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.095 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -67.12 -33.62 75.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.132 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -82.07 -32.52 30.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.055 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.558 HD22 HD11 ' A' ' 116' ' ' LEU . 21.1 mt -82.13 -7.79 59.63 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 50.94 49.95 20.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.953 0.406 . . . . 0.0 111.031 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 52' ' ' VAL . 28.0 m -126.17 33.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.091 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -83.07 -28.96 29.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.389 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.64 -42.65 34.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -65.26 -22.74 66.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.426 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 48' ' ' VAL . 11.1 p -108.91 163.2 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.393 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.44 ' N ' HG22 ' A' ' 52' ' ' VAL . 56.8 m-85 -120.2 111.17 17.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.23 0.538 . . . . 0.0 109.902 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.22 145.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -131.11 97.09 4.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.753 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.99 144.02 35.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.684 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.529 HG22 HD21 ' A' ' 60' ' ' LEU . 2.5 pt -99.96 64.28 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.105 0.479 . . . . 0.0 111.562 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -32.35 2.8 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.208 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 m -96.06 37.36 1.24 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.956 0.378 . . . . 0.0 111.576 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 64' ' ' GLU . 2.7 pp -145.58 116.76 5.03 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.231 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 28.0 Cg_exo -62.65 -176.85 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.989 2.459 . . . . 0.0 112.421 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -32.31 66.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.326 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -55.12 -41.83 72.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.273 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.595 ' HB3' HD13 ' A' ' 60' ' ' LEU . 7.0 mm-40 -77.53 -32.72 54.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.676 0.275 . . . . 0.0 110.824 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -54.15 -50.17 67.58 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.083 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.33 -42.1 98.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -38.98 75.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.14 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -73.53 -44.02 58.59 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.347 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -56.32 -39.16 72.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.49 -52.82 28.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.674 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -57.04 -54.5 46.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.337 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.46 -35.23 67.66 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.323 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -36.26 81.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.597 0.237 . . . . 0.0 111.073 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.418 ' NZ ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -81.93 -28.86 32.56 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.553 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 71' ' ' ALA . 40.0 t -81.08 -47.22 20.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.174 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 90' ' ' PHE . 12.8 m -123.37 -39.77 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.07 42.29 3.07 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.707 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -121.95 108.43 13.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.758 0.313 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.88 38.08 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -152.6 160.95 43.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.119 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 24.3 mt -123.06 155.76 63.79 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 96.6 Cg_endo -77.86 177.59 38.45 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.757 -1.351 . . . . 0.0 113.131 0.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 p -145.55 117.8 8.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 116.27 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.995 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 m -115.93 127.08 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.402 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.84 129.52 75.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.7 m120 59.61 35.1 22.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.894 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.37 32.06 78.52 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.766 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -150.75 133.2 15.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.107 0.479 . . . . 0.0 110.045 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.606 ' CE2' HG23 ' A' ' 93' ' ' THR . 3.5 t80 -59.74 102.37 0.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.256 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -106.81 -22.8 12.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.748 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.64 139.99 11.42 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.874 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.606 HG23 ' CE2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -124.71 178.1 5.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.427 ' H ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -69.07 -37.1 78.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.322 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t -98.19 -22.24 16.29 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.436 ' HA ' ' HG2' ' A' ' 99' ' ' ARG . 5.4 tt0 -57.15 -31.99 65.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.55 -43.65 96.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.95 -53.5 45.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.494 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 96' ' ' GLN . 1.7 ptt180 -59.78 -41.66 91.61 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.674 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.744 ' CB ' HD12 ' A' ' 106' ' ' LEU . 2.0 m-85 -64.83 -42.75 94.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.883 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.81 -40.73 98.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.522 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.09 90.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -73.83 -27.53 61.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.24 24.22 32.25 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.61 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.4 p -116.54 11.26 14.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.744 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -67.35 -52.08 44.56 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.671 0.272 . . . . 0.0 110.484 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -67.77 -47.73 68.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.76 -53.09 52.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.984 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.43 -41.55 76.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.885 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -63.29 -38.27 90.51 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.213 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -35.84 64.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.571 0.225 . . . . 0.0 110.57 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -66.7 -45.39 78.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.255 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.3 pt -65.42 -27.29 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.595 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.69 22.46 8.06 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.861 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 -45.46 7.04 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.78 0.29 . . . . 0.0 110.726 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.558 HD11 HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -89.35 137.84 28.92 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 C--O 1.251 1.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.611 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.408 0.147 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.69 38.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.371 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.44 -37.94 19.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.875 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.46 -48.75 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.124 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 m -60.01 -41.76 92.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -60.02 -35.61 75.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.949 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.24 98.67 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.875 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' HG13 ' A' ' 20' ' ' ILE . 7.1 mm-40 -61.23 -34.15 74.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.55 -34.87 67.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.74 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.7 mtt -68.14 -46.4 70.95 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.003 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -71.89 -17.19 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.317 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -64.99 0.76 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.695 0.284 . . . . 0.0 110.856 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 t -86.06 -27.83 24.49 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -119.78 66.27 10.16 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.553 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.36 -16.61 43.78 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.663 ' HB3' HG13 ' A' ' 52' ' ' VAL . 57.1 m-85 -90.43 68.57 6.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.435 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -112.52 136.17 52.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.265 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -128.64 112.28 14.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.293 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 117.13 27.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.039 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -138.6 169.17 18.26 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.25 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.626 ' HB2' HD11 ' A' ' 57' ' ' ILE . . . -123.25 159.65 28.27 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.187 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -103.0 21.9 14.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.423 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -153.34 32.16 0.47 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.49 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -115.4 144.49 32.45 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.915 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.77 -28.67 24.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.714 2.276 . . . . 0.0 112.763 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -111.08 23.31 14.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 16.0 m -115.15 -42.05 3.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.569 0.223 . . . . 0.0 111.059 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.58 -31.98 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.363 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -65.73 -51.77 56.56 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.091 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.425 ' HB2' HD11 ' A' ' 97' ' ' LEU . . . -57.5 -40.68 79.17 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.572 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -75.42 -30.4 60.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 t -61.43 -47.88 83.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mm -62.53 -43.81 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -64.46 -36.45 84.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.049 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -29.6 63.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.18 -33.52 32.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.606 0.241 . . . . 0.0 111.014 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.82 -7.81 59.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 53.89 46.2 26.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.037 0.446 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.98 28.92 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.977 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.38 -6.7 36.94 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.34 -45.82 17.14 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 110.457 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -68.4 -28.04 66.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 25' ' ' TYR . 42.5 t -103.1 160.12 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.682 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.456 ' N ' HG12 ' A' ' 52' ' ' VAL . 6.2 m-85 -114.46 111.18 21.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.095 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 27' ' ' GLN . 33.0 t -109.16 135.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.045 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 118.1 33.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.835 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -95.45 144.31 26.07 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.278 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 30' ' ' ALA . 2.4 pt -107.62 96.51 4.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.27 -79.61 0.1 Allowed Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.892 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 p -140.73 57.49 1.57 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.93 0.395 . . . . 0.0 110.784 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.96 136.09 66.66 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.205 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.19 -169.8 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.737 2.291 . . . . 0.0 112.133 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 2.1 mtp180 -75.7 1.19 15.29 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.51 -43.31 6.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.614 0.245 . . . . 0.0 110.984 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -75.29 -49.21 19.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.92 -35.51 75.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.361 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -67.53 -51.84 46.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.328 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -58.13 -42.39 85.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.87 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -61.9 -39.51 92.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.185 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -57.24 -54.35 47.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -68.57 -44.75 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.613 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.16 -42.06 72.63 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -70.51 -45.33 65.8 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.135 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.96 -27.96 69.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -32.36 31.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 71' ' ' ALA . 54.3 t -84.42 -41.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.32 -38.46 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 36.76 6.42 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.633 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.0 m -137.04 113.24 9.87 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 38.86 1.19 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.895 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -134.36 129.4 35.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 1.3 mp -98.6 164.95 16.02 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.401 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 7.9 Cg_exo -72.29 144.65 81.08 Favored 'Cis proline' 0 C--N 1.352 0.761 0 C-N-CA 123.593 -1.42 . . . . 0.0 111.999 -0.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.795 HG23 ' CE2' ' A' ' 90' ' ' PHE . 89.5 m -107.2 105.72 15.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -101.9 111.1 30.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.332 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.5 118.17 52.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -121.72 112.58 35.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.5 m120 66.06 42.96 3.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.059 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.48 50.74 64.3 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.122 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -173.4 138.4 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.795 ' CE2' HG23 ' A' ' 83' ' ' THR . 0.8 OUTLIER -61.97 94.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -97.6 -29.48 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.496 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.47 135.71 10.71 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.146 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.524 HG23 ' CE1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -121.86 -177.48 3.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.013 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.15 -52.24 43.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -31.66 69.43 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -51.48 -33.85 33.06 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.425 HD11 ' HB2' ' A' ' 39' ' ' ALA . 48.3 mt -51.36 -59.72 3.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.247 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -78.36 -33.04 49.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.148 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 96' ' ' GLN . 5.4 mmp_? -57.46 -49.06 77.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.5 -39.87 67.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.027 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.77 -47.82 84.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.843 0.354 . . . . 0.0 110.721 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.81 76.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.353 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -74.81 -27.78 60.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.69 23.24 43.3 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.469 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.2 p -113.57 0.07 14.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.9 -47.4 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.603 0.239 . . . . 0.0 110.92 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.06 -46.05 72.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.231 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.88 -45.74 89.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.588 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -59.42 -40.01 85.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.492 HD23 HD13 ' A' ' 116' ' ' LEU . 3.3 tp -62.63 -40.7 97.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.22 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -77.34 -33.12 55.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 110.711 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -66.61 -43.66 84.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.358 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 115' ' ' LEU . 8.6 pt -61.12 -25.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.26 21.87 6.41 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.703 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.503 ' HB2' HD11 ' A' ' 113' ' ' ILE . 1.6 tt -88.16 -55.02 3.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.745 0.307 . . . . 0.0 110.761 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.492 HD13 HD23 ' A' ' 110' ' ' LEU . 3.6 mp -89.09 140.99 29.04 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.699 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.867 2.378 . . . . 0.0 112.52 -179.864 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.01 -34.19 63.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.327 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -97.36 -37.4 10.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.28 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.0 -47.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.652 0.263 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -61.08 -43.75 98.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.658 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -63.46 -35.57 80.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.064 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.82 95.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.07 -36.66 80.22 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.806 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -69.15 -32.49 71.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -48.11 62.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.088 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 pt -70.69 -15.05 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.486 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -61.3 -61.76 2.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -83.66 -19.82 34.67 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.39 68.53 10.46 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 110.563 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.42 -18.97 38.32 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.665 2.243 . . . . 0.0 112.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.59 69.51 6.74 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.78 139.71 41.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.746 ' HB3' HG13 ' A' ' 54' ' ' VAL . 3.5 tt0 -129.15 125.87 38.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.012 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.717 ' HB2' HG23 ' A' ' 83' ' ' THR . 5.1 mp -99.83 113.63 26.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.81 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 175.88 13.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.01 170.89 15.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.319 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -102.47 -15.15 16.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -85.88 -39.44 16.99 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.6 m -72.67 141.35 82.34 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.87 -39.09 1.94 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.871 2.381 . . . . 0.0 113.122 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -61.31 -29.94 70.19 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.74 0.305 . . . . 0.0 111.047 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.4 m -72.04 -34.77 69.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.886 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -58.15 -34.84 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.72 -54.38 36.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.514 0.197 . . . . 0.0 111.198 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.34 72.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.572 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -75.15 -32.02 61.21 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.763 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -63.46 -44.51 94.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.969 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.1 mm -63.49 -43.92 98.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.038 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.627 ' CD1' HG11 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.8 -34.24 77.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.307 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -28.08 63.81 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.186 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -80.6 -32.51 36.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.897 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -81.91 -7.69 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 52.73 49.73 19.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.661 ' O ' HG12 ' A' ' 52' ' ' VAL . 13.2 m -122.69 26.17 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.299 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -26.66 65.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.734 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -81.2 -31.79 33.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.704 0.287 . . . . 0.0 110.913 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -75.9 -28.73 58.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 48' ' ' VAL . 13.5 p -112.46 161.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.815 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.461 ' N ' HG22 ' A' ' 52' ' ' VAL . 1.1 t80 -120.46 111.13 17.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.368 0.604 . . . . 0.0 109.99 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 27' ' ' GLN . 27.4 t -107.85 135.54 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.991 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.09 113.55 26.5 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.92 145.09 29.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.938 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.701 ' HA ' HD13 ' A' ' 60' ' ' LEU . 32.9 mm -112.77 78.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.86 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -43.94 0.33 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.803 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -95.55 37.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 111.169 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.701 HD13 ' HA ' ' A' ' 57' ' ' ILE . 5.6 mp -119.94 105.02 43.37 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.682 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.9 164.09 2.66 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.038 2.492 . . . . 0.0 112.678 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.13 -36.16 5.65 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.551 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -75.11 -49.5 19.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.007 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.3 -36.49 83.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.221 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -59.86 -48.05 83.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.003 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.16 -29.18 67.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -55.46 -53.45 56.2 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.228 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.446 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 36.2 p-90 -74.01 -32.35 63.34 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.73 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -49.83 74.76 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -73.93 -39.03 51.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.074 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.72 -50.75 72.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.072 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -63.61 -33.87 76.57 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -32.84 70.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.884 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -78.94 -29.59 44.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 71' ' ' ALA . 21.4 t -78.98 -44.14 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.191 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 89' ' ' LYS . 27.4 m -128.26 -42.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.27 45.97 1.11 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.45 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 p -102.76 85.35 2.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 110.415 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 22.91 1.63 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 152.68 15.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.431 HD23 ' HH2' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -124.21 159.37 57.35 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.052 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.2 156.42 98.16 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.793 0.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.717 HG23 ' HB2' ' A' ' 28' ' ' LEU . 1.3 t -144.92 131.25 19.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.9 mt -112.02 122.79 66.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.343 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.12 121.65 64.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.352 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.89 121.87 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.98 43.37 3.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.63 75.28 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.854 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.516 ' HA ' HG12 ' A' ' 76' ' ' VAL . 4.8 ptpt -174.16 134.99 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.559 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.712 ' HZ ' HG23 ' A' ' 93' ' ' THR . 75.9 t80 -62.86 101.21 0.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.977 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -113.32 -26.31 8.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.628 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.68 141.08 16.67 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.697 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.712 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -123.58 154.2 39.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.603 0.24 . . . . 0.0 111.171 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -36.72 68.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.0 m -86.0 -27.18 25.0 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -37.4 69.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.616 0.246 . . . . 0.0 111.083 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.14 -37.29 78.22 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.121 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -67.92 -54.48 18.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.186 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -60.36 -29.59 69.01 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -79.48 -45.56 19.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.343 0.116 . . . . 0.0 111.108 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.555 ' HB2' HD13 ' A' ' 106' ' ' LEU . 4.5 tm-20 -62.77 -43.98 97.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.91 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.1 -46.74 68.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.508 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -76.8 -34.8 57.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.42 32.97 3.26 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.89 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.4 p -115.39 20.57 14.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.717 0.258 . . . . 0.0 111.562 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.555 HD13 ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -81.01 -47.35 13.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.644 0.259 . . . . 0.0 110.563 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.59 -45.85 90.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.263 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.68 -41.53 98.15 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.79 -42.17 98.66 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.867 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.453 HD23 HD22 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -59.93 -38.27 81.88 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 m -77.55 -34.67 53.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.619 0.247 . . . . 0.0 110.573 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.88 -45.32 82.47 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -61.87 -24.6 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.3 23.02 7.16 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.676 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -91.33 -45.22 8.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.822 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' A' ' 110' ' ' LEU . 7.8 mp -98.71 146.28 31.35 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--O 1.248 0.989 0 C-N-CA 122.688 2.258 . . . . 0.0 112.699 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.356 0.122 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 15' ' ' LYS . . . -66.76 -10.48 47.76 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -119.8 -41.56 2.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.498 0.19 . . . . 0.0 111.205 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 t -56.76 -51.11 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 m -59.79 -33.58 71.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.06 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 13.8 mttm -65.72 -32.75 74.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.914 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.29 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.557 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.563 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -37.89 89.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.425 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -46.25 85.82 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.115 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HB ' ' HA2' ' A' ' 88' ' ' GLY . 20.8 pt -74.16 -17.5 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.646 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -61.93 2.11 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.664 0.268 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m -84.28 -19.06 34.46 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.3 69.09 59.98 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 121.046 0.45 . . . . 0.0 110.155 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 -21.37 70.3 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.943 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -90.28 66.08 6.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.864 0.364 . . . . 0.0 110.257 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -109.46 142.88 39.84 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.075 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.758 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -135.52 132.04 36.77 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 57' ' ' ILE . 18.4 tp -110.54 114.39 27.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.187 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.569 ' O ' HG22 ' A' ' 57' ' ' ILE . 1.5 m -131.97 172.71 12.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.68 -82.17 0.33 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.653 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.1 p -176.66 -62.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -139.41 42.04 2.04 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.931 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -78.97 161.19 69.48 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.577 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.64 -34.84 50.02 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.444 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.04 -35.04 14.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 71.8 m -67.58 -43.66 80.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.248 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 33' ' ' CYS . 13.5 p -57.5 -32.5 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.384 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -63.47 -51.63 64.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.593 0.235 . . . . 0.0 110.805 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.01 79.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.702 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.66 -33.28 62.48 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.709 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -58.96 -43.72 91.36 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.557 HG21 HD21 ' A' ' 106' ' ' LEU . 28.3 mm -66.48 -46.52 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.367 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -34.43 78.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.92 -39.22 87.3 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.916 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -81.79 -24.63 35.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.497 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 48' ' ' VAL . 25.5 mt -80.88 -8.28 59.68 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.4 t30 49.79 47.49 22.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.29 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 46' ' ' LEU . 14.4 m -141.23 41.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.42 -18.01 20.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.706 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -77.22 -45.32 26.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.681 0.277 . . . . 0.0 110.665 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -61.01 -24.56 66.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.414 ' CG2' HD21 ' A' ' 115' ' ' LEU . 15.7 t -102.76 160.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.363 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.1 t80 -113.92 111.12 21.17 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.374 0.607 . . . . 0.0 110.137 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.758 HG23 ' HB3' ' A' ' 27' ' ' GLN . 11.7 p -108.22 143.01 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.369 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -131.52 129.72 41.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.91 131.43 34.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.733 HG13 HD21 ' A' ' 60' ' ' LEU . 2.0 tt -91.91 29.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.52 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.29 9.97 54.13 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.146 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 29.28 7.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.009 0.405 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.733 HD21 HG13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.92 134.6 13.93 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.747 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.72 -177.62 2.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.202 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -56.79 -28.26 61.07 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.209 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.34 -56.82 13.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.962 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 10.7 mt-10 -69.91 -30.75 68.25 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -54.6 -45.52 73.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.861 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.17 -41.21 97.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.674 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -59.6 -46.78 87.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.163 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.36 90.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.211 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -60.99 -53.17 60.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 mt -63.77 -36.93 78.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.048 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -66.14 -55.13 17.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.228 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -41.22 77.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.27 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.24 69.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.517 0.198 . . . . 0.0 111.22 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -81.98 -30.37 31.66 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.581 0.229 . . . . 0.0 111.174 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 71' ' ' ALA . 37.0 t -83.3 -46.27 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.328 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.21 -38.03 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.87 36.49 7.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.514 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.72 104.25 9.19 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.22 39.43 1.02 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.468 ' O ' HG23 ' A' ' 83' ' ' THR . 18.9 t-20 -129.78 132.58 46.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -110.68 142.39 26.03 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.704 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 87.6 Cg_endo -79.17 -177.03 19.77 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.511 -1.454 . . . . 0.0 112.923 0.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.846 HG22 ' CE1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -148.17 125.61 11.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.36 118.95 52.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.337 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 m -112.95 117.67 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.799 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.1 138.53 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.39 33.15 22.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.43 ' HA2' ' HB ' ' A' ' 20' ' ' ILE . . . 64.94 45.71 91.56 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.426 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -175.24 136.64 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.846 ' CE1' HG22 ' A' ' 83' ' ' THR . 31.1 t80 -58.98 109.2 0.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.299 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.81 -21.82 10.48 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.283 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -138.28 138.06 9.24 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.041 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 96' ' ' GLN . 8.9 t -119.99 -170.44 1.96 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.502 0.178 . . . . 0.0 110.543 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.88 -33.18 34.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -29.32 34.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.666 ' H ' HG23 ' A' ' 93' ' ' THR . 17.9 tt0 -65.08 -30.22 71.16 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.7 mt -56.97 -59.72 4.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.482 0.182 . . . . 0.0 111.315 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -62.25 -38.01 87.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -67.56 -40.09 84.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.41 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -77.16 -35.31 56.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.531 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.8 -42.49 97.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.52 -49.56 68.51 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.343 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -70.95 -26.19 63.06 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.49 23.12 27.21 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.542 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.34 -20.63 21.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 42' ' ' ILE . 2.0 tp -57.3 -53.45 57.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.529 0.204 . . . . 0.0 110.825 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.78 -36.98 80.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.03 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.2 -41.57 98.49 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.149 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.555 HD13 HD11 ' A' ' 113' ' ' ILE . 4.4 mm? -66.64 -35.91 81.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.9 m -72.75 -37.22 67.76 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -47.32 83.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.249 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.555 HD11 HD13 ' A' ' 110' ' ' LEU . 33.9 pt -69.48 -24.53 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.4 26.9 9.62 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.552 HD23 ' CD1' ' A' ' 110' ' ' LEU . 4.2 tp -92.03 -40.16 11.24 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.736 0.268 . . . . 0.0 110.845 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 6.3 tp -65.42 -47.64 68.83 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.451 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 116' ' ' LEU . 70.7 Cg_exo . . . . . 0 C--O 1.252 1.204 0 C-N-CA 122.575 2.183 . . . . 0.0 112.606 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.6 -37.25 49.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -34.96 17.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.2 -48.02 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.149 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -67.31 -46.89 72.16 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -58.14 -38.27 76.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.688 0.28 . . . . 0.0 111.179 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.36 84.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' OE1' HD11 ' A' ' 20' ' ' ILE . 2.5 mm-40 -67.56 -38.28 83.88 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -61.76 -38.3 87.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.073 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.13 -47.74 73.12 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.644 HD12 ' CA ' ' A' ' 88' ' ' GLY . 43.8 pt -74.06 -14.63 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.634 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -61.7 2.36 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.59 0.234 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -83.76 -19.57 34.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -122.13 68.03 26.32 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.49 -24.02 42.94 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -92.4 69.21 5.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.487 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.09 139.62 43.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.283 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.75 ' HG3' HG23 ' A' ' 84' ' ' ILE . 1.3 mt-30 -128.37 100.05 5.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.747 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.69 94.4 5.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 p -103.25 154.49 19.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.954 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.33 29.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.215 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -94.88 36.73 1.17 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -48.55 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.087 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.6 m -69.17 137.17 89.24 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.205 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.19 -30.72 10.24 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.755 2.303 . . . . 0.0 112.858 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -58.74 -36.06 73.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.124 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m -65.23 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.58 -37.17 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.296 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.45 -46.08 84.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.566 0.222 . . . . 0.0 110.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.11 -33.46 72.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.96 -33.4 61.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.57 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -59.11 -41.76 88.95 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.802 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.675 HG22 HD12 ' A' ' 46' ' ' LEU . 22.8 mm -71.06 -36.91 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -34.05 76.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.765 0.317 . . . . 0.0 111.005 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -80.86 -31.55 35.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -83.52 -33.69 25.45 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.675 HD12 HG22 ' A' ' 42' ' ' ILE . 26.6 mt -80.75 -7.64 59.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 53.09 51.42 15.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.223 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 52' ' ' VAL . 16.1 m -114.5 26.68 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.378 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.27 -28.92 70.05 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -89.99 -25.58 20.8 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -79.16 -42.38 26.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 48' ' ' VAL . 11.4 p -120.93 154.86 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -118.26 111.13 18.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.0 110.383 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 27' ' ' GLN . 22.3 t -99.48 134.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.886 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -130.06 132.9 46.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.58 148.83 22.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.656 ' HA ' HD21 ' A' ' 60' ' ' LEU . 9.6 pt -107.79 85.19 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.52 -47.45 0.2 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.308 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -58.7 -41.45 86.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.765 0.282 . . . . 0.0 111.253 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -59.75 112.48 5.38 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.369 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.79 -173.54 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.101 2.534 . . . . 0.0 112.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -34.48 67.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.32 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -52.69 64.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.76 -34.25 69.32 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.204 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -55.38 -42.58 74.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.586 0.231 . . . . 0.0 110.845 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.52 -47.98 51.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -57.12 -48.05 79.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.192 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -38.31 81.14 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -52.42 64.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.916 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 mm -59.86 -47.11 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -59.11 -52.39 65.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -58.25 -45.91 86.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.028 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -62.72 -27.51 69.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 -28.66 36.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.971 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 71' ' ' ALA . 35.4 t -81.89 -48.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.102 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.736 HG21 ' CB ' ' A' ' 90' ' ' PHE . 10.8 p -121.29 -38.17 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.52 40.88 5.89 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.285 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.32 105.75 15.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.358 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.49 34.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 83' ' ' THR . 36.8 t30 -123.63 157.59 33.43 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -142.97 138.99 16.35 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.017 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.49 177.53 38.83 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.5 -1.458 . . . . 0.0 112.745 0.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 80' ' ' ASN . 5.4 p -132.08 137.6 47.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.06 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.75 HG23 ' HG3' ' A' ' 27' ' ' GLN . 30.7 mt -118.64 112.31 37.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.46 122.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.262 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.96 124.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.37 35.29 12.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.078 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.644 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . 67.52 46.27 70.88 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.745 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -176.15 135.94 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.736 ' CB ' HG21 ' A' ' 76' ' ' VAL . 55.7 t80 -59.49 107.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.032 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.26 4.32 7.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.117 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -149.11 141.18 8.71 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.028 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.734 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 12.0 p -121.19 -179.0 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.35 . . . . 0.0 111.237 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -72.81 -42.4 63.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.232 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.61 66.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.325 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -52.6 -38.19 59.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.571 0.224 . . . . 0.0 111.295 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.6 mt -56.88 -60.34 3.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -34.96 78.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.041 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -60.8 -44.94 96.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -79.7 -40.67 28.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -40.88 90.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.831 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -43.53 87.9 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.195 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -72.73 -29.34 63.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.531 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 24.85 19.26 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.714 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.5 p -110.88 9.83 22.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -49.01 69.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.416 0.151 . . . . 0.0 110.878 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.76 -46.39 89.8 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.67 -43.77 80.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -39.34 69.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 115' ' ' LEU . 7.8 tp -56.21 -42.9 77.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.303 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.1 m -77.47 -33.03 54.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.871 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -68.63 -43.16 76.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.528 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.4 pt -64.12 -23.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.15 25.16 8.03 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.555 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.474 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -81.78 -46.5 14.12 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -65.51 -59.69 9.0 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.899 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--O 1.248 1.002 0 C-N-CA 122.455 2.103 . . . . 0.0 112.43 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.52 -29.03 34.54 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.657 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -106.21 -38.51 6.23 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.344 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.94 -48.15 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.8 m -60.59 -42.85 97.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -58.69 -35.55 72.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 110.715 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.88 -48.22 72.24 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.449 ' OE1' HD11 ' A' ' 20' ' ' ILE . 13.9 mm-40 -63.77 -34.18 77.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.51 -33.85 73.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.59 79.53 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.449 HD11 ' OE1' ' A' ' 17' ' ' GLU . 18.3 pt -73.25 -16.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.468 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -61.48 -62.21 1.98 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.767 0.318 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -84.65 -20.39 31.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -123.14 67.92 35.35 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.393 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 38.6 Cg_endo -65.95 -22.57 55.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.665 2.243 . . . . 0.0 112.643 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -91.19 68.61 6.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.492 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' HD11 ' A' ' 28' ' ' LEU . 1.1 t80 -108.53 139.35 43.42 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.187 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -140.79 114.55 8.93 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.604 HD23 HD11 ' A' ' 57' ' ' ILE . 6.4 mp -100.87 140.4 35.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.242 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -146.5 145.69 30.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.153 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.65 -175.32 5.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.39 50.51 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.028 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -48.94 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.7 t -68.74 133.78 90.42 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.267 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.99 -34.1 48.8 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.811 2.341 . . . . 0.0 112.715 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.17 -31.94 69.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.641 0.258 . . . . 0.0 111.084 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 68.9 m -68.98 -56.33 8.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.09 -35.85 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.882 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -62.03 -45.1 95.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.5 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.01 82.15 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.348 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -75.04 -29.39 60.77 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -62.95 -45.19 93.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.8 -42.43 89.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -35.5 78.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -69.36 -31.86 70.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.156 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -78.59 -30.37 46.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.888 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.5 mt -80.46 -7.09 59.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.3 t30 56.15 47.82 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.14 30.81 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -19.46 59.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.367 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 -35.18 21.67 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -74.54 -25.12 59.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.526 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 53' ' ' PHE . 17.1 t -119.88 160.75 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.64 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -121.28 111.51 17.45 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.289 0.566 . . . . 0.0 110.336 179.397 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 p -112.15 141.65 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.516 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -125.23 124.51 41.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.22 144.99 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.072 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.604 HD11 HD23 ' A' ' 28' ' ' LEU . 16.8 mt -113.02 82.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.968 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.06 22.46 4.01 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.952 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -150.35 24.82 0.8 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.865 0.332 . . . . 0.0 111.391 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -171.79 58.28 0.25 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 111.263 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 65' ' ' GLN . 61.7 Cg_endo -89.75 160.6 5.16 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.766 2.311 . . . . 0.0 113.108 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER 64.6 -75.48 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 179.152 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.1 -50.26 73.34 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -82.6 -28.1 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.678 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 61' ' ' PRO . 28.7 mt-30 -65.17 -41.67 94.41 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.082 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 4.0 pt-20 -59.31 -40.66 86.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.624 0.25 . . . . 0.0 110.764 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 35.1 mttt -72.52 -44.61 61.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -34.72 77.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -63.81 -50.06 70.44 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.926 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 mt -60.16 -37.71 74.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.534 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -68.03 -54.66 16.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.177 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 6.4 m-85 -60.54 -36.42 78.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.164 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -65.1 -31.06 72.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -29.19 41.35 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 71' ' ' ALA . 32.3 t -81.16 -44.19 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.4 -40.82 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.27 36.58 6.55 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.423 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.0 t -111.26 105.16 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.73 0.3 . . . . 0.0 110.653 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.63 37.11 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -130.12 116.79 18.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.032 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 82' ' ' PRO . 1.0 OUTLIER -100.82 147.87 34.27 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.653 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.648 ' HA ' HD23 ' A' ' 81' ' ' LEU . 74.2 Cg_endo -74.77 175.29 48.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.813 0.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.7 p -134.93 133.62 39.77 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.8 111.07 34.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.751 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 m -107.51 124.06 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.944 0.402 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.35 127.23 73.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.723 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 8.6 m-20 62.83 37.11 12.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.006 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.84 49.44 72.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.729 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.51 136.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.65 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -59.22 102.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -115.86 -11.22 11.58 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.89 142.77 14.23 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.64 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 m -130.31 159.67 36.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.641 0.258 . . . . 0.0 111.104 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -39.68 75.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.13 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -76.88 -29.02 55.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.556 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.28 -31.81 34.45 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 mt -70.27 -49.04 53.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.057 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -59.63 -53.29 59.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.495 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -36.35 70.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.539 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.72 -42.38 34.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.1 74.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.5 97.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.357 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -73.73 -27.86 61.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.531 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.09 28.73 12.76 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.334 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 p -107.83 6.52 27.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -45.83 88.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.654 0.264 . . . . 0.0 110.73 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.76 -38.14 86.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.99 -41.64 95.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -59.12 -44.97 92.03 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.546 0.212 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.632 HD12 HD12 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.45 -41.51 85.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.212 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -80.72 -32.06 35.9 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -42.85 99.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.38 -21.83 29.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.634 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.16 26.65 13.67 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.781 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.442 ' HB3' HD13 ' A' ' 110' ' ' LEU . 2.2 tp -88.46 -43.58 11.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 110.8 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.632 HD12 HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -64.39 -56.81 20.35 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.084 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 C--O 1.25 1.102 0 C-N-CA 122.459 2.106 . . . . 0.0 112.702 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.275 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.07 73.4 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.763 0.316 . . . . 0.0 110.834 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.9 -28.05 11.34 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.444 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.83 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.635 0.255 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.2 m -61.45 -46.1 91.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -61.65 -37.65 84.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.049 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.17 87.48 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.99 -41.53 87.84 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.786 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -64.52 -35.75 81.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.63 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.3 mtp -66.34 -46.79 75.62 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.985 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.6 pt -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.636 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.88 -63.88 1.01 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.603 0.239 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -25.59 25.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.746 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -121.7 63.05 14.37 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.735 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.46 -18.21 54.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 112.845 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -88.08 73.68 8.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.91 139.96 39.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.05 98.93 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.777 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.573 HD21 HD11 ' A' ' 57' ' ' ILE . 1.7 tp -75.71 129.33 36.92 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -144.22 -176.6 5.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -132.84 109.88 9.94 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.2 p -50.29 -34.34 23.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.444 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -40.71 62.87 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.432 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 90.6 m -72.53 137.37 80.67 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.233 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -24.5 50.14 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.068 2.512 . . . . 0.0 112.836 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -55.99 -39.26 71.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.959 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -63.73 -39.45 94.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.406 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -62.84 -41.11 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.32 -47.41 73.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.861 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.16 89.74 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.538 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -75.25 -30.88 60.62 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.946 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.67 -49.01 76.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.35 -38.73 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.582 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -67.3 -34.06 76.6 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.29 -33.54 75.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.273 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 -33.2 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.944 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.14 -7.73 59.29 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 53.26 48.77 21.33 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.896 0.379 . . . . 0.0 110.929 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 ' CD1' ' A' ' 43' ' ' TRP . 26.9 m -122.69 29.4 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.385 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -69.99 -35.0 74.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.051 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.01 -33.18 26.58 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.894 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -66.82 -21.31 66.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.579 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 53' ' ' PHE . 19.9 t -125.59 161.03 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -124.17 111.58 16.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -97.42 141.72 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -127.45 96.17 4.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.992 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.35 144.2 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.688 ' HB ' HD21 ' A' ' 60' ' ' LEU . 7.3 pt -139.47 99.11 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.466 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.52 29.31 8.33 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.007 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.0 m -145.9 -83.5 0.13 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.92 0.36 . . . . 0.0 110.94 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.688 HD21 ' HB ' ' A' ' 57' ' ' ILE . 11.8 mt 60.52 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.273 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.36 62.5 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.129 2.552 . . . . 0.0 113.418 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 62.21 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -54.38 -43.13 71.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.54 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -60.01 -42.72 94.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.091 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.59 ' HA ' HD13 ' A' ' 60' ' ' LEU . 2.5 tm0? -56.23 -42.85 77.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.983 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 35.5 mt-10 -79.9 -27.03 39.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.5 -46.79 75.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.464 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.404 ' CD1' ' HA ' ' A' ' 65' ' ' GLN . 17.1 p-90 -71.99 -40.78 68.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -58.38 -39.98 81.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 69' ' ' ARG . 30.6 mt -79.38 -41.54 22.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.653 0.263 . . . . 0.0 111.08 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.03 -54.33 47.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.25 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -58.3 -41.61 84.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.469 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -61.63 -32.22 72.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.737 0.303 . . . . 0.0 111.039 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -31.01 46.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 71' ' ' ALA . 22.5 t -77.83 -43.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.08 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 89' ' ' LYS . 21.2 m -134.39 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 111.94 47.66 0.71 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.601 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.54 96.17 5.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.798 0.333 . . . . 0.0 110.492 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.93 24.75 2.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.226 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.82 170.35 15.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.149 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.23 151.19 43.7 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.24 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.46 172.77 60.98 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.786 -1.339 . . . . 0.0 112.783 0.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 t -159.32 135.53 8.98 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.791 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.45 129.08 57.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.336 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.81 131.33 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.86 125.18 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.068 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.1 m120 63.27 39.2 9.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.8 50.1 71.27 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.592 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.574 ' HA ' HG12 ' A' ' 76' ' ' VAL . 11.2 pttp -172.39 135.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.626 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 18.1 t80 -56.38 112.78 1.34 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.217 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -102.9 -29.75 11.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.538 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.32 161.74 31.84 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.095 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 90' ' ' PHE . 15.1 t -129.1 -174.93 3.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.769 0.318 . . . . 0.0 111.386 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -55.68 -45.43 77.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.843 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.5 m -64.06 -38.18 90.15 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.822 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -60.79 -30.31 69.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.6 mt -59.13 -57.8 11.46 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.516 0.198 . . . . 0.0 110.962 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -39.03 88.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.865 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -65.97 -41.3 91.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.247 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -73.72 -38.23 64.88 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.861 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.69 -52.99 31.37 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.835 0.35 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -35.86 78.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -74.25 -28.13 61.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.289 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.64 24.5 32.96 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.572 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.1 p -115.14 2.1 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -57.23 13.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.527 0.203 . . . . 0.0 110.996 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -66.83 -37.85 85.3 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.017 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.31 -52.36 65.61 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.848 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.35 -34.03 76.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.157 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD22 HD22 ' A' ' 115' ' ' LEU . 23.4 mt -61.21 -43.19 99.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.965 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.2 m -69.43 -29.22 66.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.891 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.37 -52.08 67.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.915 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.07 -25.75 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.747 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.19 7.45 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.899 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.671 HD22 HD22 ' A' ' 110' ' ' LEU . 1.2 tt -85.76 -50.65 7.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.675 0.274 . . . . 0.0 110.692 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.505 ' CD2' HD13 ' A' ' 110' ' ' LEU . 3.7 mm? -100.77 138.44 20.07 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 122.924 2.416 . . . . 0.0 112.478 -179.764 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 111.42 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.99 -29.69 20.55 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-O 120.72 0.295 . . . . 0.0 110.467 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.57 -31.58 9.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 t -64.3 -57.22 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.064 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -60.26 -44.67 95.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.107 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -61.62 -34.45 75.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.791 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.12 72.19 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -77.03 -28.51 54.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.941 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.66 -35.48 67.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.048 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 14.2 ptp -70.75 -41.58 71.59 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.812 -0.177 . . . . 0.0 111.441 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -73.86 -19.86 17.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.547 0.213 . . . . 0.0 111.412 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -62.22 1.88 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 m -87.57 -20.93 25.75 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.266 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -127.53 70.59 76.6 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 120.855 0.359 . . . . 0.0 110.72 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 41.1 Cg_endo -66.19 -22.52 53.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.718 2.278 . . . . 0.0 112.794 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CE1' HG13 ' A' ' 86' ' ' VAL . 10.7 m-85 -89.09 70.99 8.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.903 0.382 . . . . 0.0 110.275 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.83 140.68 38.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.521 ' HG2' HG23 ' A' ' 84' ' ' ILE . 49.6 mt-30 -142.77 106.91 4.72 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.783 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.699 HD21 HG12 ' A' ' 57' ' ' ILE . 6.7 tt -88.82 125.25 34.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.47 ' N ' HD23 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -140.7 172.79 12.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.009 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.73 145.57 14.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.169 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -76.39 75.74 3.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 110.739 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -142.09 -53.65 0.43 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.747 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 142.05 30.2 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.29 -34.73 81.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.962 2.441 . . . . 0.0 112.593 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -33.69 76.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.6 m -58.44 -51.34 70.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.619 0.247 . . . . 0.0 110.75 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 t -59.33 -40.32 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD2' HD13 ' A' ' 97' ' ' LEU . 82.0 t80 -59.73 -48.95 79.62 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.33 76.6 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.516 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.0 -32.45 67.21 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.561 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -62.06 -44.6 96.33 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.1 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.516 HG22 HD12 ' A' ' 46' ' ' LEU . 36.8 mm -63.13 -50.4 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.509 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.02 -32.87 74.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.916 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -66.36 -37.07 84.48 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.0 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -83.8 -27.69 28.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.471 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD12 HG22 ' A' ' 42' ' ' ILE . 20.3 mt -80.92 -7.72 59.57 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.57 49.08 20.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 m -127.28 38.9 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -93.21 16.59 12.74 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.523 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.9 -42.63 3.54 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.928 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -25.13 61.76 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.393 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 53' ' ' PHE . 21.3 t -108.34 158.3 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.645 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.414 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -116.05 111.01 19.69 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.261 0.553 . . . . 0.0 110.207 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.2 t -104.25 134.85 44.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -120.97 98.21 5.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.0 132.07 34.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.699 HG12 HD21 ' A' ' 28' ' ' LEU . 1.3 pt -120.58 91.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.402 . . . . 0.0 111.293 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 13.09 8.08 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.127 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.558 ' C ' HD13 ' A' ' 60' ' ' LEU . 4.6 t -135.72 56.75 1.82 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.018 0.437 . . . . 0.0 110.702 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -112.39 140.08 23.32 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.291 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 64' ' ' GLU . 86.3 Cg_endo -81.54 45.1 1.88 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.879 2.386 . . . . 0.0 114.314 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 67.47 -57.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.607 0.363 . . . . 0.0 111.764 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.33 -33.66 54.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.623 0.249 . . . . 0.0 111.007 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 18.9 mm-40 -70.01 -39.71 75.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.919 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -51.22 70.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.989 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -41.48 80.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.6 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -65.66 -38.67 90.0 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.884 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -62.17 -44.52 96.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.304 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.72 -41.72 87.07 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.4 mt -73.38 -43.87 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -52.27 65.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.23 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.47 -34.71 74.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -63.44 -30.31 71.45 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.047 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.84 -29.8 35.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.148 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -82.53 -44.54 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.194 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.611 HG11 HG12 ' A' ' 85' ' ' VAL . 3.7 m -123.89 -41.93 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 40.68 2.85 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.62 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.2 t -116.42 115.36 25.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -96.4 39.27 1.16 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -154.73 159.64 40.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.174 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 28' ' ' LEU . 67.7 mt -127.42 152.22 76.07 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.882 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD2' ' HG3' ' A' ' 94' ' ' GLU . 72.8 Cg_endo -76.5 174.88 50.7 Favored 'Cis proline' 0 C--N 1.354 0.834 0 C-N-CA 123.482 -1.466 . . . . 0.0 113.007 0.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.401 HG23 ' CE1' ' A' ' 90' ' ' PHE . 3.1 m -129.0 121.61 28.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.876 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.521 HG23 ' HG2' ' A' ' 27' ' ' GLN . 2.5 mt -106.1 111.23 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.871 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.611 HG12 HG11 ' A' ' 76' ' ' VAL . 6.0 m -112.18 119.46 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.51 HG13 ' CE1' ' A' ' 25' ' ' TYR . 31.2 t -117.08 122.1 69.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.963 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.421 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER 64.27 38.57 7.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.38 49.02 78.06 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.679 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -174.31 136.68 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 110.693 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.401 ' CE1' HG23 ' A' ' 83' ' ' THR . 1.8 t80 -55.05 106.15 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.283 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -24.03 9.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.752 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.4 148.11 18.5 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.595 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -124.81 175.58 7.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.71 0.29 . . . . 0.0 111.17 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 82' ' ' PRO . 15.7 tt0 -71.01 -27.64 63.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.31 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -94.45 -29.28 15.04 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.442 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 6.9 tt0 -57.91 -35.06 70.53 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 38' ' ' TYR . 2.6 pp -57.6 -42.02 82.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.569 0.223 . . . . 0.0 111.206 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.74 -35.1 52.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.941 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -70.59 -51.76 26.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-O 120.709 0.29 . . . . 0.0 111.433 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.78 -37.68 79.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.422 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.35 -50.77 68.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.907 0.384 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.92 -35.93 81.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.282 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -72.29 -25.72 61.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.49 44.19 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.557 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 p -103.75 -14.86 15.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.12 69.86 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.623 0.249 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.56 -45.37 72.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.3 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.16 -43.74 95.56 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -39.94 84.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.715 ' HG ' HD22 ' A' ' 115' ' ' LEU . 1.1 mp -58.84 -40.86 85.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.099 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 116' ' ' LEU . 30.9 m -75.59 -34.08 60.61 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.855 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -60.21 -48.22 82.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.068 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 115' ' ' LEU . 6.5 pt -65.28 -24.75 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.862 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.7 22.29 7.08 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.715 HD22 ' HG ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -82.72 -46.0 13.73 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.838 0.319 . . . . 0.0 110.906 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.562 HD12 HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -122.29 60.9 13.72 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.742 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 122.743 2.296 . . . . 0.0 112.795 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.31 -36.54 21.32 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.43 -39.32 6.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.129 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.67 -55.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.345 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -60.99 -39.11 88.42 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.684 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -35.37 78.74 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.933 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.51 92.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.834 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.8 mm-40 -60.46 -36.78 79.05 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.92 -31.66 68.35 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.968 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.1 mtt -69.22 -47.76 63.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.172 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -72.45 -16.55 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.582 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -61.48 -61.23 2.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.7 m -79.39 -18.59 52.01 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.634 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -120.89 68.21 15.97 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.411 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.4 -27.05 40.49 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.596 2.197 . . . . 0.0 112.573 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' A' ' 52' ' ' VAL . 28.5 m-85 -90.09 65.74 6.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.975 0.416 . . . . 0.0 110.356 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.74 141.73 38.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 54' ' ' VAL . 47.3 tt0 -141.12 101.35 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.392 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.46 HD21 ' CD1' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -81.32 139.04 35.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.664 0.269 . . . . 0.0 110.904 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -153.1 -176.08 5.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.373 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.36 -170.62 2.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.013 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 m -109.07 -39.78 5.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.261 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.9 37.3 3.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.664 0.269 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 t -97.08 138.33 21.26 Favored Pre-proline 0 C--O 1.234 0.272 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.958 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.14 -28.4 41.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.827 2.351 . . . . 0.0 112.239 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.91 -37.65 58.56 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.337 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.0 t -70.2 -45.99 65.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.497 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.84 -37.43 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.546 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -68.51 -46.9 68.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.674 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.27 93.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.385 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -75.39 -28.76 59.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.089 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 t -60.82 -48.31 82.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.108 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.52 -45.37 92.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.588 ' CD1' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -66.98 -31.97 72.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.35 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -68.33 -33.93 75.18 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.99 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -81.11 -36.29 30.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.707 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -80.61 -7.85 59.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.121 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.9 46.02 26.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.588 HG23 ' CD1' ' A' ' 43' ' ' TRP . 17.2 m -119.02 35.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.73 3.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -124.05 -50.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.608 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -62.19 -25.73 67.94 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 25' ' ' TYR . 10.0 p -113.21 156.75 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.418 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.37 111.14 18.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.326 0.584 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 27' ' ' GLN . 22.2 t -104.31 132.83 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.787 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -119.14 113.04 20.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.675 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -99.72 111.54 23.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.635 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.46 ' CD1' HD21 ' A' ' 28' ' ' LEU . 7.4 pt -98.69 76.9 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.614 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 26.9 8.57 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.983 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.4 30.6 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.423 HD13 ' HG2' ' A' ' 64' ' ' GLU . 15.1 mt -113.3 132.68 22.34 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 33.8 Cg_exo -62.14 -167.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.818 2.345 . . . . 0.0 112.506 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 9.58 5.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.077 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -116.07 -41.3 3.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.371 0.129 . . . . 0.0 110.93 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.423 ' HG2' HD13 ' A' ' 60' ' ' LEU . 1.1 tt0 -82.56 -40.84 20.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.898 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -60.85 -40.55 93.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -41.09 96.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.968 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -56.62 -47.7 79.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.042 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -34.46 78.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.103 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -48.36 71.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.72 -42.37 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.238 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -56.67 -42.74 79.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.269 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -64.55 -49.47 71.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.134 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -24.78 65.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.05 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.87 48.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.164 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 71' ' ' ALA . 34.2 t -87.83 -47.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.3 -41.57 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.8 38.98 2.81 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.685 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -102.98 109.01 20.4 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.443 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.22 31.06 1.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -169.52 167.81 9.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.766 0.317 . . . . 0.0 111.269 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.31 159.7 69.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HB3' ' OG ' ' A' ' 29' ' ' SER . 73.3 Cg_endo -77.77 156.15 95.24 Favored 'Cis proline' 0 C--N 1.352 0.727 0 C-N-CA 123.442 -1.482 . . . . 0.0 112.906 0.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 t -127.31 125.59 41.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.188 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.98 111.25 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 111.086 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 85' ' ' VAL . 30.2 m -109.83 120.46 60.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.555 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.37 120.46 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.024 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.84 40.11 5.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 48.99 75.2 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.971 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -171.99 134.87 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.503 ' HZ ' HG23 ' A' ' 93' ' ' THR . 55.7 t80 -56.91 115.18 2.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.4 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.0 3.09 5.29 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.07 136.7 5.27 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.91 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.503 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -122.24 167.03 13.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.927 0.394 . . . . 0.0 111.635 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.76 -38.84 89.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.746 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -29.84 29.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -55.49 -31.89 62.39 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.266 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.51 -55.65 32.25 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.624 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -34.98 74.44 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -70.19 -42.97 71.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -73.87 -41.06 62.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.93 -41.93 77.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.259 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.08 74.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.314 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.85 -26.65 63.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.264 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.41 25.58 25.57 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.519 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.9 p -114.56 13.14 17.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -45.3 68.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.619 0.247 . . . . 0.0 110.899 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.7 -43.14 97.48 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.918 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.63 -40.06 82.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.46 -40.81 92.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.752 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.718 ' HB3' HD13 ' A' ' 116' ' ' LEU . 3.5 mp -58.76 -37.07 75.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.134 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.483 ' OG1' HD22 ' A' ' 116' ' ' LEU . 51.3 m -72.57 -35.62 68.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.6 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -65.88 -46.58 77.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 pt -64.69 -25.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.43 27.04 7.0 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.407 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.429 HD22 ' HG ' ' A' ' 110' ' ' LEU . 1.1 tp -85.73 -46.54 10.6 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.603 0.202 . . . . 0.0 110.761 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.718 HD13 ' HB3' ' A' ' 110' ' ' LEU . 7.1 mp -72.55 -59.5 2.44 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.969 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.392 2.061 . . . . 0.0 112.444 179.886 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.468 0.175 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.6 -37.72 58.71 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.864 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.42 -37.5 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.101 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.413 HG12 ' OE2' ' A' ' 17' ' ' GLU . 36.6 t -67.29 -47.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.087 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -62.78 -43.67 98.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.877 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -39.33 90.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.658 0.266 . . . . 0.0 110.732 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.93 93.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.413 ' OE2' HG12 ' A' ' 13' ' ' VAL . 43.5 mt-10 -67.88 -36.6 80.53 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.71 -34.01 77.31 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.05 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -43.97 74.95 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.242 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 17' ' ' GLU . 14.0 pt -74.21 -15.12 16.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.655 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -61.49 -65.25 0.72 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.622 0.248 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.43 -23.99 27.65 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -123.56 67.58 38.84 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 110.832 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 -18.18 51.87 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.578 2.185 . . . . 0.0 112.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -92.78 73.33 4.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.367 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.33 140.03 48.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.499 ' HG3' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -132.86 102.24 5.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.554 179.513 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.547 HD22 ' CZ ' ' A' ' 72' ' ' PHE . 4.4 mp -88.83 112.32 23.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 99.6 p -162.47 -177.76 5.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.942 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 69.32 118.81 0.03 OUTLIER 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -177.5 -48.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.863 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.65 34.75 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.043 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.27 134.42 21.36 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.664 0.268 . . . . 0.0 111.499 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.88 -33.17 10.37 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.76 -34.67 71.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.5 m -64.87 -39.51 93.67 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.36 -36.02 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.116 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -57.58 -45.09 85.68 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.771 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.48 87.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.12 -31.87 61.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.813 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -49.0 77.54 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.773 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.03 -40.87 88.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.567 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.1 m-90 -67.95 -34.51 76.71 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.404 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.13 -33.06 65.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.494 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.35 -35.91 24.8 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.099 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 46' ' ' LEU . 16.1 mt -80.95 -7.94 59.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.801 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.23 47.95 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.206 0.527 . . . . 0.0 110.528 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.567 HG23 ' CD1' ' A' ' 43' ' ' TRP . 18.8 m -119.97 24.43 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.195 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.7 21.07 12.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -105.48 -43.9 4.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.933 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -76.34 -21.12 56.53 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.934 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' CG2' HD11 ' A' ' 115' ' ' LEU . 28.9 t -107.51 156.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.778 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.404 ' N ' HG12 ' A' ' 52' ' ' VAL . 3.1 t80 -114.08 110.97 20.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.263 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.07 133.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.658 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -125.36 136.25 53.26 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 29' ' ' SER . 10.0 p-10 -97.04 127.5 43.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -93.91 71.76 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.72 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.38 29.67 5.85 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.35 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.46 -45.69 2.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.998 0.399 . . . . 0.0 111.299 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.697 HD22 ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.12 122.68 30.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.763 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 12.6 Cg_exo -70.45 -170.81 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.121 2.548 . . . . 0.0 111.857 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -68.01 -30.89 70.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -72.93 -46.81 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.294 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 13.0 tp10 -62.47 -34.19 76.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -56.39 -32.28 64.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.487 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -57.85 -53.74 54.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -61.31 -40.75 95.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.542 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.05 -36.02 80.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.427 ' CD ' ' HD2' ' A' ' 79' ' ' ARG . 9.9 mtm180 -60.6 -54.66 42.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.29 -39.79 79.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.031 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -57.52 -46.27 84.01 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.867 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.547 ' CZ ' HD22 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -63.55 -46.44 85.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -26.28 68.41 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.35 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -81.96 -30.81 31.51 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.205 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 71' ' ' ALA . 43.4 t -83.8 -47.23 18.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.359 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.17 -38.9 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.29 7.27 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.74 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.95 109.74 4.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.66 0.267 . . . . 0.0 110.641 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HD2' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -99.1 42.27 1.11 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.63 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -119.73 129.17 54.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.598 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -96.38 147.86 33.6 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.42 166.85 81.64 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.652 -1.395 . . . . 0.0 112.522 0.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.3 p -125.11 115.26 20.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.697 HD11 HD21 ' A' ' 97' ' ' LEU . 31.8 mt -109.58 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -111.47 116.44 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.03 129.52 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 m120 60.9 37.03 18.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.54 81.78 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -172.84 136.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 0.0 110.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -63.31 104.59 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.103 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -110.08 -26.02 9.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.726 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -117.83 139.75 15.04 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.048 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -117.66 -170.31 1.84 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.286 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 95' ' ' SER . 24.3 pm0 -77.31 -35.13 55.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 94' ' ' GLU . 8.1 t -84.01 -34.44 24.31 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.91 -39.17 25.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.613 0.244 . . . . 0.0 111.596 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.697 HD21 HD11 ' A' ' 84' ' ' ILE . 17.2 mt -58.12 -55.6 32.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.394 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -41.54 64.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.517 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.0 mmt-85 -57.56 -36.83 72.17 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.537 0.208 . . . . 0.0 111.206 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.19 -44.99 24.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -42.98 99.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.746 0.308 . . . . 0.0 111.001 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.78 81.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -71.11 -27.26 63.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 27.42 13.17 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.493 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.7 p -112.44 14.82 20.34 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -52.27 58.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.489 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.39 -41.79 75.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.65 -46.94 80.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.799 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -62.69 -40.24 96.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -57.46 -33.65 68.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 m -74.25 -34.38 63.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -67.36 -43.86 80.42 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.304 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.27 -24.35 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.81 25.51 9.73 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.786 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.503 HD11 ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -88.45 -44.78 10.48 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.8 0.3 . . . . 0.0 110.798 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.628 ' HB2' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -128.86 56.46 23.58 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.96 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.716 2.277 . . . . 0.0 112.623 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 120.483 0.183 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -34.6 66.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.367 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -83.99 -35.47 23.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.009 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.9 t -56.06 -51.39 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -59.24 -42.39 90.97 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.248 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.34 -39.19 93.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.238 . . . . 0.0 110.736 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 75' ' ' VAL . . . -66.15 -39.84 90.13 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.693 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.22 -37.09 77.86 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.63 -33.81 76.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.909 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.5 69.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.318 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -72.51 -14.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.727 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -60.99 -57.85 10.9 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.201 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -86.25 -2.03 58.01 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -129.72 73.67 81.32 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.45 -36.35 35.02 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.709 2.273 . . . . 0.0 112.61 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.585 ' HE2' HD12 ' A' ' 115' ' ' LEU . 9.7 m-85 -99.97 68.39 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.941 0.4 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -106.89 139.38 41.38 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.513 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 54' ' ' VAL . 95.0 mt-30 -136.05 112.54 9.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.33 114.98 26.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.624 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.82 175.75 5.52 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.272 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.49 173.59 6.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.481 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 p -70.12 72.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.274 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.3 t90 55.19 64.31 1.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.353 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -85.34 163.84 43.3 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.578 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.47 -34.18 86.53 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.593 2.195 . . . . 0.0 112.484 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.59 -32.48 13.41 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.393 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.92 -42.99 89.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.851 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.44 -36.39 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.226 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.14 -56.6 18.89 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.416 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . . . -62.33 -30.96 71.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.421 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.583 ' HA ' ' CE2' ' A' ' 43' ' ' TRP . 3.1 m-80 -69.0 -38.25 79.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -65.54 -37.63 87.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.196 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 mm -57.88 -59.7 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.79 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.583 ' CE2' ' HA ' ' A' ' 40' ' ' ASN . 1.6 p90 -72.96 -16.11 61.54 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 20.9 t-20 -73.55 -43.17 60.51 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.587 0.232 . . . . 0.0 111.06 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -81.31 -31.23 33.64 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.447 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -80.48 -6.92 58.88 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 54.29 48.54 20.54 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.168 0.508 . . . . 0.0 110.794 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 52' ' ' VAL . 29.0 m -116.63 28.1 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.425 ' HG3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mt-30 -83.03 -16.23 47.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.701 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -83.63 -38.99 20.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.647 0.261 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 48' ' ' VAL . 14.0 p -110.26 162.34 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.453 ' N ' HG22 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -118.98 111.41 18.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.185 0.517 . . . . 0.0 109.958 178.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' GLN . 11.3 p -114.17 141.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.229 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -135.64 126.7 27.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.887 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.78 141.67 28.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.575 ' HB ' HD21 ' A' ' 60' ' ' LEU . 1.3 pt -89.93 52.64 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 24.31 29.17 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.014 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -126.67 28.76 5.83 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 110.881 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.575 HD21 ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -147.82 129.25 7.25 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.85 -177.05 2.02 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.721 2.281 . . . . 0.0 111.955 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -58.4 -36.69 73.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.638 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -62.85 -52.4 63.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.166 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 26.2 mm-40 -58.68 -36.18 73.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -56.36 -38.18 71.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.061 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.43 -55.49 15.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.041 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -41.29 86.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.849 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.9 t-105 -65.78 -38.7 89.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -58.73 -43.33 90.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.132 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.5 -46.29 86.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.913 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -56.92 -49.1 76.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.17 -40.99 97.88 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -61.62 -30.75 70.9 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 111.143 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 -29.68 36.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.6 t -81.02 -43.0 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.145 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.11 -44.83 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.62 0.86 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.575 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.5 100.54 8.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.773 0.32 . . . . 0.0 110.472 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -91.34 29.43 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.54 176.24 11.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.317 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.86 153.05 81.31 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.28 -178.07 21.99 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.705 -0.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.3 p -131.64 131.43 43.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.416 ' HB ' ' CA ' ' A' ' 92' ' ' GLY . 21.3 mt -114.02 111.43 35.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.787 0.327 . . . . 0.0 111.253 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.72 129.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.631 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.6 t -123.41 119.08 56.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.66 41.73 3.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.61 50.44 64.26 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.746 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -175.12 135.06 0.34 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 93' ' ' THR . 15.2 t80 -60.46 102.82 0.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.54 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -106.7 -30.21 9.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.351 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' CA ' ' HB ' ' A' ' 84' ' ' ILE . . . -122.46 146.15 16.66 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.981 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -120.95 173.05 7.48 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.812 0.339 . . . . 0.0 111.352 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -36.66 80.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.7 m -84.82 -29.63 25.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.548 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -52.23 -35.12 48.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.559 0.218 . . . . 0.0 111.513 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 39' ' ' ALA . 27.7 mt -67.52 -57.61 6.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.352 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -32.85 73.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.424 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -69.8 -40.96 75.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -78.65 -35.76 44.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.179 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.04 -43.88 87.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.56 70.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -72.31 -28.8 63.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.357 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.55 26.48 10.79 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.548 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.7 p -111.53 18.29 19.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -67.01 -50.72 61.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.568 0.223 . . . . 0.0 110.483 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.32 -38.08 81.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -43.98 98.01 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.607 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.2 -41.98 93.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.748 HD23 HD23 ' A' ' 116' ' ' LEU . 4.6 tp -65.88 -27.38 68.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.346 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.8 m -79.02 -34.9 43.54 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.605 0.24 . . . . 0.0 110.443 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -41.05 87.01 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 pt -64.9 -25.19 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.53 8.01 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.717 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.585 HD12 ' HE2' ' A' ' 25' ' ' TYR . 5.1 tt -101.77 -54.15 2.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.84 0.32 . . . . 0.0 110.77 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.748 HD23 HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -88.55 109.69 31.17 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.685 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.615 2.21 . . . . 0.0 112.478 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.68 -23.61 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.716 0.293 . . . . 0.0 110.816 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -120.7 -36.73 3.12 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 t -61.36 -55.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.876 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -70.23 -39.77 74.86 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.811 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -38.49 77.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.24 -49.32 72.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.12 -37.66 88.16 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.91 -37.47 86.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -46.14 83.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.471 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.3 pt -72.24 -16.6 18.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.597 0.237 . . . . 0.0 111.53 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -63.74 1.18 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.176 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.1 m -88.61 -16.97 31.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.484 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -124.55 70.5 56.12 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.583 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.24 -22.38 46.64 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.733 2.289 . . . . 0.0 112.614 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.406 ' HB3' HG13 ' A' ' 52' ' ' VAL . 8.2 m-85 -94.2 66.51 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.426 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -110.77 127.84 55.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.075 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.459 ' HG2' HG23 ' A' ' 84' ' ' ILE . 96.0 mt-30 -112.41 113.74 26.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.687 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -90.34 126.81 35.99 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.939 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -119.17 157.91 27.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.304 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -76.86 175.85 9.1 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.429 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -97.8 112.86 24.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.957 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 57.5 39.87 27.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.696 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 1.3 m -109.91 148.45 38.28 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.19 -30.86 52.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.877 2.385 . . . . 0.0 112.296 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -45.91 67.0 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 t -57.54 -52.62 64.65 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -62.41 -36.2 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.221 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -66.38 -55.46 15.77 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.83 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.22 68.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.746 0.307 . . . . 0.0 111.302 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.496 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 1.2 m-80 -72.34 -38.19 68.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 p -64.48 -37.61 88.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 46' ' ' LEU . 38.3 mm -58.54 -61.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.459 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.496 ' CD1' ' HA ' ' A' ' 40' ' ' ASN . 12.3 p-90 -65.92 -39.17 90.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.35 -38.36 77.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.697 0.284 . . . . 0.0 111.243 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -83.86 -32.02 25.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 42' ' ' ILE . 21.0 mt -81.07 -8.03 59.68 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 51.64 47.3 25.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 110.944 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.52 33.25 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 43' ' ' TRP . 3.4 tt0 -74.17 -15.87 61.01 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.594 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.12 -30.59 23.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.666 0.27 . . . . 0.0 110.706 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -82.27 -31.15 30.24 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.345 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.48 ' CG2' HD11 ' A' ' 115' ' ' LEU . 48.0 t -133.68 149.75 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.764 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.46 111.62 19.53 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.383 0.611 . . . . 0.0 110.715 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.466 HG11 ' NE1' ' A' ' 43' ' ' TRP . 10.8 p -100.64 141.46 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.167 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.45 135.83 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.914 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.77 177.19 6.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.582 HG23 ' H ' ' A' ' 59' ' ' SER . 2.1 tt -63.93 -24.6 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.742 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.28 5.64 55.85 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.535 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.582 ' H ' HG23 ' A' ' 57' ' ' ILE . 4.6 m 59.65 31.82 21.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.149 0.475 . . . . 0.0 110.6 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -54.94 132.02 67.3 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.704 -179.46 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.91 175.89 1.64 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.7 2.267 . . . . 0.0 111.877 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -51.91 -28.09 15.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.571 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.73 -55.4 5.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.465 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -69.25 -33.05 72.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.439 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.47 ' HA ' HD22 ' A' ' 60' ' ' LEU . 21.4 tt0 -53.49 -43.81 68.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.925 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -38.36 86.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.783 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -66.03 -37.24 85.38 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -66.9 -48.05 69.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.54 0.21 . . . . 0.0 111.096 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -56.87 -51.35 69.38 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.517 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -65.92 -45.44 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.573 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.55 -54.59 43.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.492 0.187 . . . . 0.0 111.413 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.81 -38.76 82.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.725 0.298 . . . . 0.0 110.949 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.402 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 25.6 tt0 -69.13 -27.62 65.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -31.76 40.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.251 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 71' ' ' ALA . 23.9 t -84.16 -48.59 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.333 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.36 -41.19 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 103.92 40.4 2.32 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -123.78 97.37 5.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.744 0.307 . . . . 0.0 110.552 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -86.52 49.99 1.91 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.582 ' C ' HD13 ' A' ' 81' ' ' LEU . 4.6 t-20 -170.72 170.66 6.52 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.144 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD22 ' H ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -140.61 161.71 53.09 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 179.552 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.85 169.87 72.25 Favored 'Cis proline' 0 C--N 1.355 0.881 0 C-N-CA 123.497 -1.46 . . . . 0.0 113.017 0.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.658 HG22 ' HE2' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -147.65 127.99 13.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -179.66 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.459 HG23 ' HG2' ' A' ' 27' ' ' GLN . 29.7 mm -102.01 111.6 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.89 117.14 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.981 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.68 124.17 72.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.8 m120 62.12 38.99 13.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.018 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.0 91.72 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.882 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.21 136.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.963 0.411 . . . . 0.0 110.637 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.658 ' HE2' HG22 ' A' ' 83' ' ' THR . 61.1 t80 -60.54 107.99 0.76 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.065 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -115.53 -24.82 8.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.706 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.11 140.0 12.74 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.247 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.626 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -107.29 173.36 6.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -68.08 -31.14 70.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.479 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -28.16 18.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.13 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -55.1 -37.95 67.49 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.213 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.59 -44.18 87.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.355 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.95 -34.59 59.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.4 mmt85 -72.82 -37.69 67.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.346 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.75 -45.94 56.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.11 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.23 -39.28 92.29 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.65 0.262 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.09 -50.56 65.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -69.15 -27.4 65.51 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.614 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 24.5 12.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.599 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.2 p -108.46 20.04 19.07 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.594 0.197 . . . . 0.0 111.454 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -50.72 11.3 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.658 0.266 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.44 -42.39 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.37 -51.45 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.749 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -39.58 94.72 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.94 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.49 -38.07 76.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.97 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 14.0 m -78.26 -34.48 49.03 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.628 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -64.12 -44.19 92.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.355 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.6 pt -64.58 -26.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.78 22.3 8.12 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.907 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.48 HD11 ' CG2' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -81.71 -44.47 17.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.877 0.37 . . . . 0.0 110.52 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -52.8 1.41 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.441 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 111' ' ' THR . 50.9 Cg_exo . . . . . 0 C--O 1.248 1.013 0 C-N-CA 122.387 2.058 . . . . 0.0 112.367 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.609 0.242 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.33 -27.5 55.98 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.913 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 -39.53 5.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.482 0.182 . . . . 0.0 111.427 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.78 -52.54 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.11 -40.55 96.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 110.965 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.34 -35.03 77.82 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.542 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.92 -46.56 88.82 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.4 mm-40 -61.17 -36.41 79.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.803 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.86 -33.62 74.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.902 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -49.12 61.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.6 pt -71.68 -14.43 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.406 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -63.62 1.21 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.65 0.262 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -84.41 -19.01 34.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -120.29 62.21 8.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.742 0.306 . . . . 0.0 110.829 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.97 -15.38 43.42 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.702 2.268 . . . . 0.0 113.019 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -93.88 74.27 4.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.271 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.49 121.2 40.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.003 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -112.77 121.96 46.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.997 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.6 mt -98.92 117.96 34.62 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.669 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 94.1 p -119.52 154.44 33.84 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.555 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.74 164.25 12.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.478 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.91 39.41 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.84 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -161.31 -44.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.428 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.83 147.47 88.88 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-O 120.569 0.223 . . . . 0.0 111.064 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.93 -17.7 36.63 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.19 -38.11 67.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.329 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 29' ' ' SER . 24.1 p -62.61 -39.18 92.97 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.83 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.3 -37.31 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -64.0 -49.38 72.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.749 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.34 88.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.533 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -75.35 -31.39 60.53 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.621 0.248 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -59.82 -45.97 90.7 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 46' ' ' LEU . 32.2 mm -65.74 -41.81 91.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.92 -34.69 78.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.098 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -67.17 -34.16 76.94 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -34.68 26.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 42' ' ' ILE . 19.1 mt -80.63 -7.71 59.37 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 53.53 45.82 27.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.671 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.35 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -93.62 17.63 11.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.394 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.66 -44.9 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.679 0.276 . . . . 0.0 110.861 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -64.7 -26.38 68.35 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.395 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.05 157.76 10.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.683 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.4 111.24 20.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.288 0.566 . . . . 0.0 110.477 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 t -96.06 131.55 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.99 115.61 15.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.047 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -81.48 151.06 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.485 HG13 HD21 ' A' ' 81' ' ' LEU . 34.5 mm -98.35 72.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.88 26.01 2.08 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.143 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -130.49 32.69 4.39 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -142.66 126.92 9.78 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.53 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 27.3 Cg_exo -62.76 -171.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.061 2.507 . . . . 0.0 112.507 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.11 9.44 3.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.44 -41.65 3.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.568 0.223 . . . . 0.0 110.951 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 32.1 tp10 -68.48 -37.95 80.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.059 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.606 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.9 tt0 -63.79 -35.19 79.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.92 -57.38 12.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.127 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.74 87.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.087 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -46.27 89.16 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -44.94 64.72 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.226 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.7 mt -66.69 -47.32 83.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -61.63 -39.2 90.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.437 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.505 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 10.9 m-85 -59.16 -53.5 57.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.19 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.65 -25.87 63.18 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.96 -30.85 56.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.972 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 71' ' ' ALA . 37.8 t -84.34 -44.29 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.253 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.6 m -120.52 -44.03 2.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.54 23.25 21.94 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.954 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.44 75.8 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HA ' HG21 ' A' ' 83' ' ' THR . 5.7 mtt180 -119.43 29.82 7.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.835 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.36 111.51 8.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.283 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.485 HD21 HG13 ' A' ' 57' ' ' ILE . 8.5 mt -45.9 131.92 6.94 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.38 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.14 150.48 85.66 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 124.034 -1.236 . . . . 0.0 112.747 0.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.6 HG21 ' HA ' ' A' ' 79' ' ' ARG . 26.6 m -142.98 128.63 19.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.402 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.6 mm -112.07 113.02 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.85 116.45 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.99 129.59 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.74 34.09 12.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.762 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.44 46.6 92.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.681 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -175.9 137.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.743 ' HZ ' HG23 ' A' ' 93' ' ' THR . 91.2 t80 -61.6 102.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -116.46 -25.72 7.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.712 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.12 138.61 14.57 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.933 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.743 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -123.35 -173.63 2.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.689 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.445 ' OE1' HG22 ' A' ' 93' ' ' THR . 1.8 mp0 -74.13 -37.83 63.97 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -95.24 -27.29 15.58 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.703 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.19 -39.04 66.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 93' ' ' THR . 17.1 mt -66.77 -47.23 72.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -62.28 -38.51 89.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.066 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -71.37 -38.92 71.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.276 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.425 ' HB3' HD12 ' A' ' 106' ' ' LEU . 5.1 m-85 -74.28 -35.36 63.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.008 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -50.35 20.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.738 0.304 . . . . 0.0 111.05 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -36.84 71.66 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.47 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -72.41 -27.4 62.33 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.17 25.74 20.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.52 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 p -109.07 -5.33 16.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -55.08 -42.15 72.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.539 0.209 . . . . 0.0 111.273 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.61 -51.0 70.31 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -61.56 -44.01 97.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 -36.17 76.03 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.727 HD23 HD12 ' A' ' 116' ' ' LEU . 1.2 tp -60.89 -40.51 93.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.805 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.7 m -74.6 -30.62 61.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.42 -24.62 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.736 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.06 7.19 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.769 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.89 -51.44 5.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.795 0.331 . . . . 0.0 110.743 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.727 HD12 HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -92.15 109.4 37.4 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--O 1.251 1.141 0 C-N-CA 122.546 2.164 . . . . 0.0 112.873 -179.854 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.415 0.15 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.59 -32.35 40.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -96.51 -35.45 11.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.19 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.1 t -57.8 -51.76 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.526 0.203 . . . . 0.0 111.121 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.17 -36.76 78.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -65.51 -33.45 75.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.041 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.62 58.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.74 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 -34.06 76.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -70.03 -33.38 71.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -46.48 71.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.21 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 pt -71.99 -15.13 17.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.536 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -64.99 0.76 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.676 0.274 . . . . 0.0 111.026 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -24.21 26.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -119.72 68.37 11.61 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.808 0.337 . . . . 0.0 110.861 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 58.7 Cg_endo -70.91 -19.63 30.43 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 112.945 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HB3' HG13 ' A' ' 52' ' ' VAL . 37.7 m-85 -92.94 70.51 4.64 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.73 53.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.292 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.579 ' OE1' HG23 ' A' ' 84' ' ' ILE . 2.8 mp0 -128.01 107.68 10.03 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.48 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.13 124.07 28.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.958 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 m -129.5 172.32 11.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.954 0.406 . . . . 0.0 111.428 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -103.35 -175.32 2.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.274 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.83 98.31 11.52 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.43 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.6 44.77 26.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.659 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -78.92 159.33 73.76 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.011 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.66 -36.3 14.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.642 2.228 . . . . 0.0 112.597 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.33 -36.51 13.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.24 -34.18 76.92 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.44 -33.38 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.582 0.229 . . . . 0.0 111.233 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -63.23 -48.89 76.33 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.998 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.27 76.8 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.134 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -75.35 -31.47 60.56 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -61.44 -49.19 77.85 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mm -69.05 -37.38 76.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.046 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.08 75.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.081 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.47 -30.05 57.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.271 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -81.57 -33.37 31.67 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.965 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.5 HD22 HD11 ' A' ' 116' ' ' LEU . 19.3 mt -80.7 -7.71 59.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 50.64 50.11 19.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.012 0.434 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -112.48 33.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.435 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.1 -25.29 43.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.477 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -37.07 21.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 110.993 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -84.77 -15.0 46.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.491 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 53' ' ' PHE . 23.0 t -126.03 159.36 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.466 0.174 . . . . 0.0 110.947 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.438 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -121.65 111.74 17.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.307 0.575 . . . . 0.0 110.476 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.64 133.74 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -124.21 127.49 47.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.912 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 142.19 29.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.981 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 60' ' ' LEU . 4.9 pt -136.35 72.28 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.32 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.9 28.02 7.2 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.154 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -141.2 42.55 1.79 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' CD1' ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -135.86 118.83 12.39 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 -176.97 2.11 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.676 2.251 . . . . 0.0 112.439 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -59.34 -34.4 72.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.281 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -59.19 -51.84 68.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.653 0.263 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.35 -44.33 65.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.833 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.2 -34.8 70.77 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.374 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.78 -49.43 76.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.616 0.246 . . . . 0.0 111.093 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -42.11 93.75 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.02 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -68.67 -32.01 71.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.07 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HG2' ' HD3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -56.95 -47.27 81.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.951 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mt -76.85 -44.79 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.165 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.05 -52.18 64.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.617 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -48.6 80.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.166 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.99 -23.87 65.69 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.492 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -30.98 39.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.123 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 71' ' ' ALA . 24.7 t -86.91 -48.07 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.477 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.38 -37.62 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.42 33.57 8.56 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.416 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.52 93.53 0.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HD3' ' HG2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -97.61 34.08 1.92 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.82 112.56 24.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -91.11 147.37 35.51 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.617 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 94' ' ' GLU . 10.7 Cg_exo -71.57 128.13 13.73 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.309 -0.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.93 131.25 48.42 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.579 HG23 ' OE1' ' A' ' 27' ' ' GLN . 3.5 mt -117.05 111.14 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -110.86 121.81 64.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.58 127.72 74.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 2.3 m120 60.95 39.17 16.94 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.99 49.97 72.73 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.819 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -172.65 134.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.722 ' HZ ' HG23 ' A' ' 93' ' ' THR . 30.9 t80 -67.55 106.82 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.901 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -117.55 -24.32 7.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.486 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 84' ' ' ILE . . . -112.95 139.66 15.83 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.084 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.722 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -121.01 -179.55 4.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.696 0.284 . . . . 0.0 110.714 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 9.4 pt-20 -71.36 -35.97 71.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.0 m -95.07 -25.38 16.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.18 -33.34 52.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.498 0.189 . . . . 0.0 111.236 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.68 -50.28 69.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.44 -34.64 78.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 -73.42 -42.63 61.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -67.17 -44.92 78.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.049 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.5 -48.07 82.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.07 85.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.272 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -73.25 -24.75 60.5 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.73 56.72 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.529 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.0 p -105.13 -18.11 14.25 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.44 -47.7 72.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.635 0.255 . . . . 0.0 111.002 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -45.18 82.91 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.06 -37.96 89.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -48.6 79.32 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.89 -40.57 80.59 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.174 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -33.61 73.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.734 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -49.54 65.18 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.203 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 pt -65.77 -24.91 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.799 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.14 24.21 8.62 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.738 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -82.5 -42.92 17.82 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.697 0.249 . . . . 0.0 110.581 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 46' ' ' LEU . 1.5 mp -117.5 143.14 31.59 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.244 0.821 0 C-N-CA 122.603 2.202 . . . . 0.0 112.309 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 120.43 0.157 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.3 -27.5 47.3 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.673 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.9 -38.53 5.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.157 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 t -61.78 -57.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 111.259 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -46.8 79.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.249 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -60.36 -34.12 73.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.31 96.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.642 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.62 -34.23 70.91 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -70.33 -36.56 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.8 tpp -69.26 -46.16 67.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.103 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pt -72.57 -14.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -63.71 1.13 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.658 0.265 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.05 -23.57 26.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.971 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -120.7 61.01 8.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.797 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.66 -16.64 42.48 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.766 2.31 . . . . 0.0 112.937 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -89.42 67.1 7.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.954 0.407 . . . . 0.0 110.448 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.66 137.73 45.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.199 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.532 ' CG ' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -143.42 104.98 4.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.412 HD13 ' CZ ' ' A' ' 72' ' ' PHE . 8.3 mp -78.79 125.65 29.66 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.4 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -148.03 -176.8 5.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.268 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.05 175.22 13.22 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.97 33.78 4.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.837 0.351 . . . . 0.0 111.251 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.09 -47.04 0.78 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.263 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.417 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -58.48 143.71 80.23 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.178 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.1 -39.39 13.66 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.644 2.23 . . . . 0.0 112.376 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.416 ' CB ' ' HD3' ' A' ' 82' ' ' PRO . 23.0 m-20 -71.08 -34.18 70.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.207 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.5 m -60.15 -40.54 90.23 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.818 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 33' ' ' CYS . 21.7 t -61.52 -36.93 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.746 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -71.59 -36.41 70.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.043 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.74 91.14 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.64 0.257 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -75.76 -29.5 58.85 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.577 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.8 p -61.16 -42.8 99.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.6 0.238 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.49 -52.62 39.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.245 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.495 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.4 m-90 -60.09 -35.57 75.49 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.218 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.55 -33.67 74.5 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.882 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -79.04 -31.26 44.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.862 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 116' ' ' LEU . 22.5 mt -80.79 -7.56 59.44 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 55.85 48.24 18.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.235 0.54 . . . . 0.0 110.508 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD1' ' A' ' 43' ' ' TRP . 27.5 m -129.74 39.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.461 ' OE1' HG21 ' A' ' 54' ' ' VAL . 3.9 mm100 -98.97 28.28 4.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.287 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -124.38 -49.43 1.8 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.7 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -68.29 -18.4 64.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.42 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 53' ' ' PHE . 15.4 t -106.08 159.48 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' N ' HG12 ' A' ' 52' ' ' VAL . 10.4 m-85 -116.69 111.11 19.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 110.083 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.461 HG21 ' OE1' ' A' ' 49' ' ' GLN . 21.2 t -98.71 136.34 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.474 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.68 111.7 24.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.987 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -92.73 126.18 37.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.415 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.769 HG23 HD11 ' A' ' 60' ' ' LEU . 29.9 mt -85.99 63.99 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.057 0.456 . . . . 0.0 110.434 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.17 23.4 6.5 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.973 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -155.57 36.1 0.37 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.703 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.769 HD11 HG23 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -159.13 98.4 1.63 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.819 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.44 174.82 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.107 2.538 . . . . 0.0 112.661 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.14 -32.06 4.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -48.86 73.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.624 0.25 . . . . 0.0 111.009 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -78.67 -38.64 38.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.91 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -58.7 -40.39 83.51 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.886 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -42.89 99.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.683 0.278 . . . . 0.0 110.921 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -64.17 -42.07 96.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.685 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.518 ' CE3' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -69.82 -34.21 73.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.193 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.15 -45.16 83.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 111.015 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.8 mt -74.72 -40.55 47.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.995 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.9 -54.49 44.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.233 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -58.13 -39.83 79.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.992 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -28.43 68.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -30.88 31.93 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.335 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 71' ' ' ALA . 22.0 t -85.01 -48.5 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.554 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.1 -40.99 2.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.63 42.55 1.69 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.949 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.5 101.81 5.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -94.82 37.66 1.14 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.768 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.635 ' C ' HD13 ' A' ' 81' ' ' LEU . 9.9 t30 -161.07 -175.84 5.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.303 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.67 HD22 ' H ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -137.8 165.14 36.05 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.898 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 35' ' ' ASP . 13.3 Cg_exo -70.16 146.09 82.1 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.687 0.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.755 HG22 ' CE1' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -116.94 106.66 13.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.712 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.532 HG23 ' CG ' ' A' ' 27' ' ' GLN . 4.0 mp -102.3 111.05 30.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.761 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 90' ' ' PHE . 31.7 t -117.99 116.47 51.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 91' ' ' TRP . 13.5 p -115.66 134.96 57.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.7 t30 58.02 32.9 22.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.91 32.42 80.95 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.758 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -148.16 132.26 17.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.176 0.512 . . . . 0.0 110.372 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 83' ' ' THR . 3.1 t80 -66.99 100.68 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.381 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.449 ' HB2' HG12 ' A' ' 86' ' ' VAL . 2.0 t-105 -102.44 -31.86 10.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.244 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.55 142.04 17.33 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.113 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.706 HG22 ' CE2' ' A' ' 90' ' ' PHE . 14.7 p -127.44 -172.01 2.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.563 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.91 49.23 1.78 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.271 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.84 -43.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.929 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -52.64 -33.12 45.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.02 -56.67 19.03 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.457 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -60.48 -42.56 96.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -58.3 -40.0 80.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.414 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.08 -46.21 16.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.923 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.77 -42.04 96.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.72 93.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -70.36 -27.08 64.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.279 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.26 24.22 24.94 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.497 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.1 p -113.41 19.09 17.24 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -44.45 81.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -54.91 -44.49 74.24 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.702 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.08 -38.68 83.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.723 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.66 -41.63 77.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.704 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.54 ' HA ' HD11 ' A' ' 113' ' ' ILE . 0.3 OUTLIER -78.54 -22.0 47.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.49 179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 m -77.94 -26.67 49.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.261 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -23.81 60.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -102.89 -23.66 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.13 23.93 9.36 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.166 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -38.5 11.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.949 0.375 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.444 HD11 HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -127.42 142.45 44.03 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.836 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.379 2.052 . . . . 0.0 112.636 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.58 -30.41 36.91 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 110.684 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -100.04 -31.16 11.58 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 t -61.86 -52.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.029 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 t -62.13 -37.19 84.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.853 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -36.02 77.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.15 89.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.686 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -40.69 97.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.2 -30.9 70.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.719 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -68.18 -44.26 76.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.855 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -71.88 -14.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.517 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -63.58 1.23 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.653 0.263 . . . . 0.0 110.866 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -83.97 -24.98 30.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.408 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . 14.3 m-70 -118.58 64.29 5.91 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.782 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 57.2 Cg_endo -70.82 -21.1 29.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.582 2.188 . . . . 0.0 112.793 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.422 ' HB3' HG13 ' A' ' 52' ' ' VAL . 25.9 m-85 -92.1 69.74 5.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -110.89 130.76 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -118.91 101.63 8.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.414 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.43 HD11 ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -76.83 126.61 31.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.217 -179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.75 168.19 28.18 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.438 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . . . -164.28 179.08 7.06 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.3 p -97.12 29.13 3.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.284 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -39.72 6.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.343 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.64 148.51 34.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 111.329 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.33 -39.45 7.31 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.711 2.274 . . . . 0.0 112.627 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 2.8 m-20 -59.42 -33.25 71.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.103 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.3 m -55.17 -43.1 73.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.623 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.83 -43.27 89.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.028 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -61.47 -51.68 67.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.069 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.53 -41.06 80.15 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.709 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -73.9 -29.87 62.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.231 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -60.06 -40.69 90.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.118 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.1 mm -70.02 -51.1 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.412 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -62.45 -33.35 74.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.967 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -68.26 -34.7 76.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.098 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -78.6 -32.92 47.81 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.2 mt -80.68 -7.74 59.42 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 53.49 48.91 20.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.573 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.7 m -119.1 40.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -97.02 30.2 2.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.986 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.46 -49.43 2.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -68.01 -22.86 64.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.258 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 25' ' ' TYR . 44.2 t -114.98 156.09 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.49 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -116.15 111.28 20.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.252 0.548 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.35 142.19 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.386 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -126.52 104.88 8.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.94 151.58 31.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 30' ' ' ALA . 23.5 mm -114.31 69.75 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.115 0.483 . . . . 0.0 111.066 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 -2.25 8.6 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.162 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -106.95 -34.44 7.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.016 0.408 . . . . 0.0 111.566 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 21.2 mt -64.72 122.58 79.75 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.171 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.2 Cg_exo -62.63 -172.0 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.017 2.478 . . . . 0.0 112.534 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -78.89 8.57 5.33 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.219 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -113.43 -42.61 3.45 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.604 0.24 . . . . 0.0 110.805 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.1 -36.24 72.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.275 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -57.24 -38.27 73.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.397 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -49.99 75.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.137 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -57.78 -36.28 71.95 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -37.51 79.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.828 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -66.31 -46.45 76.85 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.5 mm -67.88 -45.62 83.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.61 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.91 -53.54 57.27 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.36 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 2.9 m-85 -65.96 -28.98 69.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.651 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.512 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 5.3 mt-30 -56.92 -40.78 76.95 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 110.741 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -28.37 44.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.427 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.7 t -72.45 -48.16 48.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 110.686 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.8 m -144.45 -41.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 123.81 63.21 0.19 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.967 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.638 ' HA ' HG21 ' A' ' 83' ' ' THR . 26.1 m -96.99 44.81 1.05 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.671 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -73.49 -16.58 61.29 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.866 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -140.1 121.04 14.56 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.0 mt -82.04 155.51 69.99 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.669 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 35' ' ' ASP . 2.6 Cg_exo -75.85 174.74 51.3 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 124.074 -1.219 . . . . 0.0 112.784 0.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 78' ' ' SER . 0.9 OUTLIER -149.19 113.83 5.33 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mt -102.34 121.96 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.479 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.88 121.53 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.89 121.29 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.414 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 3.8 t-20 64.24 40.16 6.91 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.129 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.13 49.65 75.86 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.952 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.41 136.12 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.39 . . . . 0.0 110.541 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.738 ' HE2' HG23 ' A' ' 93' ' ' THR . 1.1 t80 -61.4 104.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.307 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.86 -27.68 12.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.535 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.84 141.5 14.48 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.003 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.738 HG23 ' HE2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -127.37 172.29 10.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.734 0.302 . . . . 0.0 111.282 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.94 -26.02 62.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.486 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -29.13 14.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -56.94 -34.05 67.61 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -56.44 19.45 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 110.805 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.95 -34.08 72.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -41.03 63.62 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.324 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.73 -43.45 59.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -50.57 73.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.8 0.333 . . . . 0.0 111.029 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.69 84.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -27.18 60.05 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.769 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.41 27.03 26.26 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.175 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.0 p -107.95 -6.78 16.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 -50.05 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.612 0.244 . . . . 0.0 110.755 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.09 -41.59 88.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.0 -45.79 90.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.667 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -56.15 -40.58 74.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.058 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.24 -46.33 86.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 m -78.59 -31.19 47.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.998 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -59.28 -38.89 81.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.7 pt -79.45 -24.5 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.19 25.13 8.03 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.948 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 -48.66 5.73 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.764 0.282 . . . . 0.0 110.722 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.09 113.07 66.11 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.544 2.163 . . . . 0.0 112.829 -179.702 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.572 0.225 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 t 72.9 -61.54 0.5 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.419 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.01 -36.2 17.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.69 0.281 . . . . 0.0 111.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -101.14 -33.35 10.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.205 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.9 -47.43 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.042 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.4 m -60.58 -45.46 93.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.85 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -62.59 -35.77 80.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.08 99.22 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.061 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.68 -41.5 95.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.08 -29.12 68.8 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.033 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.1 tpt -69.61 -46.58 65.95 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.139 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.4 pt -73.02 -15.0 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -61.4 -65.53 0.68 Allowed 'General case' 0 N--CA 1.458 -0.049 0 CA-C-O 120.71 0.291 . . . . 0.0 111.093 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.66 -22.81 25.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.227 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -120.63 68.12 14.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.764 0.316 . . . . 0.0 110.86 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.89 -30.96 20.83 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.628 2.218 . . . . 0.0 112.527 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.483 ' HB3' HG23 ' A' ' 52' ' ' VAL . 69.6 m-85 -90.84 68.0 6.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.59 139.79 42.88 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.379 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.496 HE21 HG23 ' A' ' 84' ' ' ILE . 20.0 mp0 -124.38 115.42 20.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.652 HD12 HD13 ' A' ' 57' ' ' ILE . 3.2 mm? -86.48 96.24 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -111.81 174.77 5.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.129 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -95.79 -176.39 3.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -94.33 -38.72 10.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -151.72 72.37 1.02 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -125.51 148.15 60.5 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.62 -24.38 36.64 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.869 2.38 . . . . 0.0 112.888 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 78.5 m-20 -88.73 -40.87 12.92 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.612 0.244 . . . . 0.0 110.669 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.51 -43.89 89.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.783 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.1 m -55.38 -32.36 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.5 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -70.16 -56.6 6.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.938 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.49 77.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.568 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -75.43 -31.81 60.48 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.893 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 t -64.76 -49.17 71.83 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.6 mm -65.13 -41.15 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.528 ' NE1' HG11 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -67.53 -38.23 83.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.029 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -72.9 -30.19 63.74 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.346 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -32.55 34.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.944 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.3 mt -81.53 -8.09 59.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 t30 53.16 46.01 27.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.169 0.509 . . . . 0.0 110.696 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 52' ' ' VAL . 11.2 m -123.98 43.45 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.68 18.42 10.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.647 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.32 -47.43 3.1 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.85 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -68.25 -23.65 64.81 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.336 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 48' ' ' VAL . 14.0 p -116.34 158.72 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' N ' HG22 ' A' ' 52' ' ' VAL . 38.9 m-85 -120.37 111.23 17.49 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.264 0.554 . . . . 0.0 110.372 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.37 132.4 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.96 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -126.71 131.69 51.31 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.69 142.74 27.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.671 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.684 ' CB ' HD21 ' A' ' 60' ' ' LEU . 10.8 pt -131.95 78.94 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.137 0.494 . . . . 0.0 111.394 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.78 -33.87 0.96 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.402 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.8 m -62.43 -37.17 84.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.073 0.436 . . . . 0.0 111.418 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.684 HD21 ' CB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -57.86 119.16 31.56 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.93 -174.73 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.133 2.555 . . . . 0.0 112.745 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -31.96 71.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.16 -48.51 78.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.553 0.216 . . . . 0.0 110.996 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.21 -33.95 65.65 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.217 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -57.07 -46.05 82.8 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.958 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -48.63 77.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.945 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.73 -48.6 79.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.472 ' HE1' HD11 ' A' ' 28' ' ' LEU . 1.2 t-105 -62.46 -39.28 92.9 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.888 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -58.74 -52.04 67.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.012 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.9 -40.53 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.07 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -59.1 -53.17 61.4 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.09 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.447 ' HE2' HG21 ' A' ' 83' ' ' THR . 0.1 OUTLIER -60.56 -36.17 77.83 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.47 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 1.9 mt-30 -61.19 -33.06 72.84 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.886 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -78.96 -28.85 43.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.196 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.9 t -76.61 -46.38 31.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.046 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.15 -44.65 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 113.13 49.12 0.58 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.441 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -130.37 103.45 6.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.794 0.331 . . . . 0.0 110.573 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 69' ' ' ARG . 8.7 ttp180 -94.63 38.62 1.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -153.08 148.43 27.0 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mt -117.11 152.65 49.15 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.7 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 35' ' ' ASP . 84.3 Cg_endo -80.01 179.1 30.51 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.652 -1.395 . . . . 0.0 113.297 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.787 HG23 ' CE2' ' A' ' 90' ' ' PHE . 97.4 m -150.13 145.22 26.19 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.496 HG23 HE21 ' A' ' 27' ' ' GLN . 4.9 mp -117.24 111.29 34.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -110.41 116.65 52.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.458 HG12 ' OD1' ' A' ' 87' ' ' ASN . 6.5 t -113.15 142.75 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.458 ' OD1' HG12 ' A' ' 86' ' ' VAL . 2.0 p-10 42.69 41.21 2.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.68 43.01 92.96 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.941 -0.572 . . . . 0.0 114.176 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 138.63 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 111.087 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.787 ' CE2' HG23 ' A' ' 83' ' ' THR . 6.9 t80 -52.51 111.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.0 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.83 -22.08 11.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.775 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.16 148.31 19.11 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.157 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -119.37 175.79 5.65 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 110.749 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.446 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 3.0 tm-20 -61.86 -25.88 67.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.558 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.8 m -82.56 -36.37 26.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.497 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.418 ' HG2' ' CD2' ' A' ' 100' ' ' PHE . 4.9 tt0 -58.01 -32.36 67.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.501 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 -48.73 73.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.689 0.28 . . . . 0.0 110.724 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -74.27 -32.61 62.99 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.182 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.33 -38.66 85.25 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.345 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CD2' ' HG2' ' A' ' 96' ' ' GLN . 5.6 m-85 -78.31 -44.05 26.3 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -58.5 -40.69 83.53 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.87 93.26 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.062 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -75.38 -28.96 59.69 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.37 23.15 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.4 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.6 p -122.96 19.63 10.06 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.93 -43.37 71.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.561 0.219 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.79 -51.19 69.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -40.03 86.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.78 -40.38 96.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.772 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HB3' HD13 ' A' ' 116' ' ' LEU . 9.3 mt -66.34 -29.77 70.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.418 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 m -78.52 -30.26 47.0 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -59.56 -44.14 93.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.277 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 pt -67.01 -24.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.83 26.07 8.72 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.673 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 116' ' ' LEU . 5.8 tp -85.26 -46.15 11.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.843 0.321 . . . . 0.0 110.74 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.616 HD12 ' HB3' ' A' ' 115' ' ' LEU . 6.5 mp -108.48 145.54 31.77 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.749 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 C--O 1.251 1.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.567 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 tpt . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m -56.31 -30.29 62.35 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.639 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.33 -35.87 29.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.211 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.7 -35.71 16.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.114 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -66.61 -49.03 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -65.64 -43.12 90.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.208 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -60.43 -37.35 80.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.566 0.222 . . . . 0.0 110.935 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.45 99.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.19 -40.31 77.14 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.82 -36.13 83.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.047 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.6 mmm -68.26 -45.64 72.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.308 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.7 pt -71.79 -14.58 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.677 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -60.92 -59.89 4.65 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -84.67 -10.91 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -124.03 72.95 55.72 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.8 -26.79 18.73 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.62 2.213 . . . . 0.0 112.792 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -93.57 70.73 4.24 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 132.98 53.09 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.152 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.462 ' HB3' HG13 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -126.94 108.16 10.72 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.603 179.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.96 136.09 33.25 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.214 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -132.47 172.8 12.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.596 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -95.92 177.9 5.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.525 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.8 m -77.15 83.87 3.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.34 45.97 16.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.402 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -70.08 155.19 93.87 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.126 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.75 -32.49 29.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.843 2.362 . . . . 0.0 112.582 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.49 -33.3 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.105 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 33' ' ' CYS . 31.2 m -69.43 -41.72 75.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.72 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -55.52 -32.69 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.592 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -59.16 -50.39 74.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 110.86 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' A' ' 97' ' ' LEU . . . -59.62 -35.87 75.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.529 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 -32.01 61.59 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.669 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -44.69 93.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.39 -48.93 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.327 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -65.34 -30.64 71.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.401 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -81.38 -32.25 32.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.974 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.0 mt -80.73 -7.73 59.45 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 52.18 43.95 30.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.875 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.47 31.6 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -102.92 28.15 6.45 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -112.71 -41.77 3.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -67.09 -24.45 65.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.281 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 53' ' ' PHE . 17.9 t -100.59 159.23 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.656 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.412 ' N ' HG12 ' A' ' 52' ' ' VAL . 2.3 t80 -110.89 111.14 22.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.386 0.612 . . . . 0.0 110.09 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 27' ' ' GLN . 14.8 t -110.65 138.88 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.111 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 138.94 54.32 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.157 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.67 129.94 47.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.764 HG23 HD21 ' A' ' 60' ' ' LEU . 52.3 mt -88.99 69.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.128 0.49 . . . . 0.0 110.287 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.34 -40.95 0.34 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.993 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.7 p -57.29 -33.73 67.96 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.418 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.764 HD21 HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -80.36 124.11 82.62 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.309 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.02 -176.24 2.54 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -36.58 75.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.8 -49.46 72.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.711 0.291 . . . . 0.0 111.009 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.57 -37.69 83.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.83 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -56.81 -31.46 64.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -52.33 65.91 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 111.081 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.493 ' HA ' HD12 ' A' ' 70' ' ' ILE . 4.3 mptt -67.16 -30.05 69.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.617 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.36 -54.37 47.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -57.92 -36.85 73.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.151 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 67' ' ' LYS . 24.9 mt -69.52 -46.61 75.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.892 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.586 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -62.68 -49.66 74.22 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.142 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -45.66 80.8 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.028 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -26.45 68.55 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.22 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -31.3 35.56 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.143 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 71' ' ' ALA . 21.8 t -83.67 -45.05 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.413 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.49 -41.28 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.56 4.29 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.441 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -120.19 107.77 13.41 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.669 0.271 . . . . 0.0 110.771 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -94.04 43.36 1.11 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.553 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 83' ' ' THR . 6.7 t-20 -147.3 158.27 43.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.162 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -138.65 153.73 72.57 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.45 167.58 79.67 Favored 'Cis proline' 0 C--N 1.353 0.8 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.921 0.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 80' ' ' ASN . 2.1 p -136.56 132.74 35.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.093 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.407 HG23 ' HG3' ' A' ' 27' ' ' GLN . 18.2 mt -110.92 114.57 47.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.17 117.1 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.695 HG12 ' HB2' ' A' ' 91' ' ' TRP . 14.4 p -114.89 128.01 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 m120 59.36 40.58 20.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.72 80.52 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.914 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -171.84 134.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 110.776 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.41 ' CE1' HG22 ' A' ' 83' ' ' THR . 73.9 t80 -68.91 106.59 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.941 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.695 ' HB2' HG12 ' A' ' 86' ' ' VAL . 1.6 m95 -124.12 0.46 8.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.34 6.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.827 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 96' ' ' GLN . 12.2 t -122.82 179.12 4.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.902 0.382 . . . . 0.0 111.297 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -41.91 96.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.575 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -67.51 -28.7 68.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' A' ' 100' ' ' PHE . 2.2 tm0? -56.98 -34.84 68.49 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 111.246 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 39' ' ' ALA . 9.3 mt -70.99 -38.68 72.7 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.183 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -79.33 -48.48 14.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.592 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -58.33 -50.25 74.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 96' ' ' GLN . 10.8 m-85 -62.22 -39.19 91.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.392 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.66 -45.97 90.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.796 0.332 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.37 94.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.044 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -75.48 -29.49 59.59 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.02 13.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.503 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -117.21 16.99 14.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -49.92 47.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.72 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.0 -41.6 71.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.85 -43.64 87.84 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.718 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -54.78 -46.95 74.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.71 0.29 . . . . 0.0 110.737 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.56 -40.17 95.09 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 116' ' ' LEU . 50.8 m -70.77 -35.27 72.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.634 0.254 . . . . 0.0 110.95 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -52.11 66.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.333 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.48 HD11 HD12 ' A' ' 115' ' ' LEU . 5.3 pt -62.21 -25.11 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.97 20.19 7.31 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.929 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.48 HD12 HD11 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -77.91 -49.06 14.92 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.843 0.322 . . . . 0.0 110.461 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 111' ' ' THR . 3.4 mt -110.15 126.61 28.6 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.839 2.359 . . . . 0.0 112.311 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.1 p -52.95 -35.13 58.41 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.352 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.51 47.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -83.86 -39.75 19.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.836 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.49 -47.72 87.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.938 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.522 HG22 ' OE2' ' A' ' 18' ' ' GLU . 19.3 m -61.19 -42.2 98.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -59.82 -39.43 85.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.751 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.74 97.32 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.973 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.07 -41.92 97.16 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' OE2' HG22 ' A' ' 14' ' ' THR . 28.7 mt-10 -61.79 -36.56 81.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.779 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.41 -49.98 67.2 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' HB ' ' HA2' ' A' ' 88' ' ' GLY . 35.0 pt -71.4 -15.27 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.48 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -63.98 1.09 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.693 0.283 . . . . 0.0 111.099 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.8 t -85.55 -23.77 27.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -118.46 66.42 6.68 Favored Pre-proline 0 CA--C 1.53 0.212 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.63 -28.95 25.25 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.692 2.261 . . . . 0.0 112.501 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.489 ' HB3' HG13 ' A' ' 52' ' ' VAL . 3.2 m-85 -94.49 67.4 3.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -108.02 127.41 53.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.425 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.527 ' HG2' HG23 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -117.24 106.08 12.9 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.27 125.08 34.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.632 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t -138.22 179.12 6.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.76 156.33 43.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.635 0.255 . . . . 0.0 111.413 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 m -84.66 55.17 3.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.079 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -127.09 -46.69 1.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.759 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 153.67 42.15 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.88 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.06 -17.61 32.2 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.877 2.385 . . . . 0.0 113.073 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -52.87 -43.81 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.445 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.88 -58.24 9.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.579 0.228 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.6 m -60.45 -31.7 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -74.48 -31.79 62.34 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.03 64.9 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-O 120.745 0.307 . . . . 0.0 111.007 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -75.6 -28.17 58.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.1 p -63.5 -47.82 80.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.887 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 46' ' ' LEU . 32.4 mm -67.47 -44.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.145 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.446 ' HE1' HG21 ' A' ' 52' ' ' VAL . 1.2 m-90 -63.44 -39.14 93.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.989 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -69.16 -31.94 70.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.89 -31.09 35.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.905 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.64 HD12 HG22 ' A' ' 42' ' ' ILE . 14.1 mt -80.53 -7.96 59.4 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 56.12 47.88 18.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 110.76 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.5 m -135.3 32.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -24.91 54.96 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.492 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.95 -41.67 22.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.627 0.251 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.35 -20.24 66.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.605 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 25' ' ' TYR . 19.6 t -117.89 163.67 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 122.16 0.184 . . . . 0.0 110.529 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.486 ' N ' HG12 ' A' ' 52' ' ' VAL . 3.1 m-85 -123.31 111.36 16.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.162 0.506 . . . . 0.0 110.294 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 27' ' ' GLN . 21.8 t -120.46 134.34 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.054 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -132.47 130.09 40.04 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -100.72 151.15 22.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HB ' HD11 ' A' ' 60' ' ' LEU . 2.6 pt -122.49 -144.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.59 14.39 25.6 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.752 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -149.1 33.81 0.74 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.806 0.303 . . . . 0.0 111.331 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -97.15 116.31 65.96 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.947 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.4 Cg_exo -62.19 -170.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.116 2.544 . . . . 0.0 112.493 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.68 2.31 14.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -106.91 -39.53 5.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.628 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.24 -39.6 62.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.324 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -60.92 -38.42 85.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.715 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.29 -35.43 79.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.551 0.215 . . . . 0.0 111.236 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -64.55 -53.14 52.52 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.314 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -69.61 -36.59 76.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.343 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -46.27 73.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.381 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.19 -51.67 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.586 0.232 . . . . 0.0 111.45 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.55 -54.98 37.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.865 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -61.48 -42.75 99.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.297 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.17 -27.81 68.97 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.539 0.209 . . . . 0.0 111.407 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -30.18 34.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.397 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 71' ' ' ALA . 38.2 t -87.94 -48.3 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 90' ' ' PHE . 9.2 p -113.57 -31.77 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.1 35.53 38.2 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.411 ' H ' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -144.57 93.09 2.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 40.21 1.06 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -113.7 89.96 3.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.634 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.48 151.91 93.4 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.063 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.23 170.51 71.25 Favored 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 123.531 -1.445 . . . . 0.0 112.99 0.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.568 HG22 ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -148.55 133.44 18.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.55 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.527 HG23 ' HG2' ' A' ' 27' ' ' GLN . 5.1 mt -112.51 111.53 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.7 t -101.77 116.72 45.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 t -125.1 131.8 72.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t30 63.28 33.07 14.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' ' 20' ' ' ILE . . . 64.89 45.18 93.26 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.832 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -175.44 137.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.545 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.568 ' CE1' HG22 ' A' ' 83' ' ' THR . 45.0 t80 -59.15 102.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -25.27 8.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.829 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 84' ' ' ILE . . . -111.1 139.01 15.34 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.233 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.96 -177.75 3.57 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -43.71 68.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.958 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 m -70.22 -32.82 70.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.891 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -52.26 -36.15 51.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.432 0.16 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.19 -54.37 41.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.18 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -33.84 66.17 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.428 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -62.02 -42.35 99.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.62 0.248 . . . . 0.0 111.304 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 109' ' ' GLU . 4.7 m-85 -77.83 -44.19 28.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.471 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -61.57 -42.42 98.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.48 67.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.596 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -83.54 -38.56 21.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.1 35.65 2.3 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.942 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 18.28 16.42 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.693 0.246 . . . . 0.0 111.47 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -51.42 66.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.606 0.241 . . . . 0.0 110.778 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -66.28 -38.46 87.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.034 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.26 -39.84 95.74 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.439 ' HG3' ' CE2' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -58.47 -49.38 77.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.911 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.785 HD12 HD13 ' A' ' 115' ' ' LEU . 3.7 mm? -59.36 -30.68 68.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.067 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.517 HG23 ' HD3' ' A' ' 117' ' ' PRO . 78.9 m -78.24 -34.12 49.35 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.741 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -47.08 86.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.53 -26.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.717 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.85 7.17 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.585 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.785 HD13 HD12 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -73.7 -45.83 49.93 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.721 0.296 . . . . 0.0 110.511 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -79.93 -60.32 0.51 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.038 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.517 ' HD3' HG23 ' A' ' 111' ' ' THR . 73.7 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.481 2.121 . . . . 0.0 112.413 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 p -173.97 -50.63 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.28 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.46 68.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.419 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.83 -38.28 23.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.851 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.89 -51.35 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -60.27 -35.36 75.36 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.795 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -57.19 -42.43 81.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.68 0.276 . . . . 0.0 110.814 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.76 88.51 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -63.27 -35.41 80.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.33 -39.07 91.93 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.5 mtp -64.46 -44.73 90.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.983 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.433 HG12 ' HA ' ' A' ' 17' ' ' GLU . 37.1 pt -73.25 -14.69 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.419 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.26 -61.29 2.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.636 0.255 . . . . 0.0 110.855 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 m -83.37 -18.84 37.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.741 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -122.5 64.39 21.28 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.438 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 34.4 Cg_endo -64.91 -23.66 61.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.514 ' HB3' HG13 ' A' ' 52' ' ' VAL . 13.2 m-85 -94.44 71.79 3.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 2.1 t80 -114.01 139.6 49.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.423 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.679 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -127.83 134.15 49.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.872 HD23 HD11 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -107.92 127.67 53.95 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -117.09 153.7 32.3 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.365 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.612 ' HB1' ' CD1' ' A' ' 32' ' ' TRP . . . -70.75 -41.91 71.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.024 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 56' ' ' ASP . 14.5 m 66.25 33.65 7.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.324 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.612 ' CD1' ' HB1' ' A' ' 30' ' ' ALA . 48.6 p-90 -159.36 -41.0 0.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.068 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.57 147.21 32.67 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.18 -20.55 24.85 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.018 2.479 . . . . 0.0 112.632 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.59 -39.86 58.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.113 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.59 -36.91 60.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.176 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.28 -35.11 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.442 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -58.47 -52.78 64.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.553 0.216 . . . . 0.0 110.875 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.97 75.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.64 -29.26 61.2 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 t -65.19 -48.95 71.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.642 HG22 HD12 ' A' ' 46' ' ' LEU . 30.8 mm -65.21 -41.38 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.407 ' HH2' HG11 ' A' ' 52' ' ' VAL . 8.6 m95 -65.94 -36.9 84.63 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.159 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -62.59 -37.2 85.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -83.83 -30.76 26.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.372 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.642 HD12 HG22 ' A' ' 42' ' ' ILE . 21.9 mt -80.71 -8.45 59.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 48.09 45.25 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 46' ' ' LEU . 30.0 m -119.89 38.27 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -99.69 31.34 3.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -120.66 -49.84 2.22 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -25.51 68.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.265 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 25' ' ' TYR . 58.2 t -118.14 154.01 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.407 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -116.4 111.29 19.82 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.269 0.557 . . . . 0.0 110.21 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG23 ' HB3' ' A' ' 27' ' ' GLN . 10.5 p -107.93 141.63 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.287 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -126.13 125.72 42.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 3.0 m-20 -90.88 126.64 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.401 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.872 HD11 HD23 ' A' ' 28' ' ' LEU . 18.4 mt -79.27 60.3 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.698 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.53 18.07 4.95 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.811 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.46 ' H ' HD22 ' A' ' 60' ' ' LEU . 83.3 p -129.97 10.02 5.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.813 0.307 . . . . 0.0 111.802 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -108.68 131.31 21.85 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-O 120.505 0.193 . . . . 0.0 111.11 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 64' ' ' GLU . 51.6 Cg_endo -68.3 -172.94 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.896 2.397 . . . . 0.0 112.095 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 6.35 4.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.91 -44.16 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.664 0.268 . . . . 0.0 110.817 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 3.5 tp10 -81.1 -42.95 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.31 -32.75 70.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.59 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -57.59 6.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.908 -0.133 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -31.73 67.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.172 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -73.11 -53.3 11.39 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.469 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -54.23 -42.16 69.55 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.452 ' N ' ' HG3' ' A' ' 69' ' ' ARG . 15.7 mt -62.04 -57.41 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.546 0.213 . . . . 0.0 111.249 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.22 -46.16 86.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.668 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.543 ' CD2' HD21 ' A' ' 28' ' ' LEU . 1.1 m-85 -64.47 -51.5 62.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -58.8 -26.27 63.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.487 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -31.43 31.81 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.439 0.162 . . . . 0.0 111.385 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 71' ' ' ALA . 50.1 t -84.96 -48.8 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.603 HG21 HG21 ' A' ' 85' ' ' VAL . 4.9 m -147.92 -37.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.912 ' HA2' HG21 ' A' ' 83' ' ' THR . . . -45.95 -35.44 6.26 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.649 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t 61.34 -166.19 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.819 0.31 . . . . 0.0 111.184 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.33 40.54 1.11 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -160.69 130.53 5.07 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 83' ' ' THR . 27.4 mt -131.98 152.99 81.22 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.749 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.72 178.7 33.2 Favored 'Cis proline' 0 C--N 1.351 0.673 0 C-N-CA 123.688 -1.38 . . . . 0.0 113.027 0.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.912 HG21 ' HA2' ' A' ' 77' ' ' GLY . 4.4 t -144.31 155.98 44.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.04 114.68 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.603 HG21 HG21 ' A' ' 76' ' ' VAL . 19.0 t -101.17 118.38 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.73 131.79 72.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.948 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER 62.51 31.5 16.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.203 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.73 44.91 94.18 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.59 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -173.12 137.76 0.71 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.362 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -57.56 108.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -130.33 5.12 4.79 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.73 139.84 8.27 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.941 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.7 177.54 7.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.932 0.396 . . . . 0.0 111.067 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -65.59 -45.38 83.44 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -37.4 85.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.31 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.01 -34.98 66.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.235 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.0 mt -66.33 -53.56 34.83 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.726 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -64.75 -35.92 82.63 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.131 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -69.31 -41.41 76.77 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.514 ' CB ' HD12 ' A' ' 106' ' ' LEU . 8.5 m-85 -76.78 -45.81 27.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.515 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -62.31 -43.23 99.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.677 0.275 . . . . 0.0 111.061 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.93 97.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -73.24 -28.15 61.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.394 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.76 28.12 14.99 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.56 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.1 p -114.93 13.41 17.04 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.514 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.3 OUTLIER -70.33 -51.7 28.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.535 0.207 . . . . 0.0 111.011 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.05 -44.25 97.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.85 -50.6 70.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.099 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.77 -37.66 87.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.192 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.438 ' HB2' HD12 ' A' ' 116' ' ' LEU . 11.5 mt -55.81 -46.23 78.11 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.083 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -64.91 -31.46 72.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.903 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.1 72.17 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.982 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.47 -27.83 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.541 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.05 21.41 7.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.055 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -93.17 -46.17 7.54 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.839 0.32 . . . . 0.0 110.799 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 110' ' ' LEU . 17.3 mt -93.11 160.26 33.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.82 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.559 2.173 . . . . 0.0 112.448 179.851 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.884 0.373 . . . . 0.0 111.595 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -60.36 -29.09 68.69 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.45 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.74 -37.86 9.12 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.664 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -90.38 -39.16 12.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.143 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.418 HG21 ' NZ ' ' A' ' 74' ' ' LYS . 30.1 t -57.83 -45.1 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.865 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -62.33 -43.7 98.21 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.77 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.67 -47.01 82.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.754 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.15 82.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.764 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -64.3 -34.27 77.75 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.172 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.56 -38.36 83.99 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.971 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -45.32 87.35 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.115 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 pt -72.16 -14.37 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.536 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -61.88 -64.59 0.89 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.603 0.24 . . . . 0.0 110.782 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -84.6 -25.99 28.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.788 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -119.72 66.17 9.93 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.809 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.39 -20.38 36.66 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.689 2.259 . . . . 0.0 112.867 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -90.41 72.94 7.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.843 0.354 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.93 137.98 42.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 102.91 6.13 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.752 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.62 122.0 25.98 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -120.56 149.99 41.57 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.185 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.53 -38.07 4.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.443 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t 67.66 13.47 9.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.691 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.44 -33.49 7.34 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.71 0.291 . . . . 0.0 110.927 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.13 155.69 36.13 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.874 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' A' ' 37' ' ' VAL . 39.8 Cg_endo -67.95 -12.37 35.06 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.748 2.299 . . . . 0.0 113.091 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.4 -29.79 59.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 48.8 t -78.65 -49.63 12.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 34' ' ' PRO . 28.9 m -51.15 -36.7 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.278 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -71.66 -43.14 66.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.96 72.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.461 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -74.12 -32.34 63.14 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.546 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -61.25 -42.74 99.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.796 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -66.32 -44.73 90.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.004 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -35.57 81.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.095 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -67.12 -33.62 75.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.132 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -82.07 -32.52 30.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.055 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.558 HD22 HD11 ' A' ' 116' ' ' LEU . 21.1 mt -82.13 -7.79 59.63 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 50.94 49.95 20.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.953 0.406 . . . . 0.0 111.031 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 52' ' ' VAL . 28.0 m -126.17 33.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.091 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -83.07 -28.96 29.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.389 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.64 -42.65 34.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -65.26 -22.74 66.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.426 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 48' ' ' VAL . 11.1 p -108.91 163.2 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.393 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.44 ' N ' HG22 ' A' ' 52' ' ' VAL . 56.8 m-85 -120.2 111.17 17.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.23 0.538 . . . . 0.0 109.902 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.22 145.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -131.11 97.09 4.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.753 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.99 144.02 35.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.684 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.529 HG22 HD21 ' A' ' 60' ' ' LEU . 2.5 pt -99.96 64.28 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.105 0.479 . . . . 0.0 111.562 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -32.35 2.8 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.208 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 m -96.06 37.36 1.24 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.956 0.378 . . . . 0.0 111.576 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 64' ' ' GLU . 2.7 pp -145.58 116.76 5.03 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.231 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 28.0 Cg_exo -62.65 -176.85 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.989 2.459 . . . . 0.0 112.421 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -32.31 66.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.326 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -55.12 -41.83 72.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.273 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.595 ' HB3' HD13 ' A' ' 60' ' ' LEU . 7.0 mm-40 -77.53 -32.72 54.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.676 0.275 . . . . 0.0 110.824 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -54.15 -50.17 67.58 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.083 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.33 -42.1 98.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -38.98 75.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.14 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -73.53 -44.02 58.59 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.347 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -56.32 -39.16 72.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.49 -52.82 28.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.674 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -57.04 -54.5 46.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.337 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.46 -35.23 67.66 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.323 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -36.26 81.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.597 0.237 . . . . 0.0 111.073 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.418 ' NZ ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -81.93 -28.86 32.56 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.553 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 71' ' ' ALA . 40.0 t -81.08 -47.22 20.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.174 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 90' ' ' PHE . 12.8 m -123.37 -39.77 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.07 42.29 3.07 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.707 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -121.95 108.43 13.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.758 0.313 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.88 38.08 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -152.6 160.95 43.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.119 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 24.3 mt -123.06 155.76 63.79 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 96.6 Cg_endo -77.86 177.59 38.45 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.757 -1.351 . . . . 0.0 113.131 0.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 p -145.55 117.8 8.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 116.27 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.995 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 m -115.93 127.08 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.402 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.84 129.52 75.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.7 m120 59.61 35.1 22.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.894 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.37 32.06 78.52 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.766 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -150.75 133.2 15.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.107 0.479 . . . . 0.0 110.045 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.606 ' CE2' HG23 ' A' ' 93' ' ' THR . 3.5 t80 -59.74 102.37 0.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.256 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -106.81 -22.8 12.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.748 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.64 139.99 11.42 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.874 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.606 HG23 ' CE2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -124.71 178.1 5.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.427 ' H ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -69.07 -37.1 78.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.322 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t -98.19 -22.24 16.29 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.436 ' HA ' ' HG2' ' A' ' 99' ' ' ARG . 5.4 tt0 -57.15 -31.99 65.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.55 -43.65 96.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.95 -53.5 45.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.494 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 96' ' ' GLN . 1.7 ptt180 -59.78 -41.66 91.61 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.674 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.744 ' CB ' HD12 ' A' ' 106' ' ' LEU . 2.0 m-85 -64.83 -42.75 94.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.883 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.81 -40.73 98.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.522 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.09 90.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -73.83 -27.53 61.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.24 24.22 32.25 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.61 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.4 p -116.54 11.26 14.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.744 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -67.35 -52.08 44.56 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.671 0.272 . . . . 0.0 110.484 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -67.77 -47.73 68.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.76 -53.09 52.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.984 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.43 -41.55 76.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.885 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -63.29 -38.27 90.51 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.213 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -35.84 64.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.571 0.225 . . . . 0.0 110.57 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -66.7 -45.39 78.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.255 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.3 pt -65.42 -27.29 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.595 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.69 22.46 8.06 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.861 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 -45.46 7.04 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.78 0.29 . . . . 0.0 110.726 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.558 HD11 HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -89.35 137.84 28.92 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 C--O 1.251 1.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.611 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.603 0.239 . . . . 0.0 111.121 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p -57.02 -34.87 68.62 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.066 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.69 38.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.371 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.44 -37.94 19.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.875 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 9' ' ' MET . 21.6 t -60.46 -48.75 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.124 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 m -60.01 -41.76 92.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -60.02 -35.61 75.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.949 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.24 98.67 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.875 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' HG13 ' A' ' 20' ' ' ILE . 7.1 mm-40 -61.23 -34.15 74.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.55 -34.87 67.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.74 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.7 mtt -68.14 -46.4 70.95 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.003 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -71.89 -17.19 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.317 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -64.99 0.76 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.695 0.284 . . . . 0.0 110.856 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 t -86.06 -27.83 24.49 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -119.78 66.27 10.16 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.553 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.36 -16.61 43.78 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.663 ' HB3' HG13 ' A' ' 52' ' ' VAL . 57.1 m-85 -90.43 68.57 6.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.435 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -112.52 136.17 52.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.265 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -128.64 112.28 14.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.293 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 117.13 27.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.039 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -138.6 169.17 18.26 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.25 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.626 ' HB2' HD11 ' A' ' 57' ' ' ILE . . . -123.25 159.65 28.27 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.187 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -103.0 21.9 14.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.423 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -153.34 32.16 0.47 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.49 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -115.4 144.49 32.45 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.915 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.77 -28.67 24.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.714 2.276 . . . . 0.0 112.763 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -111.08 23.31 14.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 16.0 m -115.15 -42.05 3.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.569 0.223 . . . . 0.0 111.059 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.58 -31.98 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.363 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -65.73 -51.77 56.56 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.091 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.425 ' HB2' HD11 ' A' ' 97' ' ' LEU . . . -57.5 -40.68 79.17 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.572 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -75.42 -30.4 60.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 t -61.43 -47.88 83.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mm -62.53 -43.81 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -64.46 -36.45 84.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.049 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -29.6 63.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.18 -33.52 32.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.606 0.241 . . . . 0.0 111.014 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.82 -7.81 59.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 53.89 46.2 26.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.037 0.446 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.98 28.92 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.977 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.38 -6.7 36.94 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.34 -45.82 17.14 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 110.457 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -68.4 -28.04 66.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 25' ' ' TYR . 42.5 t -103.1 160.12 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.682 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.456 ' N ' HG12 ' A' ' 52' ' ' VAL . 6.2 m-85 -114.46 111.18 21.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.095 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 27' ' ' GLN . 33.0 t -109.16 135.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.045 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 118.1 33.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.835 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -95.45 144.31 26.07 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.278 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 30' ' ' ALA . 2.4 pt -107.62 96.51 4.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.27 -79.61 0.1 Allowed Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.892 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 p -140.73 57.49 1.57 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.93 0.395 . . . . 0.0 110.784 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.96 136.09 66.66 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.205 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.19 -169.8 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.737 2.291 . . . . 0.0 112.133 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 2.1 mtp180 -75.7 1.19 15.29 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.51 -43.31 6.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.614 0.245 . . . . 0.0 110.984 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -75.29 -49.21 19.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.92 -35.51 75.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.361 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -67.53 -51.84 46.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.328 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -58.13 -42.39 85.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.87 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -61.9 -39.51 92.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.185 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -57.24 -54.35 47.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -68.57 -44.75 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.613 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.16 -42.06 72.63 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -70.51 -45.33 65.8 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.135 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.96 -27.96 69.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -32.36 31.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 71' ' ' ALA . 54.3 t -84.42 -41.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.32 -38.46 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 36.76 6.42 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.633 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.0 m -137.04 113.24 9.87 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 38.86 1.19 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.895 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -134.36 129.4 35.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 1.3 mp -98.6 164.95 16.02 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.401 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 7.9 Cg_exo -72.29 144.65 81.08 Favored 'Cis proline' 0 C--N 1.352 0.761 0 C-N-CA 123.593 -1.42 . . . . 0.0 111.999 -0.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.795 HG23 ' CE2' ' A' ' 90' ' ' PHE . 89.5 m -107.2 105.72 15.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -101.9 111.1 30.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.332 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.5 118.17 52.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -121.72 112.58 35.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.5 m120 66.06 42.96 3.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.059 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.48 50.74 64.3 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.122 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -173.4 138.4 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.795 ' CE2' HG23 ' A' ' 83' ' ' THR . 0.8 OUTLIER -61.97 94.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -97.6 -29.48 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.496 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.47 135.71 10.71 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.146 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.524 HG23 ' CE1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -121.86 -177.48 3.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.013 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.15 -52.24 43.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -31.66 69.43 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -51.48 -33.85 33.06 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.425 HD11 ' HB2' ' A' ' 39' ' ' ALA . 48.3 mt -51.36 -59.72 3.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.247 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -78.36 -33.04 49.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.148 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 96' ' ' GLN . 5.4 mmp_? -57.46 -49.06 77.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.5 -39.87 67.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.027 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.77 -47.82 84.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.843 0.354 . . . . 0.0 110.721 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.81 76.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.353 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -74.81 -27.78 60.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.69 23.24 43.3 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.469 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.2 p -113.57 0.07 14.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.9 -47.4 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.603 0.239 . . . . 0.0 110.92 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.06 -46.05 72.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.231 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.88 -45.74 89.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.588 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -59.42 -40.01 85.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.492 HD23 HD13 ' A' ' 116' ' ' LEU . 3.3 tp -62.63 -40.7 97.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.22 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -77.34 -33.12 55.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 110.711 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -66.61 -43.66 84.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.358 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 115' ' ' LEU . 8.6 pt -61.12 -25.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.26 21.87 6.41 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.703 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.503 ' HB2' HD11 ' A' ' 113' ' ' ILE . 1.6 tt -88.16 -55.02 3.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.745 0.307 . . . . 0.0 110.761 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.492 HD13 HD23 ' A' ' 110' ' ' LEU . 3.6 mp -89.09 140.99 29.04 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.699 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.867 2.378 . . . . 0.0 112.52 -179.864 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.641 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.1 mtt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.65 0.262 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.17 -35.62 49.41 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.01 -34.19 63.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.327 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -97.36 -37.4 10.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.28 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 9' ' ' MET . 41.3 t -58.0 -47.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.652 0.263 . . . . 0.0 110.99 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -61.08 -43.75 98.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.658 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -63.46 -35.57 80.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.064 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.82 95.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.07 -36.66 80.22 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.806 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -69.15 -32.49 71.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -48.11 62.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.088 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 pt -70.69 -15.05 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.486 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -61.3 -61.76 2.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -83.66 -19.82 34.67 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.39 68.53 10.46 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 110.563 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.42 -18.97 38.32 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.665 2.243 . . . . 0.0 112.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.59 69.51 6.74 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.78 139.71 41.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.746 ' HB3' HG13 ' A' ' 54' ' ' VAL . 3.5 tt0 -129.15 125.87 38.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.012 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.717 ' HB2' HG23 ' A' ' 83' ' ' THR . 5.1 mp -99.83 113.63 26.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.81 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 175.88 13.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.01 170.89 15.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.319 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -102.47 -15.15 16.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -85.88 -39.44 16.99 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.6 m -72.67 141.35 82.34 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.87 -39.09 1.94 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.871 2.381 . . . . 0.0 113.122 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -61.31 -29.94 70.19 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.74 0.305 . . . . 0.0 111.047 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.4 m -72.04 -34.77 69.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.886 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -58.15 -34.84 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.72 -54.38 36.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.514 0.197 . . . . 0.0 111.198 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.34 72.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.572 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -75.15 -32.02 61.21 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.763 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -63.46 -44.51 94.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.969 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.1 mm -63.49 -43.92 98.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.038 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.627 ' CD1' HG11 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.8 -34.24 77.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.307 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -28.08 63.81 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.186 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -80.6 -32.51 36.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.897 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -81.91 -7.69 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 52.73 49.73 19.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.661 ' O ' HG12 ' A' ' 52' ' ' VAL . 13.2 m -122.69 26.17 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.299 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -26.66 65.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.734 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -81.2 -31.79 33.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.704 0.287 . . . . 0.0 110.913 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -75.9 -28.73 58.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 48' ' ' VAL . 13.5 p -112.46 161.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.815 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.461 ' N ' HG22 ' A' ' 52' ' ' VAL . 1.1 t80 -120.46 111.13 17.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.368 0.604 . . . . 0.0 109.99 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 27' ' ' GLN . 27.4 t -107.85 135.54 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.991 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.09 113.55 26.5 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.92 145.09 29.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.938 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.701 ' HA ' HD13 ' A' ' 60' ' ' LEU . 32.9 mm -112.77 78.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.86 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -43.94 0.33 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.803 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -95.55 37.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 111.169 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.701 HD13 ' HA ' ' A' ' 57' ' ' ILE . 5.6 mp -119.94 105.02 43.37 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.682 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.9 164.09 2.66 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.038 2.492 . . . . 0.0 112.678 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.13 -36.16 5.65 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.551 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -75.11 -49.5 19.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.007 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.3 -36.49 83.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.221 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -59.86 -48.05 83.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.003 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.16 -29.18 67.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -55.46 -53.45 56.2 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.228 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.446 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 36.2 p-90 -74.01 -32.35 63.34 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.73 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -49.83 74.76 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -73.93 -39.03 51.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.074 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.72 -50.75 72.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.072 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -63.61 -33.87 76.57 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -32.84 70.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.884 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -78.94 -29.59 44.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 71' ' ' ALA . 21.4 t -78.98 -44.14 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.191 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 89' ' ' LYS . 27.4 m -128.26 -42.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.27 45.97 1.11 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.45 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 p -102.76 85.35 2.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 110.415 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 22.91 1.63 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 152.68 15.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.431 HD23 ' HH2' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -124.21 159.37 57.35 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.052 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.2 156.42 98.16 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.793 0.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.717 HG23 ' HB2' ' A' ' 28' ' ' LEU . 1.3 t -144.92 131.25 19.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.9 mt -112.02 122.79 66.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.343 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.12 121.65 64.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.352 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.89 121.87 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.98 43.37 3.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.63 75.28 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.854 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.516 ' HA ' HG12 ' A' ' 76' ' ' VAL . 4.8 ptpt -174.16 134.99 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.559 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.712 ' HZ ' HG23 ' A' ' 93' ' ' THR . 75.9 t80 -62.86 101.21 0.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.977 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -113.32 -26.31 8.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.628 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.68 141.08 16.67 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.697 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.712 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -123.58 154.2 39.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.603 0.24 . . . . 0.0 111.171 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -36.72 68.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.0 m -86.0 -27.18 25.0 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -37.4 69.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.616 0.246 . . . . 0.0 111.083 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.14 -37.29 78.22 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.121 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -67.92 -54.48 18.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.186 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -60.36 -29.59 69.01 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -79.48 -45.56 19.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.343 0.116 . . . . 0.0 111.108 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.555 ' HB2' HD13 ' A' ' 106' ' ' LEU . 4.5 tm-20 -62.77 -43.98 97.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.91 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.1 -46.74 68.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.508 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -76.8 -34.8 57.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.42 32.97 3.26 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.89 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.4 p -115.39 20.57 14.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.717 0.258 . . . . 0.0 111.562 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.555 HD13 ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -81.01 -47.35 13.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.644 0.259 . . . . 0.0 110.563 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.59 -45.85 90.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.263 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.68 -41.53 98.15 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.79 -42.17 98.66 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.867 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.453 HD23 HD22 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -59.93 -38.27 81.88 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 m -77.55 -34.67 53.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.619 0.247 . . . . 0.0 110.573 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.88 -45.32 82.47 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -61.87 -24.6 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.3 23.02 7.16 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.676 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -91.33 -45.22 8.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.822 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' A' ' 110' ' ' LEU . 7.8 mp -98.71 146.28 31.35 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--O 1.248 0.989 0 C-N-CA 122.688 2.258 . . . . 0.0 112.699 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.57 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.5 mtt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 120.757 0.313 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -58.63 -28.22 65.45 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.296 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 15' ' ' LYS . . . -66.76 -10.48 47.76 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -119.8 -41.56 2.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.498 0.19 . . . . 0.0 111.205 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 9' ' ' MET . 34.1 t -56.76 -51.11 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 m -59.79 -33.58 71.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.06 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 13.8 mttm -65.72 -32.75 74.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.914 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.29 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.557 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.563 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -37.89 89.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.425 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -46.25 85.82 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.115 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HB ' ' HA2' ' A' ' 88' ' ' GLY . 20.8 pt -74.16 -17.5 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.646 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -61.93 2.11 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.664 0.268 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m -84.28 -19.06 34.46 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.3 69.09 59.98 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 121.046 0.45 . . . . 0.0 110.155 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 -21.37 70.3 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.943 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -90.28 66.08 6.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.864 0.364 . . . . 0.0 110.257 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -109.46 142.88 39.84 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.075 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.758 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -135.52 132.04 36.77 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 57' ' ' ILE . 18.4 tp -110.54 114.39 27.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.187 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.569 ' O ' HG22 ' A' ' 57' ' ' ILE . 1.5 m -131.97 172.71 12.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.68 -82.17 0.33 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.653 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.1 p -176.66 -62.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -139.41 42.04 2.04 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.931 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -78.97 161.19 69.48 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.577 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.64 -34.84 50.02 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.444 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.04 -35.04 14.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 71.8 m -67.58 -43.66 80.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.248 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 33' ' ' CYS . 13.5 p -57.5 -32.5 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.384 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -63.47 -51.63 64.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.593 0.235 . . . . 0.0 110.805 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.01 79.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.702 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.66 -33.28 62.48 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.709 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -58.96 -43.72 91.36 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.557 HG21 HD21 ' A' ' 106' ' ' LEU . 28.3 mm -66.48 -46.52 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.367 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -34.43 78.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.92 -39.22 87.3 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.916 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -81.79 -24.63 35.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.497 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 48' ' ' VAL . 25.5 mt -80.88 -8.28 59.68 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.4 t30 49.79 47.49 22.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.29 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 46' ' ' LEU . 14.4 m -141.23 41.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.42 -18.01 20.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.706 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -77.22 -45.32 26.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.681 0.277 . . . . 0.0 110.665 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -61.01 -24.56 66.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.414 ' CG2' HD21 ' A' ' 115' ' ' LEU . 15.7 t -102.76 160.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.363 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.1 t80 -113.92 111.12 21.17 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.374 0.607 . . . . 0.0 110.137 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.758 HG23 ' HB3' ' A' ' 27' ' ' GLN . 11.7 p -108.22 143.01 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.369 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -131.52 129.72 41.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.91 131.43 34.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.733 HG13 HD21 ' A' ' 60' ' ' LEU . 2.0 tt -91.91 29.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.52 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.29 9.97 54.13 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.146 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 29.28 7.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.009 0.405 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.733 HD21 HG13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.92 134.6 13.93 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.747 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.72 -177.62 2.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.202 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -56.79 -28.26 61.07 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.209 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.34 -56.82 13.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.962 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 10.7 mt-10 -69.91 -30.75 68.25 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -54.6 -45.52 73.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.861 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.17 -41.21 97.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.674 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -59.6 -46.78 87.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.163 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.36 90.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.211 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -60.99 -53.17 60.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 mt -63.77 -36.93 78.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.048 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -66.14 -55.13 17.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.228 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -41.22 77.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.27 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.24 69.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.517 0.198 . . . . 0.0 111.22 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -81.98 -30.37 31.66 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.581 0.229 . . . . 0.0 111.174 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 71' ' ' ALA . 37.0 t -83.3 -46.27 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.328 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.21 -38.03 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.87 36.49 7.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.514 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.72 104.25 9.19 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.22 39.43 1.02 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.468 ' O ' HG23 ' A' ' 83' ' ' THR . 18.9 t-20 -129.78 132.58 46.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -110.68 142.39 26.03 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.704 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 87.6 Cg_endo -79.17 -177.03 19.77 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.511 -1.454 . . . . 0.0 112.923 0.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.846 HG22 ' CE1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -148.17 125.61 11.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.36 118.95 52.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.337 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 m -112.95 117.67 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.799 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.1 138.53 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.39 33.15 22.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.43 ' HA2' ' HB ' ' A' ' 20' ' ' ILE . . . 64.94 45.71 91.56 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.426 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -175.24 136.64 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.846 ' CE1' HG22 ' A' ' 83' ' ' THR . 31.1 t80 -58.98 109.2 0.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.299 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.81 -21.82 10.48 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.283 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -138.28 138.06 9.24 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.041 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 96' ' ' GLN . 8.9 t -119.99 -170.44 1.96 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.502 0.178 . . . . 0.0 110.543 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.88 -33.18 34.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -29.32 34.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.666 ' H ' HG23 ' A' ' 93' ' ' THR . 17.9 tt0 -65.08 -30.22 71.16 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.7 mt -56.97 -59.72 4.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.482 0.182 . . . . 0.0 111.315 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -62.25 -38.01 87.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -67.56 -40.09 84.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.41 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -77.16 -35.31 56.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.531 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.8 -42.49 97.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.52 -49.56 68.51 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.343 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -70.95 -26.19 63.06 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.49 23.12 27.21 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.542 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.34 -20.63 21.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 42' ' ' ILE . 2.0 tp -57.3 -53.45 57.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.529 0.204 . . . . 0.0 110.825 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.78 -36.98 80.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.03 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.2 -41.57 98.49 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.149 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.555 HD13 HD11 ' A' ' 113' ' ' ILE . 4.4 mm? -66.64 -35.91 81.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.9 m -72.75 -37.22 67.76 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -47.32 83.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.249 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.555 HD11 HD13 ' A' ' 110' ' ' LEU . 33.9 pt -69.48 -24.53 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.4 26.9 9.62 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.552 HD23 ' CD1' ' A' ' 110' ' ' LEU . 4.2 tp -92.03 -40.16 11.24 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.736 0.268 . . . . 0.0 110.845 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 6.3 tp -65.42 -47.64 68.83 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.451 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 116' ' ' LEU . 70.7 Cg_exo . . . . . 0 C--O 1.252 1.204 0 C-N-CA 122.575 2.183 . . . . 0.0 112.606 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.9 mtt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.504 0.192 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.43 -57.58 0.61 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.658 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.6 -37.25 49.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -34.96 17.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.2 -48.02 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.149 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -67.31 -46.89 72.16 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -58.14 -38.27 76.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.688 0.28 . . . . 0.0 111.179 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.36 84.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' OE1' HD11 ' A' ' 20' ' ' ILE . 2.5 mm-40 -67.56 -38.28 83.88 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -61.76 -38.3 87.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.073 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.13 -47.74 73.12 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.644 HD12 ' CA ' ' A' ' 88' ' ' GLY . 43.8 pt -74.06 -14.63 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.634 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -61.7 2.36 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.59 0.234 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -83.76 -19.57 34.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -122.13 68.03 26.32 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.49 -24.02 42.94 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -92.4 69.21 5.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.487 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.09 139.62 43.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.283 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.75 ' HG3' HG23 ' A' ' 84' ' ' ILE . 1.3 mt-30 -128.37 100.05 5.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.747 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.69 94.4 5.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 p -103.25 154.49 19.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.954 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.33 29.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.215 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -94.88 36.73 1.17 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -48.55 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.087 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.6 m -69.17 137.17 89.24 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.205 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.19 -30.72 10.24 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.755 2.303 . . . . 0.0 112.858 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -58.74 -36.06 73.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.124 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m -65.23 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.58 -37.17 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.296 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.45 -46.08 84.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.566 0.222 . . . . 0.0 110.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.11 -33.46 72.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.96 -33.4 61.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.57 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -59.11 -41.76 88.95 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.802 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.675 HG22 HD12 ' A' ' 46' ' ' LEU . 22.8 mm -71.06 -36.91 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -34.05 76.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.765 0.317 . . . . 0.0 111.005 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -80.86 -31.55 35.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -83.52 -33.69 25.45 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.675 HD12 HG22 ' A' ' 42' ' ' ILE . 26.6 mt -80.75 -7.64 59.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 53.09 51.42 15.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.223 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 52' ' ' VAL . 16.1 m -114.5 26.68 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.378 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.27 -28.92 70.05 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -89.99 -25.58 20.8 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -79.16 -42.38 26.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 48' ' ' VAL . 11.4 p -120.93 154.86 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -118.26 111.13 18.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.0 110.383 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 27' ' ' GLN . 22.3 t -99.48 134.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.886 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -130.06 132.9 46.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.58 148.83 22.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.656 ' HA ' HD21 ' A' ' 60' ' ' LEU . 9.6 pt -107.79 85.19 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.52 -47.45 0.2 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.308 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -58.7 -41.45 86.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.765 0.282 . . . . 0.0 111.253 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -59.75 112.48 5.38 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.369 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.79 -173.54 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.101 2.534 . . . . 0.0 112.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -34.48 67.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.32 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -52.69 64.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.76 -34.25 69.32 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.204 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -55.38 -42.58 74.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.586 0.231 . . . . 0.0 110.845 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.52 -47.98 51.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -57.12 -48.05 79.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.192 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -38.31 81.14 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -52.42 64.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.916 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 mm -59.86 -47.11 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -59.11 -52.39 65.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -58.25 -45.91 86.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.028 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -62.72 -27.51 69.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 -28.66 36.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.971 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 71' ' ' ALA . 35.4 t -81.89 -48.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.102 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.736 HG21 ' CB ' ' A' ' 90' ' ' PHE . 10.8 p -121.29 -38.17 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.52 40.88 5.89 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.285 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.32 105.75 15.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.358 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.49 34.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 83' ' ' THR . 36.8 t30 -123.63 157.59 33.43 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -142.97 138.99 16.35 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.017 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.49 177.53 38.83 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.5 -1.458 . . . . 0.0 112.745 0.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 80' ' ' ASN . 5.4 p -132.08 137.6 47.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.06 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.75 HG23 ' HG3' ' A' ' 27' ' ' GLN . 30.7 mt -118.64 112.31 37.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.46 122.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.262 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.96 124.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.37 35.29 12.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.078 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.644 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . 67.52 46.27 70.88 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.745 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -176.15 135.94 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.736 ' CB ' HG21 ' A' ' 76' ' ' VAL . 55.7 t80 -59.49 107.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.032 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.26 4.32 7.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.117 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -149.11 141.18 8.71 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.028 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.734 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 12.0 p -121.19 -179.0 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.35 . . . . 0.0 111.237 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -72.81 -42.4 63.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.232 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.61 66.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.325 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -52.6 -38.19 59.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.571 0.224 . . . . 0.0 111.295 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.6 mt -56.88 -60.34 3.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -34.96 78.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.041 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -60.8 -44.94 96.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -79.7 -40.67 28.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -40.88 90.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.831 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -43.53 87.9 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.195 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -72.73 -29.34 63.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.531 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 24.85 19.26 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.714 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.5 p -110.88 9.83 22.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -49.01 69.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.416 0.151 . . . . 0.0 110.878 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.76 -46.39 89.8 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.67 -43.77 80.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -39.34 69.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 115' ' ' LEU . 7.8 tp -56.21 -42.9 77.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.303 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.1 m -77.47 -33.03 54.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.871 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -68.63 -43.16 76.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.528 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.4 pt -64.12 -23.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.15 25.16 8.03 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.555 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.474 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -81.78 -46.5 14.12 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -65.51 -59.69 9.0 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.899 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--O 1.248 1.002 0 C-N-CA 122.455 2.103 . . . . 0.0 112.43 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.462 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.4 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p -53.26 -34.75 58.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.491 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.52 -29.03 34.54 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.657 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -106.21 -38.51 6.23 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.344 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 9' ' ' MET . 22.0 t -69.94 -48.15 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.8 m -60.59 -42.85 97.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -58.69 -35.55 72.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 110.715 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.88 -48.22 72.24 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.449 ' OE1' HD11 ' A' ' 20' ' ' ILE . 13.9 mm-40 -63.77 -34.18 77.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.51 -33.85 73.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.59 79.53 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.449 HD11 ' OE1' ' A' ' 17' ' ' GLU . 18.3 pt -73.25 -16.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.468 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -61.48 -62.21 1.98 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.767 0.318 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -84.65 -20.39 31.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -123.14 67.92 35.35 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.393 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 38.6 Cg_endo -65.95 -22.57 55.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.665 2.243 . . . . 0.0 112.643 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -91.19 68.61 6.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.492 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' HD11 ' A' ' 28' ' ' LEU . 1.1 t80 -108.53 139.35 43.42 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.187 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -140.79 114.55 8.93 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.604 HD23 HD11 ' A' ' 57' ' ' ILE . 6.4 mp -100.87 140.4 35.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.242 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -146.5 145.69 30.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.153 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.65 -175.32 5.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.39 50.51 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.028 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -48.94 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.7 t -68.74 133.78 90.42 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.267 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.99 -34.1 48.8 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.811 2.341 . . . . 0.0 112.715 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.17 -31.94 69.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.641 0.258 . . . . 0.0 111.084 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 68.9 m -68.98 -56.33 8.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.09 -35.85 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.882 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -62.03 -45.1 95.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.5 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.01 82.15 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.348 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -75.04 -29.39 60.77 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -62.95 -45.19 93.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.8 -42.43 89.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -35.5 78.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -69.36 -31.86 70.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.156 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -78.59 -30.37 46.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.888 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.5 mt -80.46 -7.09 59.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.3 t30 56.15 47.82 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.14 30.81 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -19.46 59.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.367 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 -35.18 21.67 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -74.54 -25.12 59.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.526 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 53' ' ' PHE . 17.1 t -119.88 160.75 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.64 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -121.28 111.51 17.45 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.289 0.566 . . . . 0.0 110.336 179.397 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 p -112.15 141.65 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.516 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -125.23 124.51 41.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.22 144.99 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.072 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.604 HD11 HD23 ' A' ' 28' ' ' LEU . 16.8 mt -113.02 82.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.968 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.06 22.46 4.01 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.952 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -150.35 24.82 0.8 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.865 0.332 . . . . 0.0 111.391 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -171.79 58.28 0.25 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 111.263 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 65' ' ' GLN . 61.7 Cg_endo -89.75 160.6 5.16 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.766 2.311 . . . . 0.0 113.108 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER 64.6 -75.48 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 179.152 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.1 -50.26 73.34 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -82.6 -28.1 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.678 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 61' ' ' PRO . 28.7 mt-30 -65.17 -41.67 94.41 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.082 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 4.0 pt-20 -59.31 -40.66 86.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.624 0.25 . . . . 0.0 110.764 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 35.1 mttt -72.52 -44.61 61.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -34.72 77.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -63.81 -50.06 70.44 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.926 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 mt -60.16 -37.71 74.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.534 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -68.03 -54.66 16.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.177 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 6.4 m-85 -60.54 -36.42 78.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.164 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -65.1 -31.06 72.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -29.19 41.35 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 71' ' ' ALA . 32.3 t -81.16 -44.19 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.4 -40.82 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.27 36.58 6.55 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.423 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.0 t -111.26 105.16 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.73 0.3 . . . . 0.0 110.653 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.63 37.11 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -130.12 116.79 18.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.032 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 82' ' ' PRO . 1.0 OUTLIER -100.82 147.87 34.27 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.653 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.648 ' HA ' HD23 ' A' ' 81' ' ' LEU . 74.2 Cg_endo -74.77 175.29 48.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.813 0.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.7 p -134.93 133.62 39.77 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.8 111.07 34.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.751 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 m -107.51 124.06 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.944 0.402 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.35 127.23 73.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.723 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 8.6 m-20 62.83 37.11 12.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.006 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.84 49.44 72.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.729 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.51 136.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.65 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -59.22 102.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -115.86 -11.22 11.58 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.89 142.77 14.23 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.64 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 m -130.31 159.67 36.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.641 0.258 . . . . 0.0 111.104 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -39.68 75.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.13 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -76.88 -29.02 55.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.556 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.28 -31.81 34.45 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 mt -70.27 -49.04 53.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.057 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -59.63 -53.29 59.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.495 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -36.35 70.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.539 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.72 -42.38 34.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.1 74.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.5 97.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.357 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -73.73 -27.86 61.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.531 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.09 28.73 12.76 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.334 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 p -107.83 6.52 27.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -45.83 88.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.654 0.264 . . . . 0.0 110.73 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.76 -38.14 86.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.99 -41.64 95.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -59.12 -44.97 92.03 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.546 0.212 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.632 HD12 HD12 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.45 -41.51 85.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.212 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -80.72 -32.06 35.9 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -42.85 99.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.38 -21.83 29.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.634 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.16 26.65 13.67 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.781 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.442 ' HB3' HD13 ' A' ' 110' ' ' LEU . 2.2 tp -88.46 -43.58 11.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 110.8 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.632 HD12 HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -64.39 -56.81 20.35 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.084 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 C--O 1.25 1.102 0 C-N-CA 122.459 2.106 . . . . 0.0 112.702 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.46 23.53 10.13 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.07 73.4 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.763 0.316 . . . . 0.0 110.834 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.9 -28.05 11.34 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.444 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.83 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.635 0.255 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.2 m -61.45 -46.1 91.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -61.65 -37.65 84.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.049 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.17 87.48 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.99 -41.53 87.84 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.786 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -64.52 -35.75 81.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.63 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.3 mtp -66.34 -46.79 75.62 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.985 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.6 pt -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.636 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.88 -63.88 1.01 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.603 0.239 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -25.59 25.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.746 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -121.7 63.05 14.37 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.735 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.46 -18.21 54.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 112.845 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -88.08 73.68 8.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.91 139.96 39.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.05 98.93 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.777 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.573 HD21 HD11 ' A' ' 57' ' ' ILE . 1.7 tp -75.71 129.33 36.92 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -144.22 -176.6 5.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -132.84 109.88 9.94 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.2 p -50.29 -34.34 23.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.444 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -40.71 62.87 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.432 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 90.6 m -72.53 137.37 80.67 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.233 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -24.5 50.14 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.068 2.512 . . . . 0.0 112.836 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -55.99 -39.26 71.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.959 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -63.73 -39.45 94.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.406 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -62.84 -41.11 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.32 -47.41 73.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.861 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.16 89.74 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.538 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -75.25 -30.88 60.62 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.946 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.67 -49.01 76.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.35 -38.73 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.582 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -67.3 -34.06 76.6 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.29 -33.54 75.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.273 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 -33.2 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.944 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.14 -7.73 59.29 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 53.26 48.77 21.33 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.896 0.379 . . . . 0.0 110.929 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 ' CD1' ' A' ' 43' ' ' TRP . 26.9 m -122.69 29.4 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.385 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -69.99 -35.0 74.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.051 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.01 -33.18 26.58 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.894 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -66.82 -21.31 66.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.579 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 53' ' ' PHE . 19.9 t -125.59 161.03 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -124.17 111.58 16.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -97.42 141.72 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -127.45 96.17 4.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.992 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.35 144.2 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.688 ' HB ' HD21 ' A' ' 60' ' ' LEU . 7.3 pt -139.47 99.11 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.466 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.52 29.31 8.33 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.007 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.0 m -145.9 -83.5 0.13 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.92 0.36 . . . . 0.0 110.94 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.688 HD21 ' HB ' ' A' ' 57' ' ' ILE . 11.8 mt 60.52 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.273 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.36 62.5 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.129 2.552 . . . . 0.0 113.418 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 62.21 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -54.38 -43.13 71.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.54 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -60.01 -42.72 94.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.091 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.59 ' HA ' HD13 ' A' ' 60' ' ' LEU . 2.5 tm0? -56.23 -42.85 77.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.983 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 35.5 mt-10 -79.9 -27.03 39.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.5 -46.79 75.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.464 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.404 ' CD1' ' HA ' ' A' ' 65' ' ' GLN . 17.1 p-90 -71.99 -40.78 68.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -58.38 -39.98 81.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 69' ' ' ARG . 30.6 mt -79.38 -41.54 22.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.653 0.263 . . . . 0.0 111.08 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.03 -54.33 47.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.25 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -58.3 -41.61 84.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.469 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -61.63 -32.22 72.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.737 0.303 . . . . 0.0 111.039 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -31.01 46.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 71' ' ' ALA . 22.5 t -77.83 -43.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.08 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 89' ' ' LYS . 21.2 m -134.39 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 111.94 47.66 0.71 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.601 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.54 96.17 5.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.798 0.333 . . . . 0.0 110.492 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.93 24.75 2.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.226 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.82 170.35 15.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.149 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.23 151.19 43.7 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.24 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.46 172.77 60.98 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.786 -1.339 . . . . 0.0 112.783 0.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 t -159.32 135.53 8.98 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.791 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.45 129.08 57.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.336 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.81 131.33 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.86 125.18 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.068 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.1 m120 63.27 39.2 9.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.8 50.1 71.27 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.592 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.574 ' HA ' HG12 ' A' ' 76' ' ' VAL . 11.2 pttp -172.39 135.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.626 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 18.1 t80 -56.38 112.78 1.34 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.217 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -102.9 -29.75 11.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.538 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.32 161.74 31.84 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.095 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 90' ' ' PHE . 15.1 t -129.1 -174.93 3.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.769 0.318 . . . . 0.0 111.386 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -55.68 -45.43 77.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.843 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.5 m -64.06 -38.18 90.15 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.822 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -60.79 -30.31 69.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.6 mt -59.13 -57.8 11.46 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.516 0.198 . . . . 0.0 110.962 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -39.03 88.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.865 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -65.97 -41.3 91.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.247 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -73.72 -38.23 64.88 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.861 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.69 -52.99 31.37 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.835 0.35 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -35.86 78.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -74.25 -28.13 61.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.289 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.64 24.5 32.96 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.572 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.1 p -115.14 2.1 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -57.23 13.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.527 0.203 . . . . 0.0 110.996 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -66.83 -37.85 85.3 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.017 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.31 -52.36 65.61 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.848 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.35 -34.03 76.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.157 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD22 HD22 ' A' ' 115' ' ' LEU . 23.4 mt -61.21 -43.19 99.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.965 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.2 m -69.43 -29.22 66.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.891 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.37 -52.08 67.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.915 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.07 -25.75 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.747 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.19 7.45 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.899 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.671 HD22 HD22 ' A' ' 110' ' ' LEU . 1.2 tt -85.76 -50.65 7.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.675 0.274 . . . . 0.0 110.692 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.505 ' CD2' HD13 ' A' ' 110' ' ' LEU . 3.7 mm? -100.77 138.44 20.07 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 122.924 2.416 . . . . 0.0 112.478 -179.764 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.491 0.186 . . . . 0.0 111.478 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m 64.12 20.88 12.37 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.42 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.99 -29.69 20.55 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-O 120.72 0.295 . . . . 0.0 110.467 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.57 -31.58 9.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 t -64.3 -57.22 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.064 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -60.26 -44.67 95.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.107 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -61.62 -34.45 75.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.791 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.12 72.19 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -77.03 -28.51 54.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.941 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.66 -35.48 67.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.048 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 14.2 ptp -70.75 -41.58 71.59 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.812 -0.177 . . . . 0.0 111.441 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -73.86 -19.86 17.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.547 0.213 . . . . 0.0 111.412 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -62.22 1.88 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 m -87.57 -20.93 25.75 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.266 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -127.53 70.59 76.6 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 120.855 0.359 . . . . 0.0 110.72 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 41.1 Cg_endo -66.19 -22.52 53.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.718 2.278 . . . . 0.0 112.794 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CE1' HG13 ' A' ' 86' ' ' VAL . 10.7 m-85 -89.09 70.99 8.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.903 0.382 . . . . 0.0 110.275 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.83 140.68 38.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.521 ' HG2' HG23 ' A' ' 84' ' ' ILE . 49.6 mt-30 -142.77 106.91 4.72 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.783 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.699 HD21 HG12 ' A' ' 57' ' ' ILE . 6.7 tt -88.82 125.25 34.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.47 ' N ' HD23 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -140.7 172.79 12.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.009 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.73 145.57 14.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.169 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -76.39 75.74 3.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 110.739 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -142.09 -53.65 0.43 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.747 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 142.05 30.2 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.29 -34.73 81.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.962 2.441 . . . . 0.0 112.593 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -33.69 76.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.6 m -58.44 -51.34 70.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.619 0.247 . . . . 0.0 110.75 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 t -59.33 -40.32 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD2' HD13 ' A' ' 97' ' ' LEU . 82.0 t80 -59.73 -48.95 79.62 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.33 76.6 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.516 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.0 -32.45 67.21 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.561 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -62.06 -44.6 96.33 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.1 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.516 HG22 HD12 ' A' ' 46' ' ' LEU . 36.8 mm -63.13 -50.4 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.509 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.02 -32.87 74.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.916 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -66.36 -37.07 84.48 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.0 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -83.8 -27.69 28.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.471 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD12 HG22 ' A' ' 42' ' ' ILE . 20.3 mt -80.92 -7.72 59.57 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.57 49.08 20.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 m -127.28 38.9 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -93.21 16.59 12.74 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.523 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.9 -42.63 3.54 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.928 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -25.13 61.76 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.393 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 53' ' ' PHE . 21.3 t -108.34 158.3 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.645 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.414 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -116.05 111.01 19.69 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.261 0.553 . . . . 0.0 110.207 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.2 t -104.25 134.85 44.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -120.97 98.21 5.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.0 132.07 34.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.699 HG12 HD21 ' A' ' 28' ' ' LEU . 1.3 pt -120.58 91.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.402 . . . . 0.0 111.293 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 13.09 8.08 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.127 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.558 ' C ' HD13 ' A' ' 60' ' ' LEU . 4.6 t -135.72 56.75 1.82 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.018 0.437 . . . . 0.0 110.702 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -112.39 140.08 23.32 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.291 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 64' ' ' GLU . 86.3 Cg_endo -81.54 45.1 1.88 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.879 2.386 . . . . 0.0 114.314 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 67.47 -57.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.607 0.363 . . . . 0.0 111.764 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.33 -33.66 54.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.623 0.249 . . . . 0.0 111.007 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 18.9 mm-40 -70.01 -39.71 75.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.919 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -51.22 70.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.989 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -41.48 80.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.6 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -65.66 -38.67 90.0 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.884 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -62.17 -44.52 96.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.304 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.72 -41.72 87.07 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.4 mt -73.38 -43.87 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -52.27 65.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.23 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.47 -34.71 74.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -63.44 -30.31 71.45 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.047 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.84 -29.8 35.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.148 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -82.53 -44.54 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.194 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.611 HG11 HG12 ' A' ' 85' ' ' VAL . 3.7 m -123.89 -41.93 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 40.68 2.85 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.62 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.2 t -116.42 115.36 25.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -96.4 39.27 1.16 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -154.73 159.64 40.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.174 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 28' ' ' LEU . 67.7 mt -127.42 152.22 76.07 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.882 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD2' ' HG3' ' A' ' 94' ' ' GLU . 72.8 Cg_endo -76.5 174.88 50.7 Favored 'Cis proline' 0 C--N 1.354 0.834 0 C-N-CA 123.482 -1.466 . . . . 0.0 113.007 0.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.401 HG23 ' CE1' ' A' ' 90' ' ' PHE . 3.1 m -129.0 121.61 28.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.876 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.521 HG23 ' HG2' ' A' ' 27' ' ' GLN . 2.5 mt -106.1 111.23 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.871 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.611 HG12 HG11 ' A' ' 76' ' ' VAL . 6.0 m -112.18 119.46 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.51 HG13 ' CE1' ' A' ' 25' ' ' TYR . 31.2 t -117.08 122.1 69.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.963 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.421 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER 64.27 38.57 7.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.38 49.02 78.06 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.679 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -174.31 136.68 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 110.693 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.401 ' CE1' HG23 ' A' ' 83' ' ' THR . 1.8 t80 -55.05 106.15 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.283 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -24.03 9.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.752 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.4 148.11 18.5 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.595 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -124.81 175.58 7.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.71 0.29 . . . . 0.0 111.17 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 82' ' ' PRO . 15.7 tt0 -71.01 -27.64 63.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.31 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -94.45 -29.28 15.04 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.442 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 6.9 tt0 -57.91 -35.06 70.53 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 38' ' ' TYR . 2.6 pp -57.6 -42.02 82.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.569 0.223 . . . . 0.0 111.206 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.74 -35.1 52.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.941 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -70.59 -51.76 26.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-O 120.709 0.29 . . . . 0.0 111.433 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.78 -37.68 79.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.422 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.35 -50.77 68.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.907 0.384 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.92 -35.93 81.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.282 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -72.29 -25.72 61.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.49 44.19 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.557 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 p -103.75 -14.86 15.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.12 69.86 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.623 0.249 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.56 -45.37 72.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.3 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.16 -43.74 95.56 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -39.94 84.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.715 ' HG ' HD22 ' A' ' 115' ' ' LEU . 1.1 mp -58.84 -40.86 85.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.099 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 116' ' ' LEU . 30.9 m -75.59 -34.08 60.61 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.855 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -60.21 -48.22 82.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.068 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 115' ' ' LEU . 6.5 pt -65.28 -24.75 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.862 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.7 22.29 7.08 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.715 HD22 ' HG ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -82.72 -46.0 13.73 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.838 0.319 . . . . 0.0 110.906 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.562 HD12 HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -122.29 60.9 13.72 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.742 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 122.743 2.296 . . . . 0.0 112.795 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -64.2 -17.39 63.49 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.31 -36.54 21.32 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.43 -39.32 6.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.129 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.67 -55.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.345 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -60.99 -39.11 88.42 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.684 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -35.37 78.74 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.933 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.51 92.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.834 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.8 mm-40 -60.46 -36.78 79.05 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.92 -31.66 68.35 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.968 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.1 mtt -69.22 -47.76 63.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.172 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -72.45 -16.55 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.582 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -61.48 -61.23 2.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.7 m -79.39 -18.59 52.01 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.634 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -120.89 68.21 15.97 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.411 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.4 -27.05 40.49 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.596 2.197 . . . . 0.0 112.573 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' A' ' 52' ' ' VAL . 28.5 m-85 -90.09 65.74 6.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.975 0.416 . . . . 0.0 110.356 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.74 141.73 38.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 54' ' ' VAL . 47.3 tt0 -141.12 101.35 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.392 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.46 HD21 ' CD1' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -81.32 139.04 35.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.664 0.269 . . . . 0.0 110.904 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -153.1 -176.08 5.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.373 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.36 -170.62 2.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.013 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 m -109.07 -39.78 5.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.261 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.9 37.3 3.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.664 0.269 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 t -97.08 138.33 21.26 Favored Pre-proline 0 C--O 1.234 0.272 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.958 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.14 -28.4 41.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.827 2.351 . . . . 0.0 112.239 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.91 -37.65 58.56 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.337 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.0 t -70.2 -45.99 65.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.497 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.84 -37.43 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.546 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -68.51 -46.9 68.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.674 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.27 93.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.385 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -75.39 -28.76 59.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.089 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 t -60.82 -48.31 82.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.108 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.52 -45.37 92.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.588 ' CD1' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -66.98 -31.97 72.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.35 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -68.33 -33.93 75.18 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.99 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -81.11 -36.29 30.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.707 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -80.61 -7.85 59.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.121 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.9 46.02 26.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.588 HG23 ' CD1' ' A' ' 43' ' ' TRP . 17.2 m -119.02 35.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.73 3.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -124.05 -50.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.608 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -62.19 -25.73 67.94 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 25' ' ' TYR . 10.0 p -113.21 156.75 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.418 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.37 111.14 18.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.326 0.584 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 27' ' ' GLN . 22.2 t -104.31 132.83 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.787 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -119.14 113.04 20.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.675 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -99.72 111.54 23.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.635 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.46 ' CD1' HD21 ' A' ' 28' ' ' LEU . 7.4 pt -98.69 76.9 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.614 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 26.9 8.57 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.983 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.4 30.6 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.423 HD13 ' HG2' ' A' ' 64' ' ' GLU . 15.1 mt -113.3 132.68 22.34 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 33.8 Cg_exo -62.14 -167.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.818 2.345 . . . . 0.0 112.506 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 9.58 5.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.077 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -116.07 -41.3 3.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.371 0.129 . . . . 0.0 110.93 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.423 ' HG2' HD13 ' A' ' 60' ' ' LEU . 1.1 tt0 -82.56 -40.84 20.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.898 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -60.85 -40.55 93.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -41.09 96.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.968 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -56.62 -47.7 79.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.042 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -34.46 78.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.103 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -48.36 71.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.72 -42.37 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.238 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -56.67 -42.74 79.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.269 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -64.55 -49.47 71.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.134 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -24.78 65.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.05 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.87 48.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.164 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 71' ' ' ALA . 34.2 t -87.83 -47.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.3 -41.57 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.8 38.98 2.81 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.685 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -102.98 109.01 20.4 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.443 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.22 31.06 1.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -169.52 167.81 9.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.766 0.317 . . . . 0.0 111.269 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.31 159.7 69.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HB3' ' OG ' ' A' ' 29' ' ' SER . 73.3 Cg_endo -77.77 156.15 95.24 Favored 'Cis proline' 0 C--N 1.352 0.727 0 C-N-CA 123.442 -1.482 . . . . 0.0 112.906 0.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 t -127.31 125.59 41.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.188 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.98 111.25 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 111.086 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 85' ' ' VAL . 30.2 m -109.83 120.46 60.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.555 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.37 120.46 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.024 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.84 40.11 5.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 48.99 75.2 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.971 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -171.99 134.87 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.503 ' HZ ' HG23 ' A' ' 93' ' ' THR . 55.7 t80 -56.91 115.18 2.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.4 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.0 3.09 5.29 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.07 136.7 5.27 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.91 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.503 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -122.24 167.03 13.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.927 0.394 . . . . 0.0 111.635 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.76 -38.84 89.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.746 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -29.84 29.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -55.49 -31.89 62.39 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.266 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.51 -55.65 32.25 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.624 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -34.98 74.44 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -70.19 -42.97 71.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -73.87 -41.06 62.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.93 -41.93 77.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.259 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.08 74.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.314 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.85 -26.65 63.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.264 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.41 25.58 25.57 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.519 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.9 p -114.56 13.14 17.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -45.3 68.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.619 0.247 . . . . 0.0 110.899 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.7 -43.14 97.48 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.918 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.63 -40.06 82.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.46 -40.81 92.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.752 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.718 ' HB3' HD13 ' A' ' 116' ' ' LEU . 3.5 mp -58.76 -37.07 75.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.134 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.483 ' OG1' HD22 ' A' ' 116' ' ' LEU . 51.3 m -72.57 -35.62 68.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.6 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -65.88 -46.58 77.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 pt -64.69 -25.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.43 27.04 7.0 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.407 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.429 HD22 ' HG ' ' A' ' 110' ' ' LEU . 1.1 tp -85.73 -46.54 10.6 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.603 0.202 . . . . 0.0 110.761 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.718 HD13 ' HB3' ' A' ' 110' ' ' LEU . 7.1 mp -72.55 -59.5 2.44 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.969 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.392 2.061 . . . . 0.0 112.444 179.886 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p -125.48 -50.31 1.64 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.468 0.175 . . . . 0.0 110.778 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.6 -37.72 58.71 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.864 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.42 -37.5 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.101 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.413 HG12 ' OE2' ' A' ' 17' ' ' GLU . 36.6 t -67.29 -47.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.087 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -62.78 -43.67 98.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.877 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -39.33 90.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.658 0.266 . . . . 0.0 110.732 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.93 93.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.413 ' OE2' HG12 ' A' ' 13' ' ' VAL . 43.5 mt-10 -67.88 -36.6 80.53 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.71 -34.01 77.31 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.05 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -43.97 74.95 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.242 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 17' ' ' GLU . 14.0 pt -74.21 -15.12 16.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.655 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -61.49 -65.25 0.72 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.622 0.248 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.43 -23.99 27.65 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -123.56 67.58 38.84 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 110.832 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 -18.18 51.87 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.578 2.185 . . . . 0.0 112.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -92.78 73.33 4.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.367 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.33 140.03 48.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.499 ' HG3' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -132.86 102.24 5.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.554 179.513 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.547 HD22 ' CZ ' ' A' ' 72' ' ' PHE . 4.4 mp -88.83 112.32 23.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 99.6 p -162.47 -177.76 5.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.942 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 69.32 118.81 0.03 OUTLIER 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -177.5 -48.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.863 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.65 34.75 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.043 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.27 134.42 21.36 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.664 0.268 . . . . 0.0 111.499 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.88 -33.17 10.37 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.76 -34.67 71.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.5 m -64.87 -39.51 93.67 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.36 -36.02 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.116 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -57.58 -45.09 85.68 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.771 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.48 87.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.12 -31.87 61.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.813 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -49.0 77.54 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.773 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.03 -40.87 88.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.567 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.1 m-90 -67.95 -34.51 76.71 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.404 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.13 -33.06 65.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.494 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.35 -35.91 24.8 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.099 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 46' ' ' LEU . 16.1 mt -80.95 -7.94 59.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.801 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.23 47.95 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.206 0.527 . . . . 0.0 110.528 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.567 HG23 ' CD1' ' A' ' 43' ' ' TRP . 18.8 m -119.97 24.43 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.195 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.7 21.07 12.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -105.48 -43.9 4.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.933 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -76.34 -21.12 56.53 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.934 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' CG2' HD11 ' A' ' 115' ' ' LEU . 28.9 t -107.51 156.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.778 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.404 ' N ' HG12 ' A' ' 52' ' ' VAL . 3.1 t80 -114.08 110.97 20.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.263 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.07 133.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.658 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -125.36 136.25 53.26 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 29' ' ' SER . 10.0 p-10 -97.04 127.5 43.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -93.91 71.76 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.72 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.38 29.67 5.85 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.35 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.46 -45.69 2.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.998 0.399 . . . . 0.0 111.299 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.697 HD22 ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.12 122.68 30.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.763 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 12.6 Cg_exo -70.45 -170.81 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.121 2.548 . . . . 0.0 111.857 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -68.01 -30.89 70.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -72.93 -46.81 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.294 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 13.0 tp10 -62.47 -34.19 76.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -56.39 -32.28 64.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.487 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -57.85 -53.74 54.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -61.31 -40.75 95.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.542 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.05 -36.02 80.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.427 ' CD ' ' HD2' ' A' ' 79' ' ' ARG . 9.9 mtm180 -60.6 -54.66 42.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.29 -39.79 79.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.031 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -57.52 -46.27 84.01 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.867 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.547 ' CZ ' HD22 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -63.55 -46.44 85.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -26.28 68.41 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.35 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -81.96 -30.81 31.51 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.205 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 71' ' ' ALA . 43.4 t -83.8 -47.23 18.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.359 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.17 -38.9 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.29 7.27 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.74 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.95 109.74 4.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.66 0.267 . . . . 0.0 110.641 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HD2' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -99.1 42.27 1.11 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.63 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -119.73 129.17 54.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.598 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -96.38 147.86 33.6 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.42 166.85 81.64 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.652 -1.395 . . . . 0.0 112.522 0.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.3 p -125.11 115.26 20.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.697 HD11 HD21 ' A' ' 97' ' ' LEU . 31.8 mt -109.58 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -111.47 116.44 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.03 129.52 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 m120 60.9 37.03 18.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.54 81.78 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -172.84 136.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 0.0 110.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -63.31 104.59 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.103 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -110.08 -26.02 9.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.726 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -117.83 139.75 15.04 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.048 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -117.66 -170.31 1.84 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.286 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 95' ' ' SER . 24.3 pm0 -77.31 -35.13 55.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 94' ' ' GLU . 8.1 t -84.01 -34.44 24.31 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.91 -39.17 25.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.613 0.244 . . . . 0.0 111.596 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.697 HD21 HD11 ' A' ' 84' ' ' ILE . 17.2 mt -58.12 -55.6 32.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.394 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -41.54 64.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.517 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.0 mmt-85 -57.56 -36.83 72.17 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.537 0.208 . . . . 0.0 111.206 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.19 -44.99 24.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -42.98 99.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.746 0.308 . . . . 0.0 111.001 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.78 81.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -71.11 -27.26 63.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 27.42 13.17 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.493 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.7 p -112.44 14.82 20.34 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -52.27 58.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.489 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.39 -41.79 75.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.65 -46.94 80.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.799 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -62.69 -40.24 96.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -57.46 -33.65 68.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 m -74.25 -34.38 63.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -67.36 -43.86 80.42 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.304 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.27 -24.35 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.81 25.51 9.73 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.786 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.503 HD11 ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -88.45 -44.78 10.48 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.8 0.3 . . . . 0.0 110.798 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.628 ' HB2' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -128.86 56.46 23.58 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.96 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.716 2.277 . . . . 0.0 112.623 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 13' ' ' VAL . 27.6 mtm . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.679 0.276 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.95 -35.23 64.02 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -34.6 66.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.367 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -83.99 -35.47 23.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.009 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 9' ' ' MET . 37.9 t -56.06 -51.39 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.099 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -59.24 -42.39 90.97 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.248 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.34 -39.19 93.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.238 . . . . 0.0 110.736 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 75' ' ' VAL . . . -66.15 -39.84 90.13 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.693 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.22 -37.09 77.86 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.63 -33.81 76.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.909 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.5 69.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.318 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -72.51 -14.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.727 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -60.99 -57.85 10.9 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.201 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -86.25 -2.03 58.01 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -129.72 73.67 81.32 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.45 -36.35 35.02 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.709 2.273 . . . . 0.0 112.61 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.585 ' HE2' HD12 ' A' ' 115' ' ' LEU . 9.7 m-85 -99.97 68.39 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.941 0.4 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -106.89 139.38 41.38 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.513 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 54' ' ' VAL . 95.0 mt-30 -136.05 112.54 9.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.33 114.98 26.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.624 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.82 175.75 5.52 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.272 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.49 173.59 6.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.481 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 p -70.12 72.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.274 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.3 t90 55.19 64.31 1.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.353 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -85.34 163.84 43.3 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.578 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.47 -34.18 86.53 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.593 2.195 . . . . 0.0 112.484 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.59 -32.48 13.41 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.393 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.92 -42.99 89.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.851 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.44 -36.39 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.226 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.14 -56.6 18.89 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.416 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . . . -62.33 -30.96 71.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.421 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.583 ' HA ' ' CE2' ' A' ' 43' ' ' TRP . 3.1 m-80 -69.0 -38.25 79.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -65.54 -37.63 87.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.196 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 mm -57.88 -59.7 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.79 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.583 ' CE2' ' HA ' ' A' ' 40' ' ' ASN . 1.6 p90 -72.96 -16.11 61.54 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 20.9 t-20 -73.55 -43.17 60.51 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.587 0.232 . . . . 0.0 111.06 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -81.31 -31.23 33.64 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.447 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -80.48 -6.92 58.88 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 54.29 48.54 20.54 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.168 0.508 . . . . 0.0 110.794 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 52' ' ' VAL . 29.0 m -116.63 28.1 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.425 ' HG3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mt-30 -83.03 -16.23 47.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.701 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -83.63 -38.99 20.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.647 0.261 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 48' ' ' VAL . 14.0 p -110.26 162.34 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.453 ' N ' HG22 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -118.98 111.41 18.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.185 0.517 . . . . 0.0 109.958 178.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' GLN . 11.3 p -114.17 141.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.229 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -135.64 126.7 27.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.887 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.78 141.67 28.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.575 ' HB ' HD21 ' A' ' 60' ' ' LEU . 1.3 pt -89.93 52.64 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 24.31 29.17 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.014 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -126.67 28.76 5.83 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 110.881 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.575 HD21 ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -147.82 129.25 7.25 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.85 -177.05 2.02 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.721 2.281 . . . . 0.0 111.955 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -58.4 -36.69 73.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.638 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -62.85 -52.4 63.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.166 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 26.2 mm-40 -58.68 -36.18 73.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -56.36 -38.18 71.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.061 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.43 -55.49 15.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.041 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -41.29 86.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.849 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.9 t-105 -65.78 -38.7 89.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -58.73 -43.33 90.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.132 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.5 -46.29 86.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.913 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -56.92 -49.1 76.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.17 -40.99 97.88 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -61.62 -30.75 70.9 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 111.143 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 -29.68 36.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.6 t -81.02 -43.0 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.145 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.11 -44.83 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.62 0.86 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.575 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.5 100.54 8.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.773 0.32 . . . . 0.0 110.472 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -91.34 29.43 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.54 176.24 11.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.317 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.86 153.05 81.31 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.28 -178.07 21.99 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.705 -0.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.3 p -131.64 131.43 43.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.416 ' HB ' ' CA ' ' A' ' 92' ' ' GLY . 21.3 mt -114.02 111.43 35.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.787 0.327 . . . . 0.0 111.253 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.72 129.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.631 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.6 t -123.41 119.08 56.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.66 41.73 3.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.61 50.44 64.26 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.746 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -175.12 135.06 0.34 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 93' ' ' THR . 15.2 t80 -60.46 102.82 0.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.54 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -106.7 -30.21 9.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.351 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' CA ' ' HB ' ' A' ' 84' ' ' ILE . . . -122.46 146.15 16.66 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.981 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -120.95 173.05 7.48 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.812 0.339 . . . . 0.0 111.352 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -36.66 80.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.7 m -84.82 -29.63 25.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.548 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -52.23 -35.12 48.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.559 0.218 . . . . 0.0 111.513 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 39' ' ' ALA . 27.7 mt -67.52 -57.61 6.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.352 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -32.85 73.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.424 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -69.8 -40.96 75.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -78.65 -35.76 44.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.179 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.04 -43.88 87.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.56 70.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -72.31 -28.8 63.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.357 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.55 26.48 10.79 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.548 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.7 p -111.53 18.29 19.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -67.01 -50.72 61.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.568 0.223 . . . . 0.0 110.483 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.32 -38.08 81.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -43.98 98.01 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.607 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.2 -41.98 93.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.748 HD23 HD23 ' A' ' 116' ' ' LEU . 4.6 tp -65.88 -27.38 68.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.346 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.8 m -79.02 -34.9 43.54 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.605 0.24 . . . . 0.0 110.443 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -41.05 87.01 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 pt -64.9 -25.19 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.53 8.01 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.717 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.585 HD12 ' HE2' ' A' ' 25' ' ' TYR . 5.1 tt -101.77 -54.15 2.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.84 0.32 . . . . 0.0 110.77 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.748 HD23 HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -88.55 109.69 31.17 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.685 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.615 2.21 . . . . 0.0 112.478 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.9 mtt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 120.757 0.313 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 p 53.87 22.95 3.55 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.364 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.68 -23.61 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.716 0.293 . . . . 0.0 110.816 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -120.7 -36.73 3.12 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 t -61.36 -55.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.876 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -70.23 -39.77 74.86 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.811 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -38.49 77.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.24 -49.32 72.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.12 -37.66 88.16 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.91 -37.47 86.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -46.14 83.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.471 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.3 pt -72.24 -16.6 18.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.597 0.237 . . . . 0.0 111.53 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -63.74 1.18 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.176 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.1 m -88.61 -16.97 31.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.484 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -124.55 70.5 56.12 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.583 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.24 -22.38 46.64 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.733 2.289 . . . . 0.0 112.614 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.406 ' HB3' HG13 ' A' ' 52' ' ' VAL . 8.2 m-85 -94.2 66.51 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.426 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -110.77 127.84 55.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.075 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.459 ' HG2' HG23 ' A' ' 84' ' ' ILE . 96.0 mt-30 -112.41 113.74 26.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.687 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -90.34 126.81 35.99 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.939 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -119.17 157.91 27.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.304 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -76.86 175.85 9.1 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.429 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -97.8 112.86 24.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.957 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 57.5 39.87 27.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.696 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 1.3 m -109.91 148.45 38.28 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.19 -30.86 52.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.877 2.385 . . . . 0.0 112.296 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -45.91 67.0 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 t -57.54 -52.62 64.65 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -62.41 -36.2 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.221 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -66.38 -55.46 15.77 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.83 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.22 68.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.746 0.307 . . . . 0.0 111.302 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.496 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 1.2 m-80 -72.34 -38.19 68.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 p -64.48 -37.61 88.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 46' ' ' LEU . 38.3 mm -58.54 -61.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.459 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.496 ' CD1' ' HA ' ' A' ' 40' ' ' ASN . 12.3 p-90 -65.92 -39.17 90.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.35 -38.36 77.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.697 0.284 . . . . 0.0 111.243 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -83.86 -32.02 25.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 42' ' ' ILE . 21.0 mt -81.07 -8.03 59.68 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 51.64 47.3 25.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 110.944 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.52 33.25 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 43' ' ' TRP . 3.4 tt0 -74.17 -15.87 61.01 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.594 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.12 -30.59 23.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.666 0.27 . . . . 0.0 110.706 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -82.27 -31.15 30.24 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.345 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.48 ' CG2' HD11 ' A' ' 115' ' ' LEU . 48.0 t -133.68 149.75 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.764 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.46 111.62 19.53 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.383 0.611 . . . . 0.0 110.715 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.466 HG11 ' NE1' ' A' ' 43' ' ' TRP . 10.8 p -100.64 141.46 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.167 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.45 135.83 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.914 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.77 177.19 6.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.582 HG23 ' H ' ' A' ' 59' ' ' SER . 2.1 tt -63.93 -24.6 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.742 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.28 5.64 55.85 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.535 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.582 ' H ' HG23 ' A' ' 57' ' ' ILE . 4.6 m 59.65 31.82 21.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.149 0.475 . . . . 0.0 110.6 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -54.94 132.02 67.3 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.704 -179.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.91 175.89 1.64 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.7 2.267 . . . . 0.0 111.877 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -51.91 -28.09 15.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.571 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.73 -55.4 5.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.465 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -69.25 -33.05 72.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.439 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.47 ' HA ' HD22 ' A' ' 60' ' ' LEU . 21.4 tt0 -53.49 -43.81 68.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.925 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -38.36 86.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.783 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -66.03 -37.24 85.38 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -66.9 -48.05 69.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.54 0.21 . . . . 0.0 111.096 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -56.87 -51.35 69.38 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.517 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -65.92 -45.44 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.573 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.55 -54.59 43.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.492 0.187 . . . . 0.0 111.413 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.81 -38.76 82.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.725 0.298 . . . . 0.0 110.949 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.402 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 25.6 tt0 -69.13 -27.62 65.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -31.76 40.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.251 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 71' ' ' ALA . 23.9 t -84.16 -48.59 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.333 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.36 -41.19 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 103.92 40.4 2.32 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -123.78 97.37 5.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.744 0.307 . . . . 0.0 110.552 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -86.52 49.99 1.91 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.582 ' C ' HD13 ' A' ' 81' ' ' LEU . 4.6 t-20 -170.72 170.66 6.52 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.144 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD22 ' H ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -140.61 161.71 53.09 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 179.552 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.85 169.87 72.25 Favored 'Cis proline' 0 C--N 1.355 0.881 0 C-N-CA 123.497 -1.46 . . . . 0.0 113.017 0.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.658 HG22 ' HE2' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -147.65 127.99 13.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -179.66 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.459 HG23 ' HG2' ' A' ' 27' ' ' GLN . 29.7 mm -102.01 111.6 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.89 117.14 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.981 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.68 124.17 72.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.8 m120 62.12 38.99 13.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.018 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.0 91.72 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.882 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.21 136.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.963 0.411 . . . . 0.0 110.637 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.658 ' HE2' HG22 ' A' ' 83' ' ' THR . 61.1 t80 -60.54 107.99 0.76 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.065 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -115.53 -24.82 8.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.706 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.11 140.0 12.74 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.247 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.626 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -107.29 173.36 6.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -68.08 -31.14 70.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.479 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -28.16 18.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.13 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -55.1 -37.95 67.49 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.213 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.59 -44.18 87.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.355 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.95 -34.59 59.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.4 mmt85 -72.82 -37.69 67.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.346 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.75 -45.94 56.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.11 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.23 -39.28 92.29 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.65 0.262 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.09 -50.56 65.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -69.15 -27.4 65.51 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.614 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 24.5 12.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.599 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.2 p -108.46 20.04 19.07 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.594 0.197 . . . . 0.0 111.454 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -50.72 11.3 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.658 0.266 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.44 -42.39 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.37 -51.45 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.749 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -39.58 94.72 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.94 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.49 -38.07 76.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.97 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 14.0 m -78.26 -34.48 49.03 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.628 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -64.12 -44.19 92.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.355 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.6 pt -64.58 -26.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.78 22.3 8.12 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.907 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.48 HD11 ' CG2' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -81.71 -44.47 17.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.877 0.37 . . . . 0.0 110.52 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -52.8 1.41 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.441 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 111' ' ' THR . 50.9 Cg_exo . . . . . 0 C--O 1.248 1.013 0 C-N-CA 122.387 2.058 . . . . 0.0 112.367 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' VAL . 6.3 mtt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.652 0.263 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.3 p -54.93 -38.36 67.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.33 -27.5 55.98 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.913 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 -39.53 5.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.482 0.182 . . . . 0.0 111.427 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 9' ' ' MET . 39.0 t -73.78 -52.54 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.11 -40.55 96.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 110.965 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.34 -35.03 77.82 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.542 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.92 -46.56 88.82 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.4 mm-40 -61.17 -36.41 79.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.803 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.86 -33.62 74.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.902 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -49.12 61.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.6 pt -71.68 -14.43 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.406 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -63.62 1.21 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.65 0.262 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -84.41 -19.01 34.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -120.29 62.21 8.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.742 0.306 . . . . 0.0 110.829 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.97 -15.38 43.42 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.702 2.268 . . . . 0.0 113.019 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -93.88 74.27 4.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.271 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.49 121.2 40.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.003 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -112.77 121.96 46.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.997 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.6 mt -98.92 117.96 34.62 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.669 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 94.1 p -119.52 154.44 33.84 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.555 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.74 164.25 12.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.478 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.91 39.41 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.84 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -161.31 -44.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.428 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.83 147.47 88.88 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-O 120.569 0.223 . . . . 0.0 111.064 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.93 -17.7 36.63 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.19 -38.11 67.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.329 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 29' ' ' SER . 24.1 p -62.61 -39.18 92.97 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.83 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.3 -37.31 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -64.0 -49.38 72.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.749 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.34 88.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.533 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -75.35 -31.39 60.53 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.621 0.248 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -59.82 -45.97 90.7 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 46' ' ' LEU . 32.2 mm -65.74 -41.81 91.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.92 -34.69 78.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.098 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -67.17 -34.16 76.94 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -34.68 26.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 42' ' ' ILE . 19.1 mt -80.63 -7.71 59.37 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 53.53 45.82 27.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.671 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.35 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -93.62 17.63 11.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.394 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.66 -44.9 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.679 0.276 . . . . 0.0 110.861 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -64.7 -26.38 68.35 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.395 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.05 157.76 10.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.683 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.4 111.24 20.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.288 0.566 . . . . 0.0 110.477 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 t -96.06 131.55 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.99 115.61 15.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.047 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -81.48 151.06 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.485 HG13 HD21 ' A' ' 81' ' ' LEU . 34.5 mm -98.35 72.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.88 26.01 2.08 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.143 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -130.49 32.69 4.39 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -142.66 126.92 9.78 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.53 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 27.3 Cg_exo -62.76 -171.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.061 2.507 . . . . 0.0 112.507 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.11 9.44 3.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.44 -41.65 3.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.568 0.223 . . . . 0.0 110.951 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 32.1 tp10 -68.48 -37.95 80.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.059 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.606 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.9 tt0 -63.79 -35.19 79.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.92 -57.38 12.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.127 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.74 87.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.087 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -46.27 89.16 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -44.94 64.72 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.226 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.7 mt -66.69 -47.32 83.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -61.63 -39.2 90.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.437 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.505 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 10.9 m-85 -59.16 -53.5 57.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.19 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.65 -25.87 63.18 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.96 -30.85 56.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.972 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 71' ' ' ALA . 37.8 t -84.34 -44.29 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.253 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.6 m -120.52 -44.03 2.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.54 23.25 21.94 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.954 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.44 75.8 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HA ' HG21 ' A' ' 83' ' ' THR . 5.7 mtt180 -119.43 29.82 7.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.835 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.36 111.51 8.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.283 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.485 HD21 HG13 ' A' ' 57' ' ' ILE . 8.5 mt -45.9 131.92 6.94 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.38 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.14 150.48 85.66 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 124.034 -1.236 . . . . 0.0 112.747 0.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.6 HG21 ' HA ' ' A' ' 79' ' ' ARG . 26.6 m -142.98 128.63 19.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.402 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.6 mm -112.07 113.02 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.85 116.45 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.99 129.59 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.74 34.09 12.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.762 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.44 46.6 92.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.681 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -175.9 137.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.743 ' HZ ' HG23 ' A' ' 93' ' ' THR . 91.2 t80 -61.6 102.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -116.46 -25.72 7.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.712 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.12 138.61 14.57 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.933 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.743 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -123.35 -173.63 2.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.689 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.445 ' OE1' HG22 ' A' ' 93' ' ' THR . 1.8 mp0 -74.13 -37.83 63.97 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -95.24 -27.29 15.58 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.703 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.19 -39.04 66.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 93' ' ' THR . 17.1 mt -66.77 -47.23 72.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -62.28 -38.51 89.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.066 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -71.37 -38.92 71.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.276 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.425 ' HB3' HD12 ' A' ' 106' ' ' LEU . 5.1 m-85 -74.28 -35.36 63.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.008 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -50.35 20.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.738 0.304 . . . . 0.0 111.05 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -36.84 71.66 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.47 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -72.41 -27.4 62.33 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.17 25.74 20.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.52 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 p -109.07 -5.33 16.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -55.08 -42.15 72.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.539 0.209 . . . . 0.0 111.273 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.61 -51.0 70.31 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -61.56 -44.01 97.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 -36.17 76.03 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.727 HD23 HD12 ' A' ' 116' ' ' LEU . 1.2 tp -60.89 -40.51 93.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.805 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.7 m -74.6 -30.62 61.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.42 -24.62 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.736 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.06 7.19 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.769 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.89 -51.44 5.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.795 0.331 . . . . 0.0 110.743 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.727 HD12 HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -92.15 109.4 37.4 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--O 1.251 1.141 0 C-N-CA 122.546 2.164 . . . . 0.0 112.873 -179.854 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.5 ttm . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.618 0.247 . . . . 0.0 111.657 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p -60.31 -27.8 67.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.203 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.59 -32.35 40.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -96.51 -35.45 11.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.19 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 9' ' ' MET . 31.1 t -57.8 -51.76 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.526 0.203 . . . . 0.0 111.121 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.17 -36.76 78.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -65.51 -33.45 75.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.041 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.62 58.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.74 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 -34.06 76.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -70.03 -33.38 71.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -46.48 71.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.21 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 pt -71.99 -15.13 17.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.536 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -64.99 0.76 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.676 0.274 . . . . 0.0 111.026 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -24.21 26.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -119.72 68.37 11.61 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.808 0.337 . . . . 0.0 110.861 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 58.7 Cg_endo -70.91 -19.63 30.43 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 112.945 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HB3' HG13 ' A' ' 52' ' ' VAL . 37.7 m-85 -92.94 70.51 4.64 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.73 53.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.292 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.579 ' OE1' HG23 ' A' ' 84' ' ' ILE . 2.8 mp0 -128.01 107.68 10.03 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.48 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.13 124.07 28.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.958 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 m -129.5 172.32 11.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.954 0.406 . . . . 0.0 111.428 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -103.35 -175.32 2.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.274 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.83 98.31 11.52 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.43 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.6 44.77 26.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.659 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -78.92 159.33 73.76 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.011 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.66 -36.3 14.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.642 2.228 . . . . 0.0 112.597 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.33 -36.51 13.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.24 -34.18 76.92 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.44 -33.38 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.582 0.229 . . . . 0.0 111.233 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -63.23 -48.89 76.33 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.998 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.27 76.8 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.134 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -75.35 -31.47 60.56 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -61.44 -49.19 77.85 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mm -69.05 -37.38 76.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.046 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.08 75.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.081 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.47 -30.05 57.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.271 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -81.57 -33.37 31.67 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.965 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.5 HD22 HD11 ' A' ' 116' ' ' LEU . 19.3 mt -80.7 -7.71 59.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 50.64 50.11 19.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.012 0.434 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -112.48 33.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.435 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.1 -25.29 43.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.477 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -37.07 21.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 110.993 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -84.77 -15.0 46.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.491 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 53' ' ' PHE . 23.0 t -126.03 159.36 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.466 0.174 . . . . 0.0 110.947 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.438 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -121.65 111.74 17.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.307 0.575 . . . . 0.0 110.476 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.64 133.74 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -124.21 127.49 47.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.912 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 142.19 29.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.981 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 60' ' ' LEU . 4.9 pt -136.35 72.28 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.32 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.9 28.02 7.2 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.154 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -141.2 42.55 1.79 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' CD1' ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -135.86 118.83 12.39 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 -176.97 2.11 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.676 2.251 . . . . 0.0 112.439 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -59.34 -34.4 72.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.281 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -59.19 -51.84 68.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.653 0.263 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.35 -44.33 65.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.833 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.2 -34.8 70.77 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.374 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.78 -49.43 76.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.616 0.246 . . . . 0.0 111.093 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -42.11 93.75 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.02 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -68.67 -32.01 71.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.07 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HG2' ' HD3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -56.95 -47.27 81.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.951 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mt -76.85 -44.79 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.165 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.05 -52.18 64.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.617 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -48.6 80.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.166 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.99 -23.87 65.69 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.492 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -30.98 39.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.123 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 71' ' ' ALA . 24.7 t -86.91 -48.07 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.477 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.38 -37.62 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.42 33.57 8.56 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.416 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.52 93.53 0.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HD3' ' HG2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -97.61 34.08 1.92 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.82 112.56 24.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -91.11 147.37 35.51 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.617 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 94' ' ' GLU . 10.7 Cg_exo -71.57 128.13 13.73 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.309 -0.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.93 131.25 48.42 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.579 HG23 ' OE1' ' A' ' 27' ' ' GLN . 3.5 mt -117.05 111.14 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -110.86 121.81 64.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.58 127.72 74.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 2.3 m120 60.95 39.17 16.94 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.99 49.97 72.73 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.819 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -172.65 134.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.722 ' HZ ' HG23 ' A' ' 93' ' ' THR . 30.9 t80 -67.55 106.82 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.901 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -117.55 -24.32 7.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.486 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 84' ' ' ILE . . . -112.95 139.66 15.83 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.084 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.722 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -121.01 -179.55 4.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.696 0.284 . . . . 0.0 110.714 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 9.4 pt-20 -71.36 -35.97 71.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.0 m -95.07 -25.38 16.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.18 -33.34 52.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.498 0.189 . . . . 0.0 111.236 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.68 -50.28 69.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.44 -34.64 78.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 -73.42 -42.63 61.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -67.17 -44.92 78.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.049 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.5 -48.07 82.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.07 85.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.272 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -73.25 -24.75 60.5 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.73 56.72 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.529 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.0 p -105.13 -18.11 14.25 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.44 -47.7 72.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.635 0.255 . . . . 0.0 111.002 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -45.18 82.91 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.06 -37.96 89.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -48.6 79.32 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.89 -40.57 80.59 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.174 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -33.61 73.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.734 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -49.54 65.18 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.203 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 pt -65.77 -24.91 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.799 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.14 24.21 8.62 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.738 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -82.5 -42.92 17.82 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.697 0.249 . . . . 0.0 110.581 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 46' ' ' LEU . 1.5 mp -117.5 143.14 31.59 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.244 0.821 0 C-N-CA 122.603 2.202 . . . . 0.0 112.309 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.572 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 120.544 0.212 . . . . 0.0 111.023 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.1 p -54.68 -31.75 58.3 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.034 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.3 -27.5 47.3 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.673 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.9 -38.53 5.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.157 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 9' ' ' MET . 26.8 t -61.78 -57.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 111.259 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -46.8 79.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.249 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -60.36 -34.12 73.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.31 96.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.642 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.62 -34.23 70.91 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -70.33 -36.56 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.8 tpp -69.26 -46.16 67.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.103 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pt -72.57 -14.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -63.71 1.13 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.658 0.265 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.05 -23.57 26.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.971 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -120.7 61.01 8.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.797 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.66 -16.64 42.48 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.766 2.31 . . . . 0.0 112.937 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -89.42 67.1 7.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.954 0.407 . . . . 0.0 110.448 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.66 137.73 45.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.199 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.532 ' CG ' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -143.42 104.98 4.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.412 HD13 ' CZ ' ' A' ' 72' ' ' PHE . 8.3 mp -78.79 125.65 29.66 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.4 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -148.03 -176.8 5.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.268 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.05 175.22 13.22 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.97 33.78 4.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.837 0.351 . . . . 0.0 111.251 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.09 -47.04 0.78 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.263 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.417 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -58.48 143.71 80.23 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.178 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.1 -39.39 13.66 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.644 2.23 . . . . 0.0 112.376 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.416 ' CB ' ' HD3' ' A' ' 82' ' ' PRO . 23.0 m-20 -71.08 -34.18 70.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.207 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.5 m -60.15 -40.54 90.23 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.818 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 33' ' ' CYS . 21.7 t -61.52 -36.93 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.746 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -71.59 -36.41 70.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.043 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.74 91.14 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.64 0.257 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -75.76 -29.5 58.85 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.577 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.8 p -61.16 -42.8 99.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.6 0.238 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.49 -52.62 39.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.245 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.495 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.4 m-90 -60.09 -35.57 75.49 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.218 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.55 -33.67 74.5 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.882 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -79.04 -31.26 44.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.862 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 116' ' ' LEU . 22.5 mt -80.79 -7.56 59.44 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 55.85 48.24 18.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.235 0.54 . . . . 0.0 110.508 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD1' ' A' ' 43' ' ' TRP . 27.5 m -129.74 39.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.461 ' OE1' HG21 ' A' ' 54' ' ' VAL . 3.9 mm100 -98.97 28.28 4.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.287 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -124.38 -49.43 1.8 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.7 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -68.29 -18.4 64.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.42 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 53' ' ' PHE . 15.4 t -106.08 159.48 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' N ' HG12 ' A' ' 52' ' ' VAL . 10.4 m-85 -116.69 111.11 19.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 110.083 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.461 HG21 ' OE1' ' A' ' 49' ' ' GLN . 21.2 t -98.71 136.34 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.474 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.68 111.7 24.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.987 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -92.73 126.18 37.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.415 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.769 HG23 HD11 ' A' ' 60' ' ' LEU . 29.9 mt -85.99 63.99 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.057 0.456 . . . . 0.0 110.434 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.17 23.4 6.5 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.973 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -155.57 36.1 0.37 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.703 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.769 HD11 HG23 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -159.13 98.4 1.63 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.819 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.44 174.82 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.107 2.538 . . . . 0.0 112.661 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.14 -32.06 4.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -48.86 73.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.624 0.25 . . . . 0.0 111.009 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -78.67 -38.64 38.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.91 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -58.7 -40.39 83.51 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.886 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -42.89 99.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.683 0.278 . . . . 0.0 110.921 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -64.17 -42.07 96.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.685 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.518 ' CE3' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -69.82 -34.21 73.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.193 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.15 -45.16 83.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 111.015 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.8 mt -74.72 -40.55 47.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.995 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.9 -54.49 44.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.233 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -58.13 -39.83 79.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.992 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -28.43 68.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -30.88 31.93 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.335 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 71' ' ' ALA . 22.0 t -85.01 -48.5 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.554 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.1 -40.99 2.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.63 42.55 1.69 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.949 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.5 101.81 5.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -94.82 37.66 1.14 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.768 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.635 ' C ' HD13 ' A' ' 81' ' ' LEU . 9.9 t30 -161.07 -175.84 5.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.303 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.67 HD22 ' H ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -137.8 165.14 36.05 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.898 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 35' ' ' ASP . 13.3 Cg_exo -70.16 146.09 82.1 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.687 0.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.755 HG22 ' CE1' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -116.94 106.66 13.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.712 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.532 HG23 ' CG ' ' A' ' 27' ' ' GLN . 4.0 mp -102.3 111.05 30.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.761 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 90' ' ' PHE . 31.7 t -117.99 116.47 51.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 91' ' ' TRP . 13.5 p -115.66 134.96 57.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.7 t30 58.02 32.9 22.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.91 32.42 80.95 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.758 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -148.16 132.26 17.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.176 0.512 . . . . 0.0 110.372 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 83' ' ' THR . 3.1 t80 -66.99 100.68 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.381 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.449 ' HB2' HG12 ' A' ' 86' ' ' VAL . 2.0 t-105 -102.44 -31.86 10.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.244 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.55 142.04 17.33 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.113 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.706 HG22 ' CE2' ' A' ' 90' ' ' PHE . 14.7 p -127.44 -172.01 2.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.563 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.91 49.23 1.78 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.271 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.84 -43.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.929 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -52.64 -33.12 45.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.02 -56.67 19.03 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.457 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -60.48 -42.56 96.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -58.3 -40.0 80.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.414 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.08 -46.21 16.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.923 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.77 -42.04 96.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.72 93.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -70.36 -27.08 64.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.279 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.26 24.22 24.94 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.497 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.1 p -113.41 19.09 17.24 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -44.45 81.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -54.91 -44.49 74.24 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.702 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.08 -38.68 83.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.723 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.66 -41.63 77.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.704 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.54 ' HA ' HD11 ' A' ' 113' ' ' ILE . 0.3 OUTLIER -78.54 -22.0 47.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.49 179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 m -77.94 -26.67 49.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.261 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -23.81 60.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -102.89 -23.66 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.13 23.93 9.36 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.166 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -38.5 11.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.949 0.375 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.444 HD11 HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -127.42 142.45 44.03 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.836 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.379 2.052 . . . . 0.0 112.636 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.805 0.336 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.82 17.67 10.66 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.82 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.58 -30.41 36.91 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 110.684 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -100.04 -31.16 11.58 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 t -61.86 -52.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.029 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 t -62.13 -37.19 84.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.853 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -36.02 77.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.15 89.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.686 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -40.69 97.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.2 -30.9 70.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.719 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -68.18 -44.26 76.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.855 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -71.88 -14.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.517 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -63.58 1.23 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.653 0.263 . . . . 0.0 110.866 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -83.97 -24.98 30.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.408 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . 14.3 m-70 -118.58 64.29 5.91 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.782 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 57.2 Cg_endo -70.82 -21.1 29.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.582 2.188 . . . . 0.0 112.793 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.422 ' HB3' HG13 ' A' ' 52' ' ' VAL . 25.9 m-85 -92.1 69.74 5.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -110.89 130.76 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -118.91 101.63 8.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.414 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.43 HD11 ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -76.83 126.61 31.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.217 -179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.75 168.19 28.18 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . . . -164.28 179.08 7.06 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.3 p -97.12 29.13 3.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.284 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -39.72 6.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.343 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.64 148.51 34.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 111.329 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.33 -39.45 7.31 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.711 2.274 . . . . 0.0 112.627 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 2.8 m-20 -59.42 -33.25 71.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.103 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.3 m -55.17 -43.1 73.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.623 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.83 -43.27 89.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.028 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -61.47 -51.68 67.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.069 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.53 -41.06 80.15 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.709 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -73.9 -29.87 62.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.231 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -60.06 -40.69 90.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.118 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.1 mm -70.02 -51.1 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.412 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -62.45 -33.35 74.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.967 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -68.26 -34.7 76.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.098 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -78.6 -32.92 47.81 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.2 mt -80.68 -7.74 59.42 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 53.49 48.91 20.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.573 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.7 m -119.1 40.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -97.02 30.2 2.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.986 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.46 -49.43 2.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -68.01 -22.86 64.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.258 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 25' ' ' TYR . 44.2 t -114.98 156.09 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.49 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -116.15 111.28 20.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.252 0.548 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.35 142.19 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.386 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -126.52 104.88 8.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.94 151.58 31.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 30' ' ' ALA . 23.5 mm -114.31 69.75 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.115 0.483 . . . . 0.0 111.066 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 -2.25 8.6 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.162 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -106.95 -34.44 7.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.016 0.408 . . . . 0.0 111.566 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 21.2 mt -64.72 122.58 79.75 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.171 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.2 Cg_exo -62.63 -172.0 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.017 2.478 . . . . 0.0 112.534 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -78.89 8.57 5.33 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.219 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -113.43 -42.61 3.45 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.604 0.24 . . . . 0.0 110.805 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.1 -36.24 72.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.275 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -57.24 -38.27 73.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.397 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -49.99 75.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.137 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -57.78 -36.28 71.95 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -37.51 79.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.828 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -66.31 -46.45 76.85 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.5 mm -67.88 -45.62 83.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.61 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.91 -53.54 57.27 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.36 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 2.9 m-85 -65.96 -28.98 69.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.651 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.512 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 5.3 mt-30 -56.92 -40.78 76.95 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 110.741 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -28.37 44.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.427 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.7 t -72.45 -48.16 48.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 110.686 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.8 m -144.45 -41.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 123.81 63.21 0.19 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.967 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.638 ' HA ' HG21 ' A' ' 83' ' ' THR . 26.1 m -96.99 44.81 1.05 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.671 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -73.49 -16.58 61.29 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.866 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -140.1 121.04 14.56 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.0 mt -82.04 155.51 69.99 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.669 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 35' ' ' ASP . 2.6 Cg_exo -75.85 174.74 51.3 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 124.074 -1.219 . . . . 0.0 112.784 0.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 78' ' ' SER . 0.9 OUTLIER -149.19 113.83 5.33 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mt -102.34 121.96 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.479 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.88 121.53 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.89 121.29 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.414 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 3.8 t-20 64.24 40.16 6.91 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.129 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.13 49.65 75.86 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.952 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.41 136.12 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.39 . . . . 0.0 110.541 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.738 ' HE2' HG23 ' A' ' 93' ' ' THR . 1.1 t80 -61.4 104.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.307 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.86 -27.68 12.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.535 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.84 141.5 14.48 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.003 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.738 HG23 ' HE2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -127.37 172.29 10.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.734 0.302 . . . . 0.0 111.282 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.94 -26.02 62.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.486 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -29.13 14.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -56.94 -34.05 67.61 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -56.44 19.45 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 110.805 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.95 -34.08 72.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -41.03 63.62 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.324 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.73 -43.45 59.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -50.57 73.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.8 0.333 . . . . 0.0 111.029 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.69 84.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -27.18 60.05 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.769 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.41 27.03 26.26 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.175 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.0 p -107.95 -6.78 16.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 -50.05 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.612 0.244 . . . . 0.0 110.755 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.09 -41.59 88.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.0 -45.79 90.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.667 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -56.15 -40.58 74.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.058 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.24 -46.33 86.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 m -78.59 -31.19 47.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.998 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -59.28 -38.89 81.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.7 pt -79.45 -24.5 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.19 25.13 8.03 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.948 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 -48.66 5.73 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.764 0.282 . . . . 0.0 110.722 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.09 113.07 66.11 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.544 2.163 . . . . 0.0 112.829 -179.702 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.463 0.201 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.01 -36.2 17.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.69 0.281 . . . . 0.0 111.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -101.14 -33.35 10.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.205 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.9 -47.43 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.042 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.4 m -60.58 -45.46 93.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.85 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -62.59 -35.77 80.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.08 99.22 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.061 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.68 -41.5 95.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.08 -29.12 68.8 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.033 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.1 tpt -69.61 -46.58 65.95 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.139 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.4 pt -73.02 -15.0 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -61.4 -65.53 0.68 Allowed 'General case' 0 N--CA 1.458 -0.049 0 CA-C-O 120.71 0.291 . . . . 0.0 111.093 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.66 -22.81 25.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.227 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.63 68.12 14.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.764 0.316 . . . . 0.0 110.86 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.89 -30.96 20.83 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.628 2.218 . . . . 0.0 112.527 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.483 ' HB3' HG23 ' A' ' 52' ' ' VAL . 69.6 m-85 -90.84 68.0 6.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.59 139.79 42.88 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.379 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.496 HE21 HG23 ' A' ' 84' ' ' ILE . 20.0 mp0 -124.38 115.42 20.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.652 HD12 HD13 ' A' ' 57' ' ' ILE . 3.2 mm? -86.48 96.24 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -111.81 174.77 5.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.129 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -95.79 -176.39 3.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -94.33 -38.72 10.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -151.72 72.37 1.02 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -125.51 148.15 60.5 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.62 -24.38 36.64 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.869 2.38 . . . . 0.0 112.888 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 78.5 m-20 -88.73 -40.87 12.92 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.612 0.244 . . . . 0.0 110.669 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.51 -43.89 89.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.783 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.1 m -55.38 -32.36 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.5 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -70.16 -56.6 6.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.938 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.49 77.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.568 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -75.43 -31.81 60.48 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.893 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 t -64.76 -49.17 71.83 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.6 mm -65.13 -41.15 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.528 ' NE1' HG11 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -67.53 -38.23 83.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.029 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -72.9 -30.19 63.74 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.346 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -32.55 34.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.944 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.3 mt -81.53 -8.09 59.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 t30 53.16 46.01 27.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.169 0.509 . . . . 0.0 110.696 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 52' ' ' VAL . 11.2 m -123.98 43.45 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.68 18.42 10.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.647 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.32 -47.43 3.1 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.85 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -68.25 -23.65 64.81 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.336 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 48' ' ' VAL . 14.0 p -116.34 158.72 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' N ' HG22 ' A' ' 52' ' ' VAL . 38.9 m-85 -120.37 111.23 17.49 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.264 0.554 . . . . 0.0 110.372 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.37 132.4 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.96 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -126.71 131.69 51.31 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.69 142.74 27.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.671 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.684 ' CB ' HD21 ' A' ' 60' ' ' LEU . 10.8 pt -131.95 78.94 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.137 0.494 . . . . 0.0 111.394 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.78 -33.87 0.96 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.402 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.8 m -62.43 -37.17 84.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.073 0.436 . . . . 0.0 111.418 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.684 HD21 ' CB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -57.86 119.16 31.56 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.93 -174.73 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.133 2.555 . . . . 0.0 112.745 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -31.96 71.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.16 -48.51 78.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.553 0.216 . . . . 0.0 110.996 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.21 -33.95 65.65 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.217 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -57.07 -46.05 82.8 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.958 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -48.63 77.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.945 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.73 -48.6 79.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.472 ' HE1' HD11 ' A' ' 28' ' ' LEU . 1.2 t-105 -62.46 -39.28 92.9 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.888 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -58.74 -52.04 67.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.012 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.9 -40.53 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.07 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -59.1 -53.17 61.4 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.09 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.447 ' HE2' HG21 ' A' ' 83' ' ' THR . 0.1 OUTLIER -60.56 -36.17 77.83 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.47 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 1.9 mt-30 -61.19 -33.06 72.84 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.886 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -78.96 -28.85 43.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.196 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.9 t -76.61 -46.38 31.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.046 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.15 -44.65 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 113.13 49.12 0.58 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.441 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -130.37 103.45 6.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.794 0.331 . . . . 0.0 110.573 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 69' ' ' ARG . 8.7 ttp180 -94.63 38.62 1.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -153.08 148.43 27.0 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mt -117.11 152.65 49.15 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.7 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 35' ' ' ASP . 84.3 Cg_endo -80.01 179.1 30.51 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.652 -1.395 . . . . 0.0 113.297 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.787 HG23 ' CE2' ' A' ' 90' ' ' PHE . 97.4 m -150.13 145.22 26.19 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.496 HG23 HE21 ' A' ' 27' ' ' GLN . 4.9 mp -117.24 111.29 34.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -110.41 116.65 52.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.458 HG12 ' OD1' ' A' ' 87' ' ' ASN . 6.5 t -113.15 142.75 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.458 ' OD1' HG12 ' A' ' 86' ' ' VAL . 2.0 p-10 42.69 41.21 2.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.68 43.01 92.96 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.941 -0.572 . . . . 0.0 114.176 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 138.63 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 111.087 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.787 ' CE2' HG23 ' A' ' 83' ' ' THR . 6.9 t80 -52.51 111.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.0 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.83 -22.08 11.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.775 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.16 148.31 19.11 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.157 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -119.37 175.79 5.65 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 110.749 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.446 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 3.0 tm-20 -61.86 -25.88 67.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.558 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.8 m -82.56 -36.37 26.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.497 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.418 ' HG2' ' CD2' ' A' ' 100' ' ' PHE . 4.9 tt0 -58.01 -32.36 67.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.501 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 -48.73 73.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.689 0.28 . . . . 0.0 110.724 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -74.27 -32.61 62.99 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.182 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.33 -38.66 85.25 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.345 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CD2' ' HG2' ' A' ' 96' ' ' GLN . 5.6 m-85 -78.31 -44.05 26.3 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -58.5 -40.69 83.53 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.87 93.26 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.062 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -75.38 -28.96 59.69 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.37 23.15 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.4 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.6 p -122.96 19.63 10.06 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.93 -43.37 71.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.561 0.219 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.79 -51.19 69.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -40.03 86.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.78 -40.38 96.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.772 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HB3' HD13 ' A' ' 116' ' ' LEU . 9.3 mt -66.34 -29.77 70.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.418 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 m -78.52 -30.26 47.0 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -59.56 -44.14 93.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.277 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 pt -67.01 -24.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.83 26.07 8.72 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.673 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 116' ' ' LEU . 5.8 tp -85.26 -46.15 11.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.843 0.321 . . . . 0.0 110.74 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.616 HD12 ' HB3' ' A' ' 115' ' ' LEU . 6.5 mp -108.48 145.54 31.77 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.749 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 C--O 1.251 1.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.567 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.33 -35.87 29.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.211 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.7 -35.71 16.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.114 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -66.61 -49.03 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -65.64 -43.12 90.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.208 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -60.43 -37.35 80.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.566 0.222 . . . . 0.0 110.935 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.45 99.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.19 -40.31 77.14 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.82 -36.13 83.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.047 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.6 mmm -68.26 -45.64 72.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.308 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.7 pt -71.79 -14.58 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.677 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -60.92 -59.89 4.65 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -84.67 -10.91 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -124.03 72.95 55.72 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.8 -26.79 18.73 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.62 2.213 . . . . 0.0 112.792 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -93.57 70.73 4.24 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 132.98 53.09 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.152 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.462 ' HB3' HG13 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -126.94 108.16 10.72 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.603 179.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.96 136.09 33.25 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.214 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -132.47 172.8 12.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.596 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -95.92 177.9 5.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.525 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.8 m -77.15 83.87 3.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.34 45.97 16.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.402 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -70.08 155.19 93.87 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.126 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.75 -32.49 29.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.843 2.362 . . . . 0.0 112.582 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.49 -33.3 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.105 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 33' ' ' CYS . 31.2 m -69.43 -41.72 75.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.72 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -55.52 -32.69 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.592 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -59.16 -50.39 74.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 110.86 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' A' ' 97' ' ' LEU . . . -59.62 -35.87 75.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.529 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 -32.01 61.59 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.669 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -44.69 93.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.39 -48.93 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.327 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -65.34 -30.64 71.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.401 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -81.38 -32.25 32.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.974 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.0 mt -80.73 -7.73 59.45 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 52.18 43.95 30.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.875 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.47 31.6 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -102.92 28.15 6.45 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -112.71 -41.77 3.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -67.09 -24.45 65.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.281 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 53' ' ' PHE . 17.9 t -100.59 159.23 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.656 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.412 ' N ' HG12 ' A' ' 52' ' ' VAL . 2.3 t80 -110.89 111.14 22.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.386 0.612 . . . . 0.0 110.09 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 27' ' ' GLN . 14.8 t -110.65 138.88 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.111 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 138.94 54.32 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.157 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.67 129.94 47.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.764 HG23 HD21 ' A' ' 60' ' ' LEU . 52.3 mt -88.99 69.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.128 0.49 . . . . 0.0 110.287 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.34 -40.95 0.34 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.993 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.7 p -57.29 -33.73 67.96 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.418 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.764 HD21 HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -80.36 124.11 82.62 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.309 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.02 -176.24 2.54 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -36.58 75.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.8 -49.46 72.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.711 0.291 . . . . 0.0 111.009 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.57 -37.69 83.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.83 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -56.81 -31.46 64.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -52.33 65.91 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 111.081 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.493 ' HA ' HD12 ' A' ' 70' ' ' ILE . 4.3 mptt -67.16 -30.05 69.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.617 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.36 -54.37 47.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -57.92 -36.85 73.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.151 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 67' ' ' LYS . 24.9 mt -69.52 -46.61 75.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.892 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.586 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -62.68 -49.66 74.22 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.142 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -45.66 80.8 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.028 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -26.45 68.55 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.22 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -31.3 35.56 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.143 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 71' ' ' ALA . 21.8 t -83.67 -45.05 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.413 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.49 -41.28 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.56 4.29 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.441 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -120.19 107.77 13.41 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.669 0.271 . . . . 0.0 110.771 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -94.04 43.36 1.11 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.553 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 83' ' ' THR . 6.7 t-20 -147.3 158.27 43.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.162 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -138.65 153.73 72.57 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.45 167.58 79.67 Favored 'Cis proline' 0 C--N 1.353 0.8 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.921 0.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 80' ' ' ASN . 2.1 p -136.56 132.74 35.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.093 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.407 HG23 ' HG3' ' A' ' 27' ' ' GLN . 18.2 mt -110.92 114.57 47.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.17 117.1 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.695 HG12 ' HB2' ' A' ' 91' ' ' TRP . 14.4 p -114.89 128.01 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 m120 59.36 40.58 20.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.72 80.52 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.914 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -171.84 134.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 110.776 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.41 ' CE1' HG22 ' A' ' 83' ' ' THR . 73.9 t80 -68.91 106.59 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.941 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.695 ' HB2' HG12 ' A' ' 86' ' ' VAL . 1.6 m95 -124.12 0.46 8.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.34 6.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.827 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 96' ' ' GLN . 12.2 t -122.82 179.12 4.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.902 0.382 . . . . 0.0 111.297 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -41.91 96.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.575 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -67.51 -28.7 68.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -56.98 -34.84 68.49 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 111.246 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 39' ' ' ALA . 9.3 mt -70.99 -38.68 72.7 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.183 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -79.33 -48.48 14.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.592 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -58.33 -50.25 74.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 96' ' ' GLN . 10.8 m-85 -62.22 -39.19 91.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.392 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.66 -45.97 90.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.796 0.332 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.37 94.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.044 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -75.48 -29.49 59.59 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.02 13.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.503 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -117.21 16.99 14.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -49.92 47.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.72 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.0 -41.6 71.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.85 -43.64 87.84 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.718 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -54.78 -46.95 74.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.71 0.29 . . . . 0.0 110.737 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.56 -40.17 95.09 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 116' ' ' LEU . 50.8 m -70.77 -35.27 72.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.634 0.254 . . . . 0.0 110.95 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -52.11 66.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.333 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.48 HD11 HD12 ' A' ' 115' ' ' LEU . 5.3 pt -62.21 -25.11 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.97 20.19 7.31 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.929 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.48 HD12 HD11 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -77.91 -49.06 14.92 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.843 0.322 . . . . 0.0 110.461 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 111' ' ' THR . 3.4 mt -110.15 126.61 28.6 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.839 2.359 . . . . 0.0 112.311 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.563 0.22 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.51 47.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -83.86 -39.75 19.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.836 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.49 -47.72 87.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.938 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.522 HG22 ' OE2' ' A' ' 18' ' ' GLU . 19.3 m -61.19 -42.2 98.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -59.82 -39.43 85.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.751 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.74 97.32 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.973 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.07 -41.92 97.16 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.522 ' OE2' HG22 ' A' ' 14' ' ' THR . 28.7 mt-10 -61.79 -36.56 81.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.779 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.41 -49.98 67.2 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' HB ' ' HA2' ' A' ' 88' ' ' GLY . 35.0 pt -71.4 -15.27 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.48 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -63.98 1.09 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.693 0.283 . . . . 0.0 111.099 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.8 t -85.55 -23.77 27.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -118.46 66.42 6.68 Favored Pre-proline 0 CA--C 1.53 0.212 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.63 -28.95 25.25 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.692 2.261 . . . . 0.0 112.501 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.489 ' HB3' HG13 ' A' ' 52' ' ' VAL . 3.2 m-85 -94.49 67.4 3.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -108.02 127.41 53.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.425 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.527 ' HG2' HG23 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -117.24 106.08 12.9 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.27 125.08 34.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.632 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t -138.22 179.12 6.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.76 156.33 43.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.635 0.255 . . . . 0.0 111.413 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 m -84.66 55.17 3.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.079 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -127.09 -46.69 1.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.759 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 153.67 42.15 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.88 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.06 -17.61 32.2 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.877 2.385 . . . . 0.0 113.073 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -52.87 -43.81 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.445 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.88 -58.24 9.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.579 0.228 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.6 m -60.45 -31.7 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -74.48 -31.79 62.34 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.03 64.9 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-O 120.745 0.307 . . . . 0.0 111.007 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -75.6 -28.17 58.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.1 p -63.5 -47.82 80.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.887 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 46' ' ' LEU . 32.4 mm -67.47 -44.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.145 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.446 ' HE1' HG21 ' A' ' 52' ' ' VAL . 1.2 m-90 -63.44 -39.14 93.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.989 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -69.16 -31.94 70.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.89 -31.09 35.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.905 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.64 HD12 HG22 ' A' ' 42' ' ' ILE . 14.1 mt -80.53 -7.96 59.4 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 56.12 47.88 18.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 110.76 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.5 m -135.3 32.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -24.91 54.96 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.492 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.95 -41.67 22.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.627 0.251 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.35 -20.24 66.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.605 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 25' ' ' TYR . 19.6 t -117.89 163.67 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 122.16 0.184 . . . . 0.0 110.529 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.486 ' N ' HG12 ' A' ' 52' ' ' VAL . 3.1 m-85 -123.31 111.36 16.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.162 0.506 . . . . 0.0 110.294 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 27' ' ' GLN . 21.8 t -120.46 134.34 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.054 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -132.47 130.09 40.04 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -100.72 151.15 22.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HB ' HD11 ' A' ' 60' ' ' LEU . 2.6 pt -122.49 -144.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.59 14.39 25.6 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.752 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -149.1 33.81 0.74 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.806 0.303 . . . . 0.0 111.331 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -97.15 116.31 65.96 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.947 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.4 Cg_exo -62.19 -170.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.116 2.544 . . . . 0.0 112.493 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.68 2.31 14.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -106.91 -39.53 5.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.628 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.24 -39.6 62.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.324 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -60.92 -38.42 85.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.715 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.29 -35.43 79.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.551 0.215 . . . . 0.0 111.236 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -64.55 -53.14 52.52 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.314 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -69.61 -36.59 76.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.343 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -46.27 73.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.381 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.19 -51.67 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.586 0.232 . . . . 0.0 111.45 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.55 -54.98 37.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.865 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.431 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -61.48 -42.75 99.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.297 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.17 -27.81 68.97 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.539 0.209 . . . . 0.0 111.407 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -30.18 34.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.397 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 71' ' ' ALA . 38.2 t -87.94 -48.3 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 90' ' ' PHE . 9.2 p -113.57 -31.77 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.1 35.53 38.2 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.411 ' H ' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -144.57 93.09 2.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 40.21 1.06 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -113.7 89.96 3.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.634 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.48 151.91 93.4 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.063 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.23 170.51 71.25 Favored 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 123.531 -1.445 . . . . 0.0 112.99 0.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.568 HG22 ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -148.55 133.44 18.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.55 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.527 HG23 ' HG2' ' A' ' 27' ' ' GLN . 5.1 mt -112.51 111.53 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.7 t -101.77 116.72 45.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 t -125.1 131.8 72.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t30 63.28 33.07 14.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' ' 20' ' ' ILE . . . 64.89 45.18 93.26 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.832 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -175.44 137.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.545 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.568 ' CE1' HG22 ' A' ' 83' ' ' THR . 45.0 t80 -59.15 102.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -25.27 8.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.829 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 84' ' ' ILE . . . -111.1 139.01 15.34 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.233 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.96 -177.75 3.57 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -43.71 68.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.958 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 m -70.22 -32.82 70.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.891 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -52.26 -36.15 51.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.432 0.16 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.19 -54.37 41.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.18 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -33.84 66.17 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.428 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -62.02 -42.35 99.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.62 0.248 . . . . 0.0 111.304 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 109' ' ' GLU . 4.7 m-85 -77.83 -44.19 28.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.471 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -61.57 -42.42 98.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.48 67.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.596 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -83.54 -38.56 21.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.1 35.65 2.3 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.942 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 18.28 16.42 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.693 0.246 . . . . 0.0 111.47 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -51.42 66.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.606 0.241 . . . . 0.0 110.778 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -66.28 -38.46 87.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.034 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.26 -39.84 95.74 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.439 ' HG3' ' CE2' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -58.47 -49.38 77.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.911 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.785 HD12 HD13 ' A' ' 115' ' ' LEU . 3.7 mm? -59.36 -30.68 68.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.067 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.517 HG23 ' HD3' ' A' ' 117' ' ' PRO . 78.9 m -78.24 -34.12 49.35 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.741 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -47.08 86.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.53 -26.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.717 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.85 7.17 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.585 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.785 HD13 HD12 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -73.7 -45.83 49.93 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.721 0.296 . . . . 0.0 110.511 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -79.93 -60.32 0.51 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.038 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.517 ' HD3' HG23 ' A' ' 111' ' ' THR . 73.7 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.481 2.121 . . . . 0.0 112.413 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 120.735 0.302 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.46 68.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.419 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.83 -38.28 23.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.851 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.89 -51.35 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -60.27 -35.36 75.36 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.795 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -57.19 -42.43 81.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.68 0.276 . . . . 0.0 110.814 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.76 88.51 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -63.27 -35.41 80.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.33 -39.07 91.93 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.5 mtp -64.46 -44.73 90.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.983 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.433 HG12 ' HA ' ' A' ' 17' ' ' GLU . 37.1 pt -73.25 -14.69 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.419 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.26 -61.29 2.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.636 0.255 . . . . 0.0 110.855 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 m -83.37 -18.84 37.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.741 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -122.5 64.39 21.28 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.438 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 34.4 Cg_endo -64.91 -23.66 61.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.514 ' HB3' HG13 ' A' ' 52' ' ' VAL . 13.2 m-85 -94.44 71.79 3.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 2.1 t80 -114.01 139.6 49.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.423 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.679 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -127.83 134.15 49.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.872 HD23 HD11 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -107.92 127.67 53.95 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -117.09 153.7 32.3 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.365 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.612 ' HB1' ' CD1' ' A' ' 32' ' ' TRP . . . -70.75 -41.91 71.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.024 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 56' ' ' ASP . 14.5 m 66.25 33.65 7.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.324 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.612 ' CD1' ' HB1' ' A' ' 30' ' ' ALA . 48.6 p-90 -159.36 -41.0 0.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.068 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.57 147.21 32.67 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.18 -20.55 24.85 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.018 2.479 . . . . 0.0 112.632 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.59 -39.86 58.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.113 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.59 -36.91 60.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.176 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.28 -35.11 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.442 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -58.47 -52.78 64.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.553 0.216 . . . . 0.0 110.875 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.97 75.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.64 -29.26 61.2 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 t -65.19 -48.95 71.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.642 HG22 HD12 ' A' ' 46' ' ' LEU . 30.8 mm -65.21 -41.38 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.407 ' HH2' HG11 ' A' ' 52' ' ' VAL . 8.6 m95 -65.94 -36.9 84.63 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.159 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -62.59 -37.2 85.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -83.83 -30.76 26.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.372 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.642 HD12 HG22 ' A' ' 42' ' ' ILE . 21.9 mt -80.71 -8.45 59.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 48.09 45.25 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 46' ' ' LEU . 30.0 m -119.89 38.27 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -99.69 31.34 3.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -120.66 -49.84 2.22 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -25.51 68.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.265 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 25' ' ' TYR . 58.2 t -118.14 154.01 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.407 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -116.4 111.29 19.82 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.269 0.557 . . . . 0.0 110.21 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG23 ' HB3' ' A' ' 27' ' ' GLN . 10.5 p -107.93 141.63 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.287 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -126.13 125.72 42.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 3.0 m-20 -90.88 126.64 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.401 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.872 HD11 HD23 ' A' ' 28' ' ' LEU . 18.4 mt -79.27 60.3 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.698 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.53 18.07 4.95 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.811 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.46 ' H ' HD22 ' A' ' 60' ' ' LEU . 83.3 p -129.97 10.02 5.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.813 0.307 . . . . 0.0 111.802 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -108.68 131.31 21.85 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-O 120.505 0.193 . . . . 0.0 111.11 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 64' ' ' GLU . 51.6 Cg_endo -68.3 -172.94 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.896 2.397 . . . . 0.0 112.095 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 6.35 4.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.91 -44.16 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.664 0.268 . . . . 0.0 110.817 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 3.5 tp10 -81.1 -42.95 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.31 -32.75 70.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.59 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -57.59 6.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.908 -0.133 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -31.73 67.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.172 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -73.11 -53.3 11.39 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.469 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -54.23 -42.16 69.55 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.452 ' N ' ' HG3' ' A' ' 69' ' ' ARG . 15.7 mt -62.04 -57.41 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.546 0.213 . . . . 0.0 111.249 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.22 -46.16 86.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.668 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.543 ' CD2' HD21 ' A' ' 28' ' ' LEU . 1.1 m-85 -64.47 -51.5 62.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -58.8 -26.27 63.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.487 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -31.43 31.81 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.439 0.162 . . . . 0.0 111.385 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 71' ' ' ALA . 50.1 t -84.96 -48.8 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.603 HG21 HG21 ' A' ' 85' ' ' VAL . 4.9 m -147.92 -37.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.912 ' HA2' HG21 ' A' ' 83' ' ' THR . . . -45.95 -35.44 6.26 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.649 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t 61.34 -166.19 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.819 0.31 . . . . 0.0 111.184 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.33 40.54 1.11 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -160.69 130.53 5.07 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 83' ' ' THR . 27.4 mt -131.98 152.99 81.22 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.749 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.72 178.7 33.2 Favored 'Cis proline' 0 C--N 1.351 0.673 0 C-N-CA 123.688 -1.38 . . . . 0.0 113.027 0.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.912 HG21 ' HA2' ' A' ' 77' ' ' GLY . 4.4 t -144.31 155.98 44.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.04 114.68 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.603 HG21 HG21 ' A' ' 76' ' ' VAL . 19.0 t -101.17 118.38 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.73 131.79 72.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.948 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER 62.51 31.5 16.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.203 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.73 44.91 94.18 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.59 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -173.12 137.76 0.71 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.362 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -57.56 108.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -130.33 5.12 4.79 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.73 139.84 8.27 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.941 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.7 177.54 7.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.932 0.396 . . . . 0.0 111.067 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -65.59 -45.38 83.44 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -37.4 85.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.31 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.01 -34.98 66.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.235 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.0 mt -66.33 -53.56 34.83 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.726 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -64.75 -35.92 82.63 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.131 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -69.31 -41.41 76.77 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.514 ' CB ' HD12 ' A' ' 106' ' ' LEU . 8.5 m-85 -76.78 -45.81 27.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.515 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -62.31 -43.23 99.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.677 0.275 . . . . 0.0 111.061 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.93 97.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -73.24 -28.15 61.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.394 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.76 28.12 14.99 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.56 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.1 p -114.93 13.41 17.04 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.514 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.3 OUTLIER -70.33 -51.7 28.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.535 0.207 . . . . 0.0 111.011 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.05 -44.25 97.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.85 -50.6 70.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.099 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.77 -37.66 87.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.192 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.438 ' HB2' HD12 ' A' ' 116' ' ' LEU . 11.5 mt -55.81 -46.23 78.11 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.083 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -64.91 -31.46 72.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.903 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.1 72.17 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.982 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.47 -27.83 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.541 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.05 21.41 7.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.055 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -93.17 -46.17 7.54 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.839 0.32 . . . . 0.0 110.799 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 110' ' ' LEU . 17.3 mt -93.11 160.26 33.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.82 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.559 2.173 . . . . 0.0 112.448 179.851 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.74 -37.86 9.12 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.664 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -90.38 -39.16 12.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.143 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.418 HG21 ' NZ ' ' A' ' 74' ' ' LYS . 30.1 t -57.83 -45.1 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.865 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -62.33 -43.7 98.21 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.77 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.67 -47.01 82.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.754 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.15 82.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.764 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -64.3 -34.27 77.75 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.172 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.56 -38.36 83.99 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.971 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -45.32 87.35 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.115 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 pt -72.16 -14.37 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.536 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -61.88 -64.59 0.89 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.603 0.24 . . . . 0.0 110.782 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -84.6 -25.99 28.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.788 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -119.72 66.17 9.93 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.809 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.39 -20.38 36.66 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.689 2.259 . . . . 0.0 112.867 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -90.41 72.94 7.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.843 0.354 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.93 137.98 42.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 102.91 6.13 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.752 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.62 122.0 25.98 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -120.56 149.99 41.57 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.185 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.53 -38.07 4.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.443 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t 67.66 13.47 9.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.691 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.44 -33.49 7.34 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.71 0.291 . . . . 0.0 110.927 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.13 155.69 36.13 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.874 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' A' ' 37' ' ' VAL . 39.8 Cg_endo -67.95 -12.37 35.06 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.748 2.299 . . . . 0.0 113.091 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.4 -29.79 59.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 48.8 t -78.65 -49.63 12.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 34' ' ' PRO . 28.9 m -51.15 -36.7 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.278 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -71.66 -43.14 66.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.96 72.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.461 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -74.12 -32.34 63.14 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.546 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -61.25 -42.74 99.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.796 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -66.32 -44.73 90.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.004 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -35.57 81.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.095 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -67.12 -33.62 75.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.132 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -82.07 -32.52 30.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.055 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.558 HD22 HD11 ' A' ' 116' ' ' LEU . 21.1 mt -82.13 -7.79 59.63 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 50.94 49.95 20.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.953 0.406 . . . . 0.0 111.031 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 52' ' ' VAL . 28.0 m -126.17 33.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.091 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -83.07 -28.96 29.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.389 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.64 -42.65 34.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -65.26 -22.74 66.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.426 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 48' ' ' VAL . 11.1 p -108.91 163.2 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.393 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.44 ' N ' HG22 ' A' ' 52' ' ' VAL . 56.8 m-85 -120.2 111.17 17.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.23 0.538 . . . . 0.0 109.902 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.22 145.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -131.11 97.09 4.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.753 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.99 144.02 35.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.684 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.529 HG22 HD21 ' A' ' 60' ' ' LEU . 2.5 pt -99.96 64.28 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.105 0.479 . . . . 0.0 111.562 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -32.35 2.8 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.208 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 m -96.06 37.36 1.24 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.956 0.378 . . . . 0.0 111.576 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 64' ' ' GLU . 2.7 pp -145.58 116.76 5.03 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.231 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 28.0 Cg_exo -62.65 -176.85 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.989 2.459 . . . . 0.0 112.421 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -32.31 66.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.326 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -55.12 -41.83 72.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.273 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.595 ' HB3' HD13 ' A' ' 60' ' ' LEU . 7.0 mm-40 -77.53 -32.72 54.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.676 0.275 . . . . 0.0 110.824 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -54.15 -50.17 67.58 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.083 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.33 -42.1 98.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -38.98 75.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.14 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -73.53 -44.02 58.59 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.347 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -56.32 -39.16 72.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.49 -52.82 28.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.674 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -57.04 -54.5 46.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.337 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.46 -35.23 67.66 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.323 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -36.26 81.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.597 0.237 . . . . 0.0 111.073 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.418 ' NZ ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -81.93 -28.86 32.56 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.553 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 71' ' ' ALA . 40.0 t -81.08 -47.22 20.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.174 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 90' ' ' PHE . 12.8 m -123.37 -39.77 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.07 42.29 3.07 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.707 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -121.95 108.43 13.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.758 0.313 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.88 38.08 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.6 160.95 43.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.119 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 24.3 mt -123.06 155.76 63.79 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 96.6 Cg_endo -77.86 177.59 38.45 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.757 -1.351 . . . . 0.0 113.131 0.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 p -145.55 117.8 8.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 116.27 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.995 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 m -115.93 127.08 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.402 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.84 129.52 75.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 59.61 35.1 22.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.894 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.37 32.06 78.52 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.766 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -150.75 133.2 15.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.107 0.479 . . . . 0.0 110.045 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.606 ' CE2' HG23 ' A' ' 93' ' ' THR . 3.5 t80 -59.74 102.37 0.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.256 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -106.81 -22.8 12.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.748 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.64 139.99 11.42 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.874 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.606 HG23 ' CE2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -124.71 178.1 5.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.427 ' H ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -69.07 -37.1 78.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.322 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t -98.19 -22.24 16.29 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.436 ' HA ' ' HG2' ' A' ' 99' ' ' ARG . 5.4 tt0 -57.15 -31.99 65.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.55 -43.65 96.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.95 -53.5 45.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.494 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 96' ' ' GLN . 1.7 ptt180 -59.78 -41.66 91.61 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.674 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.744 ' CB ' HD12 ' A' ' 106' ' ' LEU . 2.0 m-85 -64.83 -42.75 94.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.883 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.81 -40.73 98.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.522 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.09 90.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -73.83 -27.53 61.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.24 24.22 32.25 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.61 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.4 p -116.54 11.26 14.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.744 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -67.35 -52.08 44.56 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.671 0.272 . . . . 0.0 110.484 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -67.77 -47.73 68.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.76 -53.09 52.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.984 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.43 -41.55 76.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.885 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -63.29 -38.27 90.51 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.213 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -35.84 64.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.571 0.225 . . . . 0.0 110.57 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -66.7 -45.39 78.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.255 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.3 pt -65.42 -27.29 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.595 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.69 22.46 8.06 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.861 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 -45.46 7.04 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.78 0.29 . . . . 0.0 110.726 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.558 HD11 HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -89.35 137.84 28.92 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 C--O 1.251 1.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.611 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.408 0.147 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.69 38.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.371 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.44 -37.94 19.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.875 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.46 -48.75 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.124 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 m -60.01 -41.76 92.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -60.02 -35.61 75.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.949 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.24 98.67 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.875 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' HG13 ' A' ' 20' ' ' ILE . 7.1 mm-40 -61.23 -34.15 74.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.55 -34.87 67.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.74 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.7 mtt -68.14 -46.4 70.95 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.003 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -71.89 -17.19 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.317 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -64.99 0.76 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.695 0.284 . . . . 0.0 110.856 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 t -86.06 -27.83 24.49 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -119.78 66.27 10.16 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.553 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.36 -16.61 43.78 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.663 ' HB3' HG13 ' A' ' 52' ' ' VAL . 57.1 m-85 -90.43 68.57 6.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.435 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -112.52 136.17 52.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.265 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -128.64 112.28 14.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.293 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 117.13 27.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.039 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -138.6 169.17 18.26 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.25 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.626 ' HB2' HD11 ' A' ' 57' ' ' ILE . . . -123.25 159.65 28.27 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.187 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -103.0 21.9 14.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.423 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -153.34 32.16 0.47 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.49 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -115.4 144.49 32.45 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.915 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.77 -28.67 24.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.714 2.276 . . . . 0.0 112.763 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -111.08 23.31 14.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 16.0 m -115.15 -42.05 3.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.569 0.223 . . . . 0.0 111.059 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.58 -31.98 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.363 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -65.73 -51.77 56.56 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.091 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.425 ' HB2' HD11 ' A' ' 97' ' ' LEU . . . -57.5 -40.68 79.17 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.572 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -75.42 -30.4 60.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 t -61.43 -47.88 83.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mm -62.53 -43.81 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -64.46 -36.45 84.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.049 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -29.6 63.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.18 -33.52 32.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.606 0.241 . . . . 0.0 111.014 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.82 -7.81 59.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 53.89 46.2 26.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.037 0.446 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.98 28.92 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.977 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.38 -6.7 36.94 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.34 -45.82 17.14 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 110.457 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -68.4 -28.04 66.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 25' ' ' TYR . 42.5 t -103.1 160.12 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.682 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.456 ' N ' HG12 ' A' ' 52' ' ' VAL . 6.2 m-85 -114.46 111.18 21.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.095 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 27' ' ' GLN . 33.0 t -109.16 135.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.045 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 118.1 33.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.835 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -95.45 144.31 26.07 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.278 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 30' ' ' ALA . 2.4 pt -107.62 96.51 4.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.27 -79.61 0.1 Allowed Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.892 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 p -140.73 57.49 1.57 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.93 0.395 . . . . 0.0 110.784 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.96 136.09 66.66 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.205 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.19 -169.8 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.737 2.291 . . . . 0.0 112.133 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 2.1 mtp180 -75.7 1.19 15.29 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.51 -43.31 6.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.614 0.245 . . . . 0.0 110.984 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -75.29 -49.21 19.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.92 -35.51 75.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.361 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -67.53 -51.84 46.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.328 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -58.13 -42.39 85.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.87 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -61.9 -39.51 92.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.185 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -57.24 -54.35 47.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -68.57 -44.75 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.613 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.16 -42.06 72.63 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -70.51 -45.33 65.8 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.135 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.96 -27.96 69.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -32.36 31.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 71' ' ' ALA . 54.3 t -84.42 -41.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.32 -38.46 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 36.76 6.42 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.633 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.0 m -137.04 113.24 9.87 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 38.86 1.19 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.895 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -134.36 129.4 35.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 1.3 mp -98.6 164.95 16.02 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.401 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 7.9 Cg_exo -72.29 144.65 81.08 Favored 'Cis proline' 0 C--N 1.352 0.761 0 C-N-CA 123.593 -1.42 . . . . 0.0 111.999 -0.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.795 HG23 ' CE2' ' A' ' 90' ' ' PHE . 89.5 m -107.2 105.72 15.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -101.9 111.1 30.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.332 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.5 118.17 52.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.492 HG12 ' ND2' ' A' ' 87' ' ' ASN . 23.1 t -121.72 112.58 35.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.492 ' ND2' HG12 ' A' ' 86' ' ' VAL . 71.8 m-80 66.06 42.96 3.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.059 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.48 50.74 64.3 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.122 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -173.4 138.4 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.795 ' CE2' HG23 ' A' ' 83' ' ' THR . 0.8 OUTLIER -61.97 94.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -97.6 -29.48 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.496 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.47 135.71 10.71 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.146 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.524 HG23 ' CE1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -121.86 -177.48 3.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.013 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.15 -52.24 43.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -31.66 69.43 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -51.48 -33.85 33.06 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.425 HD11 ' HB2' ' A' ' 39' ' ' ALA . 48.3 mt -51.36 -59.72 3.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.247 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -78.36 -33.04 49.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.148 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 96' ' ' GLN . 5.4 mmp_? -57.46 -49.06 77.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.5 -39.87 67.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.027 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.77 -47.82 84.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.843 0.354 . . . . 0.0 110.721 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.81 76.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.353 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -74.81 -27.78 60.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.69 23.24 43.3 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.469 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.2 p -113.57 0.07 14.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.9 -47.4 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.603 0.239 . . . . 0.0 110.92 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.06 -46.05 72.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.231 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.88 -45.74 89.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.588 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -59.42 -40.01 85.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.492 HD23 HD13 ' A' ' 116' ' ' LEU . 3.3 tp -62.63 -40.7 97.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.22 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -77.34 -33.12 55.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 110.711 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -66.61 -43.66 84.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.358 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 115' ' ' LEU . 8.6 pt -61.12 -25.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.26 21.87 6.41 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.703 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.503 ' HB2' HD11 ' A' ' 113' ' ' ILE . 1.6 tt -88.16 -55.02 3.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.745 0.307 . . . . 0.0 110.761 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.492 HD13 HD23 ' A' ' 110' ' ' LEU . 3.6 mp -89.09 140.99 29.04 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.699 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.867 2.378 . . . . 0.0 112.52 -179.864 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.01 -34.19 63.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.327 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -97.36 -37.4 10.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.28 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.0 -47.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.652 0.263 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -61.08 -43.75 98.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.658 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -63.46 -35.57 80.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.064 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.82 95.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.07 -36.66 80.22 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.806 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -69.15 -32.49 71.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -48.11 62.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.088 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 pt -70.69 -15.05 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.486 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -61.3 -61.76 2.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -83.66 -19.82 34.67 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.39 68.53 10.46 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 110.563 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.42 -18.97 38.32 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.665 2.243 . . . . 0.0 112.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.59 69.51 6.74 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.78 139.71 41.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.746 ' HB3' HG13 ' A' ' 54' ' ' VAL . 3.5 tt0 -129.15 125.87 38.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.012 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.717 ' HB2' HG23 ' A' ' 83' ' ' THR . 5.1 mp -99.83 113.63 26.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.81 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 175.88 13.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.01 170.89 15.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.319 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -102.47 -15.15 16.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -85.88 -39.44 16.99 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.6 m -72.67 141.35 82.34 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.87 -39.09 1.94 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.871 2.381 . . . . 0.0 113.122 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -61.31 -29.94 70.19 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.74 0.305 . . . . 0.0 111.047 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.4 m -72.04 -34.77 69.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.886 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -58.15 -34.84 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.72 -54.38 36.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.514 0.197 . . . . 0.0 111.198 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.34 72.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.572 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -75.15 -32.02 61.21 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.763 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -63.46 -44.51 94.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.969 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.1 mm -63.49 -43.92 98.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.038 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.627 ' CD1' HG11 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.8 -34.24 77.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.307 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -28.08 63.81 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.186 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -80.6 -32.51 36.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.897 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -81.91 -7.69 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 52.73 49.73 19.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.661 ' O ' HG12 ' A' ' 52' ' ' VAL . 13.2 m -122.69 26.17 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.299 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -26.66 65.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.734 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -81.2 -31.79 33.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.704 0.287 . . . . 0.0 110.913 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -75.9 -28.73 58.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 48' ' ' VAL . 13.5 p -112.46 161.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.815 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.461 ' N ' HG22 ' A' ' 52' ' ' VAL . 1.1 t80 -120.46 111.13 17.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.368 0.604 . . . . 0.0 109.99 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 27' ' ' GLN . 27.4 t -107.85 135.54 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.991 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.09 113.55 26.5 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.92 145.09 29.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.938 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.701 ' HA ' HD13 ' A' ' 60' ' ' LEU . 32.9 mm -112.77 78.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.86 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -43.94 0.33 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.803 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -95.55 37.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 111.169 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.701 HD13 ' HA ' ' A' ' 57' ' ' ILE . 5.6 mp -119.94 105.02 43.37 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.682 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.9 164.09 2.66 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.038 2.492 . . . . 0.0 112.678 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.13 -36.16 5.65 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.551 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -75.11 -49.5 19.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.007 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.3 -36.49 83.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.221 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -59.86 -48.05 83.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.003 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.16 -29.18 67.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -55.46 -53.45 56.2 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.228 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.446 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 36.2 p-90 -74.01 -32.35 63.34 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.73 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -49.83 74.76 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -73.93 -39.03 51.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.074 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.72 -50.75 72.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.072 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -63.61 -33.87 76.57 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -32.84 70.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.884 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -78.94 -29.59 44.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 71' ' ' ALA . 21.4 t -78.98 -44.14 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.191 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 89' ' ' LYS . 27.4 m -128.26 -42.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.27 45.97 1.11 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.45 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 p -102.76 85.35 2.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 110.415 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 22.91 1.63 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 152.68 15.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.431 HD23 ' HH2' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -124.21 159.37 57.35 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.052 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.2 156.42 98.16 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.793 0.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.717 HG23 ' HB2' ' A' ' 28' ' ' LEU . 1.3 t -144.92 131.25 19.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.9 mt -112.02 122.79 66.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.343 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.12 121.65 64.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.352 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.89 121.87 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.98 43.37 3.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.63 75.28 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.854 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.516 ' HA ' HG12 ' A' ' 76' ' ' VAL . 4.8 ptpt -174.16 134.99 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.559 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.712 ' HZ ' HG23 ' A' ' 93' ' ' THR . 75.9 t80 -62.86 101.21 0.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.977 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -113.32 -26.31 8.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.628 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.68 141.08 16.67 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.697 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.712 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -123.58 154.2 39.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.603 0.24 . . . . 0.0 111.171 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -36.72 68.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.0 m -86.0 -27.18 25.0 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -37.4 69.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.616 0.246 . . . . 0.0 111.083 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.14 -37.29 78.22 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.121 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -67.92 -54.48 18.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.186 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -60.36 -29.59 69.01 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -79.48 -45.56 19.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.343 0.116 . . . . 0.0 111.108 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.555 ' HB2' HD13 ' A' ' 106' ' ' LEU . 4.5 tm-20 -62.77 -43.98 97.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.91 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.1 -46.74 68.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.508 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -76.8 -34.8 57.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.42 32.97 3.26 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.89 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.4 p -115.39 20.57 14.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.717 0.258 . . . . 0.0 111.562 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.555 HD13 ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -81.01 -47.35 13.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.644 0.259 . . . . 0.0 110.563 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.59 -45.85 90.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.263 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.68 -41.53 98.15 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.79 -42.17 98.66 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.867 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.453 HD23 HD22 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -59.93 -38.27 81.88 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 m -77.55 -34.67 53.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.619 0.247 . . . . 0.0 110.573 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.88 -45.32 82.47 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -61.87 -24.6 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.3 23.02 7.16 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.676 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -91.33 -45.22 8.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.822 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' A' ' 110' ' ' LEU . 7.8 mp -98.71 146.28 31.35 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--O 1.248 0.989 0 C-N-CA 122.688 2.258 . . . . 0.0 112.699 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.356 0.122 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 15' ' ' LYS . . . -66.76 -10.48 47.76 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -119.8 -41.56 2.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.498 0.19 . . . . 0.0 111.205 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 t -56.76 -51.11 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 m -59.79 -33.58 71.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.06 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 13.8 mttm -65.72 -32.75 74.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.914 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.29 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.557 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.563 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -37.89 89.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.425 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -46.25 85.82 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.115 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HB ' ' HA2' ' A' ' 88' ' ' GLY . 20.8 pt -74.16 -17.5 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.646 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -61.93 2.11 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.664 0.268 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m -84.28 -19.06 34.46 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.3 69.09 59.98 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 121.046 0.45 . . . . 0.0 110.155 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 -21.37 70.3 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.943 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -90.28 66.08 6.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.864 0.364 . . . . 0.0 110.257 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -109.46 142.88 39.84 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.075 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.758 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -135.52 132.04 36.77 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 57' ' ' ILE . 18.4 tp -110.54 114.39 27.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.187 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.569 ' O ' HG22 ' A' ' 57' ' ' ILE . 1.5 m -131.97 172.71 12.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.68 -82.17 0.33 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.653 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.1 p -176.66 -62.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -139.41 42.04 2.04 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.931 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -78.97 161.19 69.48 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.577 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.64 -34.84 50.02 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.444 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.04 -35.04 14.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 71.8 m -67.58 -43.66 80.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.248 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 33' ' ' CYS . 13.5 p -57.5 -32.5 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.384 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -63.47 -51.63 64.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.593 0.235 . . . . 0.0 110.805 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.01 79.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.702 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.66 -33.28 62.48 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.709 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -58.96 -43.72 91.36 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.557 HG21 HD21 ' A' ' 106' ' ' LEU . 28.3 mm -66.48 -46.52 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.367 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -34.43 78.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.92 -39.22 87.3 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.916 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -81.79 -24.63 35.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.497 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 48' ' ' VAL . 25.5 mt -80.88 -8.28 59.68 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.4 t30 49.79 47.49 22.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.29 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 46' ' ' LEU . 14.4 m -141.23 41.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.42 -18.01 20.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.706 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -77.22 -45.32 26.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.681 0.277 . . . . 0.0 110.665 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -61.01 -24.56 66.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.414 ' CG2' HD21 ' A' ' 115' ' ' LEU . 15.7 t -102.76 160.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.363 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.1 t80 -113.92 111.12 21.17 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.374 0.607 . . . . 0.0 110.137 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.758 HG23 ' HB3' ' A' ' 27' ' ' GLN . 11.7 p -108.22 143.01 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.369 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -131.52 129.72 41.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.91 131.43 34.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.733 HG13 HD21 ' A' ' 60' ' ' LEU . 2.0 tt -91.91 29.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.52 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.29 9.97 54.13 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.146 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 29.28 7.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.009 0.405 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.733 HD21 HG13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.92 134.6 13.93 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.747 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.72 -177.62 2.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.202 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -56.79 -28.26 61.07 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.209 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.34 -56.82 13.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.962 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 10.7 mt-10 -69.91 -30.75 68.25 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -54.6 -45.52 73.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.861 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.17 -41.21 97.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.674 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -59.6 -46.78 87.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.163 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.36 90.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.211 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -60.99 -53.17 60.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 mt -63.77 -36.93 78.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.048 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -66.14 -55.13 17.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.228 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -41.22 77.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.27 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.24 69.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.517 0.198 . . . . 0.0 111.22 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -81.98 -30.37 31.66 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.581 0.229 . . . . 0.0 111.174 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 71' ' ' ALA . 37.0 t -83.3 -46.27 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.328 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.21 -38.03 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.87 36.49 7.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.514 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.72 104.25 9.19 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.22 39.43 1.02 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.468 ' O ' HG23 ' A' ' 83' ' ' THR . 18.9 t-20 -129.78 132.58 46.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -110.68 142.39 26.03 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.704 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 87.6 Cg_endo -79.17 -177.03 19.77 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.511 -1.454 . . . . 0.0 112.923 0.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.846 HG22 ' CE1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -148.17 125.61 11.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.36 118.95 52.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.337 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 m -112.95 117.67 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.799 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.1 138.53 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.39 33.15 22.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.43 ' HA2' ' HB ' ' A' ' 20' ' ' ILE . . . 64.94 45.71 91.56 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.426 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -175.24 136.64 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.846 ' CE1' HG22 ' A' ' 83' ' ' THR . 31.1 t80 -58.98 109.2 0.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.299 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.81 -21.82 10.48 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.283 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -138.28 138.06 9.24 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.041 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 96' ' ' GLN . 8.9 t -119.99 -170.44 1.96 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.502 0.178 . . . . 0.0 110.543 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.88 -33.18 34.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -29.32 34.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.666 ' H ' HG23 ' A' ' 93' ' ' THR . 17.9 tt0 -65.08 -30.22 71.16 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.7 mt -56.97 -59.72 4.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.482 0.182 . . . . 0.0 111.315 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -62.25 -38.01 87.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -67.56 -40.09 84.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.41 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -77.16 -35.31 56.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.531 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.8 -42.49 97.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.52 -49.56 68.51 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.343 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -70.95 -26.19 63.06 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.49 23.12 27.21 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.542 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.34 -20.63 21.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 42' ' ' ILE . 2.0 tp -57.3 -53.45 57.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.529 0.204 . . . . 0.0 110.825 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.78 -36.98 80.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.03 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.2 -41.57 98.49 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.149 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.555 HD13 HD11 ' A' ' 113' ' ' ILE . 4.4 mm? -66.64 -35.91 81.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.9 m -72.75 -37.22 67.76 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -47.32 83.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.249 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.555 HD11 HD13 ' A' ' 110' ' ' LEU . 33.9 pt -69.48 -24.53 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.4 26.9 9.62 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.552 HD23 ' CD1' ' A' ' 110' ' ' LEU . 4.2 tp -92.03 -40.16 11.24 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.736 0.268 . . . . 0.0 110.845 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 6.3 tp -65.42 -47.64 68.83 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.451 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 116' ' ' LEU . 70.7 Cg_exo . . . . . 0 C--O 1.252 1.204 0 C-N-CA 122.575 2.183 . . . . 0.0 112.606 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.6 -37.25 49.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -34.96 17.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.2 -48.02 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.149 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -67.31 -46.89 72.16 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -58.14 -38.27 76.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.688 0.28 . . . . 0.0 111.179 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.36 84.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' OE1' HD11 ' A' ' 20' ' ' ILE . 2.5 mm-40 -67.56 -38.28 83.88 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -61.76 -38.3 87.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.073 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.13 -47.74 73.12 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.644 HD12 ' CA ' ' A' ' 88' ' ' GLY . 43.8 pt -74.06 -14.63 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.634 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -61.7 2.36 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.59 0.234 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -83.76 -19.57 34.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -122.13 68.03 26.32 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.49 -24.02 42.94 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -92.4 69.21 5.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.487 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.09 139.62 43.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.283 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.75 ' HG3' HG23 ' A' ' 84' ' ' ILE . 1.3 mt-30 -128.37 100.05 5.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.747 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.69 94.4 5.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 p -103.25 154.49 19.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.954 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.33 29.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.215 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -94.88 36.73 1.17 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -48.55 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.087 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.6 m -69.17 137.17 89.24 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.205 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.19 -30.72 10.24 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.755 2.303 . . . . 0.0 112.858 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -58.74 -36.06 73.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.124 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m -65.23 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.58 -37.17 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.296 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.45 -46.08 84.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.566 0.222 . . . . 0.0 110.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.11 -33.46 72.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -74.96 -33.4 61.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.57 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -59.11 -41.76 88.95 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.802 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.675 HG22 HD12 ' A' ' 46' ' ' LEU . 22.8 mm -71.06 -36.91 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -34.05 76.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.765 0.317 . . . . 0.0 111.005 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -80.86 -31.55 35.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -83.52 -33.69 25.45 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.675 HD12 HG22 ' A' ' 42' ' ' ILE . 26.6 mt -80.75 -7.64 59.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 53.09 51.42 15.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.223 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 52' ' ' VAL . 16.1 m -114.5 26.68 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.378 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.27 -28.92 70.05 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -89.99 -25.58 20.8 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -79.16 -42.38 26.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 48' ' ' VAL . 11.4 p -120.93 154.86 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -118.26 111.13 18.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.0 110.383 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 27' ' ' GLN . 22.3 t -99.48 134.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.886 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -130.06 132.9 46.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.58 148.83 22.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.656 ' HA ' HD21 ' A' ' 60' ' ' LEU . 9.6 pt -107.79 85.19 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.52 -47.45 0.2 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.308 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -58.7 -41.45 86.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.765 0.282 . . . . 0.0 111.253 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -59.75 112.48 5.38 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.369 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.79 -173.54 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.101 2.534 . . . . 0.0 112.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -34.48 67.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.32 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -52.69 64.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.76 -34.25 69.32 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.204 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -55.38 -42.58 74.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.586 0.231 . . . . 0.0 110.845 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.52 -47.98 51.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -57.12 -48.05 79.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.192 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -38.31 81.14 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -52.42 64.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.916 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 mm -59.86 -47.11 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -59.11 -52.39 65.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -58.25 -45.91 86.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.028 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -62.72 -27.51 69.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 -28.66 36.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.971 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 71' ' ' ALA . 35.4 t -81.89 -48.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.102 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.736 HG21 ' CB ' ' A' ' 90' ' ' PHE . 10.8 p -121.29 -38.17 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.52 40.88 5.89 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.285 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.32 105.75 15.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.358 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.49 34.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 83' ' ' THR . 36.8 t30 -123.63 157.59 33.43 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -142.97 138.99 16.35 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.017 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.49 177.53 38.83 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.5 -1.458 . . . . 0.0 112.745 0.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 80' ' ' ASN . 5.4 p -132.08 137.6 47.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.06 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.75 HG23 ' HG3' ' A' ' 27' ' ' GLN . 30.7 mt -118.64 112.31 37.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.46 122.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.262 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.96 124.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.37 35.29 12.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.078 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.644 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . 67.52 46.27 70.88 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.745 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -176.15 135.94 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.736 ' CB ' HG21 ' A' ' 76' ' ' VAL . 55.7 t80 -59.49 107.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.032 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.26 4.32 7.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.117 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -149.11 141.18 8.71 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.028 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.734 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 12.0 p -121.19 -179.0 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.35 . . . . 0.0 111.237 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -72.81 -42.4 63.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.232 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.61 66.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.325 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -52.6 -38.19 59.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.571 0.224 . . . . 0.0 111.295 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.6 mt -56.88 -60.34 3.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -34.96 78.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.041 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -60.8 -44.94 96.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -79.7 -40.67 28.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -40.88 90.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.831 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -43.53 87.9 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.195 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -72.73 -29.34 63.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.531 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 24.85 19.26 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.714 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.5 p -110.88 9.83 22.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -49.01 69.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.416 0.151 . . . . 0.0 110.878 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.76 -46.39 89.8 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.67 -43.77 80.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -39.34 69.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 115' ' ' LEU . 7.8 tp -56.21 -42.9 77.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.303 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.1 m -77.47 -33.03 54.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.871 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -68.63 -43.16 76.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.528 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.4 pt -64.12 -23.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.15 25.16 8.03 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.555 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.474 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -81.78 -46.5 14.12 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -65.51 -59.69 9.0 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.899 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--O 1.248 1.002 0 C-N-CA 122.455 2.103 . . . . 0.0 112.43 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.52 -29.03 34.54 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.657 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -106.21 -38.51 6.23 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.344 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.94 -48.15 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.8 m -60.59 -42.85 97.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -58.69 -35.55 72.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 110.715 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.88 -48.22 72.24 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.449 ' OE1' HD11 ' A' ' 20' ' ' ILE . 13.9 mm-40 -63.77 -34.18 77.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.51 -33.85 73.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.59 79.53 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.449 HD11 ' OE1' ' A' ' 17' ' ' GLU . 18.3 pt -73.25 -16.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.468 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -61.48 -62.21 1.98 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.767 0.318 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -84.65 -20.39 31.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -123.14 67.92 35.35 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.393 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 38.6 Cg_endo -65.95 -22.57 55.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.665 2.243 . . . . 0.0 112.643 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -91.19 68.61 6.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.492 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' HD11 ' A' ' 28' ' ' LEU . 1.1 t80 -108.53 139.35 43.42 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.187 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -140.79 114.55 8.93 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.604 HD23 HD11 ' A' ' 57' ' ' ILE . 6.4 mp -100.87 140.4 35.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.242 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -146.5 145.69 30.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.153 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.65 -175.32 5.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.39 50.51 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.028 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -48.94 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.7 t -68.74 133.78 90.42 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.267 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.99 -34.1 48.8 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.811 2.341 . . . . 0.0 112.715 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.17 -31.94 69.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.641 0.258 . . . . 0.0 111.084 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 68.9 m -68.98 -56.33 8.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.09 -35.85 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.882 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -62.03 -45.1 95.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.5 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.01 82.15 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.348 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -75.04 -29.39 60.77 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -62.95 -45.19 93.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.8 -42.43 89.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -35.5 78.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -69.36 -31.86 70.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.156 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -78.59 -30.37 46.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.888 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.5 mt -80.46 -7.09 59.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.3 t30 56.15 47.82 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.14 30.81 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -19.46 59.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.367 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 -35.18 21.67 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -74.54 -25.12 59.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.526 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 53' ' ' PHE . 17.1 t -119.88 160.75 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.64 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -121.28 111.51 17.45 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.289 0.566 . . . . 0.0 110.336 179.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 p -112.15 141.65 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.516 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -125.23 124.51 41.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.22 144.99 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.072 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.604 HD11 HD23 ' A' ' 28' ' ' LEU . 16.8 mt -113.02 82.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.968 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.06 22.46 4.01 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.952 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -150.35 24.82 0.8 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.865 0.332 . . . . 0.0 111.391 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -171.79 58.28 0.25 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 111.263 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 65' ' ' GLN . 61.7 Cg_endo -89.75 160.6 5.16 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.766 2.311 . . . . 0.0 113.108 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER 64.6 -75.48 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 179.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.1 -50.26 73.34 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -82.6 -28.1 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.678 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 61' ' ' PRO . 28.7 mt-30 -65.17 -41.67 94.41 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.082 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 4.0 pt-20 -59.31 -40.66 86.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.624 0.25 . . . . 0.0 110.764 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 35.1 mttt -72.52 -44.61 61.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -34.72 77.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -63.81 -50.06 70.44 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.926 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 mt -60.16 -37.71 74.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.534 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -68.03 -54.66 16.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.177 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 6.4 m-85 -60.54 -36.42 78.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.164 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.1 -31.06 72.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -29.19 41.35 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 71' ' ' ALA . 32.3 t -81.16 -44.19 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.4 -40.82 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.27 36.58 6.55 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.423 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.0 t -111.26 105.16 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.73 0.3 . . . . 0.0 110.653 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.63 37.11 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -130.12 116.79 18.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.032 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 82' ' ' PRO . 1.0 OUTLIER -100.82 147.87 34.27 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.653 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.648 ' HA ' HD23 ' A' ' 81' ' ' LEU . 74.2 Cg_endo -74.77 175.29 48.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.813 0.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.7 p -134.93 133.62 39.77 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.8 111.07 34.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.751 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 m -107.51 124.06 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.944 0.402 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.35 127.23 73.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.723 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 8.6 m-20 62.83 37.11 12.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.006 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.84 49.44 72.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.729 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.51 136.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.65 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -59.22 102.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -115.86 -11.22 11.58 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.89 142.77 14.23 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.64 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 m -130.31 159.67 36.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.641 0.258 . . . . 0.0 111.104 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -39.68 75.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.13 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -76.88 -29.02 55.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.556 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.28 -31.81 34.45 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 mt -70.27 -49.04 53.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.057 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -59.63 -53.29 59.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.495 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -36.35 70.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.539 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.72 -42.38 34.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.1 74.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.5 97.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.357 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -73.73 -27.86 61.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.531 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.09 28.73 12.76 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.334 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 p -107.83 6.52 27.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -45.83 88.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.654 0.264 . . . . 0.0 110.73 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.76 -38.14 86.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.99 -41.64 95.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -59.12 -44.97 92.03 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.546 0.212 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.632 HD12 HD12 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.45 -41.51 85.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.212 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -80.72 -32.06 35.9 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -42.85 99.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.38 -21.83 29.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.634 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.16 26.65 13.67 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.781 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.442 ' HB3' HD13 ' A' ' 110' ' ' LEU . 2.2 tp -88.46 -43.58 11.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 110.8 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.632 HD12 HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -64.39 -56.81 20.35 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.084 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 C--O 1.25 1.102 0 C-N-CA 122.459 2.106 . . . . 0.0 112.702 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.275 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.07 73.4 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.763 0.316 . . . . 0.0 110.834 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.9 -28.05 11.34 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.444 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.83 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.635 0.255 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.2 m -61.45 -46.1 91.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -61.65 -37.65 84.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.049 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.17 87.48 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.99 -41.53 87.84 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.786 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -64.52 -35.75 81.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.63 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.3 mtp -66.34 -46.79 75.62 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.985 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.6 pt -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.636 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.88 -63.88 1.01 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.603 0.239 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -25.59 25.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.746 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -121.7 63.05 14.37 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.735 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.46 -18.21 54.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 112.845 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -88.08 73.68 8.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.91 139.96 39.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.05 98.93 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.777 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.573 HD21 HD11 ' A' ' 57' ' ' ILE . 1.7 tp -75.71 129.33 36.92 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -144.22 -176.6 5.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -132.84 109.88 9.94 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.2 p -50.29 -34.34 23.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.444 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -40.71 62.87 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.432 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 90.6 m -72.53 137.37 80.67 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.233 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -24.5 50.14 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.068 2.512 . . . . 0.0 112.836 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -55.99 -39.26 71.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.959 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -63.73 -39.45 94.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.406 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -62.84 -41.11 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.32 -47.41 73.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.861 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.16 89.74 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.538 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -75.25 -30.88 60.62 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.946 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.67 -49.01 76.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.35 -38.73 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.582 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -67.3 -34.06 76.6 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.29 -33.54 75.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.273 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 -33.2 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.944 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.14 -7.73 59.29 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 53.26 48.77 21.33 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.896 0.379 . . . . 0.0 110.929 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 ' CD1' ' A' ' 43' ' ' TRP . 26.9 m -122.69 29.4 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.385 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -69.99 -35.0 74.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.051 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.01 -33.18 26.58 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.894 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -66.82 -21.31 66.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.579 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 53' ' ' PHE . 19.9 t -125.59 161.03 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -124.17 111.58 16.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -97.42 141.72 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -127.45 96.17 4.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.992 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.35 144.2 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.688 ' HB ' HD21 ' A' ' 60' ' ' LEU . 7.3 pt -139.47 99.11 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.466 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.52 29.31 8.33 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.007 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.0 m -145.9 -83.5 0.13 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.92 0.36 . . . . 0.0 110.94 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.688 HD21 ' HB ' ' A' ' 57' ' ' ILE . 11.8 mt 60.52 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.273 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.36 62.5 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.129 2.552 . . . . 0.0 113.418 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 62.21 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -54.38 -43.13 71.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.54 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -60.01 -42.72 94.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.091 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.59 ' HA ' HD13 ' A' ' 60' ' ' LEU . 2.5 tm0? -56.23 -42.85 77.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.983 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 35.5 mt-10 -79.9 -27.03 39.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.5 -46.79 75.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.464 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.404 ' CD1' ' HA ' ' A' ' 65' ' ' GLN . 17.1 p-90 -71.99 -40.78 68.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -58.38 -39.98 81.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 69' ' ' ARG . 30.6 mt -79.38 -41.54 22.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.653 0.263 . . . . 0.0 111.08 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.03 -54.33 47.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.25 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -58.3 -41.61 84.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.469 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -61.63 -32.22 72.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.737 0.303 . . . . 0.0 111.039 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -31.01 46.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 71' ' ' ALA . 22.5 t -77.83 -43.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.08 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 89' ' ' LYS . 21.2 m -134.39 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 111.94 47.66 0.71 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.601 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.54 96.17 5.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.798 0.333 . . . . 0.0 110.492 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.93 24.75 2.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.226 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.82 170.35 15.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.149 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.23 151.19 43.7 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.24 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.46 172.77 60.98 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.786 -1.339 . . . . 0.0 112.783 0.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 t -159.32 135.53 8.98 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.791 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.45 129.08 57.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.336 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.81 131.33 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.86 125.18 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.068 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 63.27 39.2 9.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.8 50.1 71.27 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.592 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.574 ' HA ' HG12 ' A' ' 76' ' ' VAL . 11.2 pttp -172.39 135.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.626 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 18.1 t80 -56.38 112.78 1.34 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.217 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -102.9 -29.75 11.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.538 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.32 161.74 31.84 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.095 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 90' ' ' PHE . 15.1 t -129.1 -174.93 3.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.769 0.318 . . . . 0.0 111.386 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -55.68 -45.43 77.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.843 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.5 m -64.06 -38.18 90.15 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.822 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -60.79 -30.31 69.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.6 mt -59.13 -57.8 11.46 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.516 0.198 . . . . 0.0 110.962 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -39.03 88.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.865 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -65.97 -41.3 91.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.247 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -73.72 -38.23 64.88 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.861 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.69 -52.99 31.37 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.835 0.35 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -35.86 78.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -74.25 -28.13 61.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.289 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.64 24.5 32.96 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.572 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.1 p -115.14 2.1 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -57.23 13.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.527 0.203 . . . . 0.0 110.996 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -66.83 -37.85 85.3 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.017 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.31 -52.36 65.61 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.848 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.35 -34.03 76.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.157 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD22 HD22 ' A' ' 115' ' ' LEU . 23.4 mt -61.21 -43.19 99.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.965 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.2 m -69.43 -29.22 66.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.891 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.37 -52.08 67.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.915 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.07 -25.75 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.747 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.19 7.45 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.899 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.671 HD22 HD22 ' A' ' 110' ' ' LEU . 1.2 tt -85.76 -50.65 7.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.675 0.274 . . . . 0.0 110.692 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.505 ' CD2' HD13 ' A' ' 110' ' ' LEU . 3.7 mm? -100.77 138.44 20.07 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 122.924 2.416 . . . . 0.0 112.478 -179.764 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 111.42 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.99 -29.69 20.55 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-O 120.72 0.295 . . . . 0.0 110.467 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.57 -31.58 9.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 t -64.3 -57.22 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.064 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -60.26 -44.67 95.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.107 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -61.62 -34.45 75.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.791 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.12 72.19 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -77.03 -28.51 54.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.941 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.66 -35.48 67.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.048 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 14.2 ptp -70.75 -41.58 71.59 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.812 -0.177 . . . . 0.0 111.441 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -73.86 -19.86 17.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.547 0.213 . . . . 0.0 111.412 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -62.22 1.88 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 m -87.57 -20.93 25.75 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.266 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -127.53 70.59 76.6 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 120.855 0.359 . . . . 0.0 110.72 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 41.1 Cg_endo -66.19 -22.52 53.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.718 2.278 . . . . 0.0 112.794 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CE1' HG13 ' A' ' 86' ' ' VAL . 10.7 m-85 -89.09 70.99 8.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.903 0.382 . . . . 0.0 110.275 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.83 140.68 38.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.521 ' HG2' HG23 ' A' ' 84' ' ' ILE . 49.6 mt-30 -142.77 106.91 4.72 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.783 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.699 HD21 HG12 ' A' ' 57' ' ' ILE . 6.7 tt -88.82 125.25 34.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.47 ' N ' HD23 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -140.7 172.79 12.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.009 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.73 145.57 14.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.169 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -76.39 75.74 3.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 110.739 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -142.09 -53.65 0.43 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.747 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 142.05 30.2 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.29 -34.73 81.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.962 2.441 . . . . 0.0 112.593 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -33.69 76.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.6 m -58.44 -51.34 70.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.619 0.247 . . . . 0.0 110.75 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 t -59.33 -40.32 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD2' HD13 ' A' ' 97' ' ' LEU . 82.0 t80 -59.73 -48.95 79.62 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.33 76.6 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.516 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.0 -32.45 67.21 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.561 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -62.06 -44.6 96.33 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.1 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.516 HG22 HD12 ' A' ' 46' ' ' LEU . 36.8 mm -63.13 -50.4 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.509 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.02 -32.87 74.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.916 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -66.36 -37.07 84.48 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.0 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -83.8 -27.69 28.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.471 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD12 HG22 ' A' ' 42' ' ' ILE . 20.3 mt -80.92 -7.72 59.57 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.57 49.08 20.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 m -127.28 38.9 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -93.21 16.59 12.74 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.523 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.9 -42.63 3.54 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.928 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -25.13 61.76 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.393 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 53' ' ' PHE . 21.3 t -108.34 158.3 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.645 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.414 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -116.05 111.01 19.69 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.261 0.553 . . . . 0.0 110.207 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.2 t -104.25 134.85 44.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -120.97 98.21 5.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.0 132.07 34.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.699 HG12 HD21 ' A' ' 28' ' ' LEU . 1.3 pt -120.58 91.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.402 . . . . 0.0 111.293 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 13.09 8.08 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.127 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.558 ' C ' HD13 ' A' ' 60' ' ' LEU . 4.6 t -135.72 56.75 1.82 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.018 0.437 . . . . 0.0 110.702 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -112.39 140.08 23.32 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.291 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 64' ' ' GLU . 86.3 Cg_endo -81.54 45.1 1.88 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.879 2.386 . . . . 0.0 114.314 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 67.47 -57.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.607 0.363 . . . . 0.0 111.764 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.33 -33.66 54.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.623 0.249 . . . . 0.0 111.007 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 18.9 mm-40 -70.01 -39.71 75.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.919 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -51.22 70.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.989 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -41.48 80.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.6 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -65.66 -38.67 90.0 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.884 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -62.17 -44.52 96.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.304 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.72 -41.72 87.07 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.4 mt -73.38 -43.87 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -52.27 65.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.23 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.47 -34.71 74.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -63.44 -30.31 71.45 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.047 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.84 -29.8 35.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.148 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -82.53 -44.54 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.194 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.611 HG11 HG12 ' A' ' 85' ' ' VAL . 3.7 m -123.89 -41.93 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 40.68 2.85 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.62 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.2 t -116.42 115.36 25.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -96.4 39.27 1.16 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -154.73 159.64 40.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.174 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 28' ' ' LEU . 67.7 mt -127.42 152.22 76.07 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.882 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD2' ' HG3' ' A' ' 94' ' ' GLU . 72.8 Cg_endo -76.5 174.88 50.7 Favored 'Cis proline' 0 C--N 1.354 0.834 0 C-N-CA 123.482 -1.466 . . . . 0.0 113.007 0.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.401 HG23 ' CE1' ' A' ' 90' ' ' PHE . 3.1 m -129.0 121.61 28.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.876 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.521 HG23 ' HG2' ' A' ' 27' ' ' GLN . 2.5 mt -106.1 111.23 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.871 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.611 HG12 HG11 ' A' ' 76' ' ' VAL . 6.0 m -112.18 119.46 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.51 HG13 ' CE1' ' A' ' 25' ' ' TYR . 31.2 t -117.08 122.1 69.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.963 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.421 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER 64.27 38.57 7.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.38 49.02 78.06 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.679 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -174.31 136.68 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 110.693 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.401 ' CE1' HG23 ' A' ' 83' ' ' THR . 1.8 t80 -55.05 106.15 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.283 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -24.03 9.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.752 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.4 148.11 18.5 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.595 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -124.81 175.58 7.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.71 0.29 . . . . 0.0 111.17 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 82' ' ' PRO . 15.7 tt0 -71.01 -27.64 63.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.31 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -94.45 -29.28 15.04 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.442 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 6.9 tt0 -57.91 -35.06 70.53 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 38' ' ' TYR . 2.6 pp -57.6 -42.02 82.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.569 0.223 . . . . 0.0 111.206 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.74 -35.1 52.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.941 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -70.59 -51.76 26.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-O 120.709 0.29 . . . . 0.0 111.433 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.78 -37.68 79.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.422 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.35 -50.77 68.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.907 0.384 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.92 -35.93 81.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.282 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -72.29 -25.72 61.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.49 44.19 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.557 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 p -103.75 -14.86 15.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.12 69.86 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.623 0.249 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.56 -45.37 72.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.3 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.16 -43.74 95.56 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -39.94 84.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.715 ' HG ' HD22 ' A' ' 115' ' ' LEU . 1.1 mp -58.84 -40.86 85.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.099 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 116' ' ' LEU . 30.9 m -75.59 -34.08 60.61 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.855 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -60.21 -48.22 82.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.068 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 115' ' ' LEU . 6.5 pt -65.28 -24.75 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.862 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.7 22.29 7.08 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.715 HD22 ' HG ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -82.72 -46.0 13.73 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.838 0.319 . . . . 0.0 110.906 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.562 HD12 HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -122.29 60.9 13.72 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.742 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 122.743 2.296 . . . . 0.0 112.795 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.31 -36.54 21.32 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.43 -39.32 6.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.129 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.67 -55.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.345 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -60.99 -39.11 88.42 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.684 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -35.37 78.74 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.933 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.51 92.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.834 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.8 mm-40 -60.46 -36.78 79.05 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.92 -31.66 68.35 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.968 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.1 mtt -69.22 -47.76 63.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.172 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -72.45 -16.55 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.582 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -61.48 -61.23 2.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.7 m -79.39 -18.59 52.01 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.634 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -120.89 68.21 15.97 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.411 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.4 -27.05 40.49 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.596 2.197 . . . . 0.0 112.573 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' A' ' 52' ' ' VAL . 28.5 m-85 -90.09 65.74 6.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.975 0.416 . . . . 0.0 110.356 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.74 141.73 38.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 54' ' ' VAL . 47.3 tt0 -141.12 101.35 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.392 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.46 HD21 ' CD1' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -81.32 139.04 35.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.664 0.269 . . . . 0.0 110.904 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -153.1 -176.08 5.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.373 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.36 -170.62 2.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.013 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 m -109.07 -39.78 5.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.261 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.9 37.3 3.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.664 0.269 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 t -97.08 138.33 21.26 Favored Pre-proline 0 C--O 1.234 0.272 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.958 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.14 -28.4 41.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.827 2.351 . . . . 0.0 112.239 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.91 -37.65 58.56 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.337 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.0 t -70.2 -45.99 65.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.497 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.84 -37.43 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.546 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -68.51 -46.9 68.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.674 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.27 93.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.385 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -75.39 -28.76 59.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.089 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 t -60.82 -48.31 82.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.108 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.52 -45.37 92.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.588 ' CD1' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -66.98 -31.97 72.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.35 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -68.33 -33.93 75.18 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.99 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -81.11 -36.29 30.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.707 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -80.61 -7.85 59.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.121 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.9 46.02 26.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.588 HG23 ' CD1' ' A' ' 43' ' ' TRP . 17.2 m -119.02 35.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.73 3.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -124.05 -50.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.608 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -62.19 -25.73 67.94 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 25' ' ' TYR . 10.0 p -113.21 156.75 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.418 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.37 111.14 18.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.326 0.584 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 27' ' ' GLN . 22.2 t -104.31 132.83 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.787 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -119.14 113.04 20.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.675 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -99.72 111.54 23.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.635 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.46 ' CD1' HD21 ' A' ' 28' ' ' LEU . 7.4 pt -98.69 76.9 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.614 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 26.9 8.57 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.983 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.4 30.6 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.423 HD13 ' HG2' ' A' ' 64' ' ' GLU . 15.1 mt -113.3 132.68 22.34 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 33.8 Cg_exo -62.14 -167.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.818 2.345 . . . . 0.0 112.506 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 9.58 5.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.077 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -116.07 -41.3 3.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.371 0.129 . . . . 0.0 110.93 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.423 ' HG2' HD13 ' A' ' 60' ' ' LEU . 1.1 tt0 -82.56 -40.84 20.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.898 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -60.85 -40.55 93.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -41.09 96.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.968 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -56.62 -47.7 79.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.042 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -34.46 78.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.103 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -48.36 71.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.72 -42.37 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.238 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -56.67 -42.74 79.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.269 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -64.55 -49.47 71.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.134 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -24.78 65.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.05 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.87 48.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.164 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 71' ' ' ALA . 34.2 t -87.83 -47.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.3 -41.57 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.8 38.98 2.81 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.685 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -102.98 109.01 20.4 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.443 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.22 31.06 1.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -169.52 167.81 9.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.766 0.317 . . . . 0.0 111.269 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.31 159.7 69.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HB3' ' OG ' ' A' ' 29' ' ' SER . 73.3 Cg_endo -77.77 156.15 95.24 Favored 'Cis proline' 0 C--N 1.352 0.727 0 C-N-CA 123.442 -1.482 . . . . 0.0 112.906 0.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 t -127.31 125.59 41.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.188 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.98 111.25 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 111.086 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 85' ' ' VAL . 30.2 m -109.83 120.46 60.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.555 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.37 120.46 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.024 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.84 40.11 5.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 48.99 75.2 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.971 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -171.99 134.87 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.503 ' HZ ' HG23 ' A' ' 93' ' ' THR . 55.7 t80 -56.91 115.18 2.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.4 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.0 3.09 5.29 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.07 136.7 5.27 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.91 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.503 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -122.24 167.03 13.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.927 0.394 . . . . 0.0 111.635 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.76 -38.84 89.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.746 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -29.84 29.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -55.49 -31.89 62.39 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.266 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.51 -55.65 32.25 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.624 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -34.98 74.44 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -70.19 -42.97 71.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -73.87 -41.06 62.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.93 -41.93 77.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.259 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.08 74.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.314 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.85 -26.65 63.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.264 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.41 25.58 25.57 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.519 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.9 p -114.56 13.14 17.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -45.3 68.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.619 0.247 . . . . 0.0 110.899 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.7 -43.14 97.48 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.918 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.63 -40.06 82.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.46 -40.81 92.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.752 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.718 ' HB3' HD13 ' A' ' 116' ' ' LEU . 3.5 mp -58.76 -37.07 75.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.134 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.483 ' OG1' HD22 ' A' ' 116' ' ' LEU . 51.3 m -72.57 -35.62 68.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.6 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -65.88 -46.58 77.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 pt -64.69 -25.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.43 27.04 7.0 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.407 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.429 HD22 ' HG ' ' A' ' 110' ' ' LEU . 1.1 tp -85.73 -46.54 10.6 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.603 0.202 . . . . 0.0 110.761 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.718 HD13 ' HB3' ' A' ' 110' ' ' LEU . 7.1 mp -72.55 -59.5 2.44 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.969 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.392 2.061 . . . . 0.0 112.444 179.886 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.468 0.175 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.6 -37.72 58.71 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.864 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.42 -37.5 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.101 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.413 HG12 ' OE2' ' A' ' 17' ' ' GLU . 36.6 t -67.29 -47.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.087 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -62.78 -43.67 98.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.877 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -39.33 90.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.658 0.266 . . . . 0.0 110.732 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.93 93.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.413 ' OE2' HG12 ' A' ' 13' ' ' VAL . 43.5 mt-10 -67.88 -36.6 80.53 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.71 -34.01 77.31 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.05 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -43.97 74.95 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.242 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 17' ' ' GLU . 14.0 pt -74.21 -15.12 16.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.655 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -61.49 -65.25 0.72 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.622 0.248 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.43 -23.99 27.65 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -123.56 67.58 38.84 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 110.832 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 -18.18 51.87 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.578 2.185 . . . . 0.0 112.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -92.78 73.33 4.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.367 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.33 140.03 48.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.499 ' HG3' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -132.86 102.24 5.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.554 179.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.547 HD22 ' CZ ' ' A' ' 72' ' ' PHE . 4.4 mp -88.83 112.32 23.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 99.6 p -162.47 -177.76 5.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.942 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 69.32 118.81 0.03 OUTLIER 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -177.5 -48.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.863 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.65 34.75 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.043 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.27 134.42 21.36 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.664 0.268 . . . . 0.0 111.499 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.88 -33.17 10.37 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.76 -34.67 71.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.5 m -64.87 -39.51 93.67 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.36 -36.02 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.116 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -57.58 -45.09 85.68 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.771 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.48 87.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.12 -31.87 61.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.813 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -49.0 77.54 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.773 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.03 -40.87 88.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.567 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.1 m-90 -67.95 -34.51 76.71 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.404 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.13 -33.06 65.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.494 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.35 -35.91 24.8 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.099 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 46' ' ' LEU . 16.1 mt -80.95 -7.94 59.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.801 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.23 47.95 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.206 0.527 . . . . 0.0 110.528 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.567 HG23 ' CD1' ' A' ' 43' ' ' TRP . 18.8 m -119.97 24.43 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.195 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.7 21.07 12.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -105.48 -43.9 4.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.933 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -76.34 -21.12 56.53 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.934 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' CG2' HD11 ' A' ' 115' ' ' LEU . 28.9 t -107.51 156.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.778 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.404 ' N ' HG12 ' A' ' 52' ' ' VAL . 3.1 t80 -114.08 110.97 20.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.263 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.07 133.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.658 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -125.36 136.25 53.26 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 29' ' ' SER . 10.0 p-10 -97.04 127.5 43.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -93.91 71.76 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.72 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.38 29.67 5.85 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.35 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.46 -45.69 2.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.998 0.399 . . . . 0.0 111.299 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.697 HD22 ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.12 122.68 30.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.763 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 12.6 Cg_exo -70.45 -170.81 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.121 2.548 . . . . 0.0 111.857 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -68.01 -30.89 70.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -72.93 -46.81 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.294 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 13.0 tp10 -62.47 -34.19 76.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -56.39 -32.28 64.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.487 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -57.85 -53.74 54.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -61.31 -40.75 95.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.542 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.05 -36.02 80.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.427 ' CD ' ' HD2' ' A' ' 79' ' ' ARG . 9.9 mtm180 -60.6 -54.66 42.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.29 -39.79 79.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.031 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -57.52 -46.27 84.01 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.867 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.547 ' CZ ' HD22 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -63.55 -46.44 85.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -26.28 68.41 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.35 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -81.96 -30.81 31.51 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.205 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 71' ' ' ALA . 43.4 t -83.8 -47.23 18.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.359 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.17 -38.9 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.29 7.27 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.74 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.95 109.74 4.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.66 0.267 . . . . 0.0 110.641 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HD2' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -99.1 42.27 1.11 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.63 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.73 129.17 54.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.598 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -96.38 147.86 33.6 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.42 166.85 81.64 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.652 -1.395 . . . . 0.0 112.522 0.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.3 p -125.11 115.26 20.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.697 HD11 HD21 ' A' ' 97' ' ' LEU . 31.8 mt -109.58 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -111.47 116.44 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.03 129.52 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 m120 60.9 37.03 18.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.54 81.78 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -172.84 136.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 0.0 110.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -63.31 104.59 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.103 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -110.08 -26.02 9.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.726 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -117.83 139.75 15.04 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.048 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -117.66 -170.31 1.84 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.286 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 95' ' ' SER . 24.3 pm0 -77.31 -35.13 55.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 94' ' ' GLU . 8.1 t -84.01 -34.44 24.31 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.91 -39.17 25.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.613 0.244 . . . . 0.0 111.596 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.697 HD21 HD11 ' A' ' 84' ' ' ILE . 17.2 mt -58.12 -55.6 32.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.394 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -41.54 64.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.517 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.0 mmt-85 -57.56 -36.83 72.17 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.537 0.208 . . . . 0.0 111.206 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.19 -44.99 24.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -42.98 99.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.746 0.308 . . . . 0.0 111.001 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.78 81.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -71.11 -27.26 63.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 27.42 13.17 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.493 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.7 p -112.44 14.82 20.34 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -52.27 58.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.489 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.39 -41.79 75.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.65 -46.94 80.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.799 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -62.69 -40.24 96.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -57.46 -33.65 68.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 m -74.25 -34.38 63.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -67.36 -43.86 80.42 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.304 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.27 -24.35 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.81 25.51 9.73 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.786 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.503 HD11 ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -88.45 -44.78 10.48 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.8 0.3 . . . . 0.0 110.798 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.628 ' HB2' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -128.86 56.46 23.58 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.96 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.716 2.277 . . . . 0.0 112.623 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 120.483 0.183 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -34.6 66.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.367 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -83.99 -35.47 23.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.009 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.9 t -56.06 -51.39 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -59.24 -42.39 90.97 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.248 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.34 -39.19 93.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.238 . . . . 0.0 110.736 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 75' ' ' VAL . . . -66.15 -39.84 90.13 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.693 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.22 -37.09 77.86 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.63 -33.81 76.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.909 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.5 69.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.318 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -72.51 -14.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.727 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -60.99 -57.85 10.9 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.201 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -86.25 -2.03 58.01 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -129.72 73.67 81.32 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.45 -36.35 35.02 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.709 2.273 . . . . 0.0 112.61 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.585 ' HE2' HD12 ' A' ' 115' ' ' LEU . 9.7 m-85 -99.97 68.39 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.941 0.4 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -106.89 139.38 41.38 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.513 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 54' ' ' VAL . 95.0 mt-30 -136.05 112.54 9.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.33 114.98 26.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.624 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.82 175.75 5.52 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.272 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.49 173.59 6.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.481 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 p -70.12 72.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.274 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.3 t90 55.19 64.31 1.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.353 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -85.34 163.84 43.3 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.578 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.47 -34.18 86.53 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.593 2.195 . . . . 0.0 112.484 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.59 -32.48 13.41 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.393 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.92 -42.99 89.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.851 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.44 -36.39 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.226 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.14 -56.6 18.89 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.416 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . . . -62.33 -30.96 71.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.421 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.583 ' HA ' ' CE2' ' A' ' 43' ' ' TRP . 3.1 m-80 -69.0 -38.25 79.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -65.54 -37.63 87.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.196 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 mm -57.88 -59.7 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.79 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.583 ' CE2' ' HA ' ' A' ' 40' ' ' ASN . 1.6 p90 -72.96 -16.11 61.54 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 20.9 t-20 -73.55 -43.17 60.51 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.587 0.232 . . . . 0.0 111.06 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -81.31 -31.23 33.64 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.447 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -80.48 -6.92 58.88 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 54.29 48.54 20.54 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.168 0.508 . . . . 0.0 110.794 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 52' ' ' VAL . 29.0 m -116.63 28.1 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.425 ' HG3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mt-30 -83.03 -16.23 47.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.701 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -83.63 -38.99 20.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.647 0.261 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 48' ' ' VAL . 14.0 p -110.26 162.34 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.453 ' N ' HG22 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -118.98 111.41 18.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.185 0.517 . . . . 0.0 109.958 178.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' GLN . 11.3 p -114.17 141.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.229 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -135.64 126.7 27.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.887 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.78 141.67 28.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.575 ' HB ' HD21 ' A' ' 60' ' ' LEU . 1.3 pt -89.93 52.64 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 24.31 29.17 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.014 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -126.67 28.76 5.83 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 110.881 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.575 HD21 ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -147.82 129.25 7.25 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.85 -177.05 2.02 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.721 2.281 . . . . 0.0 111.955 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -58.4 -36.69 73.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.638 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -62.85 -52.4 63.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.166 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 26.2 mm-40 -58.68 -36.18 73.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -56.36 -38.18 71.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.061 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.43 -55.49 15.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.041 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -41.29 86.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.849 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.9 t-105 -65.78 -38.7 89.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -58.73 -43.33 90.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.132 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.5 -46.29 86.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.913 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -56.92 -49.1 76.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.17 -40.99 97.88 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -61.62 -30.75 70.9 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 111.143 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 -29.68 36.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.6 t -81.02 -43.0 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.145 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.11 -44.83 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.62 0.86 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.575 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.5 100.54 8.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.773 0.32 . . . . 0.0 110.472 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -91.34 29.43 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.54 176.24 11.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.317 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.86 153.05 81.31 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.28 -178.07 21.99 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.705 -0.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.3 p -131.64 131.43 43.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.416 ' HB ' ' CA ' ' A' ' 92' ' ' GLY . 21.3 mt -114.02 111.43 35.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.787 0.327 . . . . 0.0 111.253 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.72 129.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.631 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.6 t -123.41 119.08 56.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.66 41.73 3.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.61 50.44 64.26 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.746 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -175.12 135.06 0.34 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 93' ' ' THR . 15.2 t80 -60.46 102.82 0.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.54 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -106.7 -30.21 9.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.351 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' CA ' ' HB ' ' A' ' 84' ' ' ILE . . . -122.46 146.15 16.66 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.981 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -120.95 173.05 7.48 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.812 0.339 . . . . 0.0 111.352 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -36.66 80.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.7 m -84.82 -29.63 25.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.548 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.23 -35.12 48.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.559 0.218 . . . . 0.0 111.513 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 39' ' ' ALA . 27.7 mt -67.52 -57.61 6.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.352 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -32.85 73.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.424 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -69.8 -40.96 75.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -78.65 -35.76 44.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.179 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.04 -43.88 87.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.56 70.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -72.31 -28.8 63.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.357 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.55 26.48 10.79 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.548 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.7 p -111.53 18.29 19.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -67.01 -50.72 61.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.568 0.223 . . . . 0.0 110.483 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.32 -38.08 81.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -43.98 98.01 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.607 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.2 -41.98 93.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.748 HD23 HD23 ' A' ' 116' ' ' LEU . 4.6 tp -65.88 -27.38 68.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.346 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.8 m -79.02 -34.9 43.54 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.605 0.24 . . . . 0.0 110.443 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -41.05 87.01 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 pt -64.9 -25.19 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.53 8.01 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.717 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.585 HD12 ' HE2' ' A' ' 25' ' ' TYR . 5.1 tt -101.77 -54.15 2.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.84 0.32 . . . . 0.0 110.77 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.748 HD23 HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -88.55 109.69 31.17 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.685 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.615 2.21 . . . . 0.0 112.478 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.68 -23.61 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.716 0.293 . . . . 0.0 110.816 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -120.7 -36.73 3.12 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 t -61.36 -55.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.876 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -70.23 -39.77 74.86 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.811 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -38.49 77.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.24 -49.32 72.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.12 -37.66 88.16 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.91 -37.47 86.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -46.14 83.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.471 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.3 pt -72.24 -16.6 18.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.597 0.237 . . . . 0.0 111.53 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -63.74 1.18 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.176 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.1 m -88.61 -16.97 31.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.484 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -124.55 70.5 56.12 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.583 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.24 -22.38 46.64 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.733 2.289 . . . . 0.0 112.614 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.406 ' HB3' HG13 ' A' ' 52' ' ' VAL . 8.2 m-85 -94.2 66.51 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.426 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -110.77 127.84 55.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.075 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.459 ' HG2' HG23 ' A' ' 84' ' ' ILE . 96.0 mt-30 -112.41 113.74 26.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.687 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -90.34 126.81 35.99 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.939 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -119.17 157.91 27.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.304 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -76.86 175.85 9.1 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.429 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -97.8 112.86 24.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.957 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 57.5 39.87 27.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.696 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 1.3 m -109.91 148.45 38.28 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.19 -30.86 52.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.877 2.385 . . . . 0.0 112.296 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -45.91 67.0 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 t -57.54 -52.62 64.65 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -62.41 -36.2 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.221 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -66.38 -55.46 15.77 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.83 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.22 68.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.746 0.307 . . . . 0.0 111.302 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.496 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 1.2 m-80 -72.34 -38.19 68.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 p -64.48 -37.61 88.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 46' ' ' LEU . 38.3 mm -58.54 -61.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.459 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.496 ' CD1' ' HA ' ' A' ' 40' ' ' ASN . 12.3 p-90 -65.92 -39.17 90.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.35 -38.36 77.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.697 0.284 . . . . 0.0 111.243 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -83.86 -32.02 25.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 42' ' ' ILE . 21.0 mt -81.07 -8.03 59.68 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 51.64 47.3 25.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 110.944 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.52 33.25 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 43' ' ' TRP . 3.4 tt0 -74.17 -15.87 61.01 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.594 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.12 -30.59 23.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.666 0.27 . . . . 0.0 110.706 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -82.27 -31.15 30.24 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.345 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.48 ' CG2' HD11 ' A' ' 115' ' ' LEU . 48.0 t -133.68 149.75 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.764 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.46 111.62 19.53 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.383 0.611 . . . . 0.0 110.715 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.466 HG11 ' NE1' ' A' ' 43' ' ' TRP . 10.8 p -100.64 141.46 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.167 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.45 135.83 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.914 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.77 177.19 6.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.582 HG23 ' H ' ' A' ' 59' ' ' SER . 2.1 tt -63.93 -24.6 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.742 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.28 5.64 55.85 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.535 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.582 ' H ' HG23 ' A' ' 57' ' ' ILE . 4.6 m 59.65 31.82 21.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.149 0.475 . . . . 0.0 110.6 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -54.94 132.02 67.3 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.704 -179.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.91 175.89 1.64 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.7 2.267 . . . . 0.0 111.877 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -51.91 -28.09 15.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.571 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.73 -55.4 5.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.465 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -69.25 -33.05 72.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.439 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.47 ' HA ' HD22 ' A' ' 60' ' ' LEU . 21.4 tt0 -53.49 -43.81 68.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.925 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -38.36 86.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.783 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -66.03 -37.24 85.38 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -66.9 -48.05 69.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.54 0.21 . . . . 0.0 111.096 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -56.87 -51.35 69.38 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.517 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -65.92 -45.44 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.573 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.55 -54.59 43.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.492 0.187 . . . . 0.0 111.413 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.81 -38.76 82.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.725 0.298 . . . . 0.0 110.949 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.402 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 25.6 tt0 -69.13 -27.62 65.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -31.76 40.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.251 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 71' ' ' ALA . 23.9 t -84.16 -48.59 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.333 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.36 -41.19 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 103.92 40.4 2.32 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -123.78 97.37 5.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.744 0.307 . . . . 0.0 110.552 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -86.52 49.99 1.91 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.582 ' C ' HD13 ' A' ' 81' ' ' LEU . 4.6 t-20 -170.72 170.66 6.52 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.144 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -140.61 161.71 53.09 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 179.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.85 169.87 72.25 Favored 'Cis proline' 0 C--N 1.355 0.881 0 C-N-CA 123.497 -1.46 . . . . 0.0 113.017 0.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.658 HG22 ' HE2' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -147.65 127.99 13.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -179.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.459 HG23 ' HG2' ' A' ' 27' ' ' GLN . 29.7 mm -102.01 111.6 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.89 117.14 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.981 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.429 HG12 ' ND2' ' A' ' 87' ' ' ASN . 24.1 t -119.68 124.17 72.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.429 ' ND2' HG12 ' A' ' 86' ' ' VAL . 70.2 m-80 62.12 38.99 13.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.018 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.0 91.72 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.882 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.21 136.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.963 0.411 . . . . 0.0 110.637 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.658 ' HE2' HG22 ' A' ' 83' ' ' THR . 61.1 t80 -60.54 107.99 0.76 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.065 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -115.53 -24.82 8.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.706 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.11 140.0 12.74 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.247 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.626 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -107.29 173.36 6.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -68.08 -31.14 70.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.479 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -28.16 18.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.13 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -55.1 -37.95 67.49 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.213 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.59 -44.18 87.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.355 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.95 -34.59 59.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.4 mmt85 -72.82 -37.69 67.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.346 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.75 -45.94 56.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.11 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.23 -39.28 92.29 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.65 0.262 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.09 -50.56 65.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -69.15 -27.4 65.51 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.614 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 24.5 12.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.599 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.2 p -108.46 20.04 19.07 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.594 0.197 . . . . 0.0 111.454 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -50.72 11.3 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.658 0.266 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.44 -42.39 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.37 -51.45 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.749 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -39.58 94.72 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.94 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.49 -38.07 76.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.97 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 14.0 m -78.26 -34.48 49.03 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.628 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -64.12 -44.19 92.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.355 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.6 pt -64.58 -26.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.78 22.3 8.12 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.907 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.48 HD11 ' CG2' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -81.71 -44.47 17.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.877 0.37 . . . . 0.0 110.52 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -52.8 1.41 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.441 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 111' ' ' THR . 50.9 Cg_exo . . . . . 0 C--O 1.248 1.013 0 C-N-CA 122.387 2.058 . . . . 0.0 112.367 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.609 0.242 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.33 -27.5 55.98 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.913 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 -39.53 5.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.482 0.182 . . . . 0.0 111.427 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.78 -52.54 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.11 -40.55 96.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 110.965 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.34 -35.03 77.82 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.542 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.92 -46.56 88.82 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.4 mm-40 -61.17 -36.41 79.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.803 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.86 -33.62 74.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.902 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -49.12 61.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.6 pt -71.68 -14.43 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.406 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -63.62 1.21 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.65 0.262 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -84.41 -19.01 34.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -120.29 62.21 8.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.742 0.306 . . . . 0.0 110.829 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.97 -15.38 43.42 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.702 2.268 . . . . 0.0 113.019 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -93.88 74.27 4.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.271 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.49 121.2 40.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.003 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -112.77 121.96 46.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.997 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.6 mt -98.92 117.96 34.62 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.669 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 94.1 p -119.52 154.44 33.84 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.555 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.74 164.25 12.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.478 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.91 39.41 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.84 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -161.31 -44.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.428 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.83 147.47 88.88 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-O 120.569 0.223 . . . . 0.0 111.064 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.93 -17.7 36.63 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.19 -38.11 67.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.329 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 29' ' ' SER . 24.1 p -62.61 -39.18 92.97 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.83 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.3 -37.31 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -64.0 -49.38 72.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.749 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.34 88.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.533 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -75.35 -31.39 60.53 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.621 0.248 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -59.82 -45.97 90.7 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 46' ' ' LEU . 32.2 mm -65.74 -41.81 91.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.92 -34.69 78.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.098 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -67.17 -34.16 76.94 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -34.68 26.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 42' ' ' ILE . 19.1 mt -80.63 -7.71 59.37 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 53.53 45.82 27.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.671 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.35 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -93.62 17.63 11.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.394 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.66 -44.9 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.679 0.276 . . . . 0.0 110.861 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -64.7 -26.38 68.35 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.395 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.05 157.76 10.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.683 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.4 111.24 20.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.288 0.566 . . . . 0.0 110.477 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 t -96.06 131.55 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.99 115.61 15.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.047 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -81.48 151.06 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.485 HG13 HD21 ' A' ' 81' ' ' LEU . 34.5 mm -98.35 72.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.88 26.01 2.08 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.143 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -130.49 32.69 4.39 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -142.66 126.92 9.78 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.53 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 27.3 Cg_exo -62.76 -171.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.061 2.507 . . . . 0.0 112.507 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.11 9.44 3.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.44 -41.65 3.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.568 0.223 . . . . 0.0 110.951 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 32.1 tp10 -68.48 -37.95 80.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.059 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.606 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.9 tt0 -63.79 -35.19 79.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.92 -57.38 12.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.127 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.74 87.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.087 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -46.27 89.16 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -44.94 64.72 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.226 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.7 mt -66.69 -47.32 83.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -61.63 -39.2 90.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.437 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.505 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 10.9 m-85 -59.16 -53.5 57.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.19 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.65 -25.87 63.18 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.96 -30.85 56.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.972 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 71' ' ' ALA . 37.8 t -84.34 -44.29 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.253 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.6 m -120.52 -44.03 2.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.54 23.25 21.94 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.954 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.44 75.8 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HA ' HG21 ' A' ' 83' ' ' THR . 5.7 mtt180 -119.43 29.82 7.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.835 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.36 111.51 8.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.283 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.485 HD21 HG13 ' A' ' 57' ' ' ILE . 8.5 mt -45.9 131.92 6.94 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.38 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.14 150.48 85.66 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 124.034 -1.236 . . . . 0.0 112.747 0.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.6 HG21 ' HA ' ' A' ' 79' ' ' ARG . 26.6 m -142.98 128.63 19.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.402 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.6 mm -112.07 113.02 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.85 116.45 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.99 129.59 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.74 34.09 12.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.762 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.44 46.6 92.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.681 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -175.9 137.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.743 ' HZ ' HG23 ' A' ' 93' ' ' THR . 91.2 t80 -61.6 102.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -116.46 -25.72 7.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.712 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.12 138.61 14.57 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.933 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.743 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -123.35 -173.63 2.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.689 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.445 ' OE1' HG22 ' A' ' 93' ' ' THR . 1.8 mp0 -74.13 -37.83 63.97 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -95.24 -27.29 15.58 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.703 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.19 -39.04 66.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 93' ' ' THR . 17.1 mt -66.77 -47.23 72.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -62.28 -38.51 89.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.066 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -71.37 -38.92 71.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.276 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.425 ' HB3' HD12 ' A' ' 106' ' ' LEU . 5.1 m-85 -74.28 -35.36 63.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.008 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -50.35 20.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.738 0.304 . . . . 0.0 111.05 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -36.84 71.66 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.47 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -72.41 -27.4 62.33 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.17 25.74 20.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.52 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 p -109.07 -5.33 16.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -55.08 -42.15 72.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.539 0.209 . . . . 0.0 111.273 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.61 -51.0 70.31 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -61.56 -44.01 97.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 -36.17 76.03 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.727 HD23 HD12 ' A' ' 116' ' ' LEU . 1.2 tp -60.89 -40.51 93.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.805 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.7 m -74.6 -30.62 61.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.42 -24.62 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.736 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.06 7.19 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.769 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.89 -51.44 5.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.795 0.331 . . . . 0.0 110.743 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.727 HD12 HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -92.15 109.4 37.4 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--O 1.251 1.141 0 C-N-CA 122.546 2.164 . . . . 0.0 112.873 -179.854 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.415 0.15 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.59 -32.35 40.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -96.51 -35.45 11.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.19 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.1 t -57.8 -51.76 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.526 0.203 . . . . 0.0 111.121 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.17 -36.76 78.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -65.51 -33.45 75.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.041 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.62 58.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.74 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 -34.06 76.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -70.03 -33.38 71.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -46.48 71.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.21 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 pt -71.99 -15.13 17.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.536 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -64.99 0.76 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.676 0.274 . . . . 0.0 111.026 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -24.21 26.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -119.72 68.37 11.61 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.808 0.337 . . . . 0.0 110.861 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 58.7 Cg_endo -70.91 -19.63 30.43 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 112.945 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HB3' HG13 ' A' ' 52' ' ' VAL . 37.7 m-85 -92.94 70.51 4.64 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.73 53.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.292 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.579 ' OE1' HG23 ' A' ' 84' ' ' ILE . 2.8 mp0 -128.01 107.68 10.03 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.48 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.13 124.07 28.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.958 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 m -129.5 172.32 11.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.954 0.406 . . . . 0.0 111.428 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -103.35 -175.32 2.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.274 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.83 98.31 11.52 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.43 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.6 44.77 26.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.659 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -78.92 159.33 73.76 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.011 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.66 -36.3 14.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.642 2.228 . . . . 0.0 112.597 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.33 -36.51 13.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.24 -34.18 76.92 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.44 -33.38 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.582 0.229 . . . . 0.0 111.233 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -63.23 -48.89 76.33 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.998 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.27 76.8 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.134 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -75.35 -31.47 60.56 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -61.44 -49.19 77.85 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mm -69.05 -37.38 76.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.046 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.08 75.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.081 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.47 -30.05 57.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.271 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -81.57 -33.37 31.67 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.965 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.5 HD22 HD11 ' A' ' 116' ' ' LEU . 19.3 mt -80.7 -7.71 59.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 50.64 50.11 19.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.012 0.434 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -112.48 33.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.435 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.1 -25.29 43.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.477 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -37.07 21.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 110.993 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -84.77 -15.0 46.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.491 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 53' ' ' PHE . 23.0 t -126.03 159.36 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.466 0.174 . . . . 0.0 110.947 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.438 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -121.65 111.74 17.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.307 0.575 . . . . 0.0 110.476 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.64 133.74 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -124.21 127.49 47.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.912 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 142.19 29.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.981 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 60' ' ' LEU . 4.9 pt -136.35 72.28 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.32 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.9 28.02 7.2 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.154 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -141.2 42.55 1.79 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' CD1' ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -135.86 118.83 12.39 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 -176.97 2.11 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.676 2.251 . . . . 0.0 112.439 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -59.34 -34.4 72.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.281 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -59.19 -51.84 68.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.653 0.263 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.35 -44.33 65.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.833 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.2 -34.8 70.77 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.374 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.78 -49.43 76.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.616 0.246 . . . . 0.0 111.093 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -42.11 93.75 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.02 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -68.67 -32.01 71.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.07 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HG2' ' HD3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -56.95 -47.27 81.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.951 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mt -76.85 -44.79 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.165 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.05 -52.18 64.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.617 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -48.6 80.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.166 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.99 -23.87 65.69 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.492 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -30.98 39.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.123 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 71' ' ' ALA . 24.7 t -86.91 -48.07 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.477 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.38 -37.62 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.42 33.57 8.56 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.416 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.52 93.53 0.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HD3' ' HG2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -97.61 34.08 1.92 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.82 112.56 24.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -91.11 147.37 35.51 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 94' ' ' GLU . 10.7 Cg_exo -71.57 128.13 13.73 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.309 -0.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.93 131.25 48.42 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.579 HG23 ' OE1' ' A' ' 27' ' ' GLN . 3.5 mt -117.05 111.14 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -110.86 121.81 64.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.58 127.72 74.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 2.3 m120 60.95 39.17 16.94 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.99 49.97 72.73 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.819 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -172.65 134.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.722 ' HZ ' HG23 ' A' ' 93' ' ' THR . 30.9 t80 -67.55 106.82 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.901 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -117.55 -24.32 7.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.486 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 84' ' ' ILE . . . -112.95 139.66 15.83 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.084 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.722 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -121.01 -179.55 4.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.696 0.284 . . . . 0.0 110.714 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 9.4 pt-20 -71.36 -35.97 71.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.0 m -95.07 -25.38 16.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.18 -33.34 52.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.498 0.189 . . . . 0.0 111.236 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.68 -50.28 69.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.44 -34.64 78.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 -73.42 -42.63 61.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -67.17 -44.92 78.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.049 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.5 -48.07 82.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.07 85.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.272 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -73.25 -24.75 60.5 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.73 56.72 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.529 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.0 p -105.13 -18.11 14.25 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.44 -47.7 72.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.635 0.255 . . . . 0.0 111.002 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -45.18 82.91 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.06 -37.96 89.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -48.6 79.32 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.89 -40.57 80.59 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.174 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -33.61 73.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.734 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -49.54 65.18 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.203 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 pt -65.77 -24.91 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.799 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.14 24.21 8.62 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.738 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -82.5 -42.92 17.82 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.697 0.249 . . . . 0.0 110.581 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 46' ' ' LEU . 1.5 mp -117.5 143.14 31.59 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.244 0.821 0 C-N-CA 122.603 2.202 . . . . 0.0 112.309 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 120.43 0.157 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.3 -27.5 47.3 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.673 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.9 -38.53 5.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.157 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 t -61.78 -57.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 111.259 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -46.8 79.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.249 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -60.36 -34.12 73.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.31 96.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.642 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.62 -34.23 70.91 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -70.33 -36.56 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.8 tpp -69.26 -46.16 67.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.103 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pt -72.57 -14.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -63.71 1.13 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.658 0.265 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.05 -23.57 26.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.971 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -120.7 61.01 8.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.797 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.66 -16.64 42.48 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.766 2.31 . . . . 0.0 112.937 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -89.42 67.1 7.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.954 0.407 . . . . 0.0 110.448 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.66 137.73 45.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.199 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.532 ' CG ' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -143.42 104.98 4.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.412 HD13 ' CZ ' ' A' ' 72' ' ' PHE . 8.3 mp -78.79 125.65 29.66 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.4 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -148.03 -176.8 5.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.268 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.05 175.22 13.22 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.97 33.78 4.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.837 0.351 . . . . 0.0 111.251 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.09 -47.04 0.78 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.263 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.417 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -58.48 143.71 80.23 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.178 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.1 -39.39 13.66 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.644 2.23 . . . . 0.0 112.376 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.416 ' CB ' ' HD3' ' A' ' 82' ' ' PRO . 23.0 m-20 -71.08 -34.18 70.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.207 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.5 m -60.15 -40.54 90.23 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.818 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 33' ' ' CYS . 21.7 t -61.52 -36.93 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.746 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -71.59 -36.41 70.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.043 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.74 91.14 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.64 0.257 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -75.76 -29.5 58.85 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.577 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.8 p -61.16 -42.8 99.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.6 0.238 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.49 -52.62 39.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.245 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.495 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.4 m-90 -60.09 -35.57 75.49 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.218 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.55 -33.67 74.5 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.882 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -79.04 -31.26 44.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.862 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 116' ' ' LEU . 22.5 mt -80.79 -7.56 59.44 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 55.85 48.24 18.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.235 0.54 . . . . 0.0 110.508 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD1' ' A' ' 43' ' ' TRP . 27.5 m -129.74 39.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.461 ' OE1' HG21 ' A' ' 54' ' ' VAL . 3.9 mm100 -98.97 28.28 4.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.287 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -124.38 -49.43 1.8 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.7 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -68.29 -18.4 64.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.42 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 53' ' ' PHE . 15.4 t -106.08 159.48 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' N ' HG12 ' A' ' 52' ' ' VAL . 10.4 m-85 -116.69 111.11 19.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 110.083 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.461 HG21 ' OE1' ' A' ' 49' ' ' GLN . 21.2 t -98.71 136.34 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.474 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.68 111.7 24.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.987 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -92.73 126.18 37.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.415 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.769 HG23 HD11 ' A' ' 60' ' ' LEU . 29.9 mt -85.99 63.99 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.057 0.456 . . . . 0.0 110.434 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.17 23.4 6.5 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.973 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -155.57 36.1 0.37 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.703 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.769 HD11 HG23 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -159.13 98.4 1.63 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.819 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.44 174.82 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.107 2.538 . . . . 0.0 112.661 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.14 -32.06 4.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -48.86 73.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.624 0.25 . . . . 0.0 111.009 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -78.67 -38.64 38.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.91 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -58.7 -40.39 83.51 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.886 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -42.89 99.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.683 0.278 . . . . 0.0 110.921 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -64.17 -42.07 96.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.685 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.518 ' CE3' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -69.82 -34.21 73.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.193 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.15 -45.16 83.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 111.015 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.8 mt -74.72 -40.55 47.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.995 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.9 -54.49 44.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.233 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -58.13 -39.83 79.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.992 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -28.43 68.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -30.88 31.93 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.335 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 71' ' ' ALA . 22.0 t -85.01 -48.5 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.554 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.1 -40.99 2.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.63 42.55 1.69 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.949 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.5 101.81 5.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -94.82 37.66 1.14 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.768 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.635 ' C ' HD13 ' A' ' 81' ' ' LEU . 9.9 t30 -161.07 -175.84 5.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.303 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.67 ' H ' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -137.8 165.14 36.05 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.898 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 35' ' ' ASP . 13.3 Cg_exo -70.16 146.09 82.1 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.687 0.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.755 HG22 ' CE1' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -116.94 106.66 13.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.712 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.532 HG23 ' CG ' ' A' ' 27' ' ' GLN . 4.0 mp -102.3 111.05 30.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.761 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 90' ' ' PHE . 31.7 t -117.99 116.47 51.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 91' ' ' TRP . 13.5 p -115.66 134.96 57.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.7 t30 58.02 32.9 22.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.91 32.42 80.95 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.758 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -148.16 132.26 17.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.176 0.512 . . . . 0.0 110.372 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 83' ' ' THR . 3.1 t80 -66.99 100.68 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.381 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.449 ' HB2' HG12 ' A' ' 86' ' ' VAL . 2.0 t-105 -102.44 -31.86 10.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.244 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.55 142.04 17.33 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.113 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.706 HG22 ' CE2' ' A' ' 90' ' ' PHE . 14.7 p -127.44 -172.01 2.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.563 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.91 49.23 1.78 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.271 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.84 -43.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.929 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -52.64 -33.12 45.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.02 -56.67 19.03 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.457 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -60.48 -42.56 96.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -58.3 -40.0 80.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.414 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.08 -46.21 16.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.923 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.77 -42.04 96.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.72 93.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -70.36 -27.08 64.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.279 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.26 24.22 24.94 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.497 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.1 p -113.41 19.09 17.24 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -44.45 81.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -54.91 -44.49 74.24 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.702 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.08 -38.68 83.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.723 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.66 -41.63 77.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.704 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.54 ' HA ' HD11 ' A' ' 113' ' ' ILE . 0.3 OUTLIER -78.54 -22.0 47.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.49 179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 m -77.94 -26.67 49.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.261 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -23.81 60.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -102.89 -23.66 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.13 23.93 9.36 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.166 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -38.5 11.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.949 0.375 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.444 HD11 HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -127.42 142.45 44.03 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.836 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.379 2.052 . . . . 0.0 112.636 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.58 -30.41 36.91 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 110.684 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -100.04 -31.16 11.58 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 t -61.86 -52.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.029 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 t -62.13 -37.19 84.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.853 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -36.02 77.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.15 89.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.686 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -40.69 97.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.2 -30.9 70.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.719 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -68.18 -44.26 76.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.855 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -71.88 -14.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.517 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -63.58 1.23 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.653 0.263 . . . . 0.0 110.866 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -83.97 -24.98 30.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.408 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . 14.3 m-70 -118.58 64.29 5.91 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.782 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 57.2 Cg_endo -70.82 -21.1 29.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.582 2.188 . . . . 0.0 112.793 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.422 ' HB3' HG13 ' A' ' 52' ' ' VAL . 25.9 m-85 -92.1 69.74 5.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -110.89 130.76 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -118.91 101.63 8.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.414 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.43 HD11 ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -76.83 126.61 31.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.217 -179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.75 168.19 28.18 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.438 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . . . -164.28 179.08 7.06 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.3 p -97.12 29.13 3.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.284 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -39.72 6.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.343 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.64 148.51 34.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 111.329 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.33 -39.45 7.31 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.711 2.274 . . . . 0.0 112.627 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 2.8 m-20 -59.42 -33.25 71.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.103 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.3 m -55.17 -43.1 73.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.623 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.83 -43.27 89.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.028 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -61.47 -51.68 67.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.069 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.53 -41.06 80.15 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.709 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -73.9 -29.87 62.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.231 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -60.06 -40.69 90.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.118 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.1 mm -70.02 -51.1 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.412 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -62.45 -33.35 74.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.967 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -68.26 -34.7 76.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.098 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -78.6 -32.92 47.81 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.2 mt -80.68 -7.74 59.42 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 53.49 48.91 20.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.573 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.7 m -119.1 40.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -97.02 30.2 2.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.986 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.46 -49.43 2.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -68.01 -22.86 64.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.258 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 25' ' ' TYR . 44.2 t -114.98 156.09 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.49 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -116.15 111.28 20.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.252 0.548 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.35 142.19 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.386 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -126.52 104.88 8.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.94 151.58 31.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 30' ' ' ALA . 23.5 mm -114.31 69.75 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.115 0.483 . . . . 0.0 111.066 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 -2.25 8.6 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.162 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -106.95 -34.44 7.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.016 0.408 . . . . 0.0 111.566 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 21.2 mt -64.72 122.58 79.75 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.171 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.2 Cg_exo -62.63 -172.0 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.017 2.478 . . . . 0.0 112.534 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -78.89 8.57 5.33 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.219 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -113.43 -42.61 3.45 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.604 0.24 . . . . 0.0 110.805 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.1 -36.24 72.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.275 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -57.24 -38.27 73.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.397 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -49.99 75.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.137 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -57.78 -36.28 71.95 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -37.51 79.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.828 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -66.31 -46.45 76.85 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.5 mm -67.88 -45.62 83.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.61 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.91 -53.54 57.27 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.36 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 2.9 m-85 -65.96 -28.98 69.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.651 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.512 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 5.3 mt-30 -56.92 -40.78 76.95 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 110.741 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -28.37 44.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.427 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.7 t -72.45 -48.16 48.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 110.686 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.8 m -144.45 -41.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 123.81 63.21 0.19 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.967 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.638 ' HA ' HG21 ' A' ' 83' ' ' THR . 26.1 m -96.99 44.81 1.05 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.671 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -73.49 -16.58 61.29 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.866 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -140.1 121.04 14.56 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.0 mt -82.04 155.51 69.99 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.669 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 35' ' ' ASP . 2.6 Cg_exo -75.85 174.74 51.3 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 124.074 -1.219 . . . . 0.0 112.784 0.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 78' ' ' SER . 0.9 OUTLIER -149.19 113.83 5.33 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mt -102.34 121.96 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.479 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.88 121.53 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.89 121.29 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.414 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 3.8 t-20 64.24 40.16 6.91 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.129 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.13 49.65 75.86 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.952 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.41 136.12 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.39 . . . . 0.0 110.541 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.738 ' HE2' HG23 ' A' ' 93' ' ' THR . 1.1 t80 -61.4 104.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.307 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.86 -27.68 12.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.535 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.84 141.5 14.48 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.003 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.738 HG23 ' HE2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -127.37 172.29 10.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.734 0.302 . . . . 0.0 111.282 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.94 -26.02 62.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.486 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -29.13 14.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -56.94 -34.05 67.61 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -56.44 19.45 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 110.805 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.95 -34.08 72.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -41.03 63.62 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.324 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.73 -43.45 59.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -50.57 73.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.8 0.333 . . . . 0.0 111.029 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.69 84.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -27.18 60.05 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.769 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.41 27.03 26.26 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.175 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.0 p -107.95 -6.78 16.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 -50.05 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.612 0.244 . . . . 0.0 110.755 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.09 -41.59 88.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.0 -45.79 90.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.667 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -56.15 -40.58 74.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.058 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.24 -46.33 86.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 m -78.59 -31.19 47.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.998 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -59.28 -38.89 81.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.7 pt -79.45 -24.5 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.19 25.13 8.03 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.948 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 -48.66 5.73 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.764 0.282 . . . . 0.0 110.722 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.09 113.07 66.11 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.544 2.163 . . . . 0.0 112.829 -179.702 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.572 0.225 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 t 72.9 -61.54 0.5 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.419 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.01 -36.2 17.26 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.69 0.281 . . . . 0.0 111.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -101.14 -33.35 10.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.205 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.9 -47.43 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.042 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.4 m -60.58 -45.46 93.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.85 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -62.59 -35.77 80.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.01 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.08 99.22 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.061 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.68 -41.5 95.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.08 -29.12 68.8 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.033 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.1 tpt -69.61 -46.58 65.95 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.139 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.4 pt -73.02 -15.0 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -61.4 -65.53 0.68 Allowed 'General case' 0 N--CA 1.458 -0.049 0 CA-C-O 120.71 0.291 . . . . 0.0 111.093 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.66 -22.81 25.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.227 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.63 68.12 14.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.764 0.316 . . . . 0.0 110.86 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.89 -30.96 20.83 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.628 2.218 . . . . 0.0 112.527 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.483 ' HB3' HG23 ' A' ' 52' ' ' VAL . 69.6 m-85 -90.84 68.0 6.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.59 139.79 42.88 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.379 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.496 HE21 HG23 ' A' ' 84' ' ' ILE . 20.0 mp0 -124.38 115.42 20.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.652 HD12 HD13 ' A' ' 57' ' ' ILE . 3.2 mm? -86.48 96.24 9.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -111.81 174.77 5.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.129 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -95.79 -176.39 3.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -94.33 -38.72 10.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -151.72 72.37 1.02 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -125.51 148.15 60.5 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.62 -24.38 36.64 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.869 2.38 . . . . 0.0 112.888 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 78.5 m-20 -88.73 -40.87 12.92 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.612 0.244 . . . . 0.0 110.669 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.9 t -58.51 -43.89 89.26 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.783 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.1 m -55.38 -32.36 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.5 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -70.16 -56.6 6.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.938 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.49 77.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.568 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -75.43 -31.81 60.48 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.893 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.6 t -64.76 -49.17 71.83 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.6 mm -65.13 -41.15 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.528 ' NE1' HG11 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -67.53 -38.23 83.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.029 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -72.9 -30.19 63.74 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.346 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -32.55 34.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.944 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.3 mt -81.53 -8.09 59.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 t30 53.16 46.01 27.47 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.169 0.509 . . . . 0.0 110.696 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 52' ' ' VAL . 11.2 m -123.98 43.45 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.731 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.68 18.42 10.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.647 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.32 -47.43 3.1 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.85 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -68.25 -23.65 64.81 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.336 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 48' ' ' VAL . 14.0 p -116.34 158.72 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' N ' HG22 ' A' ' 52' ' ' VAL . 38.9 m-85 -120.37 111.23 17.49 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.264 0.554 . . . . 0.0 110.372 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.37 132.4 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.96 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -126.71 131.69 51.31 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.995 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.69 142.74 27.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.671 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.684 ' CB ' HD21 ' A' ' 60' ' ' LEU . 10.8 pt -131.95 78.94 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.137 0.494 . . . . 0.0 111.394 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.78 -33.87 0.96 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.402 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.8 m -62.43 -37.17 84.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.073 0.436 . . . . 0.0 111.418 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.684 HD21 ' CB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -57.86 119.16 31.56 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.93 -174.73 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.133 2.555 . . . . 0.0 112.745 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -31.96 71.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.16 -48.51 78.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.553 0.216 . . . . 0.0 110.996 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.21 -33.95 65.65 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.217 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -57.07 -46.05 82.8 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.958 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -48.63 77.05 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.945 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.73 -48.6 79.13 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.472 ' HE1' HD11 ' A' ' 28' ' ' LEU . 1.2 t-105 -62.46 -39.28 92.9 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.888 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -58.74 -52.04 67.41 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.012 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.9 -40.53 89.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.07 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -59.1 -53.17 61.4 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.09 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.447 ' HE2' HG21 ' A' ' 83' ' ' THR . 0.1 OUTLIER -60.56 -36.17 77.83 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.109 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.47 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 1.9 mt-30 -61.19 -33.06 72.84 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.886 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -78.96 -28.85 43.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.196 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.9 t -76.61 -46.38 31.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.046 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.15 -44.65 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 113.13 49.12 0.58 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.441 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -130.37 103.45 6.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.794 0.331 . . . . 0.0 110.573 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 69' ' ' ARG . 8.7 ttp180 -94.63 38.62 1.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -153.08 148.43 27.0 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.982 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mt -117.11 152.65 49.15 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.7 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 35' ' ' ASP . 84.3 Cg_endo -80.01 179.1 30.51 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.652 -1.395 . . . . 0.0 113.297 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.787 HG23 ' CE2' ' A' ' 90' ' ' PHE . 97.4 m -150.13 145.22 26.19 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.496 HG23 HE21 ' A' ' 27' ' ' GLN . 4.9 mp -117.24 111.29 34.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -110.41 116.65 52.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.458 HG12 ' OD1' ' A' ' 87' ' ' ASN . 6.5 t -113.15 142.75 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.951 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.458 ' OD1' HG12 ' A' ' 86' ' ' VAL . 2.0 p-10 42.69 41.21 2.33 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.578 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.68 43.01 92.96 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.941 -0.572 . . . . 0.0 114.176 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 138.63 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 111.087 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.787 ' CE2' HG23 ' A' ' 83' ' ' THR . 6.9 t80 -52.51 111.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.0 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.83 -22.08 11.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.775 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.16 148.31 19.11 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.157 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -119.37 175.79 5.65 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 110.749 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.446 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 3.0 tm-20 -61.86 -25.88 67.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.558 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.8 m -82.56 -36.37 26.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.497 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.418 ' HG2' ' CD2' ' A' ' 100' ' ' PHE . 4.9 tt0 -58.01 -32.36 67.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.501 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.58 -48.73 73.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.689 0.28 . . . . 0.0 110.724 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -74.27 -32.61 62.99 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.182 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.33 -38.66 85.25 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.345 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CD2' ' HG2' ' A' ' 96' ' ' GLN . 5.6 m-85 -78.31 -44.05 26.3 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -58.5 -40.69 83.53 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.87 93.26 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.062 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -75.38 -28.96 59.69 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.37 23.15 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.4 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.6 p -122.96 19.63 10.06 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.93 -43.37 71.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.561 0.219 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.79 -51.19 69.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -40.03 86.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.78 -40.38 96.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.772 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HB3' HD13 ' A' ' 116' ' ' LEU . 9.3 mt -66.34 -29.77 70.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.418 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 m -78.52 -30.26 47.0 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -59.56 -44.14 93.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.277 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 pt -67.01 -24.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.83 26.07 8.72 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.673 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 116' ' ' LEU . 5.8 tp -85.26 -46.15 11.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.843 0.321 . . . . 0.0 110.74 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.616 HD12 ' HB3' ' A' ' 115' ' ' LEU . 6.5 mp -108.48 145.54 31.77 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.749 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 C--O 1.251 1.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.567 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 tpt . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.0 m -56.31 -30.29 62.35 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.639 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.33 -35.87 29.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.211 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.7 -35.71 16.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.114 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -66.61 -49.03 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -65.64 -43.12 90.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.208 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -60.43 -37.35 80.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.566 0.222 . . . . 0.0 110.935 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.45 99.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.19 -40.31 77.14 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.82 -36.13 83.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.047 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.6 mmm -68.26 -45.64 72.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.308 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.7 pt -71.79 -14.58 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.677 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -60.92 -59.89 4.65 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.155 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -84.67 -10.91 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -124.03 72.95 55.72 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.8 -26.79 18.73 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.62 2.213 . . . . 0.0 112.792 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -93.57 70.73 4.24 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 132.98 53.09 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.152 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.462 ' HB3' HG13 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -126.94 108.16 10.72 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.603 179.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.96 136.09 33.25 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.214 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -132.47 172.8 12.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.596 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -95.92 177.9 5.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.525 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.8 m -77.15 83.87 3.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.997 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.34 45.97 16.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.402 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -70.08 155.19 93.87 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.126 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.75 -32.49 29.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.843 2.362 . . . . 0.0 112.582 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.49 -33.3 17.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.689 0.281 . . . . 0.0 111.105 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 33' ' ' CYS . 31.2 m -69.43 -41.72 75.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.72 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -55.52 -32.69 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.592 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -59.16 -50.39 74.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 110.86 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.499 ' HB2' HD13 ' A' ' 97' ' ' LEU . . . -59.62 -35.87 75.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.529 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 -32.01 61.59 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.669 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -44.69 93.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.39 -48.93 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.327 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -65.34 -30.64 71.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.401 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -81.38 -32.25 32.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.974 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.0 mt -80.73 -7.73 59.45 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 52.18 43.95 30.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.875 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.47 31.6 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -102.92 28.15 6.45 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -112.71 -41.77 3.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -67.09 -24.45 65.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.281 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 53' ' ' PHE . 17.9 t -100.59 159.23 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.656 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.412 ' N ' HG12 ' A' ' 52' ' ' VAL . 2.3 t80 -110.89 111.14 22.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.386 0.612 . . . . 0.0 110.09 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 27' ' ' GLN . 14.8 t -110.65 138.88 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.111 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 138.94 54.32 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.157 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.67 129.94 47.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.764 HG23 HD21 ' A' ' 60' ' ' LEU . 52.3 mt -88.99 69.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.128 0.49 . . . . 0.0 110.287 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.34 -40.95 0.34 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.993 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.7 p -57.29 -33.73 67.96 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.418 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.764 HD21 HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -80.36 124.11 82.62 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.309 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.02 -176.24 2.54 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -36.58 75.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.8 -49.46 72.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.711 0.291 . . . . 0.0 111.009 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.57 -37.69 83.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.83 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -56.81 -31.46 64.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -52.33 65.91 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 111.081 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.493 ' HA ' HD12 ' A' ' 70' ' ' ILE . 4.3 mptt -67.16 -30.05 69.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.617 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.36 -54.37 47.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -57.92 -36.85 73.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.151 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 67' ' ' LYS . 24.9 mt -69.52 -46.61 75.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.892 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.586 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -62.68 -49.66 74.22 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.142 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -45.66 80.8 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.028 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -26.45 68.55 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.22 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -31.3 35.56 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.143 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 71' ' ' ALA . 21.8 t -83.67 -45.05 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.413 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.49 -41.28 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.56 4.29 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.441 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -120.19 107.77 13.41 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.669 0.271 . . . . 0.0 110.771 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -94.04 43.36 1.11 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.553 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 83' ' ' THR . 6.7 t-20 -147.3 158.27 43.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.162 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -138.65 153.73 72.57 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.45 167.58 79.67 Favored 'Cis proline' 0 C--N 1.353 0.8 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.921 0.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 80' ' ' ASN . 2.1 p -136.56 132.74 35.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.093 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.407 HG23 ' HG3' ' A' ' 27' ' ' GLN . 18.2 mt -110.92 114.57 47.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.17 117.1 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.695 HG12 ' HB2' ' A' ' 91' ' ' TRP . 14.4 p -114.89 128.01 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 m120 59.36 40.58 20.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.72 80.52 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.914 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -171.84 134.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 110.776 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.41 ' CE1' HG22 ' A' ' 83' ' ' THR . 73.9 t80 -68.91 106.59 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.941 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.695 ' HB2' HG12 ' A' ' 86' ' ' VAL . 1.6 m95 -124.12 0.46 8.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.34 6.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.827 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 96' ' ' GLN . 12.2 t -122.82 179.12 4.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.902 0.382 . . . . 0.0 111.297 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -41.91 96.11 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.575 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -67.51 -28.7 68.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -56.98 -34.84 68.49 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 111.246 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 39' ' ' ALA . 9.3 mt -70.99 -38.68 72.7 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.183 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -79.33 -48.48 14.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.592 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -58.33 -50.25 74.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 96' ' ' GLN . 10.8 m-85 -62.22 -39.19 91.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.392 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.66 -45.97 90.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.796 0.332 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.37 94.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.044 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -75.48 -29.49 59.59 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.02 13.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.503 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -117.21 16.99 14.87 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -49.92 47.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.464 0.173 . . . . 0.0 110.72 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.0 -41.6 71.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.85 -43.64 87.84 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.718 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -54.78 -46.95 74.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.71 0.29 . . . . 0.0 110.737 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.56 -40.17 95.09 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 116' ' ' LEU . 50.8 m -70.77 -35.27 72.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.634 0.254 . . . . 0.0 110.95 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -52.11 66.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.333 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.48 HD11 HD12 ' A' ' 115' ' ' LEU . 5.3 pt -62.21 -25.11 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.97 20.19 7.31 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.929 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.48 HD12 HD11 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -77.91 -49.06 14.92 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.843 0.322 . . . . 0.0 110.461 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 111' ' ' THR . 3.4 mt -110.15 126.61 28.6 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.839 2.359 . . . . 0.0 112.311 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.1 p -52.95 -35.13 58.41 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.352 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.51 47.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.449 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -83.86 -39.75 19.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.836 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.49 -47.72 87.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.938 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.522 HG22 ' OE2' ' A' ' 18' ' ' GLU . 19.3 m -61.19 -42.2 98.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -59.82 -39.43 85.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.751 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.74 97.32 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.973 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.07 -41.92 97.16 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.99 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' OE2' HG22 ' A' ' 14' ' ' THR . 28.7 mt-10 -61.79 -36.56 81.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.779 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.41 -49.98 67.2 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' HB ' ' HA2' ' A' ' 88' ' ' GLY . 35.0 pt -71.4 -15.27 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.48 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -63.98 1.09 Allowed 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.693 0.283 . . . . 0.0 111.099 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.8 t -85.55 -23.77 27.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.989 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -118.46 66.42 6.68 Favored Pre-proline 0 CA--C 1.53 0.212 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.63 -28.95 25.25 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.692 2.261 . . . . 0.0 112.501 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.489 ' HB3' HG13 ' A' ' 52' ' ' VAL . 3.2 m-85 -94.49 67.4 3.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -108.02 127.41 53.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.425 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.527 ' HG2' HG23 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -117.24 106.08 12.9 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.27 125.08 34.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.632 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t -138.22 179.12 6.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.76 156.33 43.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.635 0.255 . . . . 0.0 111.413 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 m -84.66 55.17 3.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.079 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -127.09 -46.69 1.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.759 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 153.67 42.15 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.88 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.06 -17.61 32.2 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.877 2.385 . . . . 0.0 113.073 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -52.87 -43.81 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.445 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.6 t -59.88 -58.24 9.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.579 0.228 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.6 m -60.45 -31.7 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -74.48 -31.79 62.34 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.03 64.9 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-O 120.745 0.307 . . . . 0.0 111.007 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -75.6 -28.17 58.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.1 p -63.5 -47.82 80.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.887 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 46' ' ' LEU . 32.4 mm -67.47 -44.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.145 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.446 ' HE1' HG21 ' A' ' 52' ' ' VAL . 1.2 m-90 -63.44 -39.14 93.68 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.989 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -69.16 -31.94 70.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.89 -31.09 35.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.905 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.64 HD12 HG22 ' A' ' 42' ' ' ILE . 14.1 mt -80.53 -7.96 59.4 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.0 t30 56.12 47.88 18.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 110.76 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.5 m -135.3 32.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -24.91 54.96 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.492 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.95 -41.67 22.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.627 0.251 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -66.35 -20.24 66.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.605 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 25' ' ' TYR . 19.6 t -117.89 163.67 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 122.16 0.184 . . . . 0.0 110.529 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.486 ' N ' HG12 ' A' ' 52' ' ' VAL . 3.1 m-85 -123.31 111.36 16.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.162 0.506 . . . . 0.0 110.294 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 27' ' ' GLN . 21.8 t -120.46 134.34 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.054 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -132.47 130.09 40.04 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -100.72 151.15 22.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HB ' HD11 ' A' ' 60' ' ' LEU . 2.6 pt -122.49 -144.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.59 14.39 25.6 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.752 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.6 m -149.1 33.81 0.74 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.806 0.303 . . . . 0.0 111.331 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -97.15 116.31 65.96 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.947 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.4 Cg_exo -62.19 -170.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.116 2.544 . . . . 0.0 112.493 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.68 2.31 14.57 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -106.91 -39.53 5.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.628 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -74.24 -39.6 62.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.324 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -60.92 -38.42 85.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.715 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.29 -35.43 79.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.551 0.215 . . . . 0.0 111.236 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -64.55 -53.14 52.52 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.314 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -69.61 -36.59 76.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.343 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -46.27 73.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.381 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.8 mt -71.19 -51.67 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.586 0.232 . . . . 0.0 111.45 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.55 -54.98 37.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.865 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -61.48 -42.75 99.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.297 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -65.17 -27.81 68.97 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.539 0.209 . . . . 0.0 111.407 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -30.18 34.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.397 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 71' ' ' ALA . 38.2 t -87.94 -48.3 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 90' ' ' PHE . 9.2 p -113.57 -31.77 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.1 35.53 38.2 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.411 ' H ' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -144.57 93.09 2.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 40.21 1.06 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -113.7 89.96 3.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.634 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.48 151.91 93.4 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.063 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.23 170.51 71.25 Favored 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 123.531 -1.445 . . . . 0.0 112.99 0.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.568 HG22 ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -148.55 133.44 18.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.55 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.527 HG23 ' HG2' ' A' ' 27' ' ' GLN . 5.1 mt -112.51 111.53 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.7 t -101.77 116.72 45.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 t -125.1 131.8 72.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t30 63.28 33.07 14.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' ' 20' ' ' ILE . . . 64.89 45.18 93.26 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.832 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -175.44 137.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.545 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.568 ' CE1' HG22 ' A' ' 83' ' ' THR . 45.0 t80 -59.15 102.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -25.27 8.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.829 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 84' ' ' ILE . . . -111.1 139.01 15.34 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.233 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.96 -177.75 3.57 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -43.71 68.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.958 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 m -70.22 -32.82 70.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.891 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -52.26 -36.15 51.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.432 0.16 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.19 -54.37 41.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.18 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -33.84 66.17 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.428 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -62.02 -42.35 99.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.62 0.248 . . . . 0.0 111.304 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 109' ' ' GLU . 4.7 m-85 -77.83 -44.19 28.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.471 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -61.57 -42.42 98.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.858 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.09 -44.48 67.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.596 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -83.54 -38.56 21.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.1 35.65 2.3 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.942 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 18.28 16.42 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.693 0.246 . . . . 0.0 111.47 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -51.42 66.18 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.606 0.241 . . . . 0.0 110.778 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -66.28 -38.46 87.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.034 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.26 -39.84 95.74 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.439 ' HG3' ' CE2' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -58.47 -49.38 77.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.911 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.785 HD12 HD13 ' A' ' 115' ' ' LEU . 3.7 mm? -59.36 -30.68 68.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.067 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.517 HG23 ' HD3' ' A' ' 117' ' ' PRO . 78.9 m -78.24 -34.12 49.35 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.741 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -47.08 86.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.53 -26.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.717 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.85 7.17 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.585 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.785 HD13 HD12 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -73.7 -45.83 49.93 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.721 0.296 . . . . 0.0 110.511 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -79.93 -60.32 0.51 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.038 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.517 ' HD3' HG23 ' A' ' 111' ' ' THR . 73.7 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.481 2.121 . . . . 0.0 112.413 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 p -173.97 -50.63 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.28 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.46 68.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.419 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.83 -38.28 23.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.851 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.89 -51.35 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -60.27 -35.36 75.36 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.795 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -57.19 -42.43 81.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.68 0.276 . . . . 0.0 110.814 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.76 88.51 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -63.27 -35.41 80.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.33 -39.07 91.93 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.5 mtp -64.46 -44.73 90.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.983 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.433 HG12 ' HA ' ' A' ' 17' ' ' GLU . 37.1 pt -73.25 -14.69 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.419 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -61.26 -61.29 2.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.636 0.255 . . . . 0.0 110.855 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 m -83.37 -18.84 37.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.741 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -122.5 64.39 21.28 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.438 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 34.4 Cg_endo -64.91 -23.66 61.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.671 2.248 . . . . 0.0 112.922 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.514 ' HB3' HG13 ' A' ' 52' ' ' VAL . 13.2 m-85 -94.44 71.79 3.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 2.1 t80 -114.01 139.6 49.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.423 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.679 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -127.83 134.15 49.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.872 HD23 HD11 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -107.92 127.67 53.95 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -117.09 153.7 32.3 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.365 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.612 ' HB1' ' CD1' ' A' ' 32' ' ' TRP . . . -70.75 -41.91 71.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.024 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 56' ' ' ASP . 14.5 m 66.25 33.65 7.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.324 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.612 ' CD1' ' HB1' ' A' ' 30' ' ' ALA . 48.6 p-90 -159.36 -41.0 0.06 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.068 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.57 147.21 32.67 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.18 -20.55 24.85 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.018 2.479 . . . . 0.0 112.632 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -51.59 -39.86 58.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.113 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.59 -36.91 60.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.176 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.28 -35.11 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.442 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -58.47 -52.78 64.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.553 0.216 . . . . 0.0 110.875 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.97 75.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.64 -29.26 61.2 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.5 t -65.19 -48.95 71.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.642 HG22 HD12 ' A' ' 46' ' ' LEU . 30.8 mm -65.21 -41.38 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.407 ' HH2' HG11 ' A' ' 52' ' ' VAL . 8.6 m95 -65.94 -36.9 84.63 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.159 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -62.59 -37.2 85.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -83.83 -30.76 26.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.372 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.642 HD12 HG22 ' A' ' 42' ' ' ILE . 21.9 mt -80.71 -8.45 59.66 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 48.09 45.25 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 46' ' ' LEU . 30.0 m -119.89 38.27 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -99.69 31.34 3.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -120.66 -49.84 2.22 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -25.51 68.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.265 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 25' ' ' TYR . 58.2 t -118.14 154.01 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.407 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -116.4 111.29 19.82 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.269 0.557 . . . . 0.0 110.21 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG23 ' HB3' ' A' ' 27' ' ' GLN . 10.5 p -107.93 141.63 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.287 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -126.13 125.72 42.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 3.0 m-20 -90.88 126.64 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.401 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.872 HD11 HD23 ' A' ' 28' ' ' LEU . 18.4 mt -79.27 60.3 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.698 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.53 18.07 4.95 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.811 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.46 ' H ' HD22 ' A' ' 60' ' ' LEU . 83.3 p -129.97 10.02 5.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.813 0.307 . . . . 0.0 111.802 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -108.68 131.31 21.85 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-O 120.505 0.193 . . . . 0.0 111.11 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 64' ' ' GLU . 51.6 Cg_endo -68.3 -172.94 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.896 2.397 . . . . 0.0 112.095 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 6.35 4.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.91 -44.16 3.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.664 0.268 . . . . 0.0 110.817 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 3.5 tp10 -81.1 -42.95 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.155 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.31 -32.75 70.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.59 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -57.59 6.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.908 -0.133 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -31.73 67.75 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.172 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -73.11 -53.3 11.39 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.469 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -54.23 -42.16 69.55 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.452 ' N ' ' HG3' ' A' ' 69' ' ' ARG . 15.7 mt -62.04 -57.41 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.546 0.213 . . . . 0.0 111.249 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.22 -46.16 86.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.668 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.543 ' CD2' HD21 ' A' ' 28' ' ' LEU . 1.1 m-85 -64.47 -51.5 62.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -58.8 -26.27 63.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.487 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -31.43 31.81 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.439 0.162 . . . . 0.0 111.385 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 71' ' ' ALA . 50.1 t -84.96 -48.8 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.603 HG21 HG21 ' A' ' 85' ' ' VAL . 4.9 m -147.92 -37.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.912 ' HA2' HG21 ' A' ' 83' ' ' THR . . . -45.95 -35.44 6.26 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.649 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.8 t 61.34 -166.19 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.819 0.31 . . . . 0.0 111.184 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.33 40.54 1.11 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -160.69 130.53 5.07 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 83' ' ' THR . 27.4 mt -131.98 152.99 81.22 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.749 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.72 178.7 33.2 Favored 'Cis proline' 0 C--N 1.351 0.673 0 C-N-CA 123.688 -1.38 . . . . 0.0 113.027 0.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.912 HG21 ' HA2' ' A' ' 77' ' ' GLY . 4.4 t -144.31 155.98 44.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.04 114.68 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.603 HG21 HG21 ' A' ' 76' ' ' VAL . 19.0 t -101.17 118.38 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.73 131.79 72.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.948 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER 62.51 31.5 16.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.203 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.73 44.91 94.18 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.59 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -173.12 137.76 0.71 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.362 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -57.56 108.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -130.33 5.12 4.79 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.73 139.84 8.27 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.941 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.7 177.54 7.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.932 0.396 . . . . 0.0 111.067 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -65.59 -45.38 83.44 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -37.4 85.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.31 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.01 -34.98 66.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.235 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.0 mt -66.33 -53.56 34.83 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.726 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -64.75 -35.92 82.63 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.131 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -69.31 -41.41 76.77 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.514 ' CB ' HD12 ' A' ' 106' ' ' LEU . 8.5 m-85 -76.78 -45.81 27.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.515 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -62.31 -43.23 99.31 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.677 0.275 . . . . 0.0 111.061 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.93 97.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -73.24 -28.15 61.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.394 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.76 28.12 14.99 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.56 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.1 p -114.93 13.41 17.04 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.514 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.3 OUTLIER -70.33 -51.7 28.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.535 0.207 . . . . 0.0 111.011 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.05 -44.25 97.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.85 -50.6 70.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.099 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.77 -37.66 87.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.192 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.438 ' HB2' HD12 ' A' ' 116' ' ' LEU . 11.5 mt -55.81 -46.23 78.11 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.083 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -64.91 -31.46 72.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.903 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.1 72.17 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.982 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.47 -27.83 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.541 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.05 21.41 7.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.055 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -93.17 -46.17 7.54 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.839 0.32 . . . . 0.0 110.799 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 110' ' ' LEU . 17.3 mt -93.11 160.26 33.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.82 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.559 2.173 . . . . 0.0 112.448 179.851 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.884 0.373 . . . . 0.0 111.595 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -60.36 -29.09 68.69 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.45 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.74 -37.86 9.12 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.664 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -90.38 -39.16 12.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.143 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.418 HG21 ' NZ ' ' A' ' 74' ' ' LYS . 30.1 t -57.83 -45.1 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.865 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -62.33 -43.7 98.21 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.77 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.67 -47.01 82.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.754 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.15 82.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.764 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -64.3 -34.27 77.75 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.172 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.56 -38.36 83.99 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.971 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -45.32 87.35 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.115 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.8 pt -72.16 -14.37 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.536 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -61.88 -64.59 0.89 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.603 0.24 . . . . 0.0 110.782 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -84.6 -25.99 28.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.788 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -119.72 66.17 9.93 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.809 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.39 -20.38 36.66 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.689 2.259 . . . . 0.0 112.867 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -90.41 72.94 7.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.843 0.354 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.93 137.98 42.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 102.91 6.13 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.752 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.62 122.0 25.98 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -120.56 149.99 41.57 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.185 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.53 -38.07 4.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.443 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t 67.66 13.47 9.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.691 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.44 -33.49 7.34 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.71 0.291 . . . . 0.0 110.927 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 p -100.13 155.69 36.13 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.874 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' A' ' 37' ' ' VAL . 39.8 Cg_endo -67.95 -12.37 35.06 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.748 2.299 . . . . 0.0 113.091 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.4 -29.79 59.9 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 48.8 t -78.65 -49.63 12.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 34' ' ' PRO . 28.9 m -51.15 -36.7 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.278 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -71.66 -43.14 66.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.61 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.96 72.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.461 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -74.12 -32.34 63.14 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.546 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -61.25 -42.74 99.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.796 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -66.32 -44.73 90.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.004 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -35.57 81.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.095 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -67.12 -33.62 75.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.132 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -82.07 -32.52 30.28 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.055 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.558 HD22 HD11 ' A' ' 116' ' ' LEU . 21.1 mt -82.13 -7.79 59.63 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 50.94 49.95 20.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.953 0.406 . . . . 0.0 111.031 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 52' ' ' VAL . 28.0 m -126.17 33.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.091 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -83.07 -28.96 29.16 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.389 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.64 -42.65 34.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -65.26 -22.74 66.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.426 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 48' ' ' VAL . 11.1 p -108.91 163.2 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.393 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.44 ' N ' HG22 ' A' ' 52' ' ' VAL . 56.8 m-85 -120.2 111.17 17.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.23 0.538 . . . . 0.0 109.902 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.22 145.48 7.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -131.11 97.09 4.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.753 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.99 144.02 35.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.684 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.529 HG22 HD21 ' A' ' 60' ' ' LEU . 2.5 pt -99.96 64.28 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.105 0.479 . . . . 0.0 111.562 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -32.35 2.8 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.208 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 m -96.06 37.36 1.24 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.956 0.378 . . . . 0.0 111.576 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 64' ' ' GLU . 2.7 pp -145.58 116.76 5.03 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.231 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 28.0 Cg_exo -62.65 -176.85 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.989 2.459 . . . . 0.0 112.421 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -32.31 66.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.326 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -55.12 -41.83 72.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.273 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.595 ' HB3' HD13 ' A' ' 60' ' ' LEU . 7.0 mm-40 -77.53 -32.72 54.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.676 0.275 . . . . 0.0 110.824 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -54.15 -50.17 67.58 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.083 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -63.33 -42.1 98.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -38.98 75.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.14 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -73.53 -44.02 58.59 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.347 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -56.32 -39.16 72.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.49 -52.82 28.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.674 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -57.04 -54.5 46.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.337 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.46 -35.23 67.66 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.323 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -36.26 81.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.597 0.237 . . . . 0.0 111.073 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.418 ' NZ ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -81.93 -28.86 32.56 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.553 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 71' ' ' ALA . 40.0 t -81.08 -47.22 20.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.174 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 90' ' ' PHE . 12.8 m -123.37 -39.77 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.07 42.29 3.07 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.707 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -121.95 108.43 13.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.758 0.313 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.88 38.08 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.6 160.95 43.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.119 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 24.3 mt -123.06 155.76 63.79 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 96.6 Cg_endo -77.86 177.59 38.45 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.757 -1.351 . . . . 0.0 113.131 0.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 p -145.55 117.8 8.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 116.27 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.995 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 m -115.93 127.08 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.402 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.84 129.52 75.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 59.61 35.1 22.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.894 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.37 32.06 78.52 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.766 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -150.75 133.2 15.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.107 0.479 . . . . 0.0 110.045 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.606 ' CE2' HG23 ' A' ' 93' ' ' THR . 3.5 t80 -59.74 102.37 0.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.256 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -106.81 -22.8 12.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.748 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.64 139.99 11.42 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.874 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.606 HG23 ' CE2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -124.71 178.1 5.63 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.427 ' H ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -69.07 -37.1 78.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.322 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t -98.19 -22.24 16.29 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.436 ' HA ' ' HG2' ' A' ' 99' ' ' ARG . 5.4 tt0 -57.15 -31.99 65.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.55 -43.65 96.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.95 -53.5 45.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.494 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 96' ' ' GLN . 1.7 ptt180 -59.78 -41.66 91.61 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.674 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.744 ' CB ' HD12 ' A' ' 106' ' ' LEU . 2.0 m-85 -64.83 -42.75 94.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.883 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.81 -40.73 98.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.522 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.09 90.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -73.83 -27.53 61.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.24 24.22 32.25 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.61 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.4 p -116.54 11.26 14.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.744 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -67.35 -52.08 44.56 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.671 0.272 . . . . 0.0 110.484 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -67.77 -47.73 68.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.76 -53.09 52.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.984 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.43 -41.55 76.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.885 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -63.29 -38.27 90.51 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.213 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.84 -35.84 64.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.571 0.225 . . . . 0.0 110.57 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -66.7 -45.39 78.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.255 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.3 pt -65.42 -27.29 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.595 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.69 22.46 8.06 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.861 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.62 -45.46 7.04 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.78 0.29 . . . . 0.0 110.726 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.558 HD11 HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -89.35 137.84 28.92 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 C--O 1.251 1.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.611 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.603 0.239 . . . . 0.0 111.121 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p -57.02 -34.87 68.62 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.066 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.69 38.85 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.371 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.44 -37.94 19.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.875 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 9' ' ' MET . 21.6 t -60.46 -48.75 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.124 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 m -60.01 -41.76 92.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.91 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -60.02 -35.61 75.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.949 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.24 98.67 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.875 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' HG13 ' A' ' 20' ' ' ILE . 7.1 mm-40 -61.23 -34.15 74.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.55 -34.87 67.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.74 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.7 mtt -68.14 -46.4 70.95 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.003 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -71.89 -17.19 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.317 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -64.99 0.76 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.695 0.284 . . . . 0.0 110.856 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.3 t -86.06 -27.83 24.49 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -119.78 66.27 10.16 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.553 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.36 -16.61 43.78 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.71 2.273 . . . . 0.0 113.168 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.663 ' HB3' HG13 ' A' ' 52' ' ' VAL . 57.1 m-85 -90.43 68.57 6.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.435 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -112.52 136.17 52.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.265 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -128.64 112.28 14.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.293 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 117.13 27.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.039 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 t -138.6 169.17 18.26 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.25 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.626 ' HB2' HD11 ' A' ' 57' ' ' ILE . . . -123.25 159.65 28.27 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.187 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -103.0 21.9 14.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.423 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -153.34 32.16 0.47 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.49 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -115.4 144.49 32.45 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.915 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.77 -28.67 24.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.714 2.276 . . . . 0.0 112.763 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -111.08 23.31 14.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 16.0 m -115.15 -42.05 3.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.569 0.223 . . . . 0.0 111.059 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.58 -31.98 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.363 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -65.73 -51.77 56.56 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.091 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.425 ' HB2' HD11 ' A' ' 97' ' ' LEU . . . -57.5 -40.68 79.17 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.572 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -75.42 -30.4 60.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 t -61.43 -47.88 83.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mm -62.53 -43.81 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -64.46 -36.45 84.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.049 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -29.6 63.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.18 -33.52 32.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.606 0.241 . . . . 0.0 111.014 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.82 -7.81 59.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 53.89 46.2 26.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.037 0.446 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.98 28.92 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.977 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.38 -6.7 36.94 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.853 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.34 -45.82 17.14 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 110.457 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -68.4 -28.04 66.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 25' ' ' TYR . 42.5 t -103.1 160.12 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.682 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.456 ' N ' HG12 ' A' ' 52' ' ' VAL . 6.2 m-85 -114.46 111.18 21.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.095 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 27' ' ' GLN . 33.0 t -109.16 135.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.045 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 118.1 33.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.835 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -95.45 144.31 26.07 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.278 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 30' ' ' ALA . 2.4 pt -107.62 96.51 4.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.27 -79.61 0.1 Allowed Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.892 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.8 p -140.73 57.49 1.57 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.93 0.395 . . . . 0.0 110.784 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.96 136.09 66.66 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.205 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.19 -169.8 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.737 2.291 . . . . 0.0 112.133 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 2.1 mtp180 -75.7 1.19 15.29 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.51 -43.31 6.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.614 0.245 . . . . 0.0 110.984 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -75.29 -49.21 19.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.92 -35.51 75.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.361 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -67.53 -51.84 46.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.328 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -58.13 -42.39 85.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.87 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -61.9 -39.51 92.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.185 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -57.24 -54.35 47.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -68.57 -44.75 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.613 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.16 -42.06 72.63 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -70.51 -45.33 65.8 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.135 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.96 -27.96 69.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -32.36 31.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 71' ' ' ALA . 54.3 t -84.42 -41.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.32 -38.46 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 36.76 6.42 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.633 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.0 m -137.04 113.24 9.87 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 38.86 1.19 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.895 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -134.36 129.4 35.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 1.3 mp -98.6 164.95 16.02 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.401 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 7.9 Cg_exo -72.29 144.65 81.08 Favored 'Cis proline' 0 C--N 1.352 0.761 0 C-N-CA 123.593 -1.42 . . . . 0.0 111.999 -0.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.795 HG23 ' CE2' ' A' ' 90' ' ' PHE . 89.5 m -107.2 105.72 15.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -101.9 111.1 30.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.332 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.5 118.17 52.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.492 HG12 ' ND2' ' A' ' 87' ' ' ASN . 23.1 t -121.72 112.58 35.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.492 ' ND2' HG12 ' A' ' 86' ' ' VAL . 71.8 m-80 66.06 42.96 3.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.059 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.48 50.74 64.3 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.122 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -173.4 138.4 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 110.562 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.795 ' CE2' HG23 ' A' ' 83' ' ' THR . 0.8 OUTLIER -61.97 94.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -97.6 -29.48 13.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.496 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.47 135.71 10.71 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.146 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.524 HG23 ' CE1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -121.86 -177.48 3.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.013 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.15 -52.24 43.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -31.66 69.43 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.463 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -51.48 -33.85 33.06 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.425 HD11 ' HB2' ' A' ' 39' ' ' ALA . 48.3 mt -51.36 -59.72 3.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.247 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -78.36 -33.04 49.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.148 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 96' ' ' GLN . 5.4 mmp_? -57.46 -49.06 77.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -72.5 -39.87 67.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.027 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.77 -47.82 84.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.843 0.354 . . . . 0.0 110.721 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.81 76.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.353 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -74.81 -27.78 60.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.69 23.24 43.3 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.469 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.2 p -113.57 0.07 14.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.9 -47.4 85.92 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.603 0.239 . . . . 0.0 110.92 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.06 -46.05 72.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.231 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.88 -45.74 89.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.588 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -59.42 -40.01 85.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.492 HD23 HD13 ' A' ' 116' ' ' LEU . 3.3 tp -62.63 -40.7 97.82 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.22 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -77.34 -33.12 55.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 110.711 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -66.61 -43.66 84.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.358 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 115' ' ' LEU . 8.6 pt -61.12 -25.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.26 21.87 6.41 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.703 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.503 ' HB2' HD11 ' A' ' 113' ' ' ILE . 1.6 tt -88.16 -55.02 3.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.745 0.307 . . . . 0.0 110.761 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.492 HD13 HD23 ' A' ' 110' ' ' LEU . 3.6 mp -89.09 140.99 29.04 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.699 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.251 1.131 0 C-N-CA 122.867 2.378 . . . . 0.0 112.52 -179.864 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.641 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.1 mtt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.65 0.262 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.17 -35.62 49.41 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.01 -34.19 63.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.327 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -97.36 -37.4 10.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.28 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 9' ' ' MET . 41.3 t -58.0 -47.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.652 0.263 . . . . 0.0 110.99 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -61.08 -43.75 98.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.658 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -63.46 -35.57 80.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.064 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.82 95.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.07 -36.66 80.22 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.806 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -69.15 -32.49 71.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -48.11 62.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.088 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 pt -70.69 -15.05 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.486 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -61.3 -61.76 2.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -83.66 -19.82 34.67 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.39 68.53 10.46 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 110.563 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.42 -18.97 38.32 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.665 2.243 . . . . 0.0 112.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.59 69.51 6.74 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.78 139.71 41.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.746 ' HB3' HG13 ' A' ' 54' ' ' VAL . 3.5 tt0 -129.15 125.87 38.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.012 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.717 ' HB2' HG23 ' A' ' 83' ' ' THR . 5.1 mp -99.83 113.63 26.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.81 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.53 175.88 13.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.181 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.01 170.89 15.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.319 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -102.47 -15.15 16.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -85.88 -39.44 16.99 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.6 m -72.67 141.35 82.34 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.87 -39.09 1.94 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.871 2.381 . . . . 0.0 113.122 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -61.31 -29.94 70.19 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.74 0.305 . . . . 0.0 111.047 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.4 m -72.04 -34.77 69.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.886 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -58.15 -34.84 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.72 -54.38 36.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.514 0.197 . . . . 0.0 111.198 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.34 72.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.572 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -75.15 -32.02 61.21 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.763 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -63.46 -44.51 94.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.969 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.1 mm -63.49 -43.92 98.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.038 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.627 ' CD1' HG11 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.8 -34.24 77.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.307 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -28.08 63.81 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.186 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -80.6 -32.51 36.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.897 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -81.91 -7.69 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.4 t30 52.73 49.73 19.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.661 ' O ' HG12 ' A' ' 52' ' ' VAL . 13.2 m -122.69 26.17 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.299 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -26.66 65.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.734 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -81.2 -31.79 33.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.704 0.287 . . . . 0.0 110.913 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -75.9 -28.73 58.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 48' ' ' VAL . 13.5 p -112.46 161.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.815 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.461 ' N ' HG22 ' A' ' 52' ' ' VAL . 1.1 t80 -120.46 111.13 17.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.368 0.604 . . . . 0.0 109.99 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 27' ' ' GLN . 27.4 t -107.85 135.54 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.991 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.09 113.55 26.5 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.92 145.09 29.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.938 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.701 ' HA ' HD13 ' A' ' 60' ' ' LEU . 32.9 mm -112.77 78.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.86 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -43.94 0.33 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.803 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 t -95.55 37.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 111.169 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.701 HD13 ' HA ' ' A' ' 57' ' ' ILE . 5.6 mp -119.94 105.02 43.37 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.682 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.9 164.09 2.66 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.038 2.492 . . . . 0.0 112.678 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.13 -36.16 5.65 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.551 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -75.11 -49.5 19.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.007 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.3 -36.49 83.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.221 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -59.86 -48.05 83.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.003 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.16 -29.18 67.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -55.46 -53.45 56.2 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.228 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.446 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 36.2 p-90 -74.01 -32.35 63.34 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.73 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -49.83 74.76 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.196 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 mm -73.93 -39.03 51.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.074 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.72 -50.75 72.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.072 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -63.61 -33.87 76.57 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -32.84 70.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.709 0.29 . . . . 0.0 110.884 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -78.94 -29.59 44.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 71' ' ' ALA . 21.4 t -78.98 -44.14 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.191 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 89' ' ' LYS . 27.4 m -128.26 -42.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.27 45.97 1.11 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.45 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 p -102.76 85.35 2.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.86 0.362 . . . . 0.0 110.415 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 22.91 1.63 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.971 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 152.68 15.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.431 HD23 ' HH2' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -124.21 159.37 57.35 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.052 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.2 156.42 98.16 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.793 0.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.717 HG23 ' HB2' ' A' ' 28' ' ' LEU . 1.3 t -144.92 131.25 19.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.9 mt -112.02 122.79 66.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.343 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.12 121.65 64.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.352 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.89 121.87 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.98 43.37 3.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.753 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.63 75.28 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.854 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.516 ' HA ' HG12 ' A' ' 76' ' ' VAL . 4.8 ptpt -174.16 134.99 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.559 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.712 ' HZ ' HG23 ' A' ' 93' ' ' THR . 75.9 t80 -62.86 101.21 0.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.977 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -113.32 -26.31 8.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.628 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.68 141.08 16.67 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.697 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.712 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -123.58 154.2 39.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.603 0.24 . . . . 0.0 111.171 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -36.72 68.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.0 m -86.0 -27.18 25.0 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.23 -37.4 69.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.616 0.246 . . . . 0.0 111.083 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.14 -37.29 78.22 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.121 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -67.92 -54.48 18.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.186 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -60.36 -29.59 69.01 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -79.48 -45.56 19.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.343 0.116 . . . . 0.0 111.108 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.555 ' HB2' HD13 ' A' ' 106' ' ' LEU . 4.5 tm-20 -62.77 -43.98 97.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.91 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.1 -46.74 68.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.508 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -76.8 -34.8 57.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.42 32.97 3.26 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.89 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.4 p -115.39 20.57 14.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.717 0.258 . . . . 0.0 111.562 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.555 HD13 ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -81.01 -47.35 13.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.644 0.259 . . . . 0.0 110.563 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.59 -45.85 90.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.263 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.68 -41.53 98.15 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.786 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.79 -42.17 98.66 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.867 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.453 HD23 HD22 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -59.93 -38.27 81.88 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 m -77.55 -34.67 53.72 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.619 0.247 . . . . 0.0 110.573 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.88 -45.32 82.47 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -61.87 -24.6 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.3 23.02 7.16 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.676 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -91.33 -45.22 8.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.822 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' A' ' 110' ' ' LEU . 7.8 mp -98.71 146.28 31.35 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--O 1.248 0.989 0 C-N-CA 122.688 2.258 . . . . 0.0 112.699 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.57 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.5 mtt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 120.757 0.313 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -58.63 -28.22 65.45 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.296 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 15' ' ' LYS . . . -66.76 -10.48 47.76 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -119.8 -41.56 2.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.498 0.19 . . . . 0.0 111.205 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 9' ' ' MET . 34.1 t -56.76 -51.11 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.688 0.28 . . . . 0.0 110.887 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 m -59.79 -33.58 71.91 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.06 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 13.8 mttm -65.72 -32.75 74.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.914 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.29 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.557 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.563 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -37.89 89.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.425 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -46.25 85.82 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.115 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HB ' ' HA2' ' A' ' 88' ' ' GLY . 20.8 pt -74.16 -17.5 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.646 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -61.93 2.11 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.664 0.268 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m -84.28 -19.06 34.46 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.3 69.09 59.98 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 121.046 0.45 . . . . 0.0 110.155 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 -21.37 70.3 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.943 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -90.28 66.08 6.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.864 0.364 . . . . 0.0 110.257 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -109.46 142.88 39.84 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.075 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.758 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -135.52 132.04 36.77 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 57' ' ' ILE . 18.4 tp -110.54 114.39 27.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.187 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.569 ' O ' HG22 ' A' ' 57' ' ' ILE . 1.5 m -131.97 172.71 12.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.088 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.68 -82.17 0.33 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.653 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.1 p -176.66 -62.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -139.41 42.04 2.04 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.931 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -78.97 161.19 69.48 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.577 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.64 -34.84 50.02 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.464 2.109 . . . . 0.0 112.444 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.04 -35.04 14.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 71.8 m -67.58 -43.66 80.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.248 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 33' ' ' CYS . 13.5 p -57.5 -32.5 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.384 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -63.47 -51.63 64.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.593 0.235 . . . . 0.0 110.805 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.01 79.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.702 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.66 -33.28 62.48 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.709 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -58.96 -43.72 91.36 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.557 HG21 HD21 ' A' ' 106' ' ' LEU . 28.3 mm -66.48 -46.52 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.367 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -34.43 78.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.064 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.92 -39.22 87.3 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.916 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -81.79 -24.63 35.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.497 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 48' ' ' VAL . 25.5 mt -80.88 -8.28 59.68 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.4 t30 49.79 47.49 22.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 111.29 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 46' ' ' LEU . 14.4 m -141.23 41.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.42 -18.01 20.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.706 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -77.22 -45.32 26.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.681 0.277 . . . . 0.0 110.665 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -61.01 -24.56 66.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.414 ' CG2' HD21 ' A' ' 115' ' ' LEU . 15.7 t -102.76 160.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.363 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.1 t80 -113.92 111.12 21.17 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.374 0.607 . . . . 0.0 110.137 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.758 HG23 ' HB3' ' A' ' 27' ' ' GLN . 11.7 p -108.22 143.01 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.369 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -131.52 129.72 41.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.828 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.91 131.43 34.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.733 HG13 HD21 ' A' ' 60' ' ' LEU . 2.0 tt -91.91 29.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.902 0.382 . . . . 0.0 111.52 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.29 9.97 54.13 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.146 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 29.28 7.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.009 0.405 . . . . 0.0 111.253 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.733 HD21 HG13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.92 134.6 13.93 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.747 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.72 -177.62 2.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.202 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -56.79 -28.26 61.07 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.209 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -63.34 -56.82 13.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.962 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 10.7 mt-10 -69.91 -30.75 68.25 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -54.6 -45.52 73.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.861 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.17 -41.21 97.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.674 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -59.6 -46.78 87.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.163 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.36 90.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.211 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -60.99 -53.17 60.57 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.102 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 mt -63.77 -36.93 78.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.048 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -66.14 -55.13 17.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.228 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -41.22 77.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.27 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.24 69.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.517 0.198 . . . . 0.0 111.22 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -81.98 -30.37 31.66 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.581 0.229 . . . . 0.0 111.174 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 71' ' ' ALA . 37.0 t -83.3 -46.27 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.328 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.21 -38.03 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.87 36.49 7.75 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.514 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.72 104.25 9.19 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.22 39.43 1.02 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.468 ' O ' HG23 ' A' ' 83' ' ' THR . 18.9 t-20 -129.78 132.58 46.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -110.68 142.39 26.03 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.704 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HG3' ' HA ' ' A' ' 36' ' ' CYS . 87.6 Cg_endo -79.17 -177.03 19.77 Favored 'Cis proline' 0 C--N 1.352 0.747 0 C-N-CA 123.511 -1.454 . . . . 0.0 112.923 0.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.846 HG22 ' CE1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -148.17 125.61 11.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.36 118.95 52.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.337 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 m -112.95 117.67 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.799 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.1 138.53 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.39 33.15 22.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.43 ' HA2' ' HB ' ' A' ' 20' ' ' ILE . . . 64.94 45.71 91.56 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.426 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -175.24 136.64 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.846 ' CE1' HG22 ' A' ' 83' ' ' THR . 31.1 t80 -58.98 109.2 0.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.299 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.81 -21.82 10.48 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.283 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -138.28 138.06 9.24 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.041 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 96' ' ' GLN . 8.9 t -119.99 -170.44 1.96 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.502 0.178 . . . . 0.0 110.543 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.88 -33.18 34.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -29.32 34.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.666 ' H ' HG23 ' A' ' 93' ' ' THR . 17.9 tt0 -65.08 -30.22 71.16 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.7 mt -56.97 -59.72 4.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.482 0.182 . . . . 0.0 111.315 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -62.25 -38.01 87.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -67.56 -40.09 84.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.41 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -77.16 -35.31 56.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.531 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.8 -42.49 97.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.52 -49.56 68.51 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.343 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -70.95 -26.19 63.06 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.49 23.12 27.21 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.542 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.34 -20.63 21.64 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 42' ' ' ILE . 2.0 tp -57.3 -53.45 57.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.529 0.204 . . . . 0.0 110.825 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -60.78 -36.98 80.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.03 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.2 -41.57 98.49 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.69 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.149 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.555 HD13 HD11 ' A' ' 113' ' ' ILE . 4.4 mm? -66.64 -35.91 81.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.9 m -72.75 -37.22 67.76 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -47.32 83.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.249 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.555 HD11 HD13 ' A' ' 110' ' ' LEU . 33.9 pt -69.48 -24.53 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.4 26.9 9.62 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.552 HD23 ' CD1' ' A' ' 110' ' ' LEU . 4.2 tp -92.03 -40.16 11.24 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.736 0.268 . . . . 0.0 110.845 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 6.3 tp -65.42 -47.64 68.83 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.451 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 116' ' ' LEU . 70.7 Cg_exo . . . . . 0 C--O 1.252 1.204 0 C-N-CA 122.575 2.183 . . . . 0.0 112.606 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.9 mtt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.504 0.192 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.43 -57.58 0.61 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.658 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.6 -37.25 49.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -34.96 17.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.2 -48.02 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.149 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -67.31 -46.89 72.16 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -58.14 -38.27 76.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.688 0.28 . . . . 0.0 111.179 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.36 84.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.861 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' OE1' HD11 ' A' ' 20' ' ' ILE . 2.5 mm-40 -67.56 -38.28 83.88 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -61.76 -38.3 87.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.073 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.13 -47.74 73.12 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.644 HD12 ' CA ' ' A' ' 88' ' ' GLY . 43.8 pt -74.06 -14.63 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.634 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -61.7 2.36 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.59 0.234 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -83.76 -19.57 34.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -122.13 68.03 26.32 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.49 -24.02 42.94 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -92.4 69.21 5.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.487 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.09 139.62 43.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.283 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.75 ' HG3' HG23 ' A' ' 84' ' ' ILE . 1.3 mt-30 -128.37 100.05 5.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.747 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.69 94.4 5.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 p -103.25 154.49 19.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.954 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -99.01 143.33 29.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.215 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -94.88 36.73 1.17 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -48.55 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.087 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 41.6 m -69.17 137.17 89.24 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.205 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.19 -30.72 10.24 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.755 2.303 . . . . 0.0 112.858 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -58.74 -36.06 73.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.124 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m -65.23 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.58 -37.17 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.296 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.45 -46.08 84.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.566 0.222 . . . . 0.0 110.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.11 -33.46 72.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -74.96 -33.4 61.9 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.57 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -59.11 -41.76 88.95 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.802 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.675 HG22 HD12 ' A' ' 46' ' ' LEU . 22.8 mm -71.06 -36.91 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -34.05 76.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.765 0.317 . . . . 0.0 111.005 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -80.86 -31.55 35.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -83.52 -33.69 25.45 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.675 HD12 HG22 ' A' ' 42' ' ' ILE . 26.6 mt -80.75 -7.64 59.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 53.09 51.42 15.76 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.223 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 52' ' ' VAL . 16.1 m -114.5 26.68 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.378 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.27 -28.92 70.05 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -89.99 -25.58 20.8 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -79.16 -42.38 26.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 48' ' ' VAL . 11.4 p -120.93 154.86 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -118.26 111.13 18.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.303 0.573 . . . . 0.0 110.383 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 27' ' ' GLN . 22.3 t -99.48 134.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.886 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -130.06 132.9 46.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.58 148.83 22.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.656 ' HA ' HD21 ' A' ' 60' ' ' LEU . 9.6 pt -107.79 85.19 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.52 -47.45 0.2 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.308 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -58.7 -41.45 86.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.765 0.282 . . . . 0.0 111.253 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -59.75 112.48 5.38 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.369 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.79 -173.54 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.101 2.534 . . . . 0.0 112.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -34.48 67.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.32 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -52.69 64.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.76 -34.25 69.32 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.204 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -55.38 -42.58 74.19 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.586 0.231 . . . . 0.0 110.845 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.52 -47.98 51.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -57.12 -48.05 79.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.192 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -38.31 81.14 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -52.42 64.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.916 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 mm -59.86 -47.11 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -59.11 -52.39 65.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -58.25 -45.91 86.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.028 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -62.72 -27.51 69.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 -28.66 36.76 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.971 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 71' ' ' ALA . 35.4 t -81.89 -48.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.102 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.736 HG21 ' CB ' ' A' ' 90' ' ' PHE . 10.8 p -121.29 -38.17 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.52 40.88 5.89 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.285 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.32 105.75 15.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.358 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.49 34.69 1.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 83' ' ' THR . 36.8 t30 -123.63 157.59 33.43 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.039 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -142.97 138.99 16.35 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.017 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.49 177.53 38.83 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.5 -1.458 . . . . 0.0 112.745 0.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 80' ' ' ASN . 5.4 p -132.08 137.6 47.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.06 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.75 HG23 ' HG3' ' A' ' 27' ' ' GLN . 30.7 mt -118.64 112.31 37.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 m -102.46 122.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.262 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.96 124.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.37 35.29 12.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.078 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.644 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . 67.52 46.27 70.88 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.745 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -176.15 135.94 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.736 ' CB ' HG21 ' A' ' 76' ' ' VAL . 55.7 t80 -59.49 107.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.032 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.26 4.32 7.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.117 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -149.11 141.18 8.71 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.028 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.734 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 12.0 p -121.19 -179.0 3.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.35 . . . . 0.0 111.237 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -72.81 -42.4 63.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.232 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.61 66.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.325 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -52.6 -38.19 59.6 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.571 0.224 . . . . 0.0 111.295 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.6 mt -56.88 -60.34 3.72 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.168 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -34.96 78.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.041 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -60.8 -44.94 96.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -79.7 -40.67 28.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.221 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -40.88 90.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.831 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -43.53 87.9 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.195 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -72.73 -29.34 63.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.531 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.82 24.85 19.26 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.714 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.5 p -110.88 9.83 22.41 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -49.01 69.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.416 0.151 . . . . 0.0 110.878 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.76 -46.39 89.8 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.401 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.67 -43.77 80.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.01 -39.34 69.26 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 115' ' ' LEU . 7.8 tp -56.21 -42.9 77.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.303 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.1 m -77.47 -33.03 54.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.871 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -68.63 -43.16 76.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.528 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.4 pt -64.12 -23.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.15 25.16 8.03 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.555 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.474 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -81.78 -46.5 14.12 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -65.51 -59.69 9.0 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.899 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--O 1.248 1.002 0 C-N-CA 122.455 2.103 . . . . 0.0 112.43 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.462 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.4 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 85.5 p -53.26 -34.75 58.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.491 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.52 -29.03 34.54 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.657 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -106.21 -38.51 6.23 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.344 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 9' ' ' MET . 22.0 t -69.94 -48.15 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.8 m -60.59 -42.85 97.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -58.69 -35.55 72.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 110.715 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.88 -48.22 72.24 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.449 ' OE1' HD11 ' A' ' 20' ' ' ILE . 13.9 mm-40 -63.77 -34.18 77.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -69.51 -33.85 73.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.655 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.59 79.53 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.449 HD11 ' OE1' ' A' ' 17' ' ' GLU . 18.3 pt -73.25 -16.29 17.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.468 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -61.48 -62.21 1.98 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.767 0.318 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -84.65 -20.39 31.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.883 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -123.14 67.92 35.35 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-O 120.881 0.372 . . . . 0.0 110.393 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 38.6 Cg_endo -65.95 -22.57 55.44 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.665 2.243 . . . . 0.0 112.643 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -91.19 68.61 6.02 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.492 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' HD11 ' A' ' 28' ' ' LEU . 1.1 t80 -108.53 139.35 43.42 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.187 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -140.79 114.55 8.93 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.741 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.604 HD23 HD11 ' A' ' 57' ' ' ILE . 6.4 mp -100.87 140.4 35.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.242 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -146.5 145.69 30.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.153 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.65 -175.32 5.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.39 50.51 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.028 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -48.94 0.09 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.7 t -68.74 133.78 90.42 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.267 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.99 -34.1 48.8 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.811 2.341 . . . . 0.0 112.715 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.17 -31.94 69.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.641 0.258 . . . . 0.0 111.084 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 68.9 m -68.98 -56.33 8.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.09 -35.85 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.882 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -62.03 -45.1 95.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.5 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.01 82.15 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.348 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -75.04 -29.39 60.77 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -62.95 -45.19 93.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.8 -42.43 89.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.98 -35.5 78.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -69.36 -31.86 70.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.156 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -78.59 -30.37 46.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.888 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.5 mt -80.46 -7.09 59.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.3 t30 56.15 47.82 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 110.832 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.14 30.81 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -19.46 59.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.367 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 -35.18 21.67 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -74.54 -25.12 59.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.526 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 53' ' ' PHE . 17.1 t -119.88 160.75 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.64 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -121.28 111.51 17.45 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.289 0.566 . . . . 0.0 110.336 179.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 p -112.15 141.65 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.516 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -125.23 124.51 41.85 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.22 144.99 25.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.072 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.604 HD11 HD23 ' A' ' 28' ' ' LEU . 16.8 mt -113.02 82.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.968 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.06 22.46 4.01 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.952 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -150.35 24.82 0.8 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.865 0.332 . . . . 0.0 111.391 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -171.79 58.28 0.25 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 111.263 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 65' ' ' GLN . 61.7 Cg_endo -89.75 160.6 5.16 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.766 2.311 . . . . 0.0 113.108 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER 64.6 -75.48 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 179.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.1 -50.26 73.34 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -82.6 -28.1 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.678 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 61' ' ' PRO . 28.7 mt-30 -65.17 -41.67 94.41 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.082 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 62' ' ' ARG . 4.0 pt-20 -59.31 -40.66 86.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.624 0.25 . . . . 0.0 110.764 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 35.1 mttt -72.52 -44.61 61.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -34.72 77.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -63.81 -50.06 70.44 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.926 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 mt -60.16 -37.71 74.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.534 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -68.03 -54.66 16.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.177 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 6.4 m-85 -60.54 -36.42 78.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.164 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.1 -31.06 72.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -29.19 41.35 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 71' ' ' ALA . 32.3 t -81.16 -44.19 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.4 -40.82 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.27 36.58 6.55 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.423 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.0 t -111.26 105.16 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.73 0.3 . . . . 0.0 110.653 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.63 37.11 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -130.12 116.79 18.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.032 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 82' ' ' PRO . 1.0 OUTLIER -100.82 147.87 34.27 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.653 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.648 ' HA ' HD23 ' A' ' 81' ' ' LEU . 74.2 Cg_endo -74.77 175.29 48.2 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.813 0.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.7 p -134.93 133.62 39.77 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.8 111.07 34.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.751 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 m -107.51 124.06 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.944 0.402 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.35 127.23 73.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.723 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 8.6 m-20 62.83 37.11 12.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.006 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.84 49.44 72.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.729 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.51 136.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.65 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -59.22 102.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -115.86 -11.22 11.58 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.89 142.77 14.23 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.64 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 m -130.31 159.67 36.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.641 0.258 . . . . 0.0 111.104 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -39.68 75.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.13 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 t -76.88 -29.02 55.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.556 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.28 -31.81 34.45 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 mt -70.27 -49.04 53.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.057 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -59.63 -53.29 59.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.495 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -36.35 70.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.539 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.72 -42.38 34.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.1 74.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.5 97.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.357 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -73.73 -27.86 61.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.531 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.09 28.73 12.76 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.334 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 p -107.83 6.52 27.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -45.83 88.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.654 0.264 . . . . 0.0 110.73 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.76 -38.14 86.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.902 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.99 -41.64 95.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -59.12 -44.97 92.03 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.546 0.212 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.632 HD12 HD12 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.45 -41.51 85.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.212 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -80.72 -32.06 35.9 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -42.85 99.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.38 -21.83 29.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.634 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.16 26.65 13.67 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.781 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.442 ' HB3' HD13 ' A' ' 110' ' ' LEU . 2.2 tp -88.46 -43.58 11.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 110.8 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.632 HD12 HD12 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -64.39 -56.81 20.35 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.084 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 C--O 1.25 1.102 0 C-N-CA 122.459 2.106 . . . . 0.0 112.702 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.46 23.53 10.13 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.07 73.4 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.763 0.316 . . . . 0.0 110.834 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.9 -28.05 11.34 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.444 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.83 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.635 0.255 . . . . 0.0 111.087 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.2 m -61.45 -46.1 91.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -61.65 -37.65 84.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.049 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.17 87.48 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.99 -41.53 87.84 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.786 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -64.52 -35.75 81.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.63 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.3 mtp -66.34 -46.79 75.62 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.985 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.6 pt -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.636 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.88 -63.88 1.01 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.603 0.239 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.01 -25.59 25.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.746 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -121.7 63.05 14.37 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.735 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.46 -18.21 54.38 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 112.845 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -88.08 73.68 8.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.91 139.96 39.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.968 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.05 98.93 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.777 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.573 HD21 HD11 ' A' ' 57' ' ' ILE . 1.7 tp -75.71 129.33 36.92 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -144.22 -176.6 5.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -132.84 109.88 9.94 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.815 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.2 p -50.29 -34.34 23.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.444 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.95 -40.71 62.87 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.432 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 90.6 m -72.53 137.37 80.67 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.233 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -24.5 50.14 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.068 2.512 . . . . 0.0 112.836 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -55.99 -39.26 71.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.959 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -63.73 -39.45 94.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.406 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -62.84 -41.11 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -66.32 -47.41 73.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.861 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.16 89.74 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.538 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -75.25 -30.88 60.62 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.946 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -62.67 -49.01 76.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.35 -38.73 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.582 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -67.3 -34.06 76.6 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.091 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.29 -33.54 75.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.273 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 -33.2 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.944 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.14 -7.73 59.29 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 53.26 48.77 21.33 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.896 0.379 . . . . 0.0 110.929 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 ' CD1' ' A' ' 43' ' ' TRP . 26.9 m -122.69 29.4 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.385 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -69.99 -35.0 74.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.051 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.01 -33.18 26.58 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.894 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -66.82 -21.31 66.04 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.579 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 53' ' ' PHE . 19.9 t -125.59 161.03 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -124.17 111.58 16.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -97.42 141.72 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -127.45 96.17 4.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.992 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.35 144.2 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.688 ' HB ' HD21 ' A' ' 60' ' ' LEU . 7.3 pt -139.47 99.11 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.466 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.52 29.31 8.33 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.007 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.0 m -145.9 -83.5 0.13 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.92 0.36 . . . . 0.0 110.94 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.688 HD21 ' HB ' ' A' ' 57' ' ' ILE . 11.8 mt 60.52 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.273 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.36 62.5 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.129 2.552 . . . . 0.0 113.418 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 62.21 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -54.38 -43.13 71.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.54 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -60.01 -42.72 94.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.091 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.59 ' HA ' HD13 ' A' ' 60' ' ' LEU . 2.5 tm0? -56.23 -42.85 77.96 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.983 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 35.5 mt-10 -79.9 -27.03 39.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.5 -46.79 75.08 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.464 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.404 ' CD1' ' HA ' ' A' ' 65' ' ' GLN . 17.1 p-90 -71.99 -40.78 68.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -58.38 -39.98 81.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 69' ' ' ARG . 30.6 mt -79.38 -41.54 22.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.653 0.263 . . . . 0.0 111.08 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.03 -54.33 47.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.25 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -58.3 -41.61 84.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.469 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -61.63 -32.22 72.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.737 0.303 . . . . 0.0 111.039 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -31.01 46.35 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 71' ' ' ALA . 22.5 t -77.83 -43.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.08 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 89' ' ' LYS . 21.2 m -134.39 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 111.94 47.66 0.71 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.601 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.54 96.17 5.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.798 0.333 . . . . 0.0 110.492 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.93 24.75 2.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.226 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.82 170.35 15.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.149 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.23 151.19 43.7 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.24 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.46 172.77 60.98 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.786 -1.339 . . . . 0.0 112.783 0.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 t -159.32 135.53 8.98 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.791 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.45 129.08 57.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.336 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.81 131.33 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.86 125.18 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.068 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 63.27 39.2 9.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.998 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.8 50.1 71.27 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.592 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.574 ' HA ' HG12 ' A' ' 76' ' ' VAL . 11.2 pttp -172.39 135.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.626 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 18.1 t80 -56.38 112.78 1.34 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.217 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -102.9 -29.75 11.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.538 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -174.32 161.74 31.84 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.095 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 90' ' ' PHE . 15.1 t -129.1 -174.93 3.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.769 0.318 . . . . 0.0 111.386 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -55.68 -45.43 77.75 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.843 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.5 m -64.06 -38.18 90.15 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.822 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -60.79 -30.31 69.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.6 mt -59.13 -57.8 11.46 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.516 0.198 . . . . 0.0 110.962 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -39.03 88.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.865 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -65.97 -41.3 91.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.247 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -73.72 -38.23 64.88 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.861 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.69 -52.99 31.37 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.835 0.35 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.03 -35.86 78.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -74.25 -28.13 61.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.289 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.64 24.5 32.96 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.572 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.1 p -115.14 2.1 14.04 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -57.23 13.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.527 0.203 . . . . 0.0 110.996 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -66.83 -37.85 85.3 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.017 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.31 -52.36 65.61 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.848 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.35 -34.03 76.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.157 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD22 HD22 ' A' ' 115' ' ' LEU . 23.4 mt -61.21 -43.19 99.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.965 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.2 m -69.43 -29.22 66.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.891 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.37 -52.08 67.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.915 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.07 -25.75 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.747 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.19 7.45 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.899 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.671 HD22 HD22 ' A' ' 110' ' ' LEU . 1.2 tt -85.76 -50.65 7.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.675 0.274 . . . . 0.0 110.692 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.505 ' CD2' HD13 ' A' ' 110' ' ' LEU . 3.7 mm? -100.77 138.44 20.07 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 122.924 2.416 . . . . 0.0 112.478 -179.764 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.491 0.186 . . . . 0.0 111.478 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m 64.12 20.88 12.37 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.42 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.99 -29.69 20.55 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-O 120.72 0.295 . . . . 0.0 110.467 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -103.57 -31.58 9.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 t -64.3 -57.22 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.064 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -60.26 -44.67 95.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.107 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -61.62 -34.45 75.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.791 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.12 72.19 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.037 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -77.03 -28.51 54.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.941 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.66 -35.48 67.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.048 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 14.2 ptp -70.75 -41.58 71.59 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.812 -0.177 . . . . 0.0 111.441 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -73.86 -19.86 17.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.547 0.213 . . . . 0.0 111.412 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -62.22 1.88 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 m -87.57 -20.93 25.75 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.266 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -127.53 70.59 76.6 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-O 120.855 0.359 . . . . 0.0 110.72 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 41.1 Cg_endo -66.19 -22.52 53.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.718 2.278 . . . . 0.0 112.794 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CE1' HG13 ' A' ' 86' ' ' VAL . 10.7 m-85 -89.09 70.99 8.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.903 0.382 . . . . 0.0 110.275 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.83 140.68 38.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.521 ' HG2' HG23 ' A' ' 84' ' ' ILE . 49.6 mt-30 -142.77 106.91 4.72 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.783 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.699 HD21 HG12 ' A' ' 57' ' ' ILE . 6.7 tt -88.82 125.25 34.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.47 ' N ' HD23 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -140.7 172.79 12.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.009 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.73 145.57 14.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.169 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -76.39 75.74 3.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 110.739 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -142.09 -53.65 0.43 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.747 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -88.87 142.05 30.2 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.29 -34.73 81.12 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.962 2.441 . . . . 0.0 112.593 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -33.69 76.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.6 m -58.44 -51.34 70.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.619 0.247 . . . . 0.0 110.75 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 t -59.33 -40.32 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD2' HD13 ' A' ' 97' ' ' LEU . 82.0 t80 -59.73 -48.95 79.62 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.33 76.6 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.516 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.0 -32.45 67.21 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.561 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -62.06 -44.6 96.33 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.1 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.516 HG22 HD12 ' A' ' 46' ' ' LEU . 36.8 mm -63.13 -50.4 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.509 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.02 -32.87 74.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.916 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -66.36 -37.07 84.48 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.0 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -83.8 -27.69 28.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.471 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD12 HG22 ' A' ' 42' ' ' ILE . 20.3 mt -80.92 -7.72 59.57 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.2 t30 53.57 49.08 20.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 m -127.28 38.9 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -93.21 16.59 12.74 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.523 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.9 -42.63 3.54 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.928 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -25.13 61.76 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.393 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 53' ' ' PHE . 21.3 t -108.34 158.3 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.645 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.414 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -116.05 111.01 19.69 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.261 0.553 . . . . 0.0 110.207 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.2 t -104.25 134.85 44.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -120.97 98.21 5.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.0 132.07 34.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.699 HG12 HD21 ' A' ' 28' ' ' LEU . 1.3 pt -120.58 91.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.402 . . . . 0.0 111.293 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 13.09 8.08 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.127 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.558 ' C ' HD13 ' A' ' 60' ' ' LEU . 4.6 t -135.72 56.75 1.82 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.018 0.437 . . . . 0.0 110.702 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -112.39 140.08 23.32 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.291 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 64' ' ' GLU . 86.3 Cg_endo -81.54 45.1 1.88 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.879 2.386 . . . . 0.0 114.314 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.2 ttt-85 67.47 -57.8 0.44 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.607 0.363 . . . . 0.0 111.764 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.33 -33.66 54.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.623 0.249 . . . . 0.0 111.007 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 18.9 mm-40 -70.01 -39.71 75.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.919 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -51.22 70.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.989 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -41.48 80.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.6 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -65.66 -38.67 90.0 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.884 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -62.17 -44.52 96.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.304 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -58.72 -41.72 87.07 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.4 mt -73.38 -43.87 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -52.27 65.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.23 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.47 -34.71 74.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -63.44 -30.31 71.45 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.047 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.84 -29.8 35.81 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.148 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -82.53 -44.54 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.194 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.611 HG11 HG12 ' A' ' 85' ' ' VAL . 3.7 m -123.89 -41.93 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.76 40.68 2.85 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.62 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.2 t -116.42 115.36 25.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -96.4 39.27 1.16 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -154.73 159.64 40.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.174 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 28' ' ' LEU . 67.7 mt -127.42 152.22 76.07 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.882 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD2' ' HG3' ' A' ' 94' ' ' GLU . 72.8 Cg_endo -76.5 174.88 50.7 Favored 'Cis proline' 0 C--N 1.354 0.834 0 C-N-CA 123.482 -1.466 . . . . 0.0 113.007 0.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.401 HG23 ' CE1' ' A' ' 90' ' ' PHE . 3.1 m -129.0 121.61 28.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.876 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.521 HG23 ' HG2' ' A' ' 27' ' ' GLN . 2.5 mt -106.1 111.23 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.871 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.611 HG12 HG11 ' A' ' 76' ' ' VAL . 6.0 m -112.18 119.46 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.51 HG13 ' CE1' ' A' ' 25' ' ' TYR . 31.2 t -117.08 122.1 69.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.963 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.421 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER 64.27 38.57 7.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.134 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.38 49.02 78.06 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.679 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -174.31 136.68 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 110.693 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.401 ' CE1' HG23 ' A' ' 83' ' ' THR . 1.8 t80 -55.05 106.15 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.283 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -24.03 9.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.752 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.4 148.11 18.5 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.595 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -124.81 175.58 7.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.71 0.29 . . . . 0.0 111.17 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 82' ' ' PRO . 15.7 tt0 -71.01 -27.64 63.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.31 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -94.45 -29.28 15.04 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.442 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 6.9 tt0 -57.91 -35.06 70.53 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 38' ' ' TYR . 2.6 pp -57.6 -42.02 82.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.569 0.223 . . . . 0.0 111.206 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.74 -35.1 52.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.941 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -70.59 -51.76 26.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-O 120.709 0.29 . . . . 0.0 111.433 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.78 -37.68 79.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.422 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.35 -50.77 68.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.907 0.384 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.92 -35.93 81.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.282 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -72.29 -25.72 61.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.49 44.19 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.557 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 p -103.75 -14.86 15.91 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.7 -48.12 69.86 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.623 0.249 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.56 -45.37 72.29 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.3 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.16 -43.74 95.56 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.817 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -39.94 84.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.715 ' HG ' HD22 ' A' ' 115' ' ' LEU . 1.1 mp -58.84 -40.86 85.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.099 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 116' ' ' LEU . 30.9 m -75.59 -34.08 60.61 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.855 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -60.21 -48.22 82.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.068 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 115' ' ' LEU . 6.5 pt -65.28 -24.75 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.862 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.7 22.29 7.08 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.715 HD22 ' HG ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -82.72 -46.0 13.73 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.838 0.319 . . . . 0.0 110.906 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.562 HD12 HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -122.29 60.9 13.72 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.742 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 122.743 2.296 . . . . 0.0 112.795 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -64.2 -17.39 63.49 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.31 -36.54 21.32 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.43 -39.32 6.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.129 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.67 -55.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.345 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -60.99 -39.11 88.42 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.684 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -35.37 78.74 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.933 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.51 92.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.834 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.8 mm-40 -60.46 -36.78 79.05 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.92 -31.66 68.35 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.968 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.1 mtt -69.22 -47.76 63.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.172 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.1 pt -72.45 -16.55 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.582 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -61.48 -61.23 2.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.7 m -79.39 -18.59 52.01 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.634 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -120.89 68.21 15.97 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.411 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.4 -27.05 40.49 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.596 2.197 . . . . 0.0 112.573 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' A' ' 52' ' ' VAL . 28.5 m-85 -90.09 65.74 6.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.975 0.416 . . . . 0.0 110.356 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.74 141.73 38.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.37 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 54' ' ' VAL . 47.3 tt0 -141.12 101.35 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.392 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.46 HD21 ' CD1' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -81.32 139.04 35.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.664 0.269 . . . . 0.0 110.904 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -153.1 -176.08 5.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.373 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.36 -170.62 2.31 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.013 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 m -109.07 -39.78 5.18 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.261 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.9 37.3 3.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.664 0.269 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 t -97.08 138.33 21.26 Favored Pre-proline 0 C--O 1.234 0.272 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.958 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.14 -28.4 41.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.827 2.351 . . . . 0.0 112.239 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.91 -37.65 58.56 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.337 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.0 t -70.2 -45.99 65.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.497 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.84 -37.43 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.546 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -68.51 -46.9 68.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.674 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.27 93.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.385 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -75.39 -28.76 59.59 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.089 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 t -60.82 -48.31 82.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.108 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.52 -45.37 92.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.588 ' CD1' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -66.98 -31.97 72.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.35 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -68.33 -33.93 75.18 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.99 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -81.11 -36.29 30.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.707 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.9 mt -80.61 -7.85 59.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.121 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.9 46.02 26.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.588 HG23 ' CD1' ' A' ' 43' ' ' TRP . 17.2 m -119.02 35.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 30.73 3.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -124.05 -50.42 1.81 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.608 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -62.19 -25.73 67.94 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 25' ' ' TYR . 10.0 p -113.21 156.75 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.418 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.37 111.14 18.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.326 0.584 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 27' ' ' GLN . 22.2 t -104.31 132.83 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.787 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -119.14 113.04 20.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.675 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -99.72 111.54 23.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.635 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.46 ' CD1' HD21 ' A' ' 28' ' ' LEU . 7.4 pt -98.69 76.9 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.614 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 26.9 8.57 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.983 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.4 30.6 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.423 HD13 ' HG2' ' A' ' 64' ' ' GLU . 15.1 mt -113.3 132.68 22.34 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 33.8 Cg_exo -62.14 -167.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.818 2.345 . . . . 0.0 112.506 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 9.58 5.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.077 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -116.07 -41.3 3.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.371 0.129 . . . . 0.0 110.93 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.423 ' HG2' HD13 ' A' ' 60' ' ' LEU . 1.1 tt0 -82.56 -40.84 20.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.898 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -60.85 -40.55 93.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -41.09 96.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.968 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -56.62 -47.7 79.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.042 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -34.46 78.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.103 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -48.36 71.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 mt -72.72 -42.37 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.238 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -56.67 -42.74 79.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.269 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -64.55 -49.47 71.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.134 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -24.78 65.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.05 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.87 48.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.164 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 71' ' ' ALA . 34.2 t -87.83 -47.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.3 -41.57 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.8 38.98 2.81 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.685 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -102.98 109.01 20.4 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.443 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.22 31.06 1.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -169.52 167.81 9.62 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.766 0.317 . . . . 0.0 111.269 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.31 159.7 69.76 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HB3' ' OG ' ' A' ' 29' ' ' SER . 73.3 Cg_endo -77.77 156.15 95.24 Favored 'Cis proline' 0 C--N 1.352 0.727 0 C-N-CA 123.442 -1.482 . . . . 0.0 112.906 0.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 t -127.31 125.59 41.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.188 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.98 111.25 31.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.864 0.364 . . . . 0.0 111.086 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 85' ' ' VAL . 30.2 m -109.83 120.46 60.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.555 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.37 120.46 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.024 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.84 40.11 5.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 48.99 75.2 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.971 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -171.99 134.87 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.0 110.611 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.503 ' HZ ' HG23 ' A' ' 93' ' ' THR . 55.7 t80 -56.91 115.18 2.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.4 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.0 3.09 5.29 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.07 136.7 5.27 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.91 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.503 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -122.24 167.03 13.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.927 0.394 . . . . 0.0 111.635 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.76 -38.84 89.5 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.746 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -29.84 29.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -55.49 -31.89 62.39 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.266 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.51 -55.65 32.25 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.624 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -34.98 74.44 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -70.19 -42.97 71.68 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -73.87 -41.06 62.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.93 -41.93 77.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.259 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.08 74.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.314 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.85 -26.65 63.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.264 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.41 25.58 25.57 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.519 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.9 p -114.56 13.14 17.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -45.3 68.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.619 0.247 . . . . 0.0 110.899 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.7 -43.14 97.48 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.918 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.63 -40.06 82.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.46 -40.81 92.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.752 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.718 ' HB3' HD13 ' A' ' 116' ' ' LEU . 3.5 mp -58.76 -37.07 75.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.134 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.483 ' OG1' HD22 ' A' ' 116' ' ' LEU . 51.3 m -72.57 -35.62 68.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.6 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -65.88 -46.58 77.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 pt -64.69 -25.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.43 27.04 7.0 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.407 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.429 HD22 ' HG ' ' A' ' 110' ' ' LEU . 1.1 tp -85.73 -46.54 10.6 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.603 0.202 . . . . 0.0 110.761 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.718 HD13 ' HB3' ' A' ' 110' ' ' LEU . 7.1 mp -72.55 -59.5 2.44 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.969 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.392 2.061 . . . . 0.0 112.444 179.886 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p -125.48 -50.31 1.64 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.468 0.175 . . . . 0.0 110.778 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.6 -37.72 58.71 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.864 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.42 -37.5 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.101 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.413 HG12 ' OE2' ' A' ' 17' ' ' GLU . 36.6 t -67.29 -47.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.087 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -62.78 -43.67 98.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.877 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -39.33 90.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.658 0.266 . . . . 0.0 110.732 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.93 93.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.413 ' OE2' HG12 ' A' ' 13' ' ' VAL . 43.5 mt-10 -67.88 -36.6 80.53 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.71 -34.01 77.31 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.05 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -43.97 74.95 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.242 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 17' ' ' GLU . 14.0 pt -74.21 -15.12 16.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.655 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -61.49 -65.25 0.72 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.622 0.248 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.43 -23.99 27.65 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -123.56 67.58 38.84 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 110.832 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 -18.18 51.87 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.578 2.185 . . . . 0.0 112.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -92.78 73.33 4.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.367 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.33 140.03 48.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.499 ' HG3' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -132.86 102.24 5.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.554 179.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.547 HD22 ' CZ ' ' A' ' 72' ' ' PHE . 4.4 mp -88.83 112.32 23.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 99.6 p -162.47 -177.76 5.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.942 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 69.32 118.81 0.03 OUTLIER 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -177.5 -48.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.863 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.65 34.75 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.043 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.27 134.42 21.36 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.664 0.268 . . . . 0.0 111.499 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.88 -33.17 10.37 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.354 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.76 -34.67 71.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.5 m -64.87 -39.51 93.67 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.36 -36.02 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.116 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -57.58 -45.09 85.68 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.771 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.48 87.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.12 -31.87 61.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.813 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -49.0 77.54 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.773 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -66.03 -40.87 88.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.299 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.567 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.1 m-90 -67.95 -34.51 76.71 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.404 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.13 -33.06 65.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.494 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.35 -35.91 24.8 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.099 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 46' ' ' LEU . 16.1 mt -80.95 -7.94 59.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.801 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.23 47.95 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.206 0.527 . . . . 0.0 110.528 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.567 HG23 ' CD1' ' A' ' 43' ' ' TRP . 18.8 m -119.97 24.43 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.195 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.7 21.07 12.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -105.48 -43.9 4.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.933 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -76.34 -21.12 56.53 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.934 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' CG2' HD11 ' A' ' 115' ' ' LEU . 28.9 t -107.51 156.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.778 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.404 ' N ' HG12 ' A' ' 52' ' ' VAL . 3.1 t80 -114.08 110.97 20.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.263 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.07 133.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.658 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -125.36 136.25 53.26 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 29' ' ' SER . 10.0 p-10 -97.04 127.5 43.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -93.91 71.76 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.72 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.38 29.67 5.85 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.35 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.46 -45.69 2.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.998 0.399 . . . . 0.0 111.299 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.697 HD22 ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.12 122.68 30.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.763 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 12.6 Cg_exo -70.45 -170.81 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.121 2.548 . . . . 0.0 111.857 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -68.01 -30.89 70.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -72.93 -46.81 50.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.294 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 13.0 tp10 -62.47 -34.19 76.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -56.39 -32.28 64.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.487 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -57.85 -53.74 54.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -61.31 -40.75 95.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.542 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.05 -36.02 80.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.024 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.427 ' CD ' ' HD2' ' A' ' 79' ' ' ARG . 9.9 mtm180 -60.6 -54.66 42.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.29 -39.79 79.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.031 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -57.52 -46.27 84.01 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.867 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.547 ' CZ ' HD22 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -63.55 -46.44 85.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -26.28 68.41 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.35 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -81.96 -30.81 31.51 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.205 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 71' ' ' ALA . 43.4 t -83.8 -47.23 18.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.359 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.17 -38.9 2.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.29 7.27 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.74 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.95 109.74 4.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.66 0.267 . . . . 0.0 110.641 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HD2' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -99.1 42.27 1.11 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.63 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.73 129.17 54.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.598 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -96.38 147.86 33.6 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.42 166.85 81.64 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.652 -1.395 . . . . 0.0 112.522 0.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.3 p -125.11 115.26 20.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.697 HD11 HD21 ' A' ' 97' ' ' LEU . 31.8 mt -109.58 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -111.47 116.44 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.03 129.52 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 m120 60.9 37.03 18.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.3 48.54 81.78 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -172.84 136.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 0.0 110.683 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -63.31 104.59 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.103 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -110.08 -26.02 9.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.726 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -117.83 139.75 15.04 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.048 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 p -117.66 -170.31 1.84 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.286 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 95' ' ' SER . 24.3 pm0 -77.31 -35.13 55.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 94' ' ' GLU . 8.1 t -84.01 -34.44 24.31 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.609 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.91 -39.17 25.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.613 0.244 . . . . 0.0 111.596 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.697 HD21 HD11 ' A' ' 84' ' ' ILE . 17.2 mt -58.12 -55.6 32.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.394 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -41.54 64.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.517 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.0 mmt-85 -57.56 -36.83 72.17 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.537 0.208 . . . . 0.0 111.206 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.19 -44.99 24.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -42.98 99.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.746 0.308 . . . . 0.0 111.001 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.78 81.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -71.11 -27.26 63.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 27.42 13.17 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.493 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.7 p -112.44 14.82 20.34 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -52.27 58.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.489 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.39 -41.79 75.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.65 -46.94 80.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.799 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -62.69 -40.24 96.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -57.46 -33.65 68.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 m -74.25 -34.38 63.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -67.36 -43.86 80.42 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.304 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.27 -24.35 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.81 25.51 9.73 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.786 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.503 HD11 ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -88.45 -44.78 10.48 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.8 0.3 . . . . 0.0 110.798 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.628 ' HB2' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -128.86 56.46 23.58 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.96 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.716 2.277 . . . . 0.0 112.623 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 13' ' ' VAL . 27.6 mtm . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.679 0.276 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.95 -35.23 64.02 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.095 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -34.6 66.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.367 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -83.99 -35.47 23.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.009 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 9' ' ' MET . 37.9 t -56.06 -51.39 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.099 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -59.24 -42.39 90.97 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.248 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.34 -39.19 93.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.238 . . . . 0.0 110.736 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 75' ' ' VAL . . . -66.15 -39.84 90.13 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.693 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.22 -37.09 77.86 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.63 -33.81 76.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.909 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.5 69.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.318 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.5 pt -72.51 -14.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.727 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -60.99 -57.85 10.9 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.201 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -86.25 -2.03 58.01 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -129.72 73.67 81.32 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.468 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.45 -36.35 35.02 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.709 2.273 . . . . 0.0 112.61 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.585 ' HE2' HD12 ' A' ' 115' ' ' LEU . 9.7 m-85 -99.97 68.39 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.941 0.4 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -106.89 139.38 41.38 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.513 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 54' ' ' VAL . 95.0 mt-30 -136.05 112.54 9.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.33 114.98 26.46 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.624 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.82 175.75 5.52 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.272 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.49 173.59 6.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.481 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 p -70.12 72.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.274 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.3 t90 55.19 64.31 1.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.353 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -85.34 163.84 43.3 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.578 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.47 -34.18 86.53 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.593 2.195 . . . . 0.0 112.484 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.59 -32.48 13.41 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.393 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.92 -42.99 89.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.851 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.44 -36.39 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.226 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.14 -56.6 18.89 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.416 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . . . -62.33 -30.96 71.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.421 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.583 ' HA ' ' CE2' ' A' ' 43' ' ' TRP . 3.1 m-80 -69.0 -38.25 79.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -65.54 -37.63 87.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.196 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 mm -57.88 -59.7 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.79 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.583 ' CE2' ' HA ' ' A' ' 40' ' ' ASN . 1.6 p90 -72.96 -16.11 61.54 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 20.9 t-20 -73.55 -43.17 60.51 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.587 0.232 . . . . 0.0 111.06 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -81.31 -31.23 33.64 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.447 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -80.48 -6.92 58.88 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 54.29 48.54 20.54 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.168 0.508 . . . . 0.0 110.794 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 52' ' ' VAL . 29.0 m -116.63 28.1 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.425 ' HG3' ' CD1' ' A' ' 43' ' ' TRP . 1.1 mt-30 -83.03 -16.23 47.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.701 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -83.63 -38.99 20.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.647 0.261 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -70.46 -27.96 64.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 48' ' ' VAL . 14.0 p -110.26 162.34 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.453 ' N ' HG22 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -118.98 111.41 18.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.185 0.517 . . . . 0.0 109.958 178.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' GLN . 11.3 p -114.17 141.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.229 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -135.64 126.7 27.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.887 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.78 141.67 28.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.575 ' HB ' HD21 ' A' ' 60' ' ' LEU . 1.3 pt -89.93 52.64 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 24.31 29.17 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.014 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -126.67 28.76 5.83 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 110.881 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.575 HD21 ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -147.82 129.25 7.25 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.85 -177.05 2.02 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.721 2.281 . . . . 0.0 111.955 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -58.4 -36.69 73.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.638 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -62.85 -52.4 63.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.166 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' CB ' ' HB2' ' A' ' 60' ' ' LEU . 26.2 mm-40 -58.68 -36.18 73.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -56.36 -38.18 71.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.061 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.43 -55.49 15.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.041 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -41.29 86.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.849 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.9 t-105 -65.78 -38.7 89.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -58.73 -43.33 90.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.132 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.5 -46.29 86.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.913 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -56.92 -49.1 76.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.899 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.17 -40.99 97.88 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -61.62 -30.75 70.9 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 111.143 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 -29.68 36.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.6 t -81.02 -43.0 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.145 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.6 m -128.11 -44.83 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.62 0.86 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.575 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.5 100.54 8.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.773 0.32 . . . . 0.0 110.472 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -91.34 29.43 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.54 176.24 11.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.317 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -131.86 153.05 81.31 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.28 -178.07 21.99 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.705 -0.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.3 p -131.64 131.43 43.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.416 ' HB ' ' CA ' ' A' ' 92' ' ' GLY . 21.3 mt -114.02 111.43 35.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.787 0.327 . . . . 0.0 111.253 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.72 129.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.631 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.6 t -123.41 119.08 56.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.66 41.73 3.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.61 50.44 64.26 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.746 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -175.12 135.06 0.34 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 93' ' ' THR . 15.2 t80 -60.46 102.82 0.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.54 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -106.7 -30.21 9.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.351 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' CA ' ' HB ' ' A' ' 84' ' ' ILE . . . -122.46 146.15 16.66 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.981 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -120.95 173.05 7.48 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.812 0.339 . . . . 0.0 111.352 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -36.66 80.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.7 m -84.82 -29.63 25.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.548 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.23 -35.12 48.67 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.559 0.218 . . . . 0.0 111.513 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 39' ' ' ALA . 27.7 mt -67.52 -57.61 6.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.352 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -32.85 73.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.424 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -69.8 -40.96 75.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -78.65 -35.76 44.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.179 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -58.04 -43.88 87.08 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.82 -47.56 70.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -72.31 -28.8 63.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.357 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.55 26.48 10.79 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.548 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.7 p -111.53 18.29 19.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -67.01 -50.72 61.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.568 0.223 . . . . 0.0 110.483 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.32 -38.08 81.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.041 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -43.98 98.01 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.607 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.2 -41.98 93.97 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.748 HD23 HD23 ' A' ' 116' ' ' LEU . 4.6 tp -65.88 -27.38 68.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.346 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.8 m -79.02 -34.9 43.54 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.605 0.24 . . . . 0.0 110.443 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -41.05 87.01 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 pt -64.9 -25.19 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 24.53 8.01 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.717 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.585 HD12 ' HE2' ' A' ' 25' ' ' TYR . 5.1 tt -101.77 -54.15 2.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.84 0.32 . . . . 0.0 110.77 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.748 HD23 HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -88.55 109.69 31.17 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.685 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.615 2.21 . . . . 0.0 112.478 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.9 mtt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 120.757 0.313 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.3 p 53.87 22.95 3.55 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.364 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.68 -23.61 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.716 0.293 . . . . 0.0 110.816 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -120.7 -36.73 3.12 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 t -61.36 -55.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.876 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -70.23 -39.77 74.86 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.811 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -38.49 77.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.24 -49.32 72.38 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.12 -37.66 88.16 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.91 -37.47 86.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -46.14 83.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.471 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.3 pt -72.24 -16.6 18.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.597 0.237 . . . . 0.0 111.53 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -63.74 1.18 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.176 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.1 m -88.61 -16.97 31.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.484 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -124.55 70.5 56.12 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 110.583 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.24 -22.38 46.64 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.733 2.289 . . . . 0.0 112.614 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.406 ' HB3' HG13 ' A' ' 52' ' ' VAL . 8.2 m-85 -94.2 66.51 3.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 110.426 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -110.77 127.84 55.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.075 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.459 ' HG2' HG23 ' A' ' 84' ' ' ILE . 96.0 mt-30 -112.41 113.74 26.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.687 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -90.34 126.81 35.99 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.939 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -119.17 157.91 27.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.304 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -76.86 175.85 9.1 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.429 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -97.8 112.86 24.6 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.957 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 57.5 39.87 27.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.696 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 1.3 m -109.91 148.45 38.28 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.19 -30.86 52.73 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.877 2.385 . . . . 0.0 112.296 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -45.91 67.0 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 t -57.54 -52.62 64.65 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.003 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 m -62.41 -36.2 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.221 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -66.38 -55.46 15.77 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.83 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.22 68.13 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.746 0.307 . . . . 0.0 111.302 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.496 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 1.2 m-80 -72.34 -38.19 68.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 p -64.48 -37.61 88.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.748 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 46' ' ' LEU . 38.3 mm -58.54 -61.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.459 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.496 ' CD1' ' HA ' ' A' ' 40' ' ' ASN . 12.3 p-90 -65.92 -39.17 90.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.35 -38.36 77.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.697 0.284 . . . . 0.0 111.243 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -83.86 -32.02 25.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 42' ' ' ILE . 21.0 mt -81.07 -8.03 59.68 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 51.64 47.3 25.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 110.944 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.52 33.25 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 43' ' ' TRP . 3.4 tt0 -74.17 -15.87 61.01 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.594 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.12 -30.59 23.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.666 0.27 . . . . 0.0 110.706 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -82.27 -31.15 30.24 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.345 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.48 ' CG2' HD11 ' A' ' 115' ' ' LEU . 48.0 t -133.68 149.75 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.764 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.46 111.62 19.53 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.383 0.611 . . . . 0.0 110.715 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.466 HG11 ' NE1' ' A' ' 43' ' ' TRP . 10.8 p -100.64 141.46 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.167 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.45 135.83 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.914 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.77 177.19 6.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.754 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.582 HG23 ' H ' ' A' ' 59' ' ' SER . 2.1 tt -63.93 -24.6 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.742 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.28 5.64 55.85 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.535 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.582 ' H ' HG23 ' A' ' 57' ' ' ILE . 4.6 m 59.65 31.82 21.13 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.149 0.475 . . . . 0.0 110.6 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -54.94 132.02 67.3 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.704 -179.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.91 175.89 1.64 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.7 2.267 . . . . 0.0 111.877 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -51.91 -28.09 15.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.571 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -74.73 -55.4 5.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.465 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -69.25 -33.05 72.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.439 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.47 ' HA ' HD22 ' A' ' 60' ' ' LEU . 21.4 tt0 -53.49 -43.81 68.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.925 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -38.36 86.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.783 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -66.03 -37.24 85.38 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -66.9 -48.05 69.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.54 0.21 . . . . 0.0 111.096 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -56.87 -51.35 69.38 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.517 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -65.92 -45.44 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.573 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.55 -54.59 43.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.492 0.187 . . . . 0.0 111.413 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.81 -38.76 82.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.725 0.298 . . . . 0.0 110.949 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.402 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 25.6 tt0 -69.13 -27.62 65.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -31.76 40.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.251 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 71' ' ' ALA . 23.9 t -84.16 -48.59 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.333 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.36 -41.19 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 103.92 40.4 2.32 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -123.78 97.37 5.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.744 0.307 . . . . 0.0 110.552 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -86.52 49.99 1.91 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.582 ' C ' HD13 ' A' ' 81' ' ' LEU . 4.6 t-20 -170.72 170.66 6.52 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.144 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -140.61 161.71 53.09 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.81 179.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.85 169.87 72.25 Favored 'Cis proline' 0 C--N 1.355 0.881 0 C-N-CA 123.497 -1.46 . . . . 0.0 113.017 0.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.658 HG22 ' HE2' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -147.65 127.99 13.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -179.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.459 HG23 ' HG2' ' A' ' 27' ' ' GLN . 29.7 mm -102.01 111.6 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.849 0.357 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.89 117.14 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.981 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.429 HG12 ' ND2' ' A' ' 87' ' ' ASN . 24.1 t -119.68 124.17 72.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.429 ' ND2' HG12 ' A' ' 86' ' ' VAL . 70.2 m-80 62.12 38.99 13.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.018 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.0 91.72 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.882 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.21 136.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.963 0.411 . . . . 0.0 110.637 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.658 ' HE2' HG22 ' A' ' 83' ' ' THR . 61.1 t80 -60.54 107.99 0.76 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.065 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -115.53 -24.82 8.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.706 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.11 140.0 12.74 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.247 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.626 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -107.29 173.36 6.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -68.08 -31.14 70.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.479 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -28.16 18.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.13 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -55.1 -37.95 67.49 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.213 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.59 -44.18 87.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.355 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.95 -34.59 59.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.4 mmt85 -72.82 -37.69 67.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.346 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.75 -45.94 56.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.11 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.23 -39.28 92.29 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.65 0.262 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.09 -50.56 65.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -69.15 -27.4 65.51 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.614 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 24.5 12.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.599 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.2 p -108.46 20.04 19.07 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.594 0.197 . . . . 0.0 111.454 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -50.72 11.3 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.658 0.266 . . . . 0.0 110.589 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.44 -42.39 87.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.37 -51.45 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.749 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -39.58 94.72 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.94 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.49 -38.07 76.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.97 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 14.0 m -78.26 -34.48 49.03 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.628 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -64.12 -44.19 92.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.355 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.6 pt -64.58 -26.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.78 22.3 8.12 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.907 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.48 HD11 ' CG2' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -81.71 -44.47 17.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.877 0.37 . . . . 0.0 110.52 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -52.8 1.41 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.441 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 111' ' ' THR . 50.9 Cg_exo . . . . . 0 C--O 1.248 1.013 0 C-N-CA 122.387 2.058 . . . . 0.0 112.367 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' VAL . 6.3 mtt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.652 0.263 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.3 p -54.93 -38.36 67.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.33 -27.5 55.98 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.913 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 -39.53 5.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.482 0.182 . . . . 0.0 111.427 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 9' ' ' MET . 39.0 t -73.78 -52.54 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.11 -40.55 96.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 110.965 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.34 -35.03 77.82 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.542 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.92 -46.56 88.82 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.4 mm-40 -61.17 -36.41 79.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.803 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.86 -33.62 74.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.902 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -49.12 61.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 17' ' ' GLU . 1.6 pt -71.68 -14.43 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.406 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -63.62 1.21 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.65 0.262 . . . . 0.0 110.921 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -84.41 -19.01 34.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -120.29 62.21 8.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.742 0.306 . . . . 0.0 110.829 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.97 -15.38 43.42 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.702 2.268 . . . . 0.0 113.019 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -93.88 74.27 4.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.271 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.49 121.2 40.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.003 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -112.77 121.96 46.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.997 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.6 mt -98.92 117.96 34.62 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.669 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 36' ' ' CYS . 94.1 p -119.52 154.44 33.84 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.555 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.74 164.25 12.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.478 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.91 39.41 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.84 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -161.31 -44.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.428 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.83 147.47 88.88 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-O 120.569 0.223 . . . . 0.0 111.064 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.93 -17.7 36.63 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.19 -38.11 67.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.329 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 29' ' ' SER . 24.1 p -62.61 -39.18 92.97 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.83 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.3 -37.31 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.692 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -64.0 -49.38 72.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.749 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.34 88.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.533 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -75.35 -31.39 60.53 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.621 0.248 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -59.82 -45.97 90.7 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 46' ' ' LEU . 32.2 mm -65.74 -41.81 91.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -66.92 -34.69 78.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.098 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -67.17 -34.16 76.94 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -34.68 26.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 42' ' ' ILE . 19.1 mt -80.63 -7.71 59.37 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 53.53 45.82 27.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.671 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.35 41.5 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -93.62 17.63 11.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.394 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.66 -44.9 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.679 0.276 . . . . 0.0 110.861 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -64.7 -26.38 68.35 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.395 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.05 157.76 10.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.683 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.4 111.24 20.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.288 0.566 . . . . 0.0 110.477 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 t -96.06 131.55 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.99 115.61 15.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.047 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -81.48 151.06 28.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.554 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.485 HG13 HD21 ' A' ' 81' ' ' LEU . 34.5 mm -98.35 72.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.88 26.01 2.08 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.143 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -130.49 32.69 4.39 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.836 0.35 . . . . 0.0 110.915 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -142.66 126.92 9.78 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.53 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 27.3 Cg_exo -62.76 -171.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.061 2.507 . . . . 0.0 112.507 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.11 9.44 3.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.44 -41.65 3.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.568 0.223 . . . . 0.0 110.951 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 32.1 tp10 -68.48 -37.95 80.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.059 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.606 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.9 tt0 -63.79 -35.19 79.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.92 -57.38 12.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.127 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -43.74 87.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.087 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -46.27 89.16 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -44.94 64.72 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.226 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.7 mt -66.69 -47.32 83.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -61.63 -39.2 90.44 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.437 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.505 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 10.9 m-85 -59.16 -53.5 57.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.19 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.65 -25.87 63.18 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.96 -30.85 56.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.972 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 71' ' ' ALA . 37.8 t -84.34 -44.29 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.253 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.6 m -120.52 -44.03 2.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.54 23.25 21.94 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.954 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.44 75.8 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HA ' HG21 ' A' ' 83' ' ' THR . 5.7 mtt180 -119.43 29.82 7.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.835 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.36 111.51 8.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.283 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.485 HD21 HG13 ' A' ' 57' ' ' ILE . 8.5 mt -45.9 131.92 6.94 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.38 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.14 150.48 85.66 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 124.034 -1.236 . . . . 0.0 112.747 0.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.6 HG21 ' HA ' ' A' ' 79' ' ' ARG . 26.6 m -142.98 128.63 19.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.402 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.6 mm -112.07 113.02 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.95 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.85 116.45 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.99 129.59 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.74 34.09 12.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.762 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.44 46.6 92.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.681 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -175.9 137.37 0.33 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.743 ' HZ ' HG23 ' A' ' 93' ' ' THR . 91.2 t80 -61.6 102.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -116.46 -25.72 7.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.712 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.12 138.61 14.57 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.933 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.743 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -123.35 -173.63 2.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.689 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.445 ' OE1' HG22 ' A' ' 93' ' ' THR . 1.8 mp0 -74.13 -37.83 63.97 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 m -95.24 -27.29 15.58 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.703 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.19 -39.04 66.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.739 0.304 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 93' ' ' THR . 17.1 mt -66.77 -47.23 72.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.881 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -62.28 -38.51 89.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.066 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -71.37 -38.92 71.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.276 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.425 ' HB3' HD12 ' A' ' 106' ' ' LEU . 5.1 m-85 -74.28 -35.36 63.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.008 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 -50.35 20.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.738 0.304 . . . . 0.0 111.05 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -36.84 71.66 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.47 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -72.41 -27.4 62.33 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.429 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.17 25.74 20.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.52 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 p -109.07 -5.33 16.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -55.08 -42.15 72.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.539 0.209 . . . . 0.0 111.273 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.61 -51.0 70.31 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -61.56 -44.01 97.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 -36.17 76.03 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.727 HD23 HD12 ' A' ' 116' ' ' LEU . 1.2 tp -60.89 -40.51 93.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.805 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.7 m -74.6 -30.62 61.75 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -50.41 74.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.42 -24.62 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.736 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.72 24.06 7.19 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.769 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.89 -51.44 5.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.795 0.331 . . . . 0.0 110.743 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.727 HD12 HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -92.15 109.4 37.4 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--O 1.251 1.141 0 C-N-CA 122.546 2.164 . . . . 0.0 112.873 -179.854 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.5 ttm . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.618 0.247 . . . . 0.0 111.657 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p -60.31 -27.8 67.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.203 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.59 -32.35 40.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -96.51 -35.45 11.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.19 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 9' ' ' MET . 31.1 t -57.8 -51.76 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.526 0.203 . . . . 0.0 111.121 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.17 -36.76 78.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -65.51 -33.45 75.95 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.041 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.62 58.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.74 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 -34.06 76.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -70.03 -33.38 71.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -46.48 71.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.21 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 pt -71.99 -15.13 17.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.536 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -64.99 0.76 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.676 0.274 . . . . 0.0 111.026 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -24.21 26.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -119.72 68.37 11.61 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.808 0.337 . . . . 0.0 110.861 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 58.7 Cg_endo -70.91 -19.63 30.43 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.714 2.276 . . . . 0.0 112.945 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HB3' HG13 ' A' ' 52' ' ' VAL . 37.7 m-85 -92.94 70.51 4.64 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.73 53.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.292 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.579 ' OE1' HG23 ' A' ' 84' ' ' ILE . 2.8 mp0 -128.01 107.68 10.03 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.48 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.13 124.07 28.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.958 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 m -129.5 172.32 11.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.954 0.406 . . . . 0.0 111.428 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . . . -103.35 -175.32 2.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.274 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.83 98.31 11.52 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.43 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.6 44.77 26.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.659 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -78.92 159.33 73.76 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.011 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.66 -36.3 14.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.642 2.228 . . . . 0.0 112.597 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.33 -36.51 13.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m -67.24 -34.18 76.92 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.44 -33.38 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.582 0.229 . . . . 0.0 111.233 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -63.23 -48.89 76.33 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.998 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.27 76.8 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.134 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -75.35 -31.47 60.56 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -61.44 -49.19 77.85 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mm -69.05 -37.38 76.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.046 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.08 75.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.081 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.47 -30.05 57.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.271 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -81.57 -33.37 31.67 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.965 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.5 HD22 HD11 ' A' ' 116' ' ' LEU . 19.3 mt -80.7 -7.71 59.42 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 50.64 50.11 19.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.012 0.434 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -112.48 33.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.435 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.1 -25.29 43.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.477 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -37.07 21.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 110.993 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -84.77 -15.0 46.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.491 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 53' ' ' PHE . 23.0 t -126.03 159.36 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.466 0.174 . . . . 0.0 110.947 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.438 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -121.65 111.74 17.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.307 0.575 . . . . 0.0 110.476 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 t -98.64 133.74 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -124.21 127.49 47.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.912 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 142.19 29.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.981 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 60' ' ' LEU . 4.9 pt -136.35 72.28 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.32 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.9 28.02 7.2 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.154 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -141.2 42.55 1.79 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.812 0.339 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' CD1' ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -135.86 118.83 12.39 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.26 -176.97 2.11 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.676 2.251 . . . . 0.0 112.439 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -59.34 -34.4 72.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.281 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -59.19 -51.84 68.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.653 0.263 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -71.35 -44.33 65.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.833 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.2 -34.8 70.77 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.374 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.78 -49.43 76.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.616 0.246 . . . . 0.0 111.093 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -42.11 93.75 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.02 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -68.67 -32.01 71.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.07 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HG2' ' HD3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -56.95 -47.27 81.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.951 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mt -76.85 -44.79 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.165 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -55.05 -52.18 64.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.617 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -48.6 80.75 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.166 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.99 -23.87 65.69 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.492 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -30.98 39.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.123 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 71' ' ' ALA . 24.7 t -86.91 -48.07 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.477 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.38 -37.62 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.42 33.57 8.56 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.416 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.52 93.53 0.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HD3' ' HG2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -97.61 34.08 1.92 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.82 112.56 24.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -91.11 147.37 35.51 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 179.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 94' ' ' GLU . 10.7 Cg_exo -71.57 128.13 13.73 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.309 -0.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.93 131.25 48.42 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.579 HG23 ' OE1' ' A' ' 27' ' ' GLN . 3.5 mt -117.05 111.14 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 m -110.86 121.81 64.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.58 127.72 74.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 2.3 m120 60.95 39.17 16.94 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.99 49.97 72.73 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.819 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -172.65 134.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.722 ' HZ ' HG23 ' A' ' 93' ' ' THR . 30.9 t80 -67.55 106.82 2.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.901 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -117.55 -24.32 7.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.486 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 84' ' ' ILE . . . -112.95 139.66 15.83 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.084 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.722 HG23 ' HZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -121.01 -179.55 4.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.696 0.284 . . . . 0.0 110.714 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 9.4 pt-20 -71.36 -35.97 71.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.149 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.0 m -95.07 -25.38 16.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.18 -33.34 52.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.498 0.189 . . . . 0.0 111.236 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.68 -50.28 69.87 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.44 -34.64 78.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 -73.42 -42.63 61.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -67.17 -44.92 78.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.049 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.5 -48.07 82.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.07 85.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.272 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -73.25 -24.75 60.5 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.73 56.72 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.529 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.0 p -105.13 -18.11 14.25 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.44 -47.7 72.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.635 0.255 . . . . 0.0 111.002 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -45.18 82.91 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.06 -37.96 89.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.91 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -48.6 79.32 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.89 -40.57 80.59 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.174 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -33.61 73.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.734 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -49.54 65.18 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.203 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 pt -65.77 -24.91 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.799 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.14 24.21 8.62 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.738 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -82.5 -42.92 17.82 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.697 0.249 . . . . 0.0 110.581 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.5 HD11 HD22 ' A' ' 46' ' ' LEU . 1.5 mp -117.5 143.14 31.59 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.025 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.244 0.821 0 C-N-CA 122.603 2.202 . . . . 0.0 112.309 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.572 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 120.544 0.212 . . . . 0.0 111.023 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.1 p -54.68 -31.75 58.3 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.034 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.3 -27.5 47.3 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.673 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.9 -38.53 5.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.157 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 9' ' ' MET . 26.8 t -61.78 -57.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 111.259 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 m -64.98 -46.8 79.95 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.249 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -60.36 -34.12 73.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.31 96.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.642 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.62 -34.23 70.91 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -70.33 -36.56 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.8 tpp -69.26 -46.16 67.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.103 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pt -72.57 -14.14 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -63.71 1.13 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.658 0.265 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -86.05 -23.57 26.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.971 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -120.7 61.01 8.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.797 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.66 -16.64 42.48 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.766 2.31 . . . . 0.0 112.937 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -89.42 67.1 7.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.954 0.407 . . . . 0.0 110.448 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.66 137.73 45.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.199 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.532 ' CG ' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -143.42 104.98 4.31 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.412 HD13 ' CZ ' ' A' ' 72' ' ' PHE . 8.3 mp -78.79 125.65 29.66 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.4 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -148.03 -176.8 5.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.268 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.05 175.22 13.22 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.97 33.78 4.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.837 0.351 . . . . 0.0 111.251 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.09 -47.04 0.78 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.263 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.417 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -58.48 143.71 80.23 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.178 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.1 -39.39 13.66 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.644 2.23 . . . . 0.0 112.376 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.416 ' CB ' ' HD3' ' A' ' 82' ' ' PRO . 23.0 m-20 -71.08 -34.18 70.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.207 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 92.5 m -60.15 -40.54 90.23 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.818 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 33' ' ' CYS . 21.7 t -61.52 -36.93 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.746 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -71.59 -36.41 70.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.043 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 -41.74 91.14 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.64 0.257 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -75.76 -29.5 58.85 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.577 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.8 p -61.16 -42.8 99.21 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.6 0.238 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.49 -52.62 39.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.245 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.495 ' CD1' HG23 ' A' ' 48' ' ' VAL . 1.4 m-90 -60.09 -35.57 75.49 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.218 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.55 -33.67 74.5 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.882 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -79.04 -31.26 44.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.862 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 116' ' ' LEU . 22.5 mt -80.79 -7.56 59.44 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 55.85 48.24 18.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.235 0.54 . . . . 0.0 110.508 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' CD1' ' A' ' 43' ' ' TRP . 27.5 m -129.74 39.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.461 ' OE1' HG21 ' A' ' 54' ' ' VAL . 3.9 mm100 -98.97 28.28 4.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.287 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -124.38 -49.43 1.8 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.7 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -68.29 -18.4 64.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.42 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 53' ' ' PHE . 15.4 t -106.08 159.48 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' N ' HG12 ' A' ' 52' ' ' VAL . 10.4 m-85 -116.69 111.11 19.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 110.083 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.461 HG21 ' OE1' ' A' ' 49' ' ' GLN . 21.2 t -98.71 136.34 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.474 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.68 111.7 24.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.987 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -92.73 126.18 37.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.415 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.769 HG23 HD11 ' A' ' 60' ' ' LEU . 29.9 mt -85.99 63.99 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.057 0.456 . . . . 0.0 110.434 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.17 23.4 6.5 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.973 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -155.57 36.1 0.37 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.703 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.769 HD11 HG23 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -159.13 98.4 1.63 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.819 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.44 174.82 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.107 2.538 . . . . 0.0 112.661 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.14 -32.06 4.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -48.86 73.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.624 0.25 . . . . 0.0 111.009 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -78.67 -38.64 38.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.91 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -58.7 -40.39 83.51 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.886 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -42.89 99.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.683 0.278 . . . . 0.0 110.921 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -64.17 -42.07 96.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.685 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.518 ' CE3' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -69.82 -34.21 73.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.193 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.15 -45.16 83.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 111.015 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.8 mt -74.72 -40.55 47.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.995 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -60.9 -54.49 44.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.233 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -58.13 -39.83 79.71 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.992 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -28.43 68.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -30.88 31.93 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.335 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 71' ' ' ALA . 22.0 t -85.01 -48.5 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.554 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.1 -40.99 2.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.63 42.55 1.69 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.949 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.5 101.81 5.1 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.699 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -94.82 37.66 1.14 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.768 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.635 ' C ' HD13 ' A' ' 81' ' ' LEU . 9.9 t30 -161.07 -175.84 5.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.303 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.67 ' H ' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -137.8 165.14 36.05 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.898 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 35' ' ' ASP . 13.3 Cg_exo -70.16 146.09 82.1 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.687 0.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.755 HG22 ' CE1' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -116.94 106.66 13.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.712 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.532 HG23 ' CG ' ' A' ' 27' ' ' GLN . 4.0 mp -102.3 111.05 30.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.761 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 90' ' ' PHE . 31.7 t -117.99 116.47 51.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 91' ' ' TRP . 13.5 p -115.66 134.96 57.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.7 t30 58.02 32.9 22.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.91 32.42 80.95 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.758 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -148.16 132.26 17.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.176 0.512 . . . . 0.0 110.372 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 83' ' ' THR . 3.1 t80 -66.99 100.68 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.381 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.449 ' HB2' HG12 ' A' ' 86' ' ' VAL . 2.0 t-105 -102.44 -31.86 10.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.244 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.55 142.04 17.33 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.113 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.706 HG22 ' CE2' ' A' ' 90' ' ' PHE . 14.7 p -127.44 -172.01 2.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.563 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.91 49.23 1.78 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 111.271 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.84 -43.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.929 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -52.64 -33.12 45.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.02 -56.67 19.03 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.457 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -60.48 -42.56 96.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -58.3 -40.0 80.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.414 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -80.08 -46.21 16.9 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.923 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.77 -42.04 96.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.72 93.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -70.36 -27.08 64.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.279 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.26 24.22 24.94 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.497 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.1 p -113.41 19.09 17.24 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -44.45 81.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -54.91 -44.49 74.24 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.702 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.08 -38.68 83.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.723 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.66 -41.63 77.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.704 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.54 ' HA ' HD11 ' A' ' 113' ' ' ILE . 0.3 OUTLIER -78.54 -22.0 47.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.49 179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 m -77.94 -26.67 49.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.261 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -23.81 60.19 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -102.89 -23.66 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.13 23.93 9.36 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.166 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -38.5 11.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.949 0.375 . . . . 0.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.444 HD11 HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -127.42 142.45 44.03 Favored Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.836 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.379 2.052 . . . . 0.0 112.636 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.805 0.336 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.82 17.67 10.66 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.82 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.58 -30.41 36.91 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 110.684 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -100.04 -31.16 11.58 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 t -61.86 -52.24 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.029 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 t -62.13 -37.19 84.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.853 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -36.02 77.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.13 -39.15 89.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.686 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -40.69 97.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.2 -30.9 70.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.719 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -68.18 -44.26 76.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.855 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -71.88 -14.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.517 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -63.58 1.23 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.653 0.263 . . . . 0.0 110.866 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -83.97 -24.98 30.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.408 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . 14.3 m-70 -118.58 64.29 5.91 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.782 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HB2' ' HA ' ' A' ' 87' ' ' ASN . 57.2 Cg_endo -70.82 -21.1 29.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.582 2.188 . . . . 0.0 112.793 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.422 ' HB3' HG13 ' A' ' 52' ' ' VAL . 25.9 m-85 -92.1 69.74 5.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -110.89 130.76 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.111 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -118.91 101.63 8.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.414 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.43 HD11 ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -76.83 126.61 31.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.217 -179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.75 168.19 28.18 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . . . -164.28 179.08 7.06 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.3 p -97.12 29.13 3.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.284 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -39.72 6.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.343 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.64 148.51 34.84 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 111.329 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.33 -39.45 7.31 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.711 2.274 . . . . 0.0 112.627 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 2.8 m-20 -59.42 -33.25 71.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.103 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.3 m -55.17 -43.1 73.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.623 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.83 -43.27 89.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.028 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -61.47 -51.68 67.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.069 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.53 -41.06 80.15 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.709 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -73.9 -29.87 62.29 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.231 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -60.06 -40.69 90.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.118 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.1 mm -70.02 -51.1 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.412 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -62.45 -33.35 74.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.967 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -68.26 -34.7 76.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.098 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -78.6 -32.92 47.81 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.2 mt -80.68 -7.74 59.42 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 53.49 48.91 20.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.573 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.7 m -119.1 40.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -97.02 30.2 2.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.986 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.46 -49.43 2.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -68.01 -22.86 64.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.258 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 25' ' ' TYR . 44.2 t -114.98 156.09 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.49 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -116.15 111.28 20.01 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.252 0.548 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -92.35 142.19 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.386 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -126.52 104.88 8.37 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.94 151.58 31.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 30' ' ' ALA . 23.5 mm -114.31 69.75 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.115 0.483 . . . . 0.0 111.066 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.99 -2.25 8.6 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.162 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -106.95 -34.44 7.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.016 0.408 . . . . 0.0 111.566 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 21.2 mt -64.72 122.58 79.75 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.171 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 30.2 Cg_exo -62.63 -172.0 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.017 2.478 . . . . 0.0 112.534 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -78.89 8.57 5.33 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.219 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -113.43 -42.61 3.45 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.604 0.24 . . . . 0.0 110.805 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.1 -36.24 72.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.275 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -57.24 -38.27 73.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.397 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -49.99 75.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.137 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -57.78 -36.28 71.95 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -37.51 79.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.828 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -66.31 -46.45 76.85 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.207 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.5 mm -67.88 -45.62 83.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.61 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -58.91 -53.54 57.27 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.36 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 2.9 m-85 -65.96 -28.98 69.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.651 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.512 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 5.3 mt-30 -56.92 -40.78 76.95 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 110.741 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -28.37 44.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.427 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 71' ' ' ALA . 39.7 t -72.45 -48.16 48.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 110.686 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.8 m -144.45 -41.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 73' ' ' GLN . . . 123.81 63.21 0.19 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.967 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.638 ' HA ' HG21 ' A' ' 83' ' ' THR . 26.1 m -96.99 44.81 1.05 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.671 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -73.49 -16.58 61.29 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.866 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -140.1 121.04 14.56 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.0 mt -82.04 155.51 69.99 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.669 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 35' ' ' ASP . 2.6 Cg_exo -75.85 174.74 51.3 Favored 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 124.074 -1.219 . . . . 0.0 112.784 0.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 78' ' ' SER . 0.9 OUTLIER -149.19 113.83 5.33 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.175 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mt -102.34 121.96 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.479 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.88 121.53 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.89 121.29 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.414 ' HA ' ' HB2' ' A' ' 24' ' ' PRO . 3.8 t-20 64.24 40.16 6.91 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.129 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.13 49.65 75.86 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.952 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.41 136.12 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.918 0.39 . . . . 0.0 110.541 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.738 ' HE2' HG23 ' A' ' 93' ' ' THR . 1.1 t80 -61.4 104.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.307 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.86 -27.68 12.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.535 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.84 141.5 14.48 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.003 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.738 HG23 ' HE2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -127.37 172.29 10.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.734 0.302 . . . . 0.0 111.282 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.94 -26.02 62.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.486 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -29.13 14.85 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -56.94 -34.05 67.61 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -56.44 19.45 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 110.805 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.95 -34.08 72.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.49 -41.03 63.62 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.324 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.73 -43.45 59.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -50.57 73.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.8 0.333 . . . . 0.0 111.029 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.69 84.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.414 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -27.18 60.05 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.769 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.41 27.03 26.26 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.175 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.0 p -107.95 -6.78 16.44 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 -50.05 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.612 0.244 . . . . 0.0 110.755 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.09 -41.59 88.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.0 -45.79 90.73 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.667 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -56.15 -40.58 74.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.058 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.24 -46.33 86.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 m -78.59 -31.19 47.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.998 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -59.28 -38.89 81.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.7 pt -79.45 -24.5 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.19 25.13 8.03 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.948 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 -48.66 5.73 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.764 0.282 . . . . 0.0 110.722 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.09 113.07 66.11 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.544 2.163 . . . . 0.0 112.829 -179.702 . . . . . . . . 0 0 . 1 stop_ save_